0000844856-22-000031.txt : 20220801 0000844856-22-000031.hdr.sgml : 20220801 20220801083700 ACCESSION NUMBER: 0000844856-22-000031 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 61 CONFORMED PERIOD OF REPORT: 20220630 FILED AS OF DATE: 20220801 DATE AS OF CHANGE: 20220801 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Healthier Choices Management Corp. CENTRAL INDEX KEY: 0000844856 STANDARD INDUSTRIAL CLASSIFICATION: TOBACCO PRODUCTS [2100] IRS NUMBER: 841070932 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-36469 FILM NUMBER: 221122923 BUSINESS ADDRESS: STREET 1: 3800 NORTH 28TH WAY CITY: HOLLYWOOD STATE: FL ZIP: 33020 BUSINESS PHONE: 305-600-5004 MAIL ADDRESS: STREET 1: 3800 NORTH 28TH WAY CITY: HOLLYWOOD STATE: FL ZIP: 33020 FORMER COMPANY: FORMER CONFORMED NAME: VAPOR CORP. DATE OF NAME CHANGE: 20100108 FORMER COMPANY: FORMER CONFORMED NAME: MILLER DIVERSIFIED CORP DATE OF NAME CHANGE: 19920703 10-Q 1 form10q.htm QUARTERLY REPORT
graphic

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

Form 10-Q

 QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended June 30, 2022

Or

 TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from _____ to _____

Commission file number: 001-36469

HEALTHIER CHOICES MANAGEMENT CORP.
(Exact name of Registrant as specified in its charter)

Delaware
 
84-1070932
(State or other jurisdiction of
 
(I.R.S. Employer
incorporation or organization)
 
Identification No.)
     
3800 North 28Th Way
   
Hollywood, Florida
 
33020
(Address of principal executive offices)
 
(Zip Code)

Registrant’s telephone number, including area code: 305-600-5004

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

 Yes  No

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).

 Yes  No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer
Accelerated filer
Non-accelerated filer
Smaller reporting company
 
Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

Yes No

Securities registered pursuant to Section 12(b) of the Act:

Title of each class
 
Trading Symbol
 
Name of each exchange on which registered
Common Stock, par value $0.0001 per share
 
HCMC
 
OTC Pink Marketplace

As of August 1, 2022, there were 339,741,632,384 shares of the registrant’s common stock, par value $0.0001 per share, outstanding.



TABLE OF CONTENTS

PAGE
   
1
   
1
   
1
   
2
   
3
   
5
   
6
   
12
   
18
   
18
   
19
   
19
   
19
   
19
   
19
   
19
   
19
   
19
   
21
   
 
   
 
   
 
   
 



PART I - FINANCIAL INFORMATION

Item 1. Financial Statements

HEALTHIER CHOICES MANAGEMENT CORP.
CONDENSED CONSOLIDATED BALANCE SHEETS


 
June 30, 2022 (Unaudited)
 
December 31,
2021
ASSETS
         
CURRENT ASSETS
         
Cash and cash equivalents
$
19,323,420
 
$
26,496,404
Accounts receivable, net
 
30,638
   
28,481
Notes receivable
 
220,793
   
247,915
Inventories
 
2,441,277
   
1,521,199
Prepaid expenses and vendor deposits
 
244,171
   
456,397
Investment
 
28,457
   
23,143
TOTAL CURRENT ASSETS
 
22,288,756
   
28,773,539
           
Property and equipment, net of accumulated depreciation
 
1,554,576
   
176,988
Intangible assets, net of accumulated amortization
 
2,248,107
   
947,593
Goodwill
 
2,657,000
   
916,000
Right of use asset – operating lease, net
 
4,964,381
   
3,543,930
Other assets
 
119,378
   
85,437
           
TOTAL ASSETS
$
33,832,198
 
$
34,443,487
           
LIABILITIES AND STOCKHOLDERS’ EQUITY
         
CURRENT LIABILITIES
         
Accounts payable and accrued expenses
$
2,171,095
 
$
1,642,848
Contract liabilities
 
56,105
   
23,178
Current portion of line of credit
 
453,232
   
418,036
Current portion of loan payment
 
2,134
   
2,604
Operating lease liability, current
 
563,300
   
437,328
TOTAL CURRENT LIABILITIES
 
3,245,866
   
2,523,994
           
Loan payable, net of current portion
 
-
   
815
Operating lease liability, net of current
 
4,016,105
   
2,685,021
TOTAL LIABILITIES
 
7,261,971
   
5,209,830
           
COMMITMENTS AND CONTINGENCIES (SEE NOTE 13)
 
   
           
STOCKHOLDERS’ EQUITY
         
Series D convertible preferred stock, $1,000 par value per share, 5,000 shares authorized; 800 shares issued and outstanding as of June 30, 2022 and December 31, 2021, respectively; aggregate liquidation preference of $0.8 million
 
800,000
   
800,000
Common Stock, $0.0001 par value per share, 750,000,000,000 shares authorized; 339,741,632,384 shares issued and outstanding as of June 30, 2022 and December 31, 2021, respectively
 
33,974,163
   
33,974,163
Additional paid-in capital
 
30,855,824
   
30,855,824
Accumulated deficit
 
(39,059,760)
   
(36,396,330)
TOTAL STOCKHOLDERS’ EQUITY
 
26,570,227
   
29,233,657
           
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY
$
33,832,198
 
$
34,443,487

See notes to unaudited condensed consolidated financial statements
1


HEALTHIER CHOICES MANAGEMENT CORP.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(UNAUDITED)

 
Three Months Ended
 
Six Months Ended
 
June 30,
 
June 30,
 
2022
 
2021
 
2022
 
2021
SALES
                     
Vapor sales, net
$
5,997
 
$
590,980
 
$
255,560
 
$
1,204,916
Grocery sales, net
 
6,126,063
   
2,794,912
   
10,925,053
   
5,646,729
TOTAL SALES, NET
 
6,132,060
   
3,385,892
   
11,180,613
   
6,851,645
                       
Cost of sales vapor
 
562
   
237,333
   
112,246
   
470,648
Cost of sales grocery
 
3,800,625
   
1,684,903
   
6,764,980
   
3,426,631
GROSS PROFIT
 
2,330,873
   
1,463,656
   
4,303,387
   
2,954,366
                       
OPERATING EXPENSES
 
3,699,273
   
2,149,087
   
7,026,693
   
4,171,970
                       
LOSS FROM OPERATIONS
 
(1,368,400)
   
(685,431)
   
(2,723,306)
   
(1,217,604)
                       
OTHER INCOME (EXPENSE)
                     
Gain (loss) on investment
 
1,800
   
(14,614)
   
5,314
   
11,511
Other income, net
 
6,175
   
-
   
23,049
   
-
Interest income (expense), net
 
14,910
   
(5,516)
   
31,513
   
(78,430)
Gain on debt extinguishment, net
 
-
   
885,226
   
-
   
767,930
Total other income (expense), net
 
22,885
   
865,096
   
59,876
   
701,011
                       
NET (LOSS) INCOME
$
(1,345,515)
 
$
179,665
 
$
(2,663,430)
 
$
(516,593)
                       
NET LOSS PER SHARE-BASIC AND DILUTED
$
0.00
 
$
0.00
 
$
0.00
 
$
0.00
                       
WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING-BASIC AND DILUTED
 
339,741,632,384
   
311,961,992,554
   
339,741,632,384
   
277,914,474,082
                       
                       

See notes to unaudited condensed consolidated financial statements

2


HEALTHIER CHOICES MANAGEMENT CORP.
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY
FOR THE THREE MONTHS ENDED JUNE 30, 2022 and 2021
(Unaudited)

 
Convertible
Preferred Stock
 
Common Stock
 
Additional
Paid-In
 
Accumulated
   
 
Shares
 
Amount
 
Shares
 
Amount
 
Capital
 
Deficit
 
Total
Balance – April 1, 2022
 
800
 
$
800,000
   
339,741,632,384
 
$
33,974,163
 
$
30,855,824
 
$
(37,714,245)
 
$
27,915,742
Net loss
 
-
   
-
   
-
   
-
   
-
   
(1,345,515)
   
(1,345,515)
Balance – June 30, 2022
 
800
 
$
800,000
   
339,741,632,384
 
$
33,974,163
 
$
30,855,824
 
$
(39,059,760)
 
$
26,570,227


 
Convertible
Preferred Stock
 
Common Stock
 
Additional
Paid-In
 
Accumulated
   
 
Shares
 
Amount
 
Shares
 
Amount
 
Capital
 
Deficit
 
Total
Balance – April 1, 2021
 
5,000
 
$
5,000,000
   
307,726,082,074
 
$
30,772,608
 
$
5,330,562
 
$
(33,055,129)
 
$
8,048,041
Stock options exercised
 
-
   
-
   
1,500,000,000
   
150,000
   
-
   
-
   
150,000
 Issuance of common stock in connection with the Rights Offering, net of offering expenses
 
-
   
-
   
27,046,800,310
   
2,704,680
   
20,873,978
   
-
   
23,578,658
Cancellation of awarded stock for officers
 
-
   
-
   
(3,025,000,000)
   
(302,500)
   
302,500
   
-
   
-
Cancellation of awarded stock for board member
 
-
   
-
   
(68,750,000)
   
(6,875)
   
6,875
   
-
   
-
Stock-based compensation expense
 
-
   
-
   
-
   
-
   
32,500
   
-
   
32,500
Net income
 
-
   
-
   
-
   
-
   
-
   
179,665
   
179,665
Balance – June 30, 2021
 
5,000
 
$
5,000,000
   
333,179,132,384
 
$
33,317,913
 
$
26,546,415
 
$
(32,875,464)
 
$
31,988,864



See notes to unaudited condensed consolidated financial statements

3


HEALTHIER CHOICES MANAGEMENT CORP.
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY
FOR THE SIX MONTHS ENDED JUNE 30, 2022 AND 2021
(UNAUDITED)

 
Convertible
Preferred Stock
 
Common Stock
 
Additional
Paid-In
 
Accumulated
   
 
Shares
 
Amount
 
Shares
 
Amount
 
Capital
 
Deficit
 
Total
Balance – January 1, 2022
 
800
 
$
800,000
   
339,741,632,384
 
$
33,974,163
 
$
30,855,824
 
$
(36,396,330)
 
$
29,233,657
Net loss
 
-
   
-
   
-
   
-
   
-
   
(2,663,430)
   
(2,663,430)
Balance – June 30, 2022
 
800
 
$
800,000
   
339,741,632,384
 
$
33,974,163
 
$
30,855,824
 
$
(39,059,760)
 
$
26,570,227




 
Convertible
Preferred Stock
 
Common Stock
 
Additional
Paid-In
 
Accumulated
   
 
Shares
 
Amount
 
Shares
 
Amount
 
Capital
 
Deficit
 
Total
Balance – January 1, 2021
 
16,277
 
$
16,277,116
   
143,840,848,017
 
$
14,384,084
 
$
3,955,039
 
$
(32,358,871)
 
$
2,257,368
Series C Preferred stock exercised
 
(16,277)
   
(16,277,116)
   
162,771,153,001
   
16,277,116
   
-
   
-
   
-
Stock options exercised
 
-
   
-
   
2,275,000,000
   
227,500
   
-
   
-
   
227,500
Stock-based compensation expense
 
-
   
-
   
-
   
-
   
34,375
   
-
   
34,375
Issuance of Series D Convertible Preferred stock in connection with the Securities Purchase Agreement
 
5,000
   
5,000,000
   
-
   
-
   
-
   
-
   
5,000,000
Issuance of common stock
 
-
   
-
   
1,182,831,056
   
118,283
   
1,289,273
   
-
   
1,407,556
Issuance of common stock in connection with the Rights Offering, net of offering cost
 
-
   
-
   
27,046,800,310
   
2,704,680
   
20,873,978
   
-
   
23,578,658
Issuance of awarded stock for officers and board member
 
-
   
-
   
2,250,000,000
   
225,000
   
(225,000)
   
-
   
-
Cancellation of awarded stock for officers and board member
 
-
   
-
   
(6,187,500,000)
   
(618,750)
   
618,750
   
-
   
-
Net loss
 
-
   
-
   
-
   
-
   
-
   
(516,593)
   
(516,593)
Balance – June 30, 2021
 
5,000
 
$
5,000,000
   
333,179,132,384
 
$
33,317,913
 
$
26,546,415
 
$
(32,875,464)
 
$
31,988,864

See notes to unaudited condensed consolidated financial statements

4


HEALTHIER CHOICES MANAGEMENT CORP.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited)

 
Six Months Ended June 30,
 
2022
 
2021
OPERATING ACTIVITIES
         
Net loss
$
(2,663,430)
 
$
(516,593)
Adjustments to reconcile net loss to net cash used in operating activities:
         
Depreciation and amortization
 
422,078
   
261,571
Gain on investment
 
(5,314)
   
(11,511)
Amortization of right-of-use asset
 
377,216
   
265,601
(Gain) on debt settlement
 
-
   
(767,930)
Accrued interest on loan
 
-
   
60,809
Write-down of obsolete and slow-moving inventory
 
73,640
   
-
Stock-based compensation expense
 
-
   
34,375
           
Changes in operating assets and liabilities:
         
Accounts receivable
 
(2,157)
   
(30,062)
Inventories
 
(189,138)
   
(157,613)
Prepaid expenses and vendor deposits
 
212,226
   
17,573
Other assets
 
(33,941)
   
3,662
Accounts payable and accrued expenses
 
528,247
   
(370,577)
Contract liabilities
 
(249,700)
   
(2,267)
Lease liability
 
(340,611)
   
(230,547)
NET CASH USED IN OPERATING ACTIVITIES
 
(1,870,884)
   
(1,443,509)
           
INVESTING ACTIVITIES
         
Acquisition of Mother Earth's Storehouse
 
(5,150,000)
   
-
Collection of note receivable
 
27,122
   
27,696
Purchases of property and equipment
 
(213,133)
   
(41,965)
NET CASH USED IN INVESTING ACTIVITIES
 
(5,336,011)
   
(14,269)
           
FINANCING ACTIVITIES
         
Proceeds from line of credit
 
35,196
   
-
Principal payments on loan payable
 
(1,285)
   
(184,970)
Principal payment on the line of credit
 
-
   
(2,000,000)
Proceeds from Rights Offering
 
-
   
24,828,657
Proceeds from loan and security agreement
 
-
   
5,000,000
Proceeds from exercise of stock options
 
-
   
227,500
NET CASH PROVIDED BY FINANCING ACTIVITIES
 
33,911
   
27,871,187
           
NET (DECREASE) INCREASE IN CASH, CASH EQUIVALENT AND RESTRICTED CASH
 
(7,172,984)
   
26,413,409
CASH, CASH EQUIVALENTS AND RESTRICTED CASH— BEGINNING OF PERIOD
 
26,496,404
   
2,925,475
CASH, CASH EQUIVALENTS AND RESTRICTED CASH — END OF PERIOD
$
19,323,420
 
$
29,338,884
           
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION
         
Cash paid for interest
$
2,910
 
$
26,115
           
NON-CASH INVESTING AND FINANCING ACTIVITIES
         
Issuance of common stock
$
-
 
$
1,290,260
Lease acquired
$
1,797,667
 
$
-

See notes to unaudited condensed consolidated financial statements

5

HEALTHIER CHOICES MANAGEMENT CORP.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)

Note 1. ORGANIZATION

Organization

Healthier Choices Management Corp. (the “Company”) is a holding company focused on providing consumers with healthier daily choices with respect to nutrition and other lifestyle alternatives. The Company operates Ada’s Natural Market, a natural and organic grocery store, through its wholly owned subsidiary Healthy Choice Markets, Inc. Ada’s Natural Market and Paradise Health and Nutrition offers fresh produce, bulk foods, vitamins and supplements, packaged groceries, meat and seafood, deli, baked goods, dairy products, frozen foods, health & beauty products and natural household items. The Company also sells vitamins and supplements on the Amazon.com marketplace through its wholly owned subsidiary Healthy U Wholesale, Inc. The Company also operates HCMC Intellectual Property Holdings, LLC, a wholly owned subsidiary formed to hold, market and expand on its current intellectual property assets. The Company markets the Q-Cup™ technology under the vape segment; this patented technology is based on a small, quartz cup called the Q-Cup™, which a customer partially fills with concentrate (approximately 50mg) purchased from a third party. The Q-Cup™ is then inserted into the Q-Cup™ Tank or Globe, which heats the cup from the outside without coming in direct contact with the solid concentrate. This Q-Cup™ technology provides significantly more efficiency and an “on the go” solution for consumers who prefer to vape concentrates either medicinally or recreationally. The Company acquired substantially all of the assets of Mother Earth’s Storehouse on February 9, 2022, which operates a two store organic and health food and vitamin chain in New York’s Hudson Valley, a business that has been operating for over 40 years. The Company expanded its operation into the Health & Wellness segment in November 2021. HCMC acquired substantially all of the assets of EIR Hydration, an IV therapy center located in Roslyn Heights, NY. The Company also has a licensing agreement for a Healthy Choice Wellness Center at the Casbah Spa and Salon in Fort Lauderdale, FL. The activities in the Wellness centers are currently reported under the Grocery segment due to its deminimus nature. From December 2021 through April 2022, the Company either closed its vape stores or sold substantially all of the assets of such stores. This will allow the Company to focus on developing wholesale business and sales through online platform.

COVID-19 Management Update

The global outbreak of COVID-19 was declared a pandemic by the World Health Organization and a national emergency by the U.S. government in March 2020 and has negatively impacted the U.S. and global economies, disrupted global supply chains and, mandated closures and stay-at-home orders and created significant disruptions of the global financial markets. The Company adjusted certain aspects of the operations to protect their employees and customers while still meeting customers’ needs. While to date the Company has not been required to close any of its grocery stores, the Company is currently operating under regular hours and we are expecting COVID-19 to have a long-term beneficial impact to the future financial results of the grocery segment. The Company continues to monitor the impact of the COVID-19 outbreak closely.  The extent to which the COVID-19 outbreak will impact our operations is manageable, and there is no imminent risk on business continuity and future operations.

Note 2. LIQUIDITY

The accompanying unaudited condensed consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (“GAAP”), which contemplate continuation of the Company as a going concern and realization of assets and satisfaction of liabilities in the normal course of business and do not include any adjustments that might result from the outcome of any uncertainties related to our going concern assessment. The carrying amounts of assets and liabilities presented in the financial statements do not necessarily purport to represent realizable or settlement values.

The Company currently and historically has reported net losses and cash outflows from operations. The Company anticipates that its current cash, cash equivalent and cash generated from operations will be sufficient to meet the projected operating expenses for the foreseeable future through at least the next twelve months from the issuance of these unaudited condensed consolidated financial statements.


6


Note 3. BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with the instructions to Form 10-Q and Regulation S-X and do not include all the information and disclosures required by generally accepted accounting principles in the United States of America (“GAAP”). The Company has made estimates and judgments affecting the amounts reported in the Company’s condensed consolidated financial statements and the accompanying notes. The actual results experienced by the Company may differ materially from the Company’s estimates. The condensed consolidated financial information is unaudited but reflects all normal adjustments that are, in the opinion of management, necessary to provide a fair statement of results for the interim periods presented. These condensed consolidated financial statements should be read in conjunction with the consolidated financial statements in the Company’s Annual Report on Form 10-K for the year ended December 31, 2021, filed with the Securities and Exchange Commission (the “SEC”) on March 31, 2022. The condensed consolidated balance sheet as of December 31, 2021 was derived from the Company’s audited 2021 financial statements contained in the above referenced Form 10-K. Results of the six months ended June 30, 2022, are not necessarily indicative of the results to be expected for the full year ending December 31, 2022.

Significant Accounting Policies

There have been no material changes in the Company’s significant accounting policies to those previously disclosed in the 2021 Annual Report.

Note 4. CONCENTRATIONS

Cash and Cash Equivalents and Restricted Cash

The Company considers all highly liquid instruments with an original maturity of three months or less, when purchased, to be cash and cash equivalents. The majority of the Company’s cash and cash equivalents are concentrated in one large financial institution, which is in excess of Federal Deposit Insurance Corporation (FDIC) coverage.

A summary of the financial institutions that had a cash and cash equivalents in excess of FDIC limits of $250,000 on June 30, 2022 and December 31, 2021 is presented below:

June 30, 2022
 
December 31, 2021
 
Total cash, cash equivalents and restricted cash in excess of FDIC limits of $250,000
 
$
18,688,069
   
$
26,023,593
 

The Company continually monitors its positions with, and the credit quality of, the financial institutions with which it invests, as deposits are held in excess of federally insured limits. The Company’s cash equivalent at June 30, 2022 and December 31, 2021, respectively, was a money market account. The Company has not experienced any losses in such account.


Note 5. DISAGGREGATION OF REVENUES
 
The Company reports the following segments in accordance with management guidance: Vapor and Grocery. When the Company prepares its internal management reporting to evaluate business performance, we disaggregate revenue into the following categories that depict how the nature, amount, timing and uncertainty of revenue and cash flows are affected by economic factors.

 
Three Months Ended June 30,
   
Six Months Ended June 30,
 
   
2022
   
2021
   
2022
   
2021
 
Vapor
 
$
5,997
   
$
590,980
   
$
255,560
   
$
1,204,916
 
Grocery
   
6,126,063
     
2,794,912
     
10,925,053
     
5,646,729
 
Total revenue
 
$
6,132,060
   
$
3,385,892
   
$
11,180,613
   
$
6,851,645
 
                                 
Retail Vapor
 
$
5,997
   
$
590,980
   
$
255,560
   
$
1,204,875
 
Retail Grocery
   
5,478,523
     
2,430,530
     
9,756,535
     
4,963,330
 
Food service/restaurant
   
643,760
     
305,566
     
1,158,846
     
602,849
 
Online/eCommerce
   
3,780
     
56,259
     
9,672
     
69,975
 
Wholesale Grocery
   
-
     
2,557
     
-
     
10,575
 
Wholesale Vapor
   
-
     
-
     
-
     
41
 
Total revenue
 
$
6,132,060
   
$
3,385,892
   
$
11,180,613
   
$
6,851,645
 
 
7


Note 6. NOTES RECEIVABLE AND OTHER INCOME

On September 6, 2018, the Company entered into a secured, 36-month promissory note (the “Note”) with VPR Brands L.P. for $582,260. The Note bears an interest rate of 7.00%, which payments thereunder are $4,141 weekly. The Company records all proceeds related to the interest of the Note as interest income as proceeds are received.

On August 31, 2021, the Company amended and restated the Secured Promissory Note (the "Amended Note") with VPRB Brands L.P. for the outstanding balance in the note of $268,126. The Amended Note bears an interest rate of 7.00%, which payments thereunder are $1,500 weekly, with such payments commencing as of September 3, 2021. The Amended Note has a balloon payment of $216,071 for all remaining accrued interest and principal balance due in the final week of the 1-year extension of the Note.

A summary of the Note as of June 30, 2022 and December 31, 2021 is presented below:

Description
 
June 30, 2022
 
December 31, 2021
Promissory Note
 
$
220,793
 
$
247,915
 

Note 7. ACQUISITION OF MOTHER EARTH’S STOREHOUSE, INC.

On February 9, 2022, the Company through its wholly owned subsidiary, Healthy Choice Markets 3, LLC, entered into an Asset Purchase Agreement with Mother Earth’s Storehouse Inc. (“HCM3”) and its shareholders. Pursuant to the Purchase Agreement, HCM3 acquired certain assets and assumed certain liabilities related to Mother Earth’s grocery stores in Kingston and Saugerties, New York. The Company intends to continue to operate the grocery stores under their existing name. The cash purchase price under the Asset Purchase Agreement was $4,472,500, with an additional $677,500 paid for inventory at closing. In addition, the Company assumed a lease obligation for the Kingston, NY store and entered into an employment agreement with the store manager.

The purchase method of accounting in accordance with ASC 805, Business Combinations, was applied for the Mother Earth's Storehouse acquisition.  This requires the total cost of an acquisition to be allocated to the tangible and identifiable intangible assets acquired and liabilities assumed based on their respective fair values at the date of acquisition with the excess cost accounted for as goodwill. Goodwill arising from the acquisition is attributable to expected operational synergies from combining the operations of the acquired business with those of the Company. Goodwill is not expected to be deductible for income tax purposes in the tax jurisdiction of the acquired business.

The following table summarizes the approximate purchase price allocation based on estimated fair values of the net assets acquired at the acquisition date:

Purchase Consideration
     
Cash Consideration paid
 
$
5,150,000
       
Purchase price allocation
     
   Inventory
   
805,000
   Property and equipment
   
1,278,000
   Intangible assets
   
1,609,000
   Right of use asset - operating lease
   
1,797,667
   Other liabilities
   
(283,000)
   Operating lease liability
   
(1,797,667)
   Goodwill
   
1,741,000
Net assets acquired
 
 $
5,150,000
       
Finite-lived intangible assets
     
   Trade Names/Trademarks
 
 $
513,000
   Customer Relationships
   
683,000
   Non-Compete Agreement
   
413,000
Total intangible assets
 
 $
1,609,000


8


Note 8. PROPERTY & EQUIPMENT

Property and equipment consist of the following:
   
June 30, 2022
   
December 31, 2021
Displays
 
$
305,558
   
$
305,558
Building
   
575,000
     
-
Furniture and fixtures
   
307,822
     
246,496
Leasehold improvements
   
727,469
     
136,504
Computer hardware & equipment
   
133,059
     
151,924
Other
   
311,294
     
315,788
     
2,360,202
     
1,156,270
Less: accumulated depreciation and amortization
   
(805,626)
     
(979,282)
Total property and equipment
 
$
1,554,576
   
$
176,988

The Company incurred approximately $63,656 and $27,951 of depreciation expense for the three months ended June 30, 2022 and 2021, and $113,592 and $66,525 of depreciation expense for the six months ended June 30, 2022 and 2021, respectively.

The Company closed all vape stores in Q2 2022, and disposed all vape stores' furniture and fixtures, computer and equipment, and leasehold improvements. Total gross carrying amount of $287,431 and total accumulated depreciation of $287,247 were reduced from the consolidated balance sheet.


Note 9. INTANGIBLE ASSETS

Intangible assets, net are as follows:

June 30, 2022
 
Useful Lives (Years)
 
Gross
Carrying Amount
 
Accumulated
Amortization
 
Net
Carrying Amount
Trade names / Trademarks
   
8-10 years
 
$
1,436,000
 
$
(610,818)
 
$
825,182
Customer relationships
   
4-5 years
   
1,566,000
   
(836,128)
   
729,872
Patents
   
10 years
   
372,165
   
(140,841)
   
231,324
Non-compete
   
4-5 years
   
651,000
   
(197,813)
   
453,187
Website
   
4 years
   
10,000
   
(1,458)
   
8,542
Intangible assets, net
       
$
4,035,165
 
$
(1,787,058)
 
$
2,248,107

December 31, 2021
 
Useful Lives (Years)
 
Gross
Carrying Amount
 
Accumulated
Amortization
 
Net
Carrying Amount
Trade names / Trademarks
   
8-10 years
 
 $
923,000
   
(536,661)
 
 $
386,339
Customer relationships
   
4-5 years
   
883,000
   
(685,823)
   
197,177
Patents
   
10 years
   
372,165
   
(122,233)
   
249,932
Non-compete
   
4 years
   
238,000
   
(133,646)
   
104,354
Website
   
4 years
   
10,000
   
(209)
   
9,791
Intangible assets, net
       
$
2,426,165
 
$
(1,478,572)
 
$
947,593

Intangible assets are amortized on a straight-line basis over their estimated useful lives. Amortization expense was approximately  $165,100 and $97,023 for the three months ended June 30, 2022 and 2021, and $308,486 and $195,046 for the six months ended June 30, 2022 and 2021, respectively. Future annual estimated amortization expense is as follows:

Years ending December 31,
     
2022 (remaining six months)
 
$
319,814
 
2023
   
411,149
 
2024
   
411,149
 
2025
   
404,107
 
2026
   
309,214
 
Thereafter
   
392,674
 
Total
 
$
2,248,107
 

9

Note 10. CONTRACT LIABILITIES

The Company’s contract liabilities consist of gift cards and loyalty rewards, for which the Company has a performance obligation to deliver products when customers redeem balances or terms expire through breakage. Our breakage policy is twenty four months for gift cards, twelve months for Grocery loyalty rewards, and six months for Vapor loyalty rewards. As such, all contract liabilities are expected to be recognized within a twenty four month period. Revenue is recognized when gift card and loyalty points are redeemed.

A summary of the net changes in contract liabilities activity at June 30, 2022 and December 31, 2021 is presented below:


 
June 30, 2022
   
December 31, 2021
 
Beginning balance as January 1,
 
$
23,178
   
$
21,262
 
Issued
   
558,859
     
39,469
 
Redeemed
   
(525,621
)
   
(37,463
)
Breakage recognized
   
(311
)
   
(90
)
Ending balance
 
$
56,105
   
$
23,178
 
 

Note 11. DEBT

The following table provides a breakdown of the Company's debt as of June 30, 2022 and December 31, 2021 is presented below:

_
   
June 30, 2022
   
December 31, 2021
Line of Credit
 
$
453,232
 
$
418,036
Other debt
   
2,134
   
3,419
Total debt
 
$
455,366
   
421,455
 

Note 12. STOCKHOLDERS’ EQUITY

Rights Offering

On June 18, 2021, the Company issued 27,046,800,310 shares of common stock in connection with the Rights Offering at a subscription price of $0.0010 per share, generating gross proceeds of $27.0 million. The Company incurred direct financing related costs of $2.7 million in connection with the offering resulting in net proceeds to the Company of $24.3 million.

Exchange Agreement

On March 29, 2021, the Company entered into exchange agreements with the holders of indebtedness pursuant to the $2.7 million Loan and Security Agreement (the "Credit Agreement"). Pursuant to the Credit Agreement with the holders of the Company’s indebtedness (the “Notes”) in an aggregate amount of $1.3 million exchanged the Notes for 1,172,964,218 shares at a conversion price of $0.0011 (the "Exchange"). The Notes were issued pursuant to the Credit Agreement dated as of August 18, 2020, among The Vape Store, Inc., the Company, Healthy Choice Markets, Inc., Sabby Healthcare Master Fund, Ltd., and Sabby Volatility Warrant Master Fund, Ltd.  In connection with the Exchange, the Credit Agreement and all related loan documents was terminated and the Holder’s on the assets of the Company and its subsidiaries was cancelled.  The Company recognized a loss on debt extinguishment of $0.1 million.

Restricted Stock

On January 14, 2021, the Compensation Committee of the Board of Directors of the Company approved an issuance of restricted stock to the Officers and a Director of the Company, in consideration for agreeing to a new vesting schedule for the existing awarded restricted stock. Each individual was granted a 10% increase from the original award agreement for a total of 2.3 billion shares of restricted common stock, which will vest quarterly and equal amounts until December 31, 2022, provided that the grantee remains an employee of the Company through the vesting date.

On March 30, 2021, the Company and the Officers and a Director of the Company agreed to forfeit a total of 3.09 billion of restricted shares of common stock that were due to vest on March 31, 2021.

On June 29, 2021, the Company and the Officers and a Director of the Company agreed to forfeit a total of 3.09 billion of restricted shares of common stock that were due to vest on June 30, 2021.
10


Stock Options

In the six months ended June 30, 2022, no stock options of the Company were exercised into common stock; in comparison to the six months ended June 30, 2021, where 2,275,000,000 stock options of the Company were exercised into common stock. During the three months ended June 30, 2022 and 2021, the Company recognized stock-based compensation of $0 and $32,500, respectively. Stock based compensation is included as part of selling, general and administrative expense in the accompanying consolidated statements of operations.

Income (Loss) Per Share

The following table summarizes the Company’s securities, in common share equivalents, which have been excluded from the calculation of dilutive loss per share as their effect would be anti-dilutive:

As of June 30,
 
 
2022
 
2021
 
Preferred stock
   
1,250,000,000
     
2,083,000,000
 
Stock options
   
67,587,000,000
     
67,587,000,000
 
Total
   
68,837,000,000
     
69,670,000,000
 
 
Note 13. COMMITMENTS AND CONTINGENCIES

Legal Proceedings

Two lawsuits were filed against the Company and its subsidiaries in connection with alleged claimed battery defects for an electronic cigarette device. Plaintiffs claim these batteries were sold by a store of the Company’s subsidiary and have sued for an undetermined amount of damages (other than a total of $0.4 million of medical costs). The initial complaints were filed between January 2019 and April 2019. We responded to the complaints in 2019 and we exchanged additional support information with the plaintiff for one of the lawsuits in 2021. Given the lack of information presented by the plaintiffs to date, the Company is unable to predict the outcome of these matters and, at this time, cannot reasonably estimate the possible loss or range of loss with respect to these legal proceedings.

On November 30, 2020, the Company filed a patent infringement lawsuit against Philip Morris USA, Inc. and Philip Morris Products S.A. in the U.S. District Court for the Northern District of Georgia.  The lawsuit alleges infringement on HCMC-owned patent(s) by the Philip Morris product known and marketed as “IQOS®”.  Philip Morris claims that it is currently approaching 14 million users of its IQOS® product and has reportedly invested over $3 billion in their smokeless tobacco products. On December 3, 2021, the District Court for the Northern District of Georgia effectively dismissed HCMC’s patent infringement action against Philip Morris USA, Inc. and Philip Morris Products S.A.  On December 14, 2021, the Company filed a notice of appeal of the District Court for the Northern District of Georgia’s dismissal of the Company’s patent infringement action against Philip Morris USA, Inc. and Philip Morris Products S.A. The appeal brief was filed on February 28, 2022.

On December 31, 2021, the District Court for the Northern District of Georgia effectively dismissed HCMC’s patent infringement action against Philip Morris USA, Inc. and Philip Morris Products S.A. In connection with such dismissal, the defendants sought to recover attorney’s fees from the Plaintiff. On February 22, 2022, the District Court for the Northern District of Georgia granted the defendant’s an award of approximately $575,000 in attorneys’ fees to be paid by the Company. The Company has fully provisioned this amount as of December 31, 2021. HCMC appealed this ruling on June 22, 2022.

From time to time the Company is involved in legal proceedings arising in the ordinary course of our business. We believe that there is no other litigation pending that is likely to have, individually or in the aggregate, a material adverse effect on our financial condition or results of operations as of June 30, 2022. With respect to legal costs, we record such costs as incurred.

Employment Agreement

On February 26, 2021, the Company entered into an amended and restated employment agreement (the “Employment Agreement Amendment”) with the Company’s President and Chief Operating Officer, Christopher Santi. Pursuant to the Employment Agreement Amendment, Mr. Santi will continue to be employed as the Company’s President and Chief Operating Officer through January 30, 2024.  Mr. Santi will receive a base salary of $0.4 million for 2021 and his salary will increase 10% in each subsequent year.

On February 02, 2022, the Company entered into a Second Amended and Restated Employment Agreement (the “Employment Agreement Amendment”) with the Company’s Chief Financial Officer, John Ollet.  Pursuant to the Employment Agreement Amendment, Mr. Ollet will continue to be employed as the Company’s Chief Financial Officer through February 14, 2025.  Mr. Ollet will receive a base salary of $0.3 million for 2022 and his salary will increase 10% in each subsequent calendar year.

11

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF CONDENSED CONSOLIDATED OPERATIONS

The following discussion and analysis should be read in conjunction with our unaudited interim condensed consolidated financial statements and related notes appearing elsewhere in this report on Form 10-Q. In addition to historical information, this discussion and analysis contains forward-looking statements that involve risks, uncertainties, and assumptions. Our actual results may differ materially from those anticipated in these forward-looking statements. The terms “we,” “us,” “our,” and the “Company” refer to Healthier Choices Management Corp. and its wholly-owned subsidiaries, Healthy Choice Markets, Inc., Healthy Choice Markets 2, LLC (“Paradise Health and Nutrition”), Healthy Choice Markets 3, LLC (“Mother Earth’s Storehouse”), Healthy Choices Markets 3 Real Estate LLC, HCMC Intellectual Property Holdings, LLC, Healthy Choice Wellness, LLC, The Vitamin Store, LLC, Healthy U Wholesale, Inc., The Vape Store, Inc. (“Vape Store”). All intercompany accounts and transactions have been eliminated in consolidation.

Company Overview

Healthier Choices Management Corp. is a holding company focused on providing consumers with healthier daily choices with respect to nutrition and other lifestyle alternatives.
Through its wholly owned subsidiary HCMC Intellectual Property Holdings, LLC, the Company manages and intends to expand on its intellectual property portfolio.
Through its wholly owned subsidiaries, Healthy Choice Markets, Inc., Healthy Choice Markets 2, LLC, and Healthy Choice Markets 3, LLC, respectively, the Company operates:
Ada’s Natural Market, a natural and organic grocery store offering fresh produce, bulk foods, vitamins and supplements, packaged groceries, meat and seafood, deli, baked goods, dairy products, frozen foods, health & beauty products and natural household items.
Paradise Health & Nutrition’s three stores that likewise offer fresh produce, bulk foods, vitamins and supplements, packaged groceries, meat and seafood, deli, baked goods, dairy products, frozen foods, health & beauty products and natural household items.
Mother Earth’s Storehouse, a two store organic and health food and vitamin chain in New York’s Hudson Valley, which has been in existence for over 40 years.
Through its wholly owned subsidiary, Healthy Choice Wellness, LLC, the Company operates:
Healthy Choice Wellness Center (Roslyn Heights, NY) a corporately owned IV therapy center offering multiple IV drip “cocktails” for clients to choose from. These cocktails are designed to help boost immunity, fight fatigue and stress, reduce inflammation, enhance weight loss, and efficiently deliver antioxidants and anti-aging mixes. Additionally, there are cocktails for health, beauty and re-hydration.
The Company also has a licensing agreement for a Healthy Choice Wellness Center at the Casbah Spa and Salon in Fort Lauderdale, FL, offering essentially the same services as the Roslyn Heights, NY location.
Through its wholly owned subsidiary, Healthy U Wholesale, the Company sells vitamins and supplements, as well as health, beauty and personal care products on its website www.TheVitaminStore.com.
Additionally, the Company markets its patented Q-Unit™ and Q-Cup® technology. Information on these products and the technology is available on the Company’s website at www.theQcup.com.
12


Liquidity

The unaudited condensed consolidated financial statements included elsewhere in this Form 10-Q have been prepared in conformity with GAAP, which contemplate continuation of the Company as a going concern and realization of assets and satisfaction of liabilities in the normal course of business and do not include any adjustments that might result from the outcome of any uncertainties related to our going concern assessment. The carrying amounts of assets and liabilities presented in the financial statements do not necessarily purport to represent realizable or settlement values. The unaudited consolidated financial statements do not include any adjustments that might result from the outcome of these uncertainties.

The Company incurred a loss from operations of approximately $2.7 million for the six months ended June 30, 2022. As of June 30, 2022, cash and cash equivalents totaled approximately $19.3 million. The Company expects to continue incurring losses for the foreseeable future but we anticipate that our current cash and cash equivalents and additional cash to be generated from operations will be sufficient to cover our projected operating expenses for the foreseeable future. Management does not believe there are any substantial doubts about the Company’s ability to continue as a going concern within a year and a day from the issuance of these unaudited consolidated financial statements.

Factors Affecting Our Performance

We believe the following factors affect our performance:

Retail: We believe the operating performance of our retail stores will affect our revenue and financial performance. The Company has four natural and organic groceries and dietary supplement stores located in Florida, as well as two located in New York. As of April 2022, the Company assigned the lease of its remaining retail vape store due to adverse industry trends and increasing federal and state regulations that, if implemented, may negatively impact future retail revenues. All of the Company's other vape stores had been either closed or had its assets sold from December 2021 to April 2022. This will allow the Company to focus on developing wholesale business and sales through online platform.

Increased Competition: Food retail is a large and competitive industry. Our competition varies and includes national, regional, and local conventional supermarkets, national superstores, alternative food retailers, natural foods stores, smaller specialty stores, and farmers’ markets. In addition, we compete with restaurants and other dining options in the food-at-home and food-away-from-home markets. The opening and closing of competitive stores, as well as restaurants and other dining options, in regions where we operate will affect our results. In addition, changing consumer preferences with respect to food choices and to dining out or at home can impact us. We also expect increased product supply and downward pressure on prices to continue and impact our operating results in the future.

Our Response to the COVID-19 Pandemic: We are proud to provide our guests with high quality, fresh foods and restaurant quality meals, delivered with impeccable service in an exceptionally clean and well-stocked store. With the ongoing COVID-19 pandemic, we continue to carefully monitor and adjust our safety protocols while following public health guideline and local ordinances. We have maintained many of the protocols established at the beginning of the pandemic to keep our team members and guests safe. The COVID-19 pandemic has presented many risks and challenges that we must manage. While we have experienced many challenges, including but not limited to, product shortages, staffing difficulties, and evolving customer shopping behaviors, our focus remains on both offering our customers a high quality service experience and supporting our essential front-line team members. Though we have successfully managed these challenges to date, our operations and financial condition could still be negatively affected by the COVID-19 pandemic and future developments, which are highly uncertain and cannot be predicted.
13


Results of Operations

The following table sets forth our unaudited condensed consolidated Statements of Operations for the three months ended June 30, 2022 and 2021 that is used in the following discussions of our results of operations:

 
Three Months Ended June 30,
 
2022 to 2021
 
2022
 
2021
 
Change $
SALES
               
Vapor sales, net
$
5,997
 
$
590,980
 
$
(584,983)
Grocery sales, net
 
6,126,063
   
2,794,912
   
3,331,151
TOTAL SALES, NET
 
6,132,060
   
3,385,892
   
2,746,168
                 
Cost of sales vapor
 
562
   
237,333
   
(236,771)
Cost of sales grocery
 
3,800,625
   
1,684,903
   
2,115,722
GROSS PROFIT
 
2,330,873
   
1,463,656
   
867,217
                 
OPERATING EXPENSES
               
Selling, general and administrative
 
3,699,273
   
2,149,087
   
1,550,186
LOSS FROM OPERATIONS
 
(1,368,400)
   
(685,431)
   
(682,969)
                 
OTHER INCOME (EXPENSE)
               
Gain (loss) on investment
 
1,800
   
(14,614)
   
16,414
Other income, net
 
6,175
   
-
   
6,175
Interest income (expense), net
 
14,910
   
(5,516)
   
20,426
Gain on debt settlements
 
-
   
885,226
   
(885,226)
Total other income (expense), net
 
22,885
   
865,096
   
(842,211)
                 
NET (LOSS) INCOME
$
(1,345,515)
 
$
179,665
 
$
(1,525,180)

Net vapor sales decreased approximately $0.6 million to $6.0 thousand for the three months ended June 30, 2022 as compared to $0.6 million for the same period in 2021. The decrease in sales is primarily due to closing the remaining retail vape stores during the three months ended June 30, 2022 as compared to the same period in 2021.

Net grocery sales increased $3.3 million to $6.1 million for the three months ended June 30, 2022 as compared to $2.8 million for the same period in 2021. The increase in sales is primarily due to an increase in the number of stores as a result of the acquisition of Mother Earth's Storehouse in February 2022.

Vapor cost of goods sold for the three months ended June 30, 2022 and 2021 were $1.0 thousand and $0.2 million, respectively, a decrease of $0.2 million. The decrease is primarily due to the closing the remaining retail vape stores during three months ended June 30, 2022 as compared to the same period in 2021. Gross profit was $5.0 thousand and $0.4 million for three months ended June 30, 2022 and 2021, respectively. Closing retail vape stores will allow the Company focus on developing wholesale business and online platform.

Grocery cost of goods sold for the three months ended June 30, 2022 and 2021 were $3.8 million and $1.7 million, respectively, an increase of $2.1 million. The increase is primarily due to an increase in the number of stores from the acquisition of Mother Earth's Storehouse during the three months ended June 30, 2022 as compared to the same period in 2021. Gross profit was $2.3 million and $1.1 million for the three months ended June 30, 2022 and 2021, respectively.

Total operating expenses increased $1.6 million to $3.7 million for the three months ended June 30, 2022 compared to $2.1 million for the same period in 2021. The increase is primarily attributable to increases in professional fees of $0.6 million, payroll and employee related cost of $0.7 million, office and store expense of $0.2 million and occupancy costs of $0.1 million.

Net other income of $23,000 for the three months ended June 30, 2022 includes other income of $6,000, interest income of $15,000 and a gain on investment of $2,000. Net other income of $865,000 for the three months ended June 30, 2021 includes a gain on debt settlements of $885,000, interest expense of $6,000, offset by a loss on investment of $15,000.

14


The following table sets forth our unaudited consolidated Statements of Operations for the six months ended June 30, 2022 and 2021 that is used in the following discussions of our results of operations:

 
Six Months Ended June 30,
 
2022 to 2021
 
2022
 
2021
 
Change $
SALES
               
Vapor sales, net
$
255,560
 
$
1,204,916
 
$
(949,356)
Grocery sales, net
 
10,925,053
   
5,646,729
   
5,278,324
TOTAL SALES, NET
 
11,180,613
   
6,851,645
   
4,328,968
                 
Cost of sales vapor
 
112,246
   
470,648
   
(358,402)
Cost of sales grocery
 
6,764,980
   
3,426,631
   
3,338,349
GROSS PROFIT
 
4,303,387
   
2,954,366
   
1,349,021
                 
OPERATING EXPENSES
               
Selling, general and administrative
 
7,026,693
   
4,171,970
   
2,854,723
LOSS FROM OPERATIONS
 
(2,723,306)
   
(1,217,604)
   
(1,505,702)
                 
OTHER INCOME (EXPENSE)
               
Gain on investment
 
5,314
   
11,511
   
(6,197)
Other income
 
23,049
   
-
   
23,049
Interest income (expense), net
 
31,513
   
(78,430)
   
109,943
Gain on extinguishment of debt, net
 
-
   
767,930
   
(767,930)
Total other income (expense), net
 
59,876
   
701,011
   
(641,135)
                 
NET LOSS
$
(2,663,430)
 
$
(516,593)
 
$
(2,146,837)

Net Vapor sales decreased $0.9 million to $0.3 million for the six months ended June 30, 2022 as compared to $1.2 million for the same period in 2021. The decrease in sales is primarily due to closing the remaining retail vape stores during the six months ended June 30, 2022 as compared to the same period in 2021.

Net Grocery sales increased $5.3 million to $10.9 million for the six months ended June 30, 2022 as compared to $5.6 million for the same period in 2021. The increase in sales is primarily due to acquisition of Mother Earth's Storehouse in February 2022.

Vapor cost of goods sold for the six months ended June 30, 2022 and 2021 were $0.1 million and $0.5 million, respectively, a decrease of $0.4 million. The decrease is primarily due to closing retail stores. Gross profit was $0.1 million and $0.7 million for the six months ended June 30, 2022 and 2021, respectively. Closing retail vape stores will allow the Company focus on developing wholesale  business and online platform.

Grocery cost of goods sold for the six months ended June 30, 2022 and 2021 were $6.8 million and $3.4 million, respectively, an increase of $3.3 million. The increase is primarily due to acquisition of Mother Earth's Storehouse in February 2022. Gross profit was $4.2 million and $2.2 million for the six months ended June 30, 2021 and 2021, respectively.

Total operating expenses increased $2.9 million to $7.0 million for the six months ended June 30, 2022 compared to $4.2 million for the same period in 2021. The increase is primarily attributable to increases in the professional fees of $1.0 million, office and store expenses of $0.2 million, payroll and employee related cost of $1.2 million, depreciation and amortization expenses of $161,000, meals, travel and entertainment of $32,000, insurance of $26,000, and occupancy of $148,000, offset by a decrease in stock compensation of $34,000.

Net other income of $0.1 million for the six months ended June 30, 2022 includes a gain on investment of $5,000, other income of $23,000,  and an interest income of $32,000. Net other income of $0.7 million for the six months ended June 30, 2021 includes a gain on debt settlement of $768,000, a gain on investment of $12,000, and interest expense of $78,000.
15


Liquidity and Capital Resources

 
Six Months Ended June 30,
 
2022
 
2021
Net cash provided by (used in)
         
 Operating activities
$
(1,870,884)
 
$
(1,443,509)
 Investing activities
 
(5,336,011)
   
(14,269)
Financing activities
 
33,911
   
27,871,187
 
$
(7,172,984)
 
$
26,413,409

Our net cash used in operating activities of approximately $1.9 million for the six months ended June 30, 2022 resulted from a net loss of $2.7 million, offset by a non-cash adjustment of $0.9 million and a net cash provided of $0.1 million from changes in operating assets and liabilities. Our net cash used in operating activities of $1.4 million for the six months ended June 30, 2021 resulted from a net loss of $0.5 million and a net cash usage of $0.8 million from changes in operating assets and liabilities, offset by a non-cash adjustment of $0.2 million.

The net cash used in investing activities of $5.3 million for the six months ended June 30, 2022 resulted from the acquisition of Mother Earth's Storehouse, collection on a note receivable, and purchases of property and equipment. The net cash used in investing activities of $14,000 for the six months ended June 30, 2021 resulted from the collection of a note receivable, and purchases of property and equipment.

The net cash provided by financing activities of $34,000 for the six months ended June 30, 2022 is due to proceeds received from the line of credit. The net cash provided by financing activities of $27.9 million for the six months ended June 30, 2021 is due to proceeds received from the stock rights offering, partially offset by a principal payment of $2.0 million on the line of credit.

At June 30, 2022 and December 31, 2021, we did not have any material financial guarantees or other contractual commitments with vendors that are reasonably likely to have an adverse effect on liquidity.

Our cash balances are kept liquid to support our growing acquisition and infrastructure needs for operational expansion. Most of our cash and cash equivalents are concentrated in one financial institution and are generally in excess of the FDIC insurance limit. The Company has not experienced any losses on its cash and cash equivalents. The following table presents the Company’s cash position as of June 30, 2022 and December 31, 2021.

 
June 30, 2022
 
December 31, 2021
Cash
$
19,323,420
 
$
26,496,404
Total assets
$
33,832,198
 
$
34,443,487
Percentage of total assets
 
57.12%
   
76.93%

The Company reported a net loss of $2.7 million for the six months ended June 30, 2022. The Company also had positive working capital of $19.0 million. The Company expects to continue incurring losses for the foreseeable future but we do not believe there are any substantial doubts about the Company’s ability to continue as a going concern.

Off-Balance Sheet Arrangements

We do not have any off-balance sheet arrangements.

16


Critical Accounting Policies and Estimates

Our management’s discussion and analysis of financial condition and results of operations is based on our unaudited condensed consolidated financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States, or U.S. GAAP. The preparation of these condensed consolidated financial statements requires us to exercise considerable judgment with respect to establishing sound accounting policies and in making estimates and assumptions that affect the reported amounts of our assets and liabilities, our recognition of revenues and expenses, and disclosure of commitments and contingencies at the date of the condensed consolidated financial statements.

We base our estimates on our historical experience, knowledge of our business and industry, current and expected economic conditions, the attributes of our products, the regulatory environment, and in certain cases, the results of outside appraisals. We periodically re-evaluate our estimates and assumptions with respect to these judgments and modify our approach when circumstances indicate that modifications are necessary. These estimates and assumptions form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources.

While we believe that the factors we evaluate provide us with a meaningful basis for establishing and applying sound accounting policies, we cannot guarantee that the results will always be accurate. Since the determination of these estimates requires the exercise of judgment, actual results could differ from such estimates.

There have been no material changes to the Company’s critical accounting policies and estimates as compared to the critical accounting policies and estimates described in the 2021 Annual Report, which we believe are the most critical to our business and the understanding of our results of operations and affect the more significant judgments and estimates that we use in the preparation of our condensed consolidated financial statements.

Seasonality

We do not consider our business to be seasonal.

Cautionary Note Regarding Forward-Looking Statements

This report includes forward-looking statements including statements regarding retail expansion, the future demand for our products, the transition to vaporizer and other products, competition, the adequacy of our cash resources and our authorized Common Stock, and our continued ability to raise capital.

The words “believe,” “may,” “estimate,” “continue,” “anticipate,” “intend,” “should,” “plan,” “could,” “target,” “potential,” “is likely,” “will,” “expect” and similar expressions, as they relate to us, are intended to identify forward-looking statements. We have based these forward-looking statements largely on our current expectations and projections about future events and financial trends that we believe may affect our financial condition, results of operations, business strategy and financial needs.

The results anticipated by any or all of these forward-looking statements might not occur. Important factors that could cause actual results to differ from those in the forward-looking statements include our future common stock price, the timing of future Series D preferred stock exercises and stock sales, customer acceptance of our products, and proposed federal and state regulation. We undertake no obligation to publicly update or revise any forward-looking statements, whether as the result of new information, future events or otherwise.


17


ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Not applicable to smaller reporting companies.


ITEM 4. CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures

Our management, including our Principal Executive Officer and Principal Financial Officer, did not carry out an evaluation on internal controls as of June 30, 2022 in regard to the effectiveness of our disclosure controls and procedures as defined in Rule 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, or the Exchange Act. As an evaluation was not carried out, our Principal Executive Officer and Principal Financial Officer concluded that our disclosure controls and procedures were ineffective as of the end of the period covered by this report.

In planning and performing its audit of our financial statements for the year ended December 31, 2021 in accordance with standards of the Public Company Accounting Oversight Board, our independent registered public accounting firm noted material weaknesses in internal control over financial reporting. A list of our material weaknesses are as follows:

Failure to have properly documented and designed disclosure controls and procedures and testing of the operating effectiveness of our internal control over financial reporting.

Failure to perform periodic and year-end inventory observations in a timely manner and adequate controls to sufficiently perform required rollback procedures of inventory counts to the year-end.

Weakness around our purchase orders and inventory procedures, inclusive of year-end physical inventory observation procedures as well as physical count procedures.

Segregation of duties due to lack of personnel.

Our management concluded that considering internal control deficiencies that, in the aggregate, rise to the level of material weaknesses, we did not maintain effective internal control over financial reporting as of June 30, 2022 based on the criteria set forth in Internal Control-Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (“COSO”).

Changes in Internal Control over Financial Reporting

Following this assessment and during the three months ended June 30, 2022, we have undertaken an action plan to
strengthen internal controls and procedures:

Management continues to devote significant efforts toward improvement of effectiveness of control over financial reporting. This includes analyzing non-routine transactions before booking journal entries; Implemented a monthly variance fluctuation analysis across all segments. Variance analyses are communicated to operations and executives to make sure the results are accurate.

Our management has increased its focus on the Company’s purchase order process in order to better manage inventory thereby improving cash management and ultimately leading to more reliable and precise financial reporting.

The Company is evaluating the addition of a new position, Inventory Analyst, to handle all matters related to the implementation of a cycle-count procedure as well as coordinating all physical inventory counts with third parties.

Vendor payments and cash disbursement are reviewed on weekly basis by management and accounting team to ensure timely payment. Cash balances are communicated to management on weekly basis to improve cash management.

Our management continues to review ways in which we can make improvements in internal control over financial reporting reporting and will further delineate milestones as they are achieved.

18


PART II - OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS.

Two lawsuits were filed against the Company and its subsidiaries in connection with alleged claimed battery defects for an electronic cigarette device. Plaintiffs claim these batteries were sold by a store of the Company’s subsidiary and have sued for an undetermined amount of damages (other than a total of $0.4 million of medical costs). The initial complaints were filed between January 2019 and April 2019. We responded to the complaints in 2019 and we exchanged additional support information with the plaintiff for one of the lawsuits in 2021. Given the lack of information presented by the plaintiffs to date, the Company is unable to predict the outcome of these matters and, at this time, cannot reasonably estimate the possible loss or range of loss with respect to these legal proceedings.

On November 30, 2020, the Company filed a patent infringement lawsuit against Philip Morris USA, Inc. and Philip Morris Products S.A. in the U.S. District Court for the Northern District of Georgia.  The lawsuit alleges infringement on HCMC-owned patent(s) by the Philip Morris product known and marketed as “IQOS®”.  Philip Morris claims that it is currently approaching 14 million users of its IQOS® product and has reportedly invested over $3 billion in their smokeless tobacco products. On December 3, 2021, the District Court for the Northern District of Georgia effectively dismissed HCMC’s patent infringement action against Philip Morris USA, Inc. and Philip Morris Products S.A.  On December 14, 2021, the Company filed a notice of appeal of the District Court for the Northern District of Georgia’s dismissal of the Company’s patent infringement action against Philip Morris USA, Inc. and Philip Morris Products S.A. The appeal brief was filed on February 28, 2022.

On December 31, 2021, the District Court for the Northern District of Georgia effectively dismissed HCMC’s patent infringement action against Philip Morris USA, Inc. and Philip Morris Products S.A. In connection with such dismissal, the defendants sought to recover attorney’s fees from the Plaintiff. On February 22, 2022, the District Court for the Northern District of Georgia granted the defendant’s an award of approximately $575,000 in attorneys’ fees to be paid by the Company. The Company has fully provisioned this amount as of December 31, 2021. HCMC appealed this ruling on June 22, 2022.

From time to time the Company is involved in legal proceedings arising in the ordinary course of our business. We believe that there is no other litigation pending that is likely to have, individually or in the aggregate, a material adverse effect on our financial condition or results of operations as of June 30, 2022. With respect to legal costs, we record such costs as incurred.

ITEM 1A. RISK FACTORS.

Not Applicable.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS.

None.

ITEM 3. DEFAULTS UPON SENIOR SECURITIES.

None.

ITEM 4. MINE SAFETY DISCLOSURES.

Not Applicable.

ITEM 5. OTHER INFORMATION.

Not Applicable.

ITEM 6. EXHIBITS.

See the exhibits listed in the accompanying “Index to Exhibits.”

19


INDEX TO EXHIBITS

Exhibit
     
Incorporated by Reference
 
Filed or Furnished
No.
 
Exhibit Description
 
Form
 
Date
 
Number
 
Herewith
31.1
               
Filed
31.2
               
Filed
32.1
               
Furnished *
32.2
               
Furnished *
101.INS
 
XBRL Instance Document
             
Filed
101.SCH
 
XBRL Taxonomy Extension Schema Document
             
Filed
101.CAL
 
XBRL Taxonomy Extension Calculation Linkbase Document
             
Filed
101.DEF
 
XBRL Taxonomy Extension Definition Linkbase Document
             
Filed
101.LAB
 
XBRL Taxonomy Extension Label Linkbase Document
             
Filed
101.PRE
 
XBRL Taxonomy Extension Presentation Linkbase Document
             
Filed
104
 
Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101)
             
Filed

*
This exhibit is being furnished rather than filed and shall not be deemed incorporated by reference into any filing, in accordance with Item 601 of Regulation S-K.

20


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 
HEALTHIER CHOICES MANAGEMENT CORP.
     
Date: August 1, 2022
By:
/s/ Jeffrey Holman
   
Jeffrey Holman
   
Chief Executive Officer
     
Date: August 1, 2022
By:
/s/ John Ollet
   
John Ollet
   
Chief Financial Officer

21
EX-31.1 2 ex31_1.htm EXHIBIT 31.1  
Exhibit 31.1

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER

I, Jeffrey Holman, certify that:

1.
I have reviewed this quarterly report on Form 10-Q of Healthier Choices Management Corp.;

2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.
The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a)
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b)
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c)
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d)
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting;

5.
The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a)
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b)
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: August 1, 2022

 
/s/ Jeffrey Holman
 
Jeffrey Holman
 
Chief Executive Officer
 
(Principal Executive Officer)

EX-31.2 3 ex31_2.htm EXHIBIT 31.2  
Exhibit 31.2

CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER

I, John Ollet, certify that:

1.
I have reviewed this quarterly report on Form 10-Q of Healthier Choices Management Corp.;

2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.
The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a)
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b)
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c)
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d)
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting;

5.
The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a)
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b)
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: August 1, 2022

 
/s/ John Ollet
 
John Ollet
 
Chief Financial Officer
 
(Principal Financial Officer)

EX-32.1 4 ex32_1.htm EXHIBIT 32.1  
Exhibit 32.1

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the quarterly report of Healthier Choices Management Corp. (the “Company”) on Form 10-Q for the quarter ending June 30, 2022, as filed with the Securities and Exchange Commission on the date hereof, I, Jeffrey Holman, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:

1.
The quarterly report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934 and

2.
The information contained in the quarterly report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: August 1, 2022

 
/s/ Jeffrey Holman
 
Jeffrey Holman
 
Chief Executive Officer
 
(Principal Executive Officer)

EX-32.2 5 ex32_2.htm EXHIBIT 32.2  
Exhibit 32.2

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the quarterly report of Healthier Choices Management Corp. (the “Company”) on Form 10-Q for the quarter ending June 30, 2022, as filed with the Securities and Exchange Commission on the date hereof, I, John Ollet, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:

1.
The quarterly report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934 and

2.
The information contained in the quarterly report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: August 1, 2022

 
/s/ John Ollet
 
John Ollet
 
Chief Financial Officer
 
(Principal Financial Officer)

EX-101.SCH 6 hcmc-20220630.xsd XBRL TAXONOMY EXTENSION SCHEMA 000100 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 010000 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS link:presentationLink link:calculationLink link:definitionLink 010100 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 020000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS link:presentationLink link:calculationLink link:definitionLink 030000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY link:presentationLink link:calculationLink link:definitionLink 040000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS link:presentationLink link:calculationLink link:definitionLink 060100 - Disclosure - ORGANIZATION link:presentationLink link:calculationLink link:definitionLink 060200 - Disclosure - LIQUIDITY link:presentationLink link:calculationLink link:definitionLink 060300 - Disclosure - BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES link:presentationLink link:calculationLink link:definitionLink 060400 - Disclosure - CONCENTRATIONS link:presentationLink link:calculationLink link:definitionLink 060500 - Disclosure - DISAGGREGATION OF REVENUES link:presentationLink link:calculationLink link:definitionLink 060600 - Disclosure - NOTES RECEIVABLE AND OTHER INCOME link:presentationLink link:calculationLink link:definitionLink 060700 - Disclosure - ACQUISITION OF MOTHER EARTH'S STOREHOUSE, INC. link:presentationLink link:calculationLink link:definitionLink 060800 - Disclosure - PROPERTY & EQUIPMENT link:presentationLink link:calculationLink link:definitionLink 060900 - Disclosure - INTANGIBLE ASSETS link:presentationLink link:calculationLink link:definitionLink 061000 - Disclosure - CONTRACT LIABILITIES link:presentationLink link:calculationLink link:definitionLink 061100 - Disclosure - DEBT link:presentationLink link:calculationLink link:definitionLink 061200 - Disclosure - STOCKHOLDERS' EQUITY link:presentationLink link:calculationLink link:definitionLink 061300 - Disclosure - COMMITMENTS AND CONTINGENCIES link:presentationLink link:calculationLink link:definitionLink 080400 - Disclosure - CONCENTRATIONS (Tables) link:presentationLink link:calculationLink link:definitionLink 080500 - Disclosure - DISAGGREGATION OF REVENUES (Tables) link:presentationLink link:calculationLink link:definitionLink 080600 - Disclosure - NOTES RECEIVABLE AND OTHER INCOME (Tables) link:presentationLink link:calculationLink link:definitionLink 080700 - Disclosure - ACQUISITION OF MOTHER EARTH'S STOREHOUSE, INC. (Tables) link:presentationLink link:calculationLink link:definitionLink 080800 - Disclosure - PROPERTY & EQUIPMENT (Tables) link:presentationLink link:calculationLink link:definitionLink 080900 - Disclosure - INTANGIBLE ASSETS (Tables) link:presentationLink link:calculationLink link:definitionLink 081000 - Disclosure - CONTRACT LIABILITIES (Tables) link:presentationLink link:calculationLink link:definitionLink 081100 - Disclosure - DEBT (Tables) link:presentationLink link:calculationLink link:definitionLink 081200 - Disclosure - STOCKHOLDERS' EQUITY (Tables) link:presentationLink link:calculationLink link:definitionLink 090100 - Disclosure - ORGANIZATION (Details) link:presentationLink link:calculationLink link:definitionLink 090400 - Disclosure - CONCENTRATIONS (Details) link:presentationLink link:calculationLink link:definitionLink 090500 - Disclosure - DISAGGREGATION OF REVENUES (Details) link:presentationLink link:calculationLink link:definitionLink 090600 - Disclosure - NOTES RECEIVABLE AND OTHER INCOME (Details) link:presentationLink link:calculationLink link:definitionLink 090700 - Disclosure - ACQUISITION OF MOTHER EARTH'S STOREHOUSE, INC. (Details) link:presentationLink link:calculationLink link:definitionLink 090800 - Disclosure - PROPERTY & EQUIPMENT (Details) link:presentationLink link:calculationLink link:definitionLink 090900 - Disclosure - INTANGIBLE ASSETS, Intangible Assets, Net (Details) link:presentationLink link:calculationLink link:definitionLink 090902 - Disclosure - INTANGIBLE ASSETS, Future Annual Estimated Amortization Expense (Details) link:presentationLink link:calculationLink link:definitionLink 091000 - Disclosure - CONTRACT LIABILITIES (Details) link:presentationLink link:calculationLink link:definitionLink 091100 - Disclosure - DEBT (Details) link:presentationLink link:calculationLink link:definitionLink 091200 - Disclosure - STOCKHOLDERS' EQUITY, Rights Offering (Details) link:presentationLink link:calculationLink link:definitionLink 091202 - Disclosure - STOCKHOLDERS' EQUITY, Exchange Agreement and Restricted Stock (Details) link:presentationLink link:calculationLink link:definitionLink 091204 - Disclosure - STOCKHOLDERS' EQUITY, Stock Options (Details) link:presentationLink link:calculationLink link:definitionLink 091206 - Disclosure - STOCKHOLDERS' EQUITY, Income (Loss) Per Share (Details) link:presentationLink link:calculationLink link:definitionLink 091300 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 7 hcmc-20220630_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 8 hcmc-20220630_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 9 hcmc-20220630_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Award Type [Axis] BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES [Abstract] Accounts payable and accrued expenses Accounts receivable, net Receivable Type [Axis] Accounts, Notes, Loans and Financing Receivable [Line Items] Less: accumulated depreciation and amortization Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Additional paid-in capital Additional Paid-In Capital [Member] Additional Paid-in Capital [Member] Adjustments to reconcile net loss to net cash used in operating activities: Stock-based compensation expense Amortization expense Antidilutive Securities [Axis] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive securities excluded from computation of diluted loss per share (in shares) Antidilutive Securities, Name [Domain] TOTAL ASSETS Assets ASSETS Assets [Abstract] TOTAL CURRENT ASSETS Assets, Current CURRENT ASSETS Building [Member] ACQUISITION OF MOTHER EARTH'S STOREHOUSE, INC. [Abstract] Cash Consideration paid Business Combination, Consideration Transferred Other liabilities Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other Finite-Lived Intangible Assets [Abstract] Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill [Abstract] Acquisition of Mother Earth's Storehouse, Inc. [Abstract] Business Combinations [Abstract] Business Acquisition [Axis] Business Acquisition [Line Items] Business Acquisition, Acquiree [Domain] Inventory Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory ACQUISITION OF MOTHER EARTH'S STOREHOUSE, INC. Intangible assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles Property and equipment Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment Net assets acquired Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net Purchase Price Allocation [Abstract] Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Less Noncontrolling Interest [Abstract] NET (DECREASE) INCREASE IN CASH, CASH EQUIVALENT AND RESTRICTED CASH Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect CASH, CASH EQUIVALENTS AND RESTRICTED CASH - END OF PERIOD CASH, CASH EQUIVALENTS AND RESTRICTED CASH - BEGINNING OF PERIOD Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents Cash, Cash Equivalents and Restricted Cash [Abstract] Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents [Abstract] Cash and cash equivalents NON-CASH INVESTING AND FINANCING ACTIVITIES FDIC insured amount Changes in Contract Liabilities Activity [Roll Forward] Class of Stock [Domain] COMMITMENTS AND CONTINGENCIES [Abstract] COMMITMENTS AND CONTINGENCIES COMMITMENTS AND CONTINGENCIES (SEE NOTE 13) Common Stock [Member] Common Stock [Member] Common stock, shares issued (in shares) Common stock, par value (in dollars per share) Common Stock, $0.0001 par value per share, 750,000,000,000 shares authorized; 339,741,632,384 shares issued and outstanding as of June 30, 2022 and December 31, 2021, respectively Common stock, shares authorized (in shares) Common stock, shares outstanding (in shares) Computer Hardware & Equipment [Member] CONCENTRATIONS Contract with Customer, Sales Channel [Domain] Contract with Customer, Sales Channel [Axis] Deferred Revenue [Abstract] CONTRACT LIABILITIES [Abstract] Contract liabilities Summary of Net Changes in Contract Liabilities Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block] Contract assets Ending balance Beginning balance Contract with Customer, Liability Series C Preferred stock exercised Convertible Preferred Stock Converted to Other Securities Convertible Preferred Stock [Member] Cost of sales Credit Facility [Axis] Credit Facility [Domain] Customer Relationships [Member] Customer Relationships [Member] Disaggregation of Revenue [Line Items] Disaggregation of Revenue [Table] Disaggregated Revenue Disaggregation of Revenue [Abstract] Disaggregation of Revenue [Abstract] DEBT [Abstract] DEBT Debt Instrument [Axis] Face amount Schedule of Long-term Debt Instruments [Table] Debt Instrument [Line Items] Debt Instrument, Name [Domain] Increment percentage on salary each subsequent year Depreciation expense Depreciation and amortization Derivative liabilities, warrants Derivative Liability, Current NET LOSS PER SHARE, BASIC (in dollars per share) NET LOSS PER SHARE, DILUTED (in dollars per share) Stock Options [Member] Share-based Payment Arrangement, Option [Member] Compensation Expense Recognized [Abstract] Equity Component [Domain] Restricted Stock [Abstract] STOCKHOLDERS' EQUITY [Abstract] Intangible Assets, Net [Abstract] 2026 2022 (remaining six months) 2024 Useful lives Accumulated amortization Finite-Lived Intangible Assets, Accumulated Amortization Finite-Lived Intangible Assets, Major Class Name [Domain] Finite-Lived Intangible Assets [Line Items] 2025 Future Annual Estimated Amortization Expense [Abstract] Gross carrying amount 2023 Finite-Lived Intangible Assets by Major Class [Axis] Intangible assets, net of accumulated amortization Net carrying amount Furniture and Fixtures [Member] Grantee Status [Domain] Grantee Status [Axis] Gain on investment Gain (loss) on investment Gain (Loss) on Investments (Gain) on debt settlement Gain on debt extinguishment, net Loss on extinguishment of debt INTANGIBLE ASSETS Goodwill Goodwill INTANGIBLE ASSETS [Abstract] GROSS PROFIT Gross Profit Impairment of intangible assets Impairment of Intangible Assets, Finite-lived CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS [Abstract] Contract assets Increase (Decrease) in Contract with Customer, Asset Contract liabilities Increase (Decrease) in Contract with Customer, Liability Accounts payable and accrued expenses Increase (Decrease) in Accounts Payable and Accrued Liabilities Accrued expenses Inventories Increase (Decrease) in Inventories Changes in operating assets and liabilities: Other assets Increase (Decrease) in Other Operating Assets Accounts receivable Increase (Decrease) in Receivables Increase (Decrease) in Stockholders' Equity [Roll Forward] Accrued interest on loan Interest income (expense), net Cash paid for interest Website [Member] Internet Domain Names [Member] Write-down of obsolete and slow-moving inventory Inventory Write-down Inventories Leasehold Improvements [Member] TOTAL LIABILITIES Liabilities LIABILITIES AND STOCKHOLDERS' EQUITY Liabilities and Equity [Abstract] TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY Liabilities and Equity TOTAL CURRENT LIABILITIES Liabilities, Current CURRENT LIABILITIES Line of Credit [Member] Current portion of line of credit Attorney fees paid Litigation Settlement, Amount Awarded to Other Party Current portion of loan payment NOTES RECEIVABLE AND OTHER INCOME Debt Long-term Debt Debt [Abstract] Long-term Debt, by Current and Noncurrent [Abstract] Loan payable, net of current portion Loss Contingency Nature [Axis] Damages sought Loss Contingencies [Line Items] Loss Contingencies [Table] Number of lawsuits Loss Contingency, Pending Claims, Number Loss Contingency, Nature [Domain] Legal Proceedings [Abstract] Loss Contingency, Information about Litigation Matters [Abstract] NET CASH PROVIDED BY FINANCING ACTIVITIES Net Cash Provided by (Used in) Financing Activities FINANCING ACTIVITIES NET CASH USED IN OPERATING ACTIVITIES Net Cash Provided by (Used in) Operating Activities INVESTING ACTIVITIES OPERATING ACTIVITIES NET CASH USED IN INVESTING ACTIVITIES Net Cash Provided by (Used in) Investing Activities Net income (loss) Net loss NET (LOSS) INCOME Acquisition non cash expense Non-Compete [Member] Non-Compete Agreement [Member] Total other income (expense), net Nonoperating Income (Expense) OTHER INCOME (EXPENSE) Nonoperating Income (Expense) [Abstract] Notes receivable Note receivable Number of stores Number of Stores Operating lease liability, current Operating lease liability, net of current Right of use asset - operating lease, net Amortization of right-of-use asset Operating Lease, Right-of-Use Asset, Amortization Expense OPERATING EXPENSES LOSS FROM OPERATIONS Operating Income (Loss) ORGANIZATION Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] ORGANIZATION [Abstract] Other assets Other [Member] Other Machinery and Equipment [Member] Other income, net Patents [Member] Direct financing costs Purchases of property and equipment Payments to Acquire Intangible Assets Acquisition of Mother Earth's Storehouse Cash purchase price Payments to Acquire Businesses, Gross Issuance of note receivable Payments to Acquire Notes Receivable Purchases of patent Payments to Acquire Property, Plant, and Equipment Preferred Stock [Member] Preferred stock, aggregate liquidation preference Convertible preferred stock Preferred stock, shares authorized (in shares) Preferred stock, par value (in dollars per share) Preferred stock, shares outstanding (in shares) Preferred stock, shares issued (in shares) Proceeds from preferred stock Proceeds from line of credit Proceeds from Rights Offering Net proceeds Proceeds from Issuance of Common Stock Proceeds from loan and security agreement Collection of note receivable Proceeds Proceeds from exercise of stock options Property, Plant and Equipment [Line Items] PROPERTY & EQUIPMENT PROPERTY & EQUIPMENT [Abstract] Property and Equipment Property, Plant and Equipment [Table Text Block] Property, Plant and Equipment, Type [Axis] Property, Plant and Equipment, Type [Domain] Property and equipment, net of accumulated depreciation Total property and equipment Property plant and equipment, gross Property and equipment [Abstract] Bad debt expense Lease acquired Right-of-Use Asset Obtained in Exchange for Operating Lease Liability Remaining balance Receivable [Domain] Interest rate Receivable with Imputed Interest, Effective Yield (Interest Rate) Loan amount Receivable with Imputed Interest, Face Amount Receivables with Imputed Interest [Abstract] NOTES RECEIVABLE AND OTHER INCOME [Abstract] Principal payment on the line of credit Repayments of Lines of Credit Principal payments on loan payable Repayments of Short-term Debt Restricted cash Restricted Stock [Member] Accumulated Deficit [Member] Accumulated deficit DISAGGREGATION OF REVENUES [Abstract] Revenue SALES, NET DISAGGREGATION OF REVENUES Revenue from Contract with Customer [Text Block] SALES CONCENTRATIONS [Abstract] Future Annual Estimated Amortization Expense Base salary Intangible Assets, Net Schedule of Finite-Lived Intangible Assets [Table] Breakdown of Debt Common Share Equivalent Excluded from Calculation of Dilutive Loss Per Share Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Preliminary Purchase Price Allocation for Mother Earth's Storehouse, Inc. Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Schedule of Business Acquisitions, by Acquisition [Table] Property, Plant and Equipment [Table] Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Schedule of Accounts, Notes, Loans and Financing Receivable [Table] Stock-based compensation expense Stock-based compensation Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Granted (in shares) Award Type [Domain] Subscription price (in dollars per share) Common stock at a price per share (in dollars per share) Balance (in shares) Balance (in shares) Shares, Outstanding Investment BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES CONDENSED CONSOLIDATED BALANCE SHEETS [Abstract] Class of Stock [Axis] Statement [Table] Statement [Line Items] CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS [Abstract] Equity Components [Axis] CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY [Abstract] Stock options exercised (in shares) Issuance of Convertible Preferred stock in connection with the Securities Purchase Agreement (in shares) Stock Issued During Period, Shares, Conversion of Convertible Securities Common stock shares issued from offering (in shares) Issuance of common stock (in shares) Exchange of notes for shares of common stock (in shares) Issuance of awarded stock for officers and board (in shares) Cancellation of awarded stock (in shares) Stock Issued During Period, Shares, Restricted Stock Award, Forfeited Stock options exercised Issuance of common stock Indebtedness aggregate amount Issuance of Convertible Preferred stock in connection with the Securities Purchase Agreement Stock Issued During Period, Value, Conversion of Convertible Securities Issuance of awarded stock for officers and board member Cancellation of awarded stock Stock Issued During Period, Value, Restricted Stock Award, Forfeitures Balance Balance TOTAL STOCKHOLDERS' EQUITY Stockholders' Equity Attributable to Parent STOCKHOLDERS' EQUITY Stockholders' Equity Note Disclosure [Text Block] STOCKHOLDERS' EQUITY SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION Total Cash and cash equivalents in excess of FDIC limits of $250,000 Trade Names / Trademarks [Member] Trade Names [Member] Trade Names/Trademarks [Member] Warrants [Member] Warrant [Member] WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING-DILUTED (in shares) WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING-BASIC (in shares) Board Member [Member] Board of Directors Chairman [Member] Counterparty Name [Axis] Chief Operating Officer [Member] Chief Executive Officer [Member] Chief Financial Officer [Member] Director [Member] Litigation Case [Axis] Litigation Case [Domain] Maximum [Member] Minimum [Member] Officers [Member] Product and Service [Domain] Product and Service [Axis] Statistical Measurement [Domain] Statistical Measurement [Axis] Counterparty Name [Domain] Title of Individual [Domain] Title of Individual [Axis] Cover [Abstract] Document Type Document Quarterly Report Document Transition Report Entity Interactive Data Current Amendment Flag Document Fiscal Year Focus Document Fiscal Period Focus Document Period End Date Entity Registrant Name Entity Central Index Key Entity File Number Entity Tax Identification Number Entity Incorporation, State or Country Code Current Fiscal Year End Date Entity Current Reporting Status Entity Shell Company Entity Filer Category Entity Small Business Entity Emerging Growth Company Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code City Area Code Local Phone Number Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Entity Common Stock, Shares Outstanding The entire disclosure of contract balances and changes in contract balances. Contract with Customer, Asset and Liability [Text Block] CONTRACT LIABILITIES Rights Offering [Abstract] Rights Offering [Abstract] The gross proceeds from the additional capital contribution to the entity. Gross Proceeds from Issuance of Common Stock Gross proceeds Preferred stock that may be exchanged into common shares or other types of securities at the owner's option. Series C Convertible Preferred Stock [Member] Series C Convertible Preferred Stock [Member] Preferred stock that may be exchanged into common shares or other types of securities at the owner's option. Series D Convertible Preferred Stock [Member] Series D Convertible Preferred Stock [Member] Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of vendor deposits that are expected to be realized or consumed within one year or the normal operating cycle, if longer. Prepaid Expense and Vendor Deposits, Current Prepaid expenses and vendor deposits Exchange Agreement [Abstract] Exchange Agreement [Abstract] The percentage of increase in grants from its original award agreement, made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan). Share Based Compensation Arrangement by Share Based Payment Award Equity Instruments Other Than Options Grants, Increase in Vesting Percentage from its Original Awards In Period Percentage of increase in restricted stock grants from its original award agreement to officers The percentage of forfeited from current amended award agreement. Percentage of Forfeited from Current Amended Award Agreement Percentage of forfeited from current amended award agreement Persons with designation of chief executive officer, chief operating officer, chief financial officer and a director of the company. Officers and Director [Member] On August 18, 2020, the Company agreed to a term loan and security agreement (the "Loan") with Sabby Healthcare Master Fund, LTD and Sabby Volatility Warrant Master Fund, LTD ("collectively, the Lender"). Term Loan and Security Agreement [Member] Loan and Security Agreement [Member] Amount of cost associated with fulfillment of contract with customer. Contract with Customer, Liability, Fulfillment of Contract Fulfillment of contract Amount of increase (decrease) in revenue recognized for adjustment from contract modification which (increases) decreases obligation to transfer good or service to customer for which consideration from customer has been received or is due. Contract with Customer, Liability, Breakage Recognized Breakage recognized Amount of expense from redemption of gift cards and loyalty rewards in exchange for good or service transferred to customer when right is conditioned on something other than passage of time. Contract with Customer, Liability, Redeemed Redeemed Refers to product of the vapor loyalty rewards. Vapor Loyalty Rewards [Member] Vapor Loyalty Rewards [Member] Period of time between issuance and redemption of gift cards, rewards and points, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Breakage Policy Period Breakage policy period Refers to product of the grocery loyalty rewards. Grocery Loyalty Rewards [Member] Grocery Loyalty Rewards [Member] Amount of gift cards and loyalty rewards issued as obligation to transfer good or service to customer for which consideration has been received or is receivable. Contract with Customer, Liability, Issued Issued Period in which contract liabilities is expected to be recognized, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Contract Liabilities Expected Recognition Period Contract liabilities expected recognition period Refers to product of gift cards. Gift Cards [Member] Gift Cards [Member] Common Share Equivalents Excluded from Calculation of Dilutive Loss Per Share [Abstract] Common Share Equivalents Excluded from Calculation of Dilutive Loss Per Share [Abstract] Related to other debt. Other Debt [Member] Other Debt [Member] Number of shares of convertible preferred stock that were converted to other securities. Convertible Preferred Stock Converted to Other Securities, Shares Preferred stock exercised (in shares) Number of new stock issued in connection with Rights Offering during the period. Stock Issued During Period, Shares, New Issues, Rights Offering Issuance of common stock in connection with the Rights Offering, net of offering expenses (in shares) Equity impact of the value of new stock issued during the period in connection with Rights Offering. Stock Issued During Period, Value, New Issues, Rights Offering Issuance of common stock in connection with the Rights Offering, net of offering expenses Refers to a substance diffused or suspended in the air, especially one normally liquid or solid. Vapor [Member] Vapor [Member] A grocer is a bulk seller of food and products. Grocery [Member] Grocery [Member] Refers to the online stores and other e-commerce platforms that sell vape products. Online and E-commerce [Member] Online/eCommerce [Member] A person that is a dealer primarily engaged in the full-line wholesale distribution of vape products. Wholesale Vapor [Member] Wholesale Vapor [Member] A grocery retailer primarily sells food. Grocery stores also offer non-perishable foods that are packaged in bottles, boxes, and cans; some also have bakeries, butchers, delis, and fresh produce. Retail Grocery [Member] Retail Grocery [Member] Refers to food service and restaurants stores that sell vapor products. Food Service and Restaurant [Member] Food Service/Restaurant [Member] A retail vapor outlet specializing in the selling of electronic cigarette products. Retail Vapor [Member] Retail Vapor [Member] A person that is a dealer primarily engaged in the full-line wholesale distribution and resale of grocery and related nonfood items. Wholesale Grocery [Member] Wholesale Grocery [Member] Number of financial institutions in which company concentrated. Number of Financial Institution Number of financial institution An organic and natural health food grocery store company. Mother Earth's Storehouse [Member] Mother Earth's Storehouse [Member] The period of time the company has been in existence, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Age of Company Number of years the company has been operating Company Organization [Abstract] Amount of increase (decrease) in prepaid expenses, and vendor deposits. Increase (Decrease) in Prepaid Expense and Vendor Deposits Prepaid expenses and vendor deposits The increase (decrease) during the period lease liability. Increase (Decrease) in Lease liability Lease liability Issuance of common stock in connection with cashless exercise of Series A warrants. Issuance Of Common Stock In Connection With Cashless Exercise Of Series A Warrants Issuance of common stock Represents the name of an entity. Philip Morris [Member] Alleged claimed battery defects for an electronic cigarette device. Alleged Claimed Battery Defects For Electronic Cigarette Device [Member] Medical costs claimed by Plaintiffs. Medical Costs [Member] The number of users approached by the entity. Number of Users Approached Number of users approached The amount of investment under litigation. Loss Contingencies, Investment Amount Invested amount Person with designation of president and chief operating officer. President and Chief Operating Officer [Member] President and Chief Operating Officer [Member] The patent infringement litigation. Patent Infringement Litigation [Member] Patent Infringement Litigation [Member] Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach). Finite-Lived Intangible Asset, Expected Amortization, after Year Four Thereafter LIQUIDITY [Abstract] The entire disclosure of liquidity. Liquidity [Text Block] LIQUIDITY Tabular disclosure of the components of cash and cash equivalents and cash and cash equivalents restricted as to withdrawal or usage. Schedule of Cash and Cash Equivalents and Restricted Cash [Table Text Block] Cash, Cash Equivalents and Restricted Cash Promissory notes a signed document containing a written promise to pay a stated sum to a specified person or the bearer at a specified date or on demand. Promissory Notes [Member] Promissory Note [Member] The payment term of notes receivable in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Notes Receivable Payment Term Payment term The extension term of notes receivable in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Notes Receivable, Extension Term Extension term The cash inflow associated with the balloon payment. Proceeds from Balloon Payment Balloon payment Promissory notes a signed document containing a written promise to pay a stated sum to a specified person or the bearer at a specified date or on demand and Secured note is a type of loan that is backed by the borrower's assets. Promissory Notes and Secured Notes [Member] Tabular disclosure of notes receivable. Schedule Of Accounts Notes Receivable [Text Block] Summary of Notes The amount of operating lease right-of-use assets recognized as of the acquisition date. Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Operating Lease, Right-of-use Asset Right of use asset - operating lease Amount of operating lease liabilities assumed at the acquisition date. Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Operating Lease Liability Operating lease liability The cash outflow for purchases of inventory. Payments to Acquire Inventory Cash paid for inventory Displays [Member] Displays [Member] Includes equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities, additions or improvements to assets held under a lease arrangement, and long lived, depreciable assets that are used in the creation, maintenance and utilization of information systems. Vape Stores' Disposal [Member] Vape Stores' Disposal [Member] EX-101.PRE 10 hcmc-20220630_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE GRAPHIC 11 image1.jpg begin 644 image1.jpg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end XML 12 R1.htm IDEA: XBRL DOCUMENT v3.22.2
Document and Entity Information - shares
6 Months Ended
Jun. 30, 2022
Aug. 01, 2022
Cover [Abstract]    
Document Type 10-Q  
Amendment Flag false  
Document Quarterly Report true  
Document Period End Date Jun. 30, 2022  
Current Fiscal Year End Date --12-31  
Document Fiscal Year Focus 2022  
Document Fiscal Period Focus Q2  
Document Transition Report false  
Entity File Number 001-36469  
Entity Registrant Name HEALTHIER CHOICES MANAGEMENT CORP.  
Entity Central Index Key 0000844856  
Entity Incorporation, State or Country Code DE  
Entity Tax Identification Number 84-1070932  
Entity Address, Address Line One 3800 North 28Th Way  
Entity Address, City or Town Hollywood  
Entity Address, State or Province FL  
Entity Address, Postal Zip Code 33020  
City Area Code 305  
Local Phone Number 600-5004  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company false  
Entity Shell Company false  
Title of 12(b) Security Common Stock, par value $0.0001 per share  
Trading Symbol HCMC  
Security Exchange Name NONE  
Entity Common Stock, Shares Outstanding   339,741,632,384
XML 13 R2.htm IDEA: XBRL DOCUMENT v3.22.2
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
Jun. 30, 2022
Dec. 31, 2021
CURRENT ASSETS    
Cash and cash equivalents $ 19,323,420 $ 26,496,404
Accounts receivable, net 30,638 28,481
Notes receivable 220,793 247,915
Inventories 2,441,277 1,521,199
Prepaid expenses and vendor deposits 244,171 456,397
Investment 28,457 23,143
TOTAL CURRENT ASSETS 22,288,756 28,773,539
Property and equipment, net of accumulated depreciation 1,554,576 176,988
Intangible assets, net of accumulated amortization 2,248,107 947,593
Goodwill 2,657,000 916,000
Right of use asset - operating lease, net 4,964,381 3,543,930
Other assets 119,378 85,437
TOTAL ASSETS 33,832,198 34,443,487
CURRENT LIABILITIES    
Accounts payable and accrued expenses 2,171,095 1,642,848
Contract liabilities 56,105 23,178
Current portion of line of credit 453,232 418,036
Current portion of loan payment 2,134 2,604
Operating lease liability, current 563,300 437,328
TOTAL CURRENT LIABILITIES 3,245,866 2,523,994
Loan payable, net of current portion 0 815
Operating lease liability, net of current 4,016,105 2,685,021
TOTAL LIABILITIES 7,261,971 5,209,830
COMMITMENTS AND CONTINGENCIES (SEE NOTE 13)
STOCKHOLDERS' EQUITY    
Common Stock, $0.0001 par value per share, 750,000,000,000 shares authorized; 339,741,632,384 shares issued and outstanding as of June 30, 2022 and December 31, 2021, respectively 33,974,163 33,974,163
Additional paid-in capital 30,855,824 30,855,824
Accumulated deficit (39,059,760) (36,396,330)
TOTAL STOCKHOLDERS' EQUITY 26,570,227 29,233,657
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY 33,832,198 34,443,487
Series D Convertible Preferred Stock [Member]    
STOCKHOLDERS' EQUITY    
Convertible preferred stock $ 800,000 $ 800,000
XML 14 R3.htm IDEA: XBRL DOCUMENT v3.22.2
CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($)
$ in Millions
Jun. 30, 2022
Dec. 31, 2021
STOCKHOLDERS' EQUITY    
Common stock, par value (in dollars per share) $ 0.0001 $ 0.0001
Common stock, shares authorized (in shares) 750,000,000,000 750,000,000,000
Common stock, shares issued (in shares) 339,741,632,384 339,741,632,384
Common stock, shares outstanding (in shares) 339,741,632,384 339,741,632,384
Series D Convertible Preferred Stock [Member]    
STOCKHOLDERS' EQUITY    
Preferred stock, par value (in dollars per share) $ 1,000 $ 1,000
Preferred stock, shares authorized (in shares) 5,000 5,000
Preferred stock, shares issued (in shares) 800 800
Preferred stock, shares outstanding (in shares) 800 800
Preferred stock, aggregate liquidation preference $ 0.8 $ 0.8
XML 15 R4.htm IDEA: XBRL DOCUMENT v3.22.2
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
SALES        
SALES, NET $ 6,132,060 $ 3,385,892 $ 11,180,613 $ 6,851,645
GROSS PROFIT 2,330,873 1,463,656 4,303,387 2,954,366
OPERATING EXPENSES 3,699,273 2,149,087 7,026,693 4,171,970
LOSS FROM OPERATIONS (1,368,400) (685,431) (2,723,306) (1,217,604)
OTHER INCOME (EXPENSE)        
Gain (loss) on investment 1,800 (14,614) 5,314 11,511
Other income, net 6,175 0 23,049 0
Interest income (expense), net 14,910 (5,516) 31,513 (78,430)
Gain on debt extinguishment, net 0 885,226 0 767,930
Total other income (expense), net 22,885 865,096 59,876 701,011
NET (LOSS) INCOME $ (1,345,515) $ 179,665 $ (2,663,430) $ (516,593)
NET LOSS PER SHARE, BASIC (in dollars per share) $ 0.00 $ 0.00 $ 0.00 $ 0.00
NET LOSS PER SHARE, DILUTED (in dollars per share) $ 0.00 $ 0.00 $ 0.00 $ 0.00
WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING-BASIC (in shares) 339,741,632,384 311,961,992,554 339,741,632,384 277,914,474,082
WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING-DILUTED (in shares) 339,741,632,384 311,961,992,554 339,741,632,384 277,914,474,082
Vapor [Member]        
SALES        
SALES, NET $ 5,997 $ 590,980 $ 255,560 $ 1,204,916
Cost of sales 562 237,333 112,246 470,648
Grocery [Member]        
SALES        
SALES, NET 6,126,063 2,794,912 10,925,053 5,646,729
Cost of sales $ 3,800,625 $ 1,684,903 $ 6,764,980 $ 3,426,631
XML 16 R5.htm IDEA: XBRL DOCUMENT v3.22.2
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($)
Preferred Stock [Member]
Preferred Stock [Member]
Officers [Member]
Preferred Stock [Member]
Board Member [Member]
Preferred Stock [Member]
Convertible Preferred Stock [Member]
Preferred Stock [Member]
Series C Convertible Preferred Stock [Member]
Preferred Stock [Member]
Series D Convertible Preferred Stock [Member]
Common Stock [Member]
Common Stock [Member]
Officers [Member]
Common Stock [Member]
Board Member [Member]
Common Stock [Member]
Series C Convertible Preferred Stock [Member]
Common Stock [Member]
Series D Convertible Preferred Stock [Member]
Additional Paid-In Capital [Member]
Additional Paid-In Capital [Member]
Officers [Member]
Additional Paid-In Capital [Member]
Board Member [Member]
Additional Paid-In Capital [Member]
Series C Convertible Preferred Stock [Member]
Additional Paid-In Capital [Member]
Series D Convertible Preferred Stock [Member]
Accumulated Deficit [Member]
Accumulated Deficit [Member]
Officers [Member]
Accumulated Deficit [Member]
Board Member [Member]
Accumulated Deficit [Member]
Series C Convertible Preferred Stock [Member]
Accumulated Deficit [Member]
Series D Convertible Preferred Stock [Member]
Total
Officers [Member]
Board Member [Member]
Series C Convertible Preferred Stock [Member]
Series D Convertible Preferred Stock [Member]
Balance at Dec. 31, 2020       $ 16,277,116     $ 14,384,084         $ 3,955,039         $ (32,358,871)         $ 2,257,368        
Balance (in shares) at Dec. 31, 2020       16,277     143,840,848,017                                      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                                    
Series C Preferred stock exercised         $ (16,277,116)         $ 16,277,116         $ 0         $ 0         $ 0  
Preferred stock exercised (in shares)         (16,277)         162,771,153,001                                
Stock options exercised $ 0           $ 227,500         0         0         $ 227,500        
Stock options exercised (in shares) 0           2,275,000,000                             2,275,000,000        
Issuance of Convertible Preferred stock in connection with the Securities Purchase Agreement           $ 5,000,000         $ 0         $ 0         $ 0         $ 5,000,000
Issuance of Convertible Preferred stock in connection with the Securities Purchase Agreement (in shares)           5,000         0                              
Issuance of common stock $ 0           $ 118,283         1,289,273         0         $ 1,407,556        
Issuance of common stock (in shares) 0           1,182,831,056                                      
Issuance of common stock in connection with the Rights Offering, net of offering expenses $ 0           $ 2,704,680         20,873,978         0         23,578,658        
Issuance of common stock in connection with the Rights Offering, net of offering expenses (in shares) 0           27,046,800,310                                      
Issuance of awarded stock for officers and board member $ 0           $ 225,000         (225,000)         0         0        
Issuance of awarded stock for officers and board (in shares) 0           2,250,000,000                                      
Cancellation of awarded stock $ 0           $ (618,750)         618,750         0         0        
Cancellation of awarded stock (in shares) 0           (6,187,500,000)                                      
Stock-based compensation expense $ 0           $ 0         34,375         0         34,375        
Net income (loss) 0           0         0         (516,593)         (516,593)        
Balance at Jun. 30, 2021       $ 5,000,000     $ 33,317,913         26,546,415         (32,875,464)         31,988,864        
Balance (in shares) at Jun. 30, 2021       5,000     333,179,132,384                                      
Balance at Mar. 31, 2021       $ 5,000,000     $ 30,772,608         5,330,562         (33,055,129)         8,048,041        
Balance (in shares) at Mar. 31, 2021       5,000     307,726,082,074                                      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                                    
Stock options exercised $ 0           $ 150,000         0         0         150,000        
Stock options exercised (in shares) 0           1,500,000,000                                      
Issuance of common stock in connection with the Rights Offering, net of offering expenses $ 0           $ 2,704,680         20,873,978         0         23,578,658        
Issuance of common stock in connection with the Rights Offering, net of offering expenses (in shares) 0           27,046,800,310                                      
Cancellation of awarded stock   $ 0 $ 0         $ (302,500) $ (6,875)       $ 302,500 $ 6,875       $ 0 $ 0       $ 0 $ 0    
Cancellation of awarded stock (in shares)   0 0         (3,025,000,000) (68,750,000)                                  
Stock-based compensation expense $ 0           $ 0         32,500         0         32,500        
Net income (loss) 0           0         0         179,665         179,665        
Balance at Jun. 30, 2021       $ 5,000,000     $ 33,317,913         26,546,415         (32,875,464)         31,988,864        
Balance (in shares) at Jun. 30, 2021       5,000     333,179,132,384                                      
Balance at Dec. 31, 2021       $ 800,000     $ 33,974,163         30,855,824         (36,396,330)         $ 29,233,657        
Balance (in shares) at Dec. 31, 2021       800     339,741,632,384                                      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                                    
Stock options exercised (in shares)                                           0        
Net income (loss) 0           $ 0         0         (2,663,430)         $ (2,663,430)        
Balance at Jun. 30, 2022       $ 800,000     $ 33,974,163         30,855,824         (39,059,760)         26,570,227        
Balance (in shares) at Jun. 30, 2022       800     339,741,632,384                                      
Balance at Mar. 31, 2022       $ 800,000     $ 33,974,163         30,855,824         (37,714,245)         27,915,742        
Balance (in shares) at Mar. 31, 2022       800     339,741,632,384                                      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                                    
Net income (loss) $ 0           $ 0         0         (1,345,515)         (1,345,515)        
Balance at Jun. 30, 2022       $ 800,000     $ 33,974,163         $ 30,855,824         $ (39,059,760)         $ 26,570,227        
Balance (in shares) at Jun. 30, 2022       800     339,741,632,384                                      
XML 17 R6.htm IDEA: XBRL DOCUMENT v3.22.2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
OPERATING ACTIVITIES    
Net loss $ (2,663,430) $ (516,593)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 422,078 261,571
Gain on investment (5,314) (11,511)
Amortization of right-of-use asset 377,216 265,601
(Gain) on debt settlement 0 (767,930)
Accrued interest on loan 0 60,809
Write-down of obsolete and slow-moving inventory 73,640 0
Stock-based compensation expense 0 34,375
Changes in operating assets and liabilities:    
Accounts receivable (2,157) (30,062)
Inventories (189,138) (157,613)
Prepaid expenses and vendor deposits 212,226 17,573
Other assets (33,941) 3,662
Accounts payable and accrued expenses 528,247 (370,577)
Contract liabilities (249,700) (2,267)
Lease liability (340,611) (230,547)
NET CASH USED IN OPERATING ACTIVITIES (1,870,884) (1,443,509)
INVESTING ACTIVITIES    
Acquisition of Mother Earth's Storehouse (5,150,000) 0
Collection of note receivable 27,122 27,696
Purchases of property and equipment (213,133) (41,965)
NET CASH USED IN INVESTING ACTIVITIES (5,336,011) (14,269)
FINANCING ACTIVITIES    
Proceeds from line of credit 35,196 0
Principal payments on loan payable (1,285) (184,970)
Principal payment on the line of credit 0 (2,000,000)
Proceeds from Rights Offering 0 24,828,657
Proceeds from loan and security agreement 0 5,000,000
Proceeds from exercise of stock options 0 227,500
NET CASH PROVIDED BY FINANCING ACTIVITIES 33,911 27,871,187
NET (DECREASE) INCREASE IN CASH, CASH EQUIVALENT AND RESTRICTED CASH (7,172,984) 26,413,409
CASH, CASH EQUIVALENTS AND RESTRICTED CASH - BEGINNING OF PERIOD 26,496,404 2,925,475
CASH, CASH EQUIVALENTS AND RESTRICTED CASH - END OF PERIOD 19,323,420 29,338,884
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION    
Cash paid for interest 2,910 26,115
NON-CASH INVESTING AND FINANCING ACTIVITIES    
Issuance of common stock 0 1,290,260
Lease acquired $ 1,797,667 $ 0
XML 18 R7.htm IDEA: XBRL DOCUMENT v3.22.2
ORGANIZATION
6 Months Ended
Jun. 30, 2022
ORGANIZATION [Abstract]  
ORGANIZATION
Note 1. ORGANIZATION

Organization

Healthier Choices Management Corp. (the “Company”) is a holding company focused on providing consumers with healthier daily choices with respect to nutrition and other lifestyle alternatives. The Company operates Ada’s Natural Market, a natural and organic grocery store, through its wholly owned subsidiary Healthy Choice Markets, Inc. Ada’s Natural Market and Paradise Health and Nutrition offers fresh produce, bulk foods, vitamins and supplements, packaged groceries, meat and seafood, deli, baked goods, dairy products, frozen foods, health & beauty products and natural household items. The Company also sells vitamins and supplements on the Amazon.com marketplace through its wholly owned subsidiary Healthy U Wholesale, Inc. The Company also operates HCMC Intellectual Property Holdings, LLC, a wholly owned subsidiary formed to hold, market and expand on its current intellectual property assets. The Company markets the Q-Cup™ technology under the vape segment; this patented technology is based on a small, quartz cup called the Q-Cup™, which a customer partially fills with concentrate (approximately 50mg) purchased from a third party. The Q-Cup™ is then inserted into the Q-Cup™ Tank or Globe, which heats the cup from the outside without coming in direct contact with the solid concentrate. This Q-Cup™ technology provides significantly more efficiency and an “on the go” solution for consumers who prefer to vape concentrates either medicinally or recreationally. The Company acquired substantially all of the assets of Mother Earth’s Storehouse on February 9, 2022, which operates a two store organic and health food and vitamin chain in New York’s Hudson Valley, a business that has been operating for over 40 years. The Company expanded its operation into the Health & Wellness segment in November 2021. HCMC acquired substantially all of the assets of EIR Hydration, an IV therapy center located in Roslyn Heights, NY. The Company also has a licensing agreement for a Healthy Choice Wellness Center at the Casbah Spa and Salon in Fort Lauderdale, FL. The activities in the Wellness centers are currently reported under the Grocery segment due to its deminimus nature. From December 2021 through April 2022, the Company either closed its vape stores or sold substantially all of the assets of such stores. This will allow the Company to focus on developing wholesale business and sales through online platform.

COVID-19 Management Update

The global outbreak of COVID-19 was declared a pandemic by the World Health Organization and a national emergency by the U.S. government in March 2020 and has negatively impacted the U.S. and global economies, disrupted global supply chains and, mandated closures and stay-at-home orders and created significant disruptions of the global financial markets. The Company adjusted certain aspects of the operations to protect their employees and customers while still meeting customers’ needs. While to date the Company has not been required to close any of its grocery stores, the Company is currently operating under regular hours and we are expecting COVID-19 to have a long-term beneficial impact to the future financial results of the grocery segment. The Company continues to monitor the impact of the COVID-19 outbreak closely.  The extent to which the COVID-19 outbreak will impact our operations is manageable, and there is no imminent risk on business continuity and future operations.
XML 19 R8.htm IDEA: XBRL DOCUMENT v3.22.2
LIQUIDITY
6 Months Ended
Jun. 30, 2022
LIQUIDITY [Abstract]  
LIQUIDITY
Note 2. LIQUIDITY

The accompanying unaudited condensed consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (“GAAP”), which contemplate continuation of the Company as a going concern and realization of assets and satisfaction of liabilities in the normal course of business and do not include any adjustments that might result from the outcome of any uncertainties related to our going concern assessment. The carrying amounts of assets and liabilities presented in the financial statements do not necessarily purport to represent realizable or settlement values.

The Company currently and historically has reported net losses and cash outflows from operations. The Company anticipates that its current cash, cash equivalent and cash generated from operations will be sufficient to meet the projected operating expenses for the foreseeable future through at least the next twelve months from the issuance of these unaudited condensed consolidated financial statements.
XML 20 R9.htm IDEA: XBRL DOCUMENT v3.22.2
BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES
6 Months Ended
Jun. 30, 2022
BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES [Abstract]  
BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES
Note 3. BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with the instructions to Form 10-Q and Regulation S-X and do not include all the information and disclosures required by generally accepted accounting principles in the United States of America (“GAAP”). The Company has made estimates and judgments affecting the amounts reported in the Company’s condensed consolidated financial statements and the accompanying notes. The actual results experienced by the Company may differ materially from the Company’s estimates. The condensed consolidated financial information is unaudited but reflects all normal adjustments that are, in the opinion of management, necessary to provide a fair statement of results for the interim periods presented. These condensed consolidated financial statements should be read in conjunction with the consolidated financial statements in the Company’s Annual Report on Form 10-K for the year ended December 31, 2021, filed with the Securities and Exchange Commission (the “SEC”) on March 31, 2022. The condensed consolidated balance sheet as of December 31, 2021 was derived from the Company’s audited 2021 financial statements contained in the above referenced Form 10-K. Results of the six months ended June 30, 2022, are not necessarily indicative of the results to be expected for the full year ending December 31, 2022.

Significant Accounting Policies

There have been no material changes in the Company’s significant accounting policies to those previously disclosed in the 2021 Annual Report.
XML 21 R10.htm IDEA: XBRL DOCUMENT v3.22.2
CONCENTRATIONS
6 Months Ended
Jun. 30, 2022
CONCENTRATIONS [Abstract]  
CONCENTRATIONS
Note 4. CONCENTRATIONS

Cash and Cash Equivalents and Restricted Cash

The Company considers all highly liquid instruments with an original maturity of three months or less, when purchased, to be cash and cash equivalents. The majority of the Company’s cash and cash equivalents are concentrated in one large financial institution, which is in excess of Federal Deposit Insurance Corporation (FDIC) coverage.

A summary of the financial institutions that had a cash and cash equivalents in excess of FDIC limits of $250,000 on June 30, 2022 and December 31, 2021 is presented below:

June 30, 2022
 
December 31, 2021
 
Total cash, cash equivalents and restricted cash in excess of FDIC limits of $250,000
 
$
18,688,069
   
$
26,023,593
 

The Company continually monitors its positions with, and the credit quality of, the financial institutions with which it invests, as deposits are held in excess of federally insured limits. The Company’s cash equivalent at June 30, 2022 and December 31, 2021, respectively, was a money market account. The Company has not experienced any losses in such account.
XML 22 R11.htm IDEA: XBRL DOCUMENT v3.22.2
DISAGGREGATION OF REVENUES
6 Months Ended
Jun. 30, 2022
DISAGGREGATION OF REVENUES [Abstract]  
DISAGGREGATION OF REVENUES
Note 5. DISAGGREGATION OF REVENUES
 
The Company reports the following segments in accordance with management guidance: Vapor and Grocery. When the Company prepares its internal management reporting to evaluate business performance, we disaggregate revenue into the following categories that depict how the nature, amount, timing and uncertainty of revenue and cash flows are affected by economic factors.

 
Three Months Ended June 30,
   
Six Months Ended June 30,
 
   
2022
   
2021
   
2022
   
2021
 
Vapor
 
$
5,997
   
$
590,980
   
$
255,560
   
$
1,204,916
 
Grocery
   
6,126,063
     
2,794,912
     
10,925,053
     
5,646,729
 
Total revenue
 
$
6,132,060
   
$
3,385,892
   
$
11,180,613
   
$
6,851,645
 
                                 
Retail Vapor
 
$
5,997
   
$
590,980
   
$
255,560
   
$
1,204,875
 
Retail Grocery
   
5,478,523
     
2,430,530
     
9,756,535
     
4,963,330
 
Food service/restaurant
   
643,760
     
305,566
     
1,158,846
     
602,849
 
Online/eCommerce
   
3,780
     
56,259
     
9,672
     
69,975
 
Wholesale Grocery
   
-
     
2,557
     
-
     
10,575
 
Wholesale Vapor
   
-
     
-
     
-
     
41
 
Total revenue
 
$
6,132,060
   
$
3,385,892
   
$
11,180,613
   
$
6,851,645
 
 
XML 23 R12.htm IDEA: XBRL DOCUMENT v3.22.2
NOTES RECEIVABLE AND OTHER INCOME
6 Months Ended
Jun. 30, 2022
NOTES RECEIVABLE AND OTHER INCOME [Abstract]  
NOTES RECEIVABLE AND OTHER INCOME
Note 6. NOTES RECEIVABLE AND OTHER INCOME

On September 6, 2018, the Company entered into a secured, 36-month promissory note (the “Note”) with VPR Brands L.P. for $582,260. The Note bears an interest rate of 7.00%, which payments thereunder are $4,141 weekly. The Company records all proceeds related to the interest of the Note as interest income as proceeds are received.

On August 31, 2021, the Company amended and restated the Secured Promissory Note (the "Amended Note") with VPRB Brands L.P. for the outstanding balance in the note of $268,126. The Amended Note bears an interest rate of 7.00%, which payments thereunder are $1,500 weekly, with such payments commencing as of September 3, 2021. The Amended Note has a balloon payment of $216,071 for all remaining accrued interest and principal balance due in the final week of the 1-year extension of the Note.

A summary of the Note as of June 30, 2022 and December 31, 2021 is presented below:

Description
 
June 30, 2022
 
December 31, 2021
Promissory Note
 
$
220,793
 
$
247,915
 
XML 24 R13.htm IDEA: XBRL DOCUMENT v3.22.2
ACQUISITION OF MOTHER EARTH'S STOREHOUSE, INC.
6 Months Ended
Jun. 30, 2022
ACQUISITION OF MOTHER EARTH'S STOREHOUSE, INC. [Abstract]  
ACQUISITION OF MOTHER EARTH'S STOREHOUSE, INC.
Note 7. ACQUISITION OF MOTHER EARTH’S STOREHOUSE, INC.

On February 9, 2022, the Company through its wholly owned subsidiary, Healthy Choice Markets 3, LLC, entered into an Asset Purchase Agreement with Mother Earth’s Storehouse Inc. (“HCM3”) and its shareholders. Pursuant to the Purchase Agreement, HCM3 acquired certain assets and assumed certain liabilities related to Mother Earth’s grocery stores in Kingston and Saugerties, New York. The Company intends to continue to operate the grocery stores under their existing name. The cash purchase price under the Asset Purchase Agreement was $4,472,500, with an additional $677,500 paid for inventory at closing. In addition, the Company assumed a lease obligation for the Kingston, NY store and entered into an employment agreement with the store manager.

The purchase method of accounting in accordance with ASC 805, Business Combinations, was applied for the Mother Earth's Storehouse acquisition.  This requires the total cost of an acquisition to be allocated to the tangible and identifiable intangible assets acquired and liabilities assumed based on their respective fair values at the date of acquisition with the excess cost accounted for as goodwill. Goodwill arising from the acquisition is attributable to expected operational synergies from combining the operations of the acquired business with those of the Company. Goodwill is not expected to be deductible for income tax purposes in the tax jurisdiction of the acquired business.

The following table summarizes the approximate purchase price allocation based on estimated fair values of the net assets acquired at the acquisition date:

Purchase Consideration
     
Cash Consideration paid
 
$
5,150,000
       
Purchase price allocation
     
   Inventory
   
805,000
   Property and equipment
   
1,278,000
   Intangible assets
   
1,609,000
   Right of use asset - operating lease
   
1,797,667
   Other liabilities
   
(283,000)
   Operating lease liability
   
(1,797,667)
   Goodwill
   
1,741,000
Net assets acquired
 
 $
5,150,000
       
Finite-lived intangible assets
     
   Trade Names/Trademarks
 
 $
513,000
   Customer Relationships
   
683,000
   Non-Compete Agreement
   
413,000
Total intangible assets
 
 $
1,609,000
XML 25 R14.htm IDEA: XBRL DOCUMENT v3.22.2
PROPERTY & EQUIPMENT
6 Months Ended
Jun. 30, 2022
PROPERTY & EQUIPMENT [Abstract]  
PROPERTY & EQUIPMENT
Note 8. PROPERTY & EQUIPMENT

Property and equipment consist of the following:
   
June 30, 2022
   
December 31, 2021
Displays
 
$
305,558
   
$
305,558
Building
   
575,000
     
-
Furniture and fixtures
   
307,822
     
246,496
Leasehold improvements
   
727,469
     
136,504
Computer hardware & equipment
   
133,059
     
151,924
Other
   
311,294
     
315,788
     
2,360,202
     
1,156,270
Less: accumulated depreciation and amortization
   
(805,626)
     
(979,282)
Total property and equipment
 
$
1,554,576
   
$
176,988

The Company incurred approximately $63,656 and $27,951 of depreciation expense for the three months ended June 30, 2022 and 2021, and $113,592 and $66,525 of depreciation expense for the six months ended June 30, 2022 and 2021, respectively.

The Company closed all vape stores in Q2 2022, and disposed all vape stores' furniture and fixtures, computer and equipment, and leasehold improvements. Total gross carrying amount of $287,431 and total accumulated depreciation of $287,247 were reduced from the consolidated balance sheet.
XML 26 R15.htm IDEA: XBRL DOCUMENT v3.22.2
INTANGIBLE ASSETS
6 Months Ended
Jun. 30, 2022
INTANGIBLE ASSETS [Abstract]  
INTANGIBLE ASSETS
Note 9. INTANGIBLE ASSETS

Intangible assets, net are as follows:

June 30, 2022
 
Useful Lives (Years)
 
Gross
Carrying Amount
 
Accumulated
Amortization
 
Net
Carrying Amount
Trade names / Trademarks
   
8-10 years
 
$
1,436,000
 
$
(610,818)
 
$
825,182
Customer relationships
   
4-5 years
   
1,566,000
   
(836,128)
   
729,872
Patents
   
10 years
   
372,165
   
(140,841)
   
231,324
Non-compete
   
4-5 years
   
651,000
   
(197,813)
   
453,187
Website
   
4 years
   
10,000
   
(1,458)
   
8,542
Intangible assets, net
       
$
4,035,165
 
$
(1,787,058)
 
$
2,248,107

December 31, 2021
 
Useful Lives (Years)
 
Gross
Carrying Amount
 
Accumulated
Amortization
 
Net
Carrying Amount
Trade names / Trademarks
   
8-10 years
 
 $
923,000
   
(536,661)
 
 $
386,339
Customer relationships
   
4-5 years
   
883,000
   
(685,823)
   
197,177
Patents
   
10 years
   
372,165
   
(122,233)
   
249,932
Non-compete
   
4 years
   
238,000
   
(133,646)
   
104,354
Website
   
4 years
   
10,000
   
(209)
   
9,791
Intangible assets, net
       
$
2,426,165
 
$
(1,478,572)
 
$
947,593

Intangible assets are amortized on a straight-line basis over their estimated useful lives. Amortization expense was approximately  $165,100 and $97,023 for the three months ended June 30, 2022 and 2021, and $308,486 and $195,046 for the six months ended June 30, 2022 and 2021, respectively. Future annual estimated amortization expense is as follows:

Years ending December 31,
     
2022 (remaining six months)
 
$
319,814
 
2023
   
411,149
 
2024
   
411,149
 
2025
   
404,107
 
2026
   
309,214
 
Thereafter
   
392,674
 
Total
 
$
2,248,107
 
XML 27 R16.htm IDEA: XBRL DOCUMENT v3.22.2
CONTRACT LIABILITIES
6 Months Ended
Jun. 30, 2022
CONTRACT LIABILITIES [Abstract]  
CONTRACT LIABILITIES
Note 10. CONTRACT LIABILITIES

The Company’s contract liabilities consist of gift cards and loyalty rewards, for which the Company has a performance obligation to deliver products when customers redeem balances or terms expire through breakage. Our breakage policy is twenty four months for gift cards, twelve months for Grocery loyalty rewards, and six months for Vapor loyalty rewards. As such, all contract liabilities are expected to be recognized within a twenty four month period. Revenue is recognized when gift card and loyalty points are redeemed.

A summary of the net changes in contract liabilities activity at June 30, 2022 and December 31, 2021 is presented below:


 
June 30, 2022
   
December 31, 2021
 
Beginning balance as January 1,
 
$
23,178
   
$
21,262
 
Issued
   
558,859
     
39,469
 
Redeemed
   
(525,621
)
   
(37,463
)
Breakage recognized
   
(311
)
   
(90
)
Ending balance
 
$
56,105
   
$
23,178
 
 
XML 28 R17.htm IDEA: XBRL DOCUMENT v3.22.2
DEBT
6 Months Ended
Jun. 30, 2022
DEBT [Abstract]  
DEBT
Note 11. DEBT

The following table provides a breakdown of the Company's debt as of June 30, 2022 and December 31, 2021 is presented below:

_
   
June 30, 2022
   
December 31, 2021
Line of Credit
 
$
453,232
 
$
418,036
Other debt
   
2,134
   
3,419
Total debt
 
$
455,366
   
421,455
 
XML 29 R18.htm IDEA: XBRL DOCUMENT v3.22.2
STOCKHOLDERS' EQUITY
6 Months Ended
Jun. 30, 2022
STOCKHOLDERS' EQUITY [Abstract]  
STOCKHOLDERS' EQUITY
Note 12. STOCKHOLDERS’ EQUITY

Rights Offering

On June 18, 2021, the Company issued 27,046,800,310 shares of common stock in connection with the Rights Offering at a subscription price of $0.0010 per share, generating gross proceeds of $27.0 million. The Company incurred direct financing related costs of $2.7 million in connection with the offering resulting in net proceeds to the Company of $24.3 million.

Exchange Agreement

On March 29, 2021, the Company entered into exchange agreements with the holders of indebtedness pursuant to the $2.7 million Loan and Security Agreement (the "Credit Agreement"). Pursuant to the Credit Agreement with the holders of the Company’s indebtedness (the “Notes”) in an aggregate amount of $1.3 million exchanged the Notes for 1,172,964,218 shares at a conversion price of $0.0011 (the "Exchange"). The Notes were issued pursuant to the Credit Agreement dated as of August 18, 2020, among The Vape Store, Inc., the Company, Healthy Choice Markets, Inc., Sabby Healthcare Master Fund, Ltd., and Sabby Volatility Warrant Master Fund, Ltd.  In connection with the Exchange, the Credit Agreement and all related loan documents was terminated and the Holder’s on the assets of the Company and its subsidiaries was cancelled.  The Company recognized a loss on debt extinguishment of $0.1 million.

Restricted Stock

On January 14, 2021, the Compensation Committee of the Board of Directors of the Company approved an issuance of restricted stock to the Officers and a Director of the Company, in consideration for agreeing to a new vesting schedule for the existing awarded restricted stock. Each individual was granted a 10% increase from the original award agreement for a total of 2.3 billion shares of restricted common stock, which will vest quarterly and equal amounts until December 31, 2022, provided that the grantee remains an employee of the Company through the vesting date.

On March 30, 2021, the Company and the Officers and a Director of the Company agreed to forfeit a total of 3.09 billion of restricted shares of common stock that were due to vest on March 31, 2021.

On June 29, 2021, the Company and the Officers and a Director of the Company agreed to forfeit a total of 3.09 billion of restricted shares of common stock that were due to vest on June 30, 2021.

Stock Options

In the six months ended June 30, 2022, no stock options of the Company were exercised into common stock; in comparison to the six months ended June 30, 2021, where 2,275,000,000 stock options of the Company were exercised into common stock. During the three months ended June 30, 2022 and 2021, the Company recognized stock-based compensation of $0 and $32,500, respectively. Stock based compensation is included as part of selling, general and administrative expense in the accompanying consolidated statements of operations.

Income (Loss) Per Share

The following table summarizes the Company’s securities, in common share equivalents, which have been excluded from the calculation of dilutive loss per share as their effect would be anti-dilutive:

As of June 30,
 
 
2022
 
2021
 
Preferred stock
   
1,250,000,000
     
2,083,000,000
 
Stock options
   
67,587,000,000
     
67,587,000,000
 
Total
   
68,837,000,000
     
69,670,000,000
 
 
XML 30 R19.htm IDEA: XBRL DOCUMENT v3.22.2
COMMITMENTS AND CONTINGENCIES
6 Months Ended
Jun. 30, 2022
COMMITMENTS AND CONTINGENCIES [Abstract]  
COMMITMENTS AND CONTINGENCIES
Note 13. COMMITMENTS AND CONTINGENCIES

Legal Proceedings

Two lawsuits were filed against the Company and its subsidiaries in connection with alleged claimed battery defects for an electronic cigarette device. Plaintiffs claim these batteries were sold by a store of the Company’s subsidiary and have sued for an undetermined amount of damages (other than a total of $0.4 million of medical costs). The initial complaints were filed between January 2019 and April 2019. We responded to the complaints in 2019 and we exchanged additional support information with the plaintiff for one of the lawsuits in 2021. Given the lack of information presented by the plaintiffs to date, the Company is unable to predict the outcome of these matters and, at this time, cannot reasonably estimate the possible loss or range of loss with respect to these legal proceedings.

On November 30, 2020, the Company filed a patent infringement lawsuit against Philip Morris USA, Inc. and Philip Morris Products S.A. in the U.S. District Court for the Northern District of Georgia.  The lawsuit alleges infringement on HCMC-owned patent(s) by the Philip Morris product known and marketed as “IQOS®”.  Philip Morris claims that it is currently approaching 14 million users of its IQOS® product and has reportedly invested over $3 billion in their smokeless tobacco products. On December 3, 2021, the District Court for the Northern District of Georgia effectively dismissed HCMC’s patent infringement action against Philip Morris USA, Inc. and Philip Morris Products S.A.  On December 14, 2021, the Company filed a notice of appeal of the District Court for the Northern District of Georgia’s dismissal of the Company’s patent infringement action against Philip Morris USA, Inc. and Philip Morris Products S.A. The appeal brief was filed on February 28, 2022.

On December 31, 2021, the District Court for the Northern District of Georgia effectively dismissed HCMC’s patent infringement action against Philip Morris USA, Inc. and Philip Morris Products S.A. In connection with such dismissal, the defendants sought to recover attorney’s fees from the Plaintiff. On February 22, 2022, the District Court for the Northern District of Georgia granted the defendant’s an award of approximately $575,000 in attorneys’ fees to be paid by the Company. The Company has fully provisioned this amount as of December 31, 2021. HCMC appealed this ruling on June 22, 2022.

From time to time the Company is involved in legal proceedings arising in the ordinary course of our business. We believe that there is no other litigation pending that is likely to have, individually or in the aggregate, a material adverse effect on our financial condition or results of operations as of June 30, 2022. With respect to legal costs, we record such costs as incurred.

Employment Agreement

On February 26, 2021, the Company entered into an amended and restated employment agreement (the “Employment Agreement Amendment”) with the Company’s President and Chief Operating Officer, Christopher Santi. Pursuant to the Employment Agreement Amendment, Mr. Santi will continue to be employed as the Company’s President and Chief Operating Officer through January 30, 2024.  Mr. Santi will receive a base salary of $0.4 million for 2021 and his salary will increase 10% in each subsequent year.

On February 02, 2022, the Company entered into a Second Amended and Restated Employment Agreement (the “Employment Agreement Amendment”) with the Company’s Chief Financial Officer, John Ollet.  Pursuant to the Employment Agreement Amendment, Mr. Ollet will continue to be employed as the Company’s Chief Financial Officer through February 14, 2025.  Mr. Ollet will receive a base salary of $0.3 million for 2022 and his salary will increase 10% in each subsequent calendar year.
XML 31 R20.htm IDEA: XBRL DOCUMENT v3.22.2
CONCENTRATIONS (Tables)
6 Months Ended
Jun. 30, 2022
CONCENTRATIONS [Abstract]  
Cash, Cash Equivalents and Restricted Cash
A summary of the financial institutions that had a cash and cash equivalents in excess of FDIC limits of $250,000 on June 30, 2022 and December 31, 2021 is presented below:

June 30, 2022
 
December 31, 2021
 
Total cash, cash equivalents and restricted cash in excess of FDIC limits of $250,000
 
$
18,688,069
   
$
26,023,593
 
XML 32 R21.htm IDEA: XBRL DOCUMENT v3.22.2
DISAGGREGATION OF REVENUES (Tables)
6 Months Ended
Jun. 30, 2022
DISAGGREGATION OF REVENUES [Abstract]  
Disaggregated Revenue
The Company reports the following segments in accordance with management guidance: Vapor and Grocery. When the Company prepares its internal management reporting to evaluate business performance, we disaggregate revenue into the following categories that depict how the nature, amount, timing and uncertainty of revenue and cash flows are affected by economic factors.

 
Three Months Ended June 30,
   
Six Months Ended June 30,
 
   
2022
   
2021
   
2022
   
2021
 
Vapor
 
$
5,997
   
$
590,980
   
$
255,560
   
$
1,204,916
 
Grocery
   
6,126,063
     
2,794,912
     
10,925,053
     
5,646,729
 
Total revenue
 
$
6,132,060
   
$
3,385,892
   
$
11,180,613
   
$
6,851,645
 
                                 
Retail Vapor
 
$
5,997
   
$
590,980
   
$
255,560
   
$
1,204,875
 
Retail Grocery
   
5,478,523
     
2,430,530
     
9,756,535
     
4,963,330
 
Food service/restaurant
   
643,760
     
305,566
     
1,158,846
     
602,849
 
Online/eCommerce
   
3,780
     
56,259
     
9,672
     
69,975
 
Wholesale Grocery
   
-
     
2,557
     
-
     
10,575
 
Wholesale Vapor
   
-
     
-
     
-
     
41
 
Total revenue
 
$
6,132,060
   
$
3,385,892
   
$
11,180,613
   
$
6,851,645
 
XML 33 R22.htm IDEA: XBRL DOCUMENT v3.22.2
NOTES RECEIVABLE AND OTHER INCOME (Tables)
6 Months Ended
Jun. 30, 2022
NOTES RECEIVABLE AND OTHER INCOME [Abstract]  
Summary of Notes
A summary of the Note as of June 30, 2022 and December 31, 2021 is presented below:

Description
 
June 30, 2022
 
December 31, 2021
Promissory Note
 
$
220,793
 
$
247,915
XML 34 R23.htm IDEA: XBRL DOCUMENT v3.22.2
ACQUISITION OF MOTHER EARTH'S STOREHOUSE, INC. (Tables)
6 Months Ended
Jun. 30, 2022
ACQUISITION OF MOTHER EARTH'S STOREHOUSE, INC. [Abstract]  
Preliminary Purchase Price Allocation for Mother Earth's Storehouse, Inc.
The following table summarizes the approximate purchase price allocation based on estimated fair values of the net assets acquired at the acquisition date:

Purchase Consideration
     
Cash Consideration paid
 
$
5,150,000
       
Purchase price allocation
     
   Inventory
   
805,000
   Property and equipment
   
1,278,000
   Intangible assets
   
1,609,000
   Right of use asset - operating lease
   
1,797,667
   Other liabilities
   
(283,000)
   Operating lease liability
   
(1,797,667)
   Goodwill
   
1,741,000
Net assets acquired
 
 $
5,150,000
       
Finite-lived intangible assets
     
   Trade Names/Trademarks
 
 $
513,000
   Customer Relationships
   
683,000
   Non-Compete Agreement
   
413,000
Total intangible assets
 
 $
1,609,000
XML 35 R24.htm IDEA: XBRL DOCUMENT v3.22.2
PROPERTY & EQUIPMENT (Tables)
6 Months Ended
Jun. 30, 2022
PROPERTY & EQUIPMENT [Abstract]  
Property and Equipment
Property and equipment consist of the following:
   
June 30, 2022
   
December 31, 2021
Displays
 
$
305,558
   
$
305,558
Building
   
575,000
     
-
Furniture and fixtures
   
307,822
     
246,496
Leasehold improvements
   
727,469
     
136,504
Computer hardware & equipment
   
133,059
     
151,924
Other
   
311,294
     
315,788
     
2,360,202
     
1,156,270
Less: accumulated depreciation and amortization
   
(805,626)
     
(979,282)
Total property and equipment
 
$
1,554,576
   
$
176,988
XML 36 R25.htm IDEA: XBRL DOCUMENT v3.22.2
INTANGIBLE ASSETS (Tables)
6 Months Ended
Jun. 30, 2022
INTANGIBLE ASSETS [Abstract]  
Intangible Assets, Net
Intangible assets, net are as follows:

June 30, 2022
 
Useful Lives (Years)
 
Gross
Carrying Amount
 
Accumulated
Amortization
 
Net
Carrying Amount
Trade names / Trademarks
   
8-10 years
 
$
1,436,000
 
$
(610,818)
 
$
825,182
Customer relationships
   
4-5 years
   
1,566,000
   
(836,128)
   
729,872
Patents
   
10 years
   
372,165
   
(140,841)
   
231,324
Non-compete
   
4-5 years
   
651,000
   
(197,813)
   
453,187
Website
   
4 years
   
10,000
   
(1,458)
   
8,542
Intangible assets, net
       
$
4,035,165
 
$
(1,787,058)
 
$
2,248,107

December 31, 2021
 
Useful Lives (Years)
 
Gross
Carrying Amount
 
Accumulated
Amortization
 
Net
Carrying Amount
Trade names / Trademarks
   
8-10 years
 
 $
923,000
   
(536,661)
 
 $
386,339
Customer relationships
   
4-5 years
   
883,000
   
(685,823)
   
197,177
Patents
   
10 years
   
372,165
   
(122,233)
   
249,932
Non-compete
   
4 years
   
238,000
   
(133,646)
   
104,354
Website
   
4 years
   
10,000
   
(209)
   
9,791
Intangible assets, net
       
$
2,426,165
 
$
(1,478,572)
 
$
947,593
Future Annual Estimated Amortization Expense
Intangible assets are amortized on a straight-line basis over their estimated useful lives. Amortization expense was approximately  $165,100 and $97,023 for the three months ended June 30, 2022 and 2021, and $308,486 and $195,046 for the six months ended June 30, 2022 and 2021, respectively. Future annual estimated amortization expense is as follows:

Years ending December 31,
     
2022 (remaining six months)
 
$
319,814
 
2023
   
411,149
 
2024
   
411,149
 
2025
   
404,107
 
2026
   
309,214
 
Thereafter
   
392,674
 
Total
 
$
2,248,107
 
XML 37 R26.htm IDEA: XBRL DOCUMENT v3.22.2
CONTRACT LIABILITIES (Tables)
6 Months Ended
Jun. 30, 2022
CONTRACT LIABILITIES [Abstract]  
Summary of Net Changes in Contract Liabilities
A summary of the net changes in contract liabilities activity at June 30, 2022 and December 31, 2021 is presented below:


 
June 30, 2022
   
December 31, 2021
 
Beginning balance as January 1,
 
$
23,178
   
$
21,262
 
Issued
   
558,859
     
39,469
 
Redeemed
   
(525,621
)
   
(37,463
)
Breakage recognized
   
(311
)
   
(90
)
Ending balance
 
$
56,105
   
$
23,178
 
XML 38 R27.htm IDEA: XBRL DOCUMENT v3.22.2
DEBT (Tables)
6 Months Ended
Jun. 30, 2022
DEBT [Abstract]  
Breakdown of Debt
The following table provides a breakdown of the Company's debt as of June 30, 2022 and December 31, 2021 is presented below:

_
   
June 30, 2022
   
December 31, 2021
Line of Credit
 
$
453,232
 
$
418,036
Other debt
   
2,134
   
3,419
Total debt
 
$
455,366
   
421,455
XML 39 R28.htm IDEA: XBRL DOCUMENT v3.22.2
STOCKHOLDERS' EQUITY (Tables)
6 Months Ended
Jun. 30, 2022
STOCKHOLDERS' EQUITY [Abstract]  
Common Share Equivalent Excluded from Calculation of Dilutive Loss Per Share
The following table summarizes the Company’s securities, in common share equivalents, which have been excluded from the calculation of dilutive loss per share as their effect would be anti-dilutive:

As of June 30,
 
 
2022
 
2021
 
Preferred stock
   
1,250,000,000
     
2,083,000,000
 
Stock options
   
67,587,000,000
     
67,587,000,000
 
Total
   
68,837,000,000
     
69,670,000,000
 
XML 40 R29.htm IDEA: XBRL DOCUMENT v3.22.2
ORGANIZATION (Details) - Mother Earth's Storehouse [Member] - Store
6 Months Ended
Jun. 30, 2022
Feb. 09, 2022
Company Organization [Abstract]    
Number of stores   2
Number of years the company has been operating 40 years  
XML 41 R30.htm IDEA: XBRL DOCUMENT v3.22.2
CONCENTRATIONS (Details)
6 Months Ended
Jun. 30, 2022
USD ($)
FinancialInstitution
Dec. 31, 2021
USD ($)
Cash, Cash Equivalents and Restricted Cash [Abstract]    
Number of financial institution | FinancialInstitution 1  
FDIC insured amount $ 250,000  
Total Cash and cash equivalents in excess of FDIC limits of $250,000 $ 18,688,069 $ 26,023,593
XML 42 R31.htm IDEA: XBRL DOCUMENT v3.22.2
DISAGGREGATION OF REVENUES (Details) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Disaggregation of Revenue [Abstract]        
Revenue $ 6,132,060 $ 3,385,892 $ 11,180,613 $ 6,851,645
Vapor [Member]        
Disaggregation of Revenue [Abstract]        
Revenue 5,997 590,980 255,560 1,204,916
Grocery [Member]        
Disaggregation of Revenue [Abstract]        
Revenue 6,126,063 2,794,912 10,925,053 5,646,729
Retail Vapor [Member]        
Disaggregation of Revenue [Abstract]        
Revenue 5,997 590,980 255,560 1,204,875
Retail Grocery [Member]        
Disaggregation of Revenue [Abstract]        
Revenue 5,478,523 2,430,530 9,756,535 4,963,330
Food Service/Restaurant [Member]        
Disaggregation of Revenue [Abstract]        
Revenue 643,760 305,566 1,158,846 602,849
Online/eCommerce [Member]        
Disaggregation of Revenue [Abstract]        
Revenue 3,780 56,259 9,672 69,975
Wholesale Grocery [Member]        
Disaggregation of Revenue [Abstract]        
Revenue 0 2,557 0 10,575
Wholesale Vapor [Member]        
Disaggregation of Revenue [Abstract]        
Revenue $ 0 $ 0 $ 0 $ 41
XML 43 R32.htm IDEA: XBRL DOCUMENT v3.22.2
NOTES RECEIVABLE AND OTHER INCOME (Details) - USD ($)
6 Months Ended
Aug. 31, 2021
Sep. 06, 2018
Jun. 30, 2022
Jun. 30, 2021
Dec. 31, 2021
Receivables with Imputed Interest [Abstract]          
Proceeds     $ 27,122 $ 27,696  
Promissory Note [Member]          
Receivables with Imputed Interest [Abstract]          
Payment term     36 months    
Loan amount $ 268,126 $ 582,260      
Interest rate 7.00% 7.00%      
Proceeds $ 1,500 $ 4,141      
Balloon payment $ 216,071        
Extension term     1 year    
Remaining balance     $ 220,793   $ 247,915
XML 44 R33.htm IDEA: XBRL DOCUMENT v3.22.2
ACQUISITION OF MOTHER EARTH'S STOREHOUSE, INC. (Details) - USD ($)
6 Months Ended
Feb. 09, 2022
Feb. 08, 2022
Jun. 30, 2022
Jun. 30, 2021
Dec. 31, 2021
Acquisition of Mother Earth's Storehouse, Inc. [Abstract]          
Cash purchase price     $ 5,150,000 $ 0  
Purchase Price Allocation [Abstract]          
Goodwill     $ 2,657,000   $ 916,000
Mother Earth's Storehouse [Member]          
Acquisition of Mother Earth's Storehouse, Inc. [Abstract]          
Cash purchase price $ 4,472,500        
Cash paid for inventory $ 677,500        
Cash Consideration paid   $ 5,150,000      
Purchase Price Allocation [Abstract]          
Inventory   805,000      
Property and equipment   1,278,000      
Intangible assets   1,609,000      
Right of use asset - operating lease   1,797,667      
Other liabilities   (283,000)      
Operating lease liability   (1,797,667)      
Goodwill   1,741,000      
Net assets acquired   5,150,000      
Finite-Lived Intangible Assets [Abstract]          
Intangible assets   1,609,000      
Mother Earth's Storehouse [Member] | Trade Names/Trademarks [Member]          
Purchase Price Allocation [Abstract]          
Intangible assets   513,000      
Finite-Lived Intangible Assets [Abstract]          
Intangible assets   513,000      
Mother Earth's Storehouse [Member] | Customer Relationships [Member]          
Purchase Price Allocation [Abstract]          
Intangible assets   683,000      
Finite-Lived Intangible Assets [Abstract]          
Intangible assets   683,000      
Mother Earth's Storehouse [Member] | Non-Compete Agreement [Member]          
Purchase Price Allocation [Abstract]          
Intangible assets   413,000      
Finite-Lived Intangible Assets [Abstract]          
Intangible assets   $ 413,000      
XML 45 R34.htm IDEA: XBRL DOCUMENT v3.22.2
PROPERTY & EQUIPMENT (Details) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Dec. 31, 2021
Property and equipment [Abstract]          
Property plant and equipment, gross $ 2,360,202   $ 2,360,202   $ 1,156,270
Less: accumulated depreciation and amortization (805,626)   (805,626)   (979,282)
Total property and equipment 1,554,576   1,554,576   176,988
Depreciation expense 63,656 $ 27,951 113,592 $ 66,525  
Displays [Member]          
Property and equipment [Abstract]          
Property plant and equipment, gross 305,558   305,558   305,558
Building [Member]          
Property and equipment [Abstract]          
Property plant and equipment, gross 575,000   575,000   0
Furniture and Fixtures [Member]          
Property and equipment [Abstract]          
Property plant and equipment, gross 307,822   307,822   246,496
Leasehold Improvements [Member]          
Property and equipment [Abstract]          
Property plant and equipment, gross 727,469   727,469   136,504
Computer Hardware & Equipment [Member]          
Property and equipment [Abstract]          
Property plant and equipment, gross 133,059   133,059   151,924
Other [Member]          
Property and equipment [Abstract]          
Property plant and equipment, gross 311,294   311,294   $ 315,788
Vape Stores' Disposal [Member]          
Property and equipment [Abstract]          
Property plant and equipment, gross 287,431   287,431    
Less: accumulated depreciation and amortization $ (287,247)   $ (287,247)    
XML 46 R35.htm IDEA: XBRL DOCUMENT v3.22.2
INTANGIBLE ASSETS, Intangible Assets, Net (Details) - USD ($)
6 Months Ended 12 Months Ended
Jun. 30, 2022
Dec. 31, 2021
Intangible Assets, Net [Abstract]    
Gross carrying amount $ 4,035,165 $ 2,426,165
Accumulated amortization (1,787,058) (1,478,572)
Net carrying amount 2,248,107 947,593
Trade Names / Trademarks [Member]    
Intangible Assets, Net [Abstract]    
Gross carrying amount 1,436,000 923,000
Accumulated amortization (610,818) (536,661)
Net carrying amount $ 825,182 $ 386,339
Trade Names / Trademarks [Member] | Minimum [Member]    
Intangible Assets, Net [Abstract]    
Useful lives 8 years 8 years
Trade Names / Trademarks [Member] | Maximum [Member]    
Intangible Assets, Net [Abstract]    
Useful lives 10 years 10 years
Customer Relationships [Member]    
Intangible Assets, Net [Abstract]    
Gross carrying amount $ 1,566,000 $ 883,000
Accumulated amortization (836,128) (685,823)
Net carrying amount $ 729,872 $ 197,177
Customer Relationships [Member] | Minimum [Member]    
Intangible Assets, Net [Abstract]    
Useful lives 4 years 4 years
Customer Relationships [Member] | Maximum [Member]    
Intangible Assets, Net [Abstract]    
Useful lives 5 years 5 years
Patents [Member]    
Intangible Assets, Net [Abstract]    
Useful lives 10 years 10 years
Gross carrying amount $ 372,165 $ 372,165
Accumulated amortization (140,841) (122,233)
Net carrying amount 231,324 $ 249,932
Non-Compete [Member]    
Intangible Assets, Net [Abstract]    
Useful lives   4 years
Gross carrying amount 651,000 $ 238,000
Accumulated amortization (197,813) (133,646)
Net carrying amount $ 453,187 $ 104,354
Non-Compete [Member] | Minimum [Member]    
Intangible Assets, Net [Abstract]    
Useful lives 4 years  
Non-Compete [Member] | Maximum [Member]    
Intangible Assets, Net [Abstract]    
Useful lives 5 years  
Website [Member]    
Intangible Assets, Net [Abstract]    
Useful lives 4 years 4 years
Gross carrying amount $ 10,000 $ 10,000
Accumulated amortization (1,458) (209)
Net carrying amount $ 8,542 $ 9,791
XML 47 R36.htm IDEA: XBRL DOCUMENT v3.22.2
INTANGIBLE ASSETS, Future Annual Estimated Amortization Expense (Details) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Dec. 31, 2021
INTANGIBLE ASSETS [Abstract]          
Amortization expense $ 165,100 $ 97,023 $ 308,486 $ 195,046  
Future Annual Estimated Amortization Expense [Abstract]          
2022 (remaining six months) 319,814   319,814    
2023 411,149   411,149    
2024 411,149   411,149    
2025 404,107   404,107    
2026 309,214   309,214    
Thereafter 392,674   392,674    
Net carrying amount $ 2,248,107   $ 2,248,107   $ 947,593
XML 48 R37.htm IDEA: XBRL DOCUMENT v3.22.2
CONTRACT LIABILITIES (Details) - USD ($)
6 Months Ended 12 Months Ended
Jun. 30, 2022
Dec. 31, 2021
Deferred Revenue [Abstract]    
Contract liabilities expected recognition period 24 months  
Changes in Contract Liabilities Activity [Roll Forward]    
Beginning balance $ 23,178 $ 21,262
Issued 558,859 39,469
Redeemed (525,621) (37,463)
Breakage recognized (311) (90)
Ending balance $ 56,105 $ 23,178
Gift Cards [Member]    
Deferred Revenue [Abstract]    
Breakage policy period 24 months  
Grocery Loyalty Rewards [Member]    
Deferred Revenue [Abstract]    
Breakage policy period 12 months  
Vapor Loyalty Rewards [Member]    
Deferred Revenue [Abstract]    
Breakage policy period 6 months  
XML 49 R38.htm IDEA: XBRL DOCUMENT v3.22.2
DEBT (Details) - USD ($)
Jun. 30, 2022
Dec. 31, 2021
Debt [Abstract]    
Debt $ 455,366 $ 421,455
Other Debt [Member]    
Debt [Abstract]    
Debt 2,134 3,419
Line of Credit [Member]    
Debt [Abstract]    
Debt $ 453,232 $ 418,036
XML 50 R39.htm IDEA: XBRL DOCUMENT v3.22.2
STOCKHOLDERS' EQUITY, Rights Offering (Details) - USD ($)
6 Months Ended
Jun. 18, 2021
Mar. 29, 2021
Jun. 30, 2022
Jun. 30, 2021
Rights Offering [Abstract]        
Common stock shares issued from offering (in shares) 27,046,800,310 1,172,964,218    
Subscription price (in dollars per share) $ 0.0010 $ 0.0011    
Gross proceeds $ 27,000,000.0      
Direct financing costs 2,700,000      
Net proceeds $ 24,300,000   $ 0 $ 24,828,657
XML 51 R40.htm IDEA: XBRL DOCUMENT v3.22.2
STOCKHOLDERS' EQUITY, Exchange Agreement and Restricted Stock (Details) - USD ($)
3 Months Ended 6 Months Ended
Jun. 29, 2021
Jun. 18, 2021
Mar. 30, 2021
Mar. 29, 2021
Jan. 14, 2021
Jun. 30, 2022
Jun. 30, 2021
Mar. 31, 2021
Jun. 30, 2022
Jun. 30, 2021
Exchange Agreement [Abstract]                    
Indebtedness aggregate amount       $ 1,300,000           $ 1,407,556
Exchange of notes for shares of common stock (in shares)   27,046,800,310   1,172,964,218            
Common stock at a price per share (in dollars per share)   $ 0.0010   $ 0.0011            
Loss on extinguishment of debt           $ 0 $ 885,226 $ (100,000) $ 0 $ 767,930
Restricted Stock [Member]                    
Restricted Stock [Abstract]                    
Granted (in shares) 3,090,000,000.00   3,090,000,000.00              
Restricted Stock [Member] | Officers and Director [Member]                    
Restricted Stock [Abstract]                    
Percentage of increase in restricted stock grants from its original award agreement to officers         10.00%          
Granted (in shares)         2,300,000,000          
Loan and Security Agreement [Member]                    
Exchange Agreement [Abstract]                    
Face amount       $ 2,700,000            
XML 52 R41.htm IDEA: XBRL DOCUMENT v3.22.2
STOCKHOLDERS' EQUITY, Stock Options (Details) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Compensation Expense Recognized [Abstract]        
Stock options exercised (in shares)     0 2,275,000,000
Stock-based compensation $ 0 $ 32,500 $ 0 $ 34,375
XML 53 R42.htm IDEA: XBRL DOCUMENT v3.22.2
STOCKHOLDERS' EQUITY, Income (Loss) Per Share (Details) - shares
6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Common Share Equivalents Excluded from Calculation of Dilutive Loss Per Share [Abstract]    
Antidilutive securities excluded from computation of diluted loss per share (in shares) 68,837,000,000 69,670,000,000
Preferred Stock [Member]    
Common Share Equivalents Excluded from Calculation of Dilutive Loss Per Share [Abstract]    
Antidilutive securities excluded from computation of diluted loss per share (in shares) 1,250,000,000 2,083,000,000
Stock Options [Member]    
Common Share Equivalents Excluded from Calculation of Dilutive Loss Per Share [Abstract]    
Antidilutive securities excluded from computation of diluted loss per share (in shares) 67,587,000,000 67,587,000,000
XML 54 R43.htm IDEA: XBRL DOCUMENT v3.22.2
COMMITMENTS AND CONTINGENCIES (Details)
User in Millions
6 Months Ended
Feb. 22, 2022
USD ($)
Feb. 02, 2022
USD ($)
Feb. 26, 2021
USD ($)
Jun. 30, 2022
USD ($)
Lawsuit
Nov. 30, 2020
USD ($)
User
President and Chief Operating Officer [Member]          
Legal Proceedings [Abstract]          
Base salary     $ 400,000    
Increment percentage on salary each subsequent year     10.00%    
Chief Financial Officer [Member]          
Legal Proceedings [Abstract]          
Base salary   $ 300,000      
Increment percentage on salary each subsequent year   10.00%      
Alleged Claimed Battery Defects For Electronic Cigarette Device [Member]          
Legal Proceedings [Abstract]          
Number of lawsuits | Lawsuit       2  
Philip Morris [Member]          
Legal Proceedings [Abstract]          
Number of users approached | User         14
Invested amount         $ 3,000,000,000
Philip Morris [Member] | Patent Infringement Litigation [Member]          
Legal Proceedings [Abstract]          
Attorney fees paid $ 575,000        
Medical Costs [Member] | Alleged Claimed Battery Defects For Electronic Cigarette Device [Member]          
Legal Proceedings [Abstract]          
Damages sought       $ 400,000  
XML 55 form10q_htm.xml IDEA: XBRL DOCUMENT 0000844856 2022-01-01 2022-06-30 0000844856 2022-08-01 0000844856 2021-12-31 0000844856 2022-06-30 0000844856 hcmc:SeriesDConvertiblePreferredStockMember 2022-06-30 0000844856 hcmc:SeriesDConvertiblePreferredStockMember 2021-12-31 0000844856 hcmc:GroceryMember 2022-01-01 2022-06-30 0000844856 hcmc:GroceryMember 2022-04-01 2022-06-30 0000844856 hcmc:VaporMember 2021-04-01 2021-06-30 0000844856 2021-04-01 2021-06-30 0000844856 hcmc:GroceryMember 2021-01-01 2021-06-30 0000844856 2021-01-01 2021-06-30 0000844856 hcmc:VaporMember 2021-01-01 2021-06-30 0000844856 hcmc:VaporMember 2022-01-01 2022-06-30 0000844856 2022-04-01 2022-06-30 0000844856 hcmc:VaporMember 2022-04-01 2022-06-30 0000844856 hcmc:GroceryMember 2021-04-01 2021-06-30 0000844856 us-gaap:RetainedEarningsMember 2021-12-31 0000844856 us-gaap:RetainedEarningsMember 2020-12-31 0000844856 us-gaap:AdditionalPaidInCapitalMember 2021-03-31 0000844856 2021-03-31 0000844856 us-gaap:CommonStockMember 2021-12-31 0000844856 2022-03-31 0000844856 us-gaap:RetainedEarningsMember 2022-03-31 0000844856 us-gaap:ConvertiblePreferredStockMember us-gaap:PreferredStockMember 2022-03-31 0000844856 us-gaap:ConvertiblePreferredStockMember us-gaap:PreferredStockMember 2021-03-31 0000844856 us-gaap:RetainedEarningsMember 2021-03-31 0000844856 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0000844856 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0000844856 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0000844856 us-gaap:CommonStockMember 2022-03-31 0000844856 us-gaap:ConvertiblePreferredStockMember us-gaap:PreferredStockMember 2021-12-31 0000844856 us-gaap:CommonStockMember 2020-12-31 0000844856 us-gaap:CommonStockMember 2021-03-31 0000844856 us-gaap:ConvertiblePreferredStockMember us-gaap:PreferredStockMember 2020-12-31 0000844856 2020-12-31 0000844856 hcmc:SeriesCConvertiblePreferredStockMember us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-06-30 0000844856 hcmc:SeriesCConvertiblePreferredStockMember us-gaap:PreferredStockMember 2021-01-01 2021-06-30 0000844856 hcmc:SeriesCConvertiblePreferredStockMember us-gaap:CommonStockMember 2021-01-01 2021-06-30 0000844856 hcmc:SeriesCConvertiblePreferredStockMember us-gaap:RetainedEarningsMember 2021-01-01 2021-06-30 0000844856 hcmc:SeriesCConvertiblePreferredStockMember 2021-01-01 2021-06-30 0000844856 us-gaap:RetainedEarningsMember 2021-04-01 2021-06-30 0000844856 us-gaap:AdditionalPaidInCapitalMember 2021-04-01 2021-06-30 0000844856 us-gaap:PreferredStockMember 2021-01-01 2021-06-30 0000844856 us-gaap:PreferredStockMember 2021-04-01 2021-06-30 0000844856 us-gaap:CommonStockMember 2021-01-01 2021-06-30 0000844856 us-gaap:RetainedEarningsMember 2021-01-01 2021-06-30 0000844856 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-06-30 0000844856 us-gaap:CommonStockMember 2021-04-01 2021-06-30 0000844856 hcmc:SeriesDConvertiblePreferredStockMember us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-06-30 0000844856 hcmc:SeriesDConvertiblePreferredStockMember 2021-01-01 2021-06-30 0000844856 hcmc:SeriesDConvertiblePreferredStockMember us-gaap:CommonStockMember 2021-01-01 2021-06-30 0000844856 hcmc:SeriesDConvertiblePreferredStockMember us-gaap:RetainedEarningsMember 2021-01-01 2021-06-30 0000844856 hcmc:SeriesDConvertiblePreferredStockMember us-gaap:PreferredStockMember 2021-01-01 2021-06-30 0000844856 srt:OfficerMember 2021-04-01 2021-06-30 0000844856 srt:BoardOfDirectorsChairmanMember us-gaap:AdditionalPaidInCapitalMember 2021-04-01 2021-06-30 0000844856 srt:BoardOfDirectorsChairmanMember us-gaap:PreferredStockMember 2021-04-01 2021-06-30 0000844856 srt:BoardOfDirectorsChairmanMember 2021-04-01 2021-06-30 0000844856 srt:BoardOfDirectorsChairmanMember us-gaap:CommonStockMember 2021-04-01 2021-06-30 0000844856 srt:OfficerMember us-gaap:AdditionalPaidInCapitalMember 2021-04-01 2021-06-30 0000844856 srt:OfficerMember us-gaap:PreferredStockMember 2021-04-01 2021-06-30 0000844856 srt:OfficerMember us-gaap:CommonStockMember 2021-04-01 2021-06-30 0000844856 srt:OfficerMember us-gaap:RetainedEarningsMember 2021-04-01 2021-06-30 0000844856 srt:BoardOfDirectorsChairmanMember us-gaap:RetainedEarningsMember 2021-04-01 2021-06-30 0000844856 us-gaap:CommonStockMember 2022-01-01 2022-06-30 0000844856 us-gaap:RetainedEarningsMember 2022-04-01 2022-06-30 0000844856 us-gaap:PreferredStockMember 2022-01-01 2022-06-30 0000844856 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-06-30 0000844856 us-gaap:PreferredStockMember 2022-04-01 2022-06-30 0000844856 us-gaap:CommonStockMember 2022-04-01 2022-06-30 0000844856 us-gaap:AdditionalPaidInCapitalMember 2022-04-01 2022-06-30 0000844856 us-gaap:RetainedEarningsMember 2022-01-01 2022-06-30 0000844856 us-gaap:RetainedEarningsMember 2022-06-30 0000844856 us-gaap:ConvertiblePreferredStockMember us-gaap:PreferredStockMember 2022-06-30 0000844856 us-gaap:CommonStockMember 2021-06-30 0000844856 us-gaap:CommonStockMember 2022-06-30 0000844856 us-gaap:AdditionalPaidInCapitalMember 2022-06-30 0000844856 2021-06-30 0000844856 us-gaap:RetainedEarningsMember 2021-06-30 0000844856 us-gaap:ConvertiblePreferredStockMember us-gaap:PreferredStockMember 2021-06-30 0000844856 us-gaap:AdditionalPaidInCapitalMember 2021-06-30 0000844856 hcmc:MotherEarthsStorehouseMember 2022-02-09 0000844856 hcmc:MotherEarthsStorehouseMember 2022-01-01 2022-06-30 0000844856 hcmc:RetailGroceryMember 2021-04-01 2021-06-30 0000844856 hcmc:RetailVaporMember 2022-04-01 2022-06-30 0000844856 hcmc:FoodServiceAndRestaurantMember 2022-04-01 2022-06-30 0000844856 hcmc:WholesaleVaporMember 2022-01-01 2022-06-30 0000844856 hcmc:OnlineAndECommerceMember 2021-04-01 2021-06-30 0000844856 hcmc:WholesaleGroceryMember 2021-01-01 2021-06-30 0000844856 hcmc:FoodServiceAndRestaurantMember 2021-04-01 2021-06-30 0000844856 hcmc:RetailGroceryMember 2022-04-01 2022-06-30 0000844856 hcmc:WholesaleGroceryMember 2022-01-01 2022-06-30 0000844856 hcmc:WholesaleGroceryMember 2022-04-01 2022-06-30 0000844856 hcmc:RetailVaporMember 2022-01-01 2022-06-30 0000844856 hcmc:WholesaleVaporMember 2022-04-01 2022-06-30 0000844856 hcmc:FoodServiceAndRestaurantMember 2022-01-01 2022-06-30 0000844856 hcmc:OnlineAndECommerceMember 2022-04-01 2022-06-30 0000844856 hcmc:WholesaleVaporMember 2021-04-01 2021-06-30 0000844856 hcmc:RetailGroceryMember 2022-01-01 2022-06-30 0000844856 hcmc:WholesaleGroceryMember 2021-04-01 2021-06-30 0000844856 hcmc:OnlineAndECommerceMember 2022-01-01 2022-06-30 0000844856 hcmc:FoodServiceAndRestaurantMember 2021-01-01 2021-06-30 0000844856 hcmc:OnlineAndECommerceMember 2021-01-01 2021-06-30 0000844856 hcmc:RetailVaporMember 2021-01-01 2021-06-30 0000844856 hcmc:RetailVaporMember 2021-04-01 2021-06-30 0000844856 hcmc:RetailGroceryMember 2021-01-01 2021-06-30 0000844856 hcmc:WholesaleVaporMember 2021-01-01 2021-06-30 0000844856 hcmc:PromissoryNotesMember 2022-01-01 2022-06-30 0000844856 hcmc:PromissoryNotesMember 2018-09-06 0000844856 hcmc:PromissoryNotesMember 2021-08-31 0000844856 hcmc:PromissoryNotesMember 2018-09-06 2018-09-06 0000844856 hcmc:PromissoryNotesMember 2021-08-31 2021-08-31 0000844856 hcmc:PromissoryNotesMember 2021-12-31 0000844856 hcmc:PromissoryNotesMember 2022-06-30 0000844856 hcmc:MotherEarthsStorehouseMember 2022-02-09 2022-02-09 0000844856 hcmc:MotherEarthsStorehouseMember 2022-02-08 2022-02-08 0000844856 hcmc:MotherEarthsStorehouseMember 2022-02-08 0000844856 hcmc:MotherEarthsStorehouseMember us-gaap:TrademarksAndTradeNamesMember 2022-02-08 0000844856 hcmc:MotherEarthsStorehouseMember us-gaap:NoncompeteAgreementsMember 2022-02-08 0000844856 hcmc:MotherEarthsStorehouseMember us-gaap:CustomerRelationshipsMember 2022-02-08 0000844856 us-gaap:ComputerEquipmentMember 2022-06-30 0000844856 us-gaap:LeaseholdImprovementsMember 2021-12-31 0000844856 us-gaap:ComputerEquipmentMember 2021-12-31 0000844856 us-gaap:BuildingMember 2021-12-31 0000844856 hcmc:DisplaysMember 2022-06-30 0000844856 hcmc:DisplaysMember 2021-12-31 0000844856 us-gaap:OtherMachineryAndEquipmentMember 2022-06-30 0000844856 us-gaap:BuildingMember 2022-06-30 0000844856 us-gaap:FurnitureAndFixturesMember 2021-12-31 0000844856 us-gaap:LeaseholdImprovementsMember 2022-06-30 0000844856 hcmc:VapeStoresDisposalsMember 2022-06-30 0000844856 us-gaap:FurnitureAndFixturesMember 2022-06-30 0000844856 us-gaap:OtherMachineryAndEquipmentMember 2021-12-31 0000844856 srt:MaximumMember us-gaap:TradeNamesMember 2021-01-01 2021-12-31 0000844856 srt:MinimumMember us-gaap:CustomerRelationshipsMember 2022-01-01 2022-06-30 0000844856 us-gaap:PatentsMember 2021-01-01 2021-12-31 0000844856 srt:MaximumMember us-gaap:CustomerRelationshipsMember 2022-01-01 2022-06-30 0000844856 us-gaap:InternetDomainNamesMember 2022-01-01 2022-06-30 0000844856 srt:MinimumMember us-gaap:TradeNamesMember 2022-01-01 2022-06-30 0000844856 srt:MinimumMember us-gaap:NoncompeteAgreementsMember 2022-01-01 2022-06-30 0000844856 srt:MaximumMember us-gaap:TradeNamesMember 2022-01-01 2022-06-30 0000844856 srt:MinimumMember us-gaap:CustomerRelationshipsMember 2021-01-01 2021-12-31 0000844856 us-gaap:NoncompeteAgreementsMember 2021-01-01 2021-12-31 0000844856 srt:MinimumMember us-gaap:TradeNamesMember 2021-01-01 2021-12-31 0000844856 srt:MaximumMember us-gaap:NoncompeteAgreementsMember 2022-01-01 2022-06-30 0000844856 us-gaap:PatentsMember 2022-01-01 2022-06-30 0000844856 srt:MaximumMember us-gaap:CustomerRelationshipsMember 2021-01-01 2021-12-31 0000844856 us-gaap:InternetDomainNamesMember 2021-01-01 2021-12-31 0000844856 us-gaap:PatentsMember 2022-06-30 0000844856 us-gaap:PatentsMember 2021-12-31 0000844856 us-gaap:NoncompeteAgreementsMember 2022-06-30 0000844856 us-gaap:CustomerRelationshipsMember 2021-12-31 0000844856 us-gaap:TradeNamesMember 2022-06-30 0000844856 us-gaap:InternetDomainNamesMember 2021-12-31 0000844856 us-gaap:InternetDomainNamesMember 2022-06-30 0000844856 us-gaap:TradeNamesMember 2021-12-31 0000844856 us-gaap:CustomerRelationshipsMember 2022-06-30 0000844856 us-gaap:NoncompeteAgreementsMember 2021-12-31 0000844856 hcmc:VaporLoyaltyRewardsMember 2022-01-01 2022-06-30 0000844856 hcmc:GiftCardsMember 2022-01-01 2022-06-30 0000844856 hcmc:GroceryLoyaltyRewardsMember 2022-01-01 2022-06-30 0000844856 2021-01-01 2021-12-31 0000844856 hcmc:OtherDebtMember 2021-12-31 0000844856 us-gaap:LineOfCreditMember 2021-12-31 0000844856 us-gaap:LineOfCreditMember 2022-06-30 0000844856 hcmc:OtherDebtMember 2022-06-30 0000844856 2021-06-18 2021-06-18 0000844856 2021-06-18 0000844856 hcmc:TermLoanAndSecurityAgreementMember 2021-03-29 0000844856 2021-03-29 2021-03-29 0000844856 2021-03-29 0000844856 2021-01-01 2021-03-31 0000844856 us-gaap:RestrictedStockMember hcmc:OfficersAndDirectorMember 2021-01-14 2021-01-14 0000844856 us-gaap:RestrictedStockMember 2021-03-30 2021-03-30 0000844856 us-gaap:RestrictedStockMember 2021-06-29 2021-06-29 0000844856 us-gaap:PreferredStockMember 2021-01-01 2021-06-30 0000844856 us-gaap:EmployeeStockOptionMember 2022-01-01 2022-06-30 0000844856 us-gaap:PreferredStockMember 2022-01-01 2022-06-30 0000844856 us-gaap:EmployeeStockOptionMember 2021-01-01 2021-06-30 0000844856 hcmc:AllegedClaimedBatteryDefectsForElectronicCigaretteDeviceMember 2022-06-30 0000844856 hcmc:AllegedClaimedBatteryDefectsForElectronicCigaretteDeviceMember hcmc:MedicalCostsMember 2022-01-01 2022-06-30 0000844856 hcmc:PhilipMorrisMember 2020-11-30 0000844856 hcmc:PhilipMorrisMember hcmc:PatentInfringementLitigationMember 2022-02-22 2022-02-22 0000844856 hcmc:PresidentAndChiefOperatingOfficerMember 2021-02-26 2021-02-26 0000844856 srt:ChiefFinancialOfficerMember 2022-02-02 2022-02-02 shares iso4217:USD iso4217:USD shares hcmc:Store hcmc:FinancialInstitution pure hcmc:Lawsuit hcmc:User false --12-31 2022 Q2 0000844856 NONE 10-Q true 2022-06-30 false 001-36469 HEALTHIER CHOICES MANAGEMENT CORP. DE 84-1070932 3800 North 28Th Way Hollywood FL 33020 305 600-5004 Yes Yes Non-accelerated Filer true false false Common Stock, par value $0.0001 per share HCMC 339741632384 19323420 26496404 30638 28481 220793 247915 2441277 1521199 244171 456397 28457 23143 22288756 28773539 1554576 176988 2248107 947593 2657000 916000 4964381 3543930 119378 85437 33832198 34443487 2171095 1642848 56105 23178 453232 418036 2134 2604 563300 437328 3245866 2523994 0 815 4016105 2685021 7261971 5209830 1000 1000 5000 5000 800 800 800 800 800000 800000 800000 800000 0.0001 0.0001 750000000000 750000000000 339741632384 339741632384 339741632384 339741632384 33974163 33974163 30855824 30855824 -39059760 -36396330 26570227 29233657 33832198 34443487 5997 590980 255560 1204916 6126063 2794912 10925053 5646729 6132060 3385892 11180613 6851645 562 237333 112246 470648 3800625 1684903 6764980 3426631 2330873 1463656 4303387 2954366 3699273 2149087 7026693 4171970 -1368400 -685431 -2723306 -1217604 1800 -14614 5314 11511 6175 0 23049 0 14910 -5516 31513 -78430 0 885226 0 767930 22885 865096 59876 701011 -1345515 179665 -2663430 -516593 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 339741632384 339741632384 311961992554 311961992554 339741632384 339741632384 277914474082 277914474082 800 800000 339741632384 33974163 30855824 -37714245 27915742 0 0 0 -1345515 -1345515 800 800000 339741632384 33974163 30855824 -39059760 26570227 5000 5000000 307726082074 30772608 5330562 -33055129 8048041 0 0 1500000000 150000 0 0 150000 0 0 27046800310 2704680 20873978 0 23578658 0 0 3025000000 302500 -302500 0 0 0 0 68750000 6875 -6875 0 0 0 0 32500 0 32500 0 0 0 179665 179665 5000 5000000 333179132384 33317913 26546415 -32875464 31988864 800 800000 339741632384 33974163 30855824 -36396330 29233657 0 0 0 -2663430 -2663430 800 800000 339741632384 33974163 30855824 -39059760 26570227 16277 16277116 143840848017 14384084 3955039 -32358871 2257368 -16277 16277116 162771153001 -16277116 0 0 0 0 0 2275000000 227500 0 0 227500 0 0 34375 0 34375 5000 5000000 0 0 0 0 5000000 0 0 1182831056 118283 1289273 0 1407556 0 0 27046800310 2704680 20873978 0 23578658 0 0 2250000000 225000 -225000 0 0 0 0 6187500000 618750 -618750 0 0 0 0 0 -516593 -516593 5000 5000000 333179132384 33317913 26546415 -32875464 31988864 -2663430 -516593 422078 261571 5314 11511 377216 265601 0 767930 0 60809 73640 0 0 34375 2157 30062 189138 157613 -212226 -17573 33941 -3662 528247 -370577 -249700 -2267 340611 230547 -1870884 -1443509 5150000 0 27122 27696 213133 41965 -5336011 -14269 35196 0 1285 184970 0 2000000 0 24828657 0 5000000 0 227500 33911 27871187 -7172984 26413409 26496404 2925475 19323420 29338884 2910 26115 0 1290260 1797667 0 <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Note 1. ORGANIZATION</div> <div><br/></div> <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold;">Organization</div> <div><br/></div> <div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">Healthier Choices Management Corp. (the “Company”) is a holding company focused on providing consumers with healthier daily choices with respect to nutrition and other lifestyle alternatives. The Company operates Ada’s Natural Market, a natural and organic grocery store, through its wholly owned subsidiary Healthy Choice Markets, Inc. Ada’s Natural Market and Paradise Health and Nutrition offers fresh produce, bulk foods, vitamins and supplements, packaged groceries, meat and seafood, deli, baked goods, dairy products, frozen foods, health &amp; beauty products and natural household items. The Company also sells vitamins and supplements on the Amazon.com marketplace through its wholly owned subsidiary Healthy U Wholesale, Inc. The Company also operates HCMC Intellectual Property Holdings, LLC, a wholly owned subsidiary formed to hold, market and expand on its current intellectual property assets. The Company markets the Q-Cup™ technology under the vape segment; this patented technology is based on a small, quartz cup called the Q-Cup™, which a customer partially fills with concentrate (approximately 50mg) purchased from a third party. The Q-Cup™ is then inserted into the Q-Cup™ Tank or Globe, which heats the cup from the outside without coming in direct contact with the solid concentrate. This Q-Cup™ technology provides significantly more efficiency and an “on the go” solution for consumers who prefer to vape concentrates either medicinally or recreationally. The Company acquired substantially all of the assets of Mother Earth’s Storehouse on February 9, 2022, which operates a </span>two<span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"> store organic and health food and vitamin chain in New York’s Hudson Valley, a business that has been operating for over </span>40<span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"> years. The Company </span><span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">expanded its operation into the Health &amp; Wellness segment in November 2021. HCMC acquired substantially all of the assets of EIR Hydration, an IV therapy center located in Roslyn Heights, NY. </span>The Company also has a licensing agreement for a Healthy Choice Wellness Center at the Casbah Spa and Salon in Fort Lauderdale, FL. The activities in the Wellness centers are currently reported under the Grocery segment due to its deminimus nature. From December 2021 through April 2022, the Company either closed its vape stores or sold substantially all of the assets of such stores. <span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">This will allow the Company to focus on developing wholesale business and sales through online platform.</span></div> <div><br/></div> <div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold;">COVID-19 Management Update</div> <div><br/></div> <div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">The global outbreak of COVID-19 was declared a pandemic by the World Health Organization and a national emergency by the U.S. government in March 2020 and has negatively impacted the U.S. and global economies, disrupted global supply chains and, mandated closures and stay-at-home orders and created significant disruptions of the global financial markets. The Company adjusted certain aspects of the operations to protect their employees and customers while still meeting customers’ needs. While to date the Company has not been required to close any of its grocery stores, the Company is currently operating under regular hours and we are expecting COVID-19 to have a long-term beneficial impact to the future financial results of the grocery segment. The Company continues to monitor the impact of the COVID-19 outbreak closely.  The extent to which the COVID-19 outbreak will impact our operations is manageable, and there is no imminent risk on business continuity and future operations.</div> 2 P40Y <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Note 2. LIQUIDITY</div> <div><br/></div> <div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">The accompanying unaudited condensed consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (“GAAP”), which contemplate continuation of the Company as a going concern and realization of assets and satisfaction of liabilities in the normal course of business and do not include any adjustments that might result from the outcome of any uncertainties related to our going concern assessment. The carrying amounts of assets and liabilities presented in the financial statements do not necessarily purport to represent realizable or settlement values.</div> <div><br/></div> <div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">The Company currently and historically has reported net losses and cash outflows from operations. </span>The Company<span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"> anticipates that its current cash, cash equivalent and cash generated from operations will be sufficient to meet the projected operating expenses for the foreseeable future through at least the next twelve months from the issuance of these unaudited condensed consolidated financial statements.</span></div> <div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Note 3. BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES</div> <div><br/></div> <div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with the instructions to Form 10-Q and Regulation S-X and do not include all the information and disclosures required by generally accepted accounting principles in the United States of America (“GAAP”). The Company has made estimates and judgments affecting the amounts reported in the Company’s condensed consolidated financial statements and the accompanying notes. The actual results experienced by the Company may differ materially from the Company’s estimates. The condensed consolidated financial information is unaudited but reflects all normal adjustments that are, in the opinion of management, necessary to provide a fair statement of results for the interim periods presented. These condensed consolidated financial statements should be read in conjunction with the consolidated financial statements in the Company’s Annual Report on Form 10-K for the year ended December 31, 2021, filed with the Securities and Exchange Commission (the “SEC”) on March 31, 2022. The condensed consolidated balance sheet as of December 31, 2021 was derived from the Company’s audited 2021 financial statements contained in the above referenced Form 10-K. Results of the six months ended June 30, 2022, are not necessarily indicative of the results to be expected for the full year ending December 31, 2022.</div> <div><br/></div> <div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold;">Significant Accounting Policies</div> <div><br/></div> <div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">There have been no material changes in the Company’s significant accounting policies to those previously disclosed in the 2021 Annual Report.</div> <div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Note 4. CONCENTRATIONS</div> <div><br/></div> <div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold;">Cash and Cash Equivalents and Restricted Cash</div> <div><br/></div> <div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">The Company considers all highly liquid instruments with an original maturity of three months or less, when purchased, to be cash and cash equivalents. The majority of the Company’s cash and cash equivalents are concentrated in one large financial institution, which is in excess of Federal Deposit Insurance Corporation (FDIC) coverage.</div> <div><br/></div> <div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">A summary of the financial institutions that had a cash and cash equivalents in excess of FDIC limits of $250,000 on June 30, 2022 and December 31, 2021 is presented below:</div> <div style="text-align: justify;"><br/></div> <table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000; width: 100%;"> <tr> <td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"><div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"/></td> <td colspan="3" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom"><div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">June 30, 2022</div></td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="3" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom"><div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">December 31, 2021</div></td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"><div><div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">Total cash, cash equivalents and restricted ca</span>sh <span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">in excess of FDIC limits of $</span>250,000</div></div></td> <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"><div><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">$</div></div></td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"><div><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">18,688,069</div></div></td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"><div><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;">$</div></div></td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"><div><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;">26,023,593</div></div></td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> </tr> </table> <div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 12pt;"><br/></div> <div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">The Company continually monitors its positions with, and the credit quality of, the financial institutions with which it invests, as deposits are held in excess of federally insured limits. The Company’s cash equivalent at June 30, 2022 and December 31, 2021, respectively, was a money market account. The Company has not experienced any losses in such account.</div> 1 <div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">A summary of the financial institutions that had a cash and cash equivalents in excess of FDIC limits of $250,000 on June 30, 2022 and December 31, 2021 is presented below:</div> <div style="text-align: justify;"><br/></div> <table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000; width: 100%;"> <tr> <td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"><div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"/></td> <td colspan="3" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom"><div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">June 30, 2022</div></td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="3" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom"><div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">December 31, 2021</div></td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"><div><div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">Total cash, cash equivalents and restricted ca</span>sh <span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">in excess of FDIC limits of $</span>250,000</div></div></td> <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"><div><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">$</div></div></td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"><div><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">18,688,069</div></div></td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"><div><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;">$</div></div></td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"><div><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;">26,023,593</div></div></td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> </tr> </table> 250000 250000 18688069 26023593 <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Note 5. DISAGGREGATION OF REVENUES</div> <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"> </div> <div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">The Company reports the following segments in accordance with management guidance: Vapor and Grocery. When the Company prepares its internal management reporting to evaluate business performance, we disaggregate revenue into the following categories that depict how the nature, amount, timing and uncertainty of revenue and cash flows are affected by economic factors.</div> <div><br/></div> <table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000; width: 100%;"> <tr> <td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"><div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"/></td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="6" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom"><div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Three Months Ended June 30,</div></td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="6" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom"><div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Six Months Ended June 30,</div></td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom"><div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">2022</div></td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom"><div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">2021</div></td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom"><div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-indent: -7pt;"><span style="text-indent: 0pt;">2022</span></div></td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom"><div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-indent: -7pt;"><span style="text-indent: 0pt;">2021</span></div></td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 52%; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Vapor</div></td> <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">$</div></td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">5,997</div></td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;">$</div></td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;">590,980</div></td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">$</div></td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">255,560</div></td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;">$</div></td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;">1,204,916</div></td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 52%; padding-bottom: 2px;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Grocery</div></td> <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">6,126,063</div></td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;">2,794,912</div></td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">10,925,053</div></td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;">5,646,729</div></td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 52%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Total revenue</div></td> <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">$</div></td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">6,132,060</div></td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;">$</div></td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;">3,385,892</div></td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">$</div></td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">11,180,613</div></td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;">$</div></td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;">6,851,645</div></td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 52%;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 52%; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Retail Vapor</div></td> <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">$</div></td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">5,997</div></td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;">$</div></td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;">590,980</div></td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">$</div></td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">255,560</div></td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;">$</div></td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;">1,204,875</div></td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 52%;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Retail Grocery</div></td> <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">5,478,523</div></td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;">2,430,530</div></td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">9,756,535</div></td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;">4,963,330</div></td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 52%; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Food service/restaurant</div></td> <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">643,760</div></td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;">305,566</div></td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">1,158,846</div></td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;">602,849</div></td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 52%;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Online/eCommerce</div></td> <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">3,780</div></td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;">56,259</div></td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">9,672</div></td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;">69,975</div></td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 52%; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Wholesale Grocery</div></td> <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">-</div></td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;">2,557</div></td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">-</div></td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;">10,575</div></td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 52%; padding-bottom: 2px;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Wholesale Vapor</div></td> <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">-</div></td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;">-</div></td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">-</div></td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;">41</div></td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 52%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Total revenue</div></td> <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">$</div></td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">6,132,060</div></td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;">$</div></td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;">3,385,892</div></td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">$</div></td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">11,180,613</div></td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;">$</div></td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;">6,851,645</div></td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> </tr> </table> <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"> </div> <div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">The Company reports the following segments in accordance with management guidance: Vapor and Grocery. When the Company prepares its internal management reporting to evaluate business performance, we disaggregate revenue into the following categories that depict how the nature, amount, timing and uncertainty of revenue and cash flows are affected by economic factors.</div> <div><br/></div> <table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000; width: 100%;"> <tr> <td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"><div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"/></td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="6" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom"><div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Three Months Ended June 30,</div></td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="6" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom"><div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Six Months Ended June 30,</div></td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom"><div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">2022</div></td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom"><div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">2021</div></td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom"><div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-indent: -7pt;"><span style="text-indent: 0pt;">2022</span></div></td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom"><div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-indent: -7pt;"><span style="text-indent: 0pt;">2021</span></div></td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 52%; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Vapor</div></td> <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">$</div></td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">5,997</div></td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;">$</div></td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;">590,980</div></td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">$</div></td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">255,560</div></td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;">$</div></td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;">1,204,916</div></td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 52%; padding-bottom: 2px;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Grocery</div></td> <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">6,126,063</div></td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;">2,794,912</div></td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">10,925,053</div></td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;">5,646,729</div></td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 52%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Total revenue</div></td> <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">$</div></td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">6,132,060</div></td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;">$</div></td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;">3,385,892</div></td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">$</div></td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">11,180,613</div></td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;">$</div></td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;">6,851,645</div></td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 52%;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 52%; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Retail Vapor</div></td> <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">$</div></td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">5,997</div></td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;">$</div></td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;">590,980</div></td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">$</div></td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">255,560</div></td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;">$</div></td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;">1,204,875</div></td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 52%;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Retail Grocery</div></td> <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">5,478,523</div></td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;">2,430,530</div></td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">9,756,535</div></td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;">4,963,330</div></td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 52%; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Food service/restaurant</div></td> <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">643,760</div></td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;">305,566</div></td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">1,158,846</div></td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;">602,849</div></td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 52%;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Online/eCommerce</div></td> <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">3,780</div></td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;">56,259</div></td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">9,672</div></td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;">69,975</div></td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 52%; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Wholesale Grocery</div></td> <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">-</div></td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;">2,557</div></td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">-</div></td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;">10,575</div></td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 52%; padding-bottom: 2px;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Wholesale Vapor</div></td> <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">-</div></td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;">-</div></td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">-</div></td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;">41</div></td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 52%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Total revenue</div></td> <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">$</div></td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">6,132,060</div></td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;">$</div></td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;">3,385,892</div></td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">$</div></td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">11,180,613</div></td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;">$</div></td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;">6,851,645</div></td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> </tr> </table> 5997 590980 255560 1204916 6126063 2794912 10925053 5646729 6132060 3385892 11180613 6851645 5997 590980 255560 1204875 5478523 2430530 9756535 4963330 643760 305566 1158846 602849 3780 56259 9672 69975 0 2557 0 10575 0 0 0 41 6132060 3385892 11180613 6851645 <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Note 6. NOTES RECEIVABLE AND OTHER INCOME</div> <div style="text-align: justify;"><br/></div> <div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">On September 6, 2018, the Company entered into a secured, </span>36<span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">-month promissory note </span>(the “Note”) <span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">with VPR Brands L.P. for $</span>582,260<span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">. The Note bears an interest rate of </span>7.00%<span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">, which payments thereunder are $</span>4,141<span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"> weekly. The Company records all proceeds related to the interest of the Note as interest income as proceeds are received.</span></div> <div><br/></div> <div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">On August 31, 2021, the Company amended and restated the Secured Promissory Note (the "Amended Note") with VPRB Brands L.P. for the outstanding balance in the note of $268,126. The Amended Note bears an interest rate of 7.00%, which payments thereunder are $1,500 weekly, with such payments commencing as of September 3, 2021. The Amended Note has a balloon payment of $216,071 for all remaining accrued interest and principal balance due in the final week of the 1-year extension of the Note.</div> <div><br/></div> <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">A summary of the Note as of June 30, 2022 and December 31, 2021 is presented below:</span></div> <div><br/></div> <table cellpadding="0" cellspacing="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;"> <tr> <td style="width: 63.03%; vertical-align: bottom; background-color: #CCEEFF; border-bottom: #000000 2px solid;"><div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Description</div></td> <td style="width: 1.57%; vertical-align: bottom; background-color: #CCEEFF;"> </td> <td colspan="2" style="width: 17.32%; vertical-align: bottom; background-color: #CCEEFF; border-bottom: #000000 2px solid;"><div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">June 30, 2022</div></td> <td style="width: 1.57%; vertical-align: bottom; background-color: #CCEEFF;"> </td> <td colspan="2" style="width: 16.52%; vertical-align: bottom; background-color: #CCEEFF; border-bottom: #000000 2px solid;"><div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">December 31, 2021</div></td> </tr> <tr> <td style="width: 63.03%; vertical-align: bottom;"><div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Promissory Note</div></td> <td style="width: 1.57%; vertical-align: bottom;"> </td> <td style="width: 1.57%; vertical-align: bottom; border-bottom: #000000 4px double;"><div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">$</div></td> <td style="width: 15.75%; vertical-align: bottom; border-bottom: #000000 4px double;"><div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">220,793</div></td> <td style="width: 1.57%; vertical-align: bottom;"> </td> <td style="width: 1.57%; vertical-align: bottom; border-bottom: #000000 4px double;"><div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">$</div></td> <td style="width: 14.95%; vertical-align: bottom; border-bottom: #000000 4px double;"><div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">247,915</div></td> </tr> </table> <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"> </div> P36M 582260 0.0700 4141 268126 0.0700 1500 216071 P1Y <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">A summary of the Note as of June 30, 2022 and December 31, 2021 is presented below:</span></div> <div><br/></div> <table cellpadding="0" cellspacing="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;"> <tr> <td style="width: 63.03%; vertical-align: bottom; background-color: #CCEEFF; border-bottom: #000000 2px solid;"><div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Description</div></td> <td style="width: 1.57%; vertical-align: bottom; background-color: #CCEEFF;"> </td> <td colspan="2" style="width: 17.32%; vertical-align: bottom; background-color: #CCEEFF; border-bottom: #000000 2px solid;"><div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">June 30, 2022</div></td> <td style="width: 1.57%; vertical-align: bottom; background-color: #CCEEFF;"> </td> <td colspan="2" style="width: 16.52%; vertical-align: bottom; background-color: #CCEEFF; border-bottom: #000000 2px solid;"><div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">December 31, 2021</div></td> </tr> <tr> <td style="width: 63.03%; vertical-align: bottom;"><div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Promissory Note</div></td> <td style="width: 1.57%; vertical-align: bottom;"> </td> <td style="width: 1.57%; vertical-align: bottom; border-bottom: #000000 4px double;"><div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">$</div></td> <td style="width: 15.75%; vertical-align: bottom; border-bottom: #000000 4px double;"><div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">220,793</div></td> <td style="width: 1.57%; vertical-align: bottom;"> </td> <td style="width: 1.57%; vertical-align: bottom; border-bottom: #000000 4px double;"><div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">$</div></td> <td style="width: 14.95%; vertical-align: bottom; border-bottom: #000000 4px double;"><div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">247,915</div></td> </tr> </table> 220793 247915 <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Note 7. ACQUISITION OF MOTHER EARTH’S STOREHOUSE, INC.</div> <div><br/></div> <div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">On February 9, 2022, the Company through its wholly owned subsidiary, Healthy Choice Markets 3, LLC, entered into an Asset Purchase Agreement with Mother Earth’s Storehouse Inc. (“HCM3”) and its shareholders. Pursuant to the Purchase Agreement, HCM3 acquired certain assets and assumed certain liabilities related to Mother Earth’s grocery stores in Kingston and Saugerties, New York. The Company intends to continue to operate the grocery stores under their existing name. The cash purchase price under the Asset Purchase Agreement was $4,472,500, with an additional $677,500 paid for inventory at closing. In addition, the Company assumed a lease obligation for the Kingston, NY store and entered into an employment agreement with the store manager.</div> <div><br/></div> <div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">The purchase method of accounting in accordance with ASC 805, <span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-style: italic;">Business Combinations</span>, was applied for the Mother Earth's Storehouse acquisition.  This requires the total cost of an acquisition to be allocated to the tangible and identifiable intangible assets acquired and liabilities assumed based on their respective fair values at the date of acquisition with the excess cost accounted for as goodwill. Goodwill arising from the acquisition is attributable to expected operational synergies from combining the operations of the acquired business with those of the Company<span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">. Goodwill is not expected to be deductible for income tax purposes in the tax jurisdiction of the acquired business.</span></div> <div><br/></div> <div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">The following table summarizes the approximate purchase price allocation based on estimated fair values of the net assets acquired at the acquisition date:</div> <div><br/></div> <table cellpadding="0" cellspacing="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;"> <tr> <td style="width: 68.69%; vertical-align: top; background-color: #CCEEFF;"><div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Purchase Consideration</div></td> <td style="width: 14.18%; vertical-align: top; background-color: #CCEEFF;"> </td> <td style="width: 2.18%; vertical-align: top; background-color: #CCEEFF;"> </td> <td style="width: 14.95%; vertical-align: top; background-color: #CCEEFF;"> </td> </tr> <tr> <td style="width: 68.69%; vertical-align: top;"><div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Cash Consideration paid</div></td> <td style="width: 14.18%; vertical-align: top;"> </td> <td style="width: 2.18%; vertical-align: top;"><div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">$</div></td> <td style="width: 14.95%; vertical-align: top;"><div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">5,150,000</div></td> </tr> <tr> <td style="width: 68.69%; vertical-align: top; background-color: #CCEEFF;"> </td> <td style="width: 14.18%; vertical-align: top; background-color: #CCEEFF;"> </td> <td style="width: 2.18%; vertical-align: top; background-color: #CCEEFF;"> </td> <td style="width: 14.95%; vertical-align: top; background-color: #CCEEFF;"> </td> </tr> <tr> <td style="width: 68.69%; vertical-align: top;"><div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Purchase price allocation</div></td> <td style="width: 14.18%; vertical-align: top;"> </td> <td style="width: 2.18%; vertical-align: top;"> </td> <td style="width: 14.95%; vertical-align: top;"> </td> </tr> <tr> <td style="width: 68.69%; vertical-align: top; background-color: #CCEEFF;"><div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">   Inventory</div></td> <td style="width: 14.18%; vertical-align: top; background-color: #CCEEFF;"> </td> <td style="width: 2.18%; vertical-align: top; background-color: #CCEEFF;"> </td> <td style="width: 14.95%; vertical-align: top; background-color: #CCEEFF;"><div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">805,000</div></td> </tr> <tr> <td style="width: 68.69%; vertical-align: top;"><div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">   Property and equipment</div></td> <td style="width: 14.18%; vertical-align: top;"> </td> <td style="width: 2.18%; vertical-align: top;"> </td> <td style="width: 14.95%; vertical-align: top;"><div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">1,278,000</div></td> </tr> <tr> <td style="width: 68.69%; vertical-align: top; background-color: #CCEEFF;"><div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">   Intangible assets</div></td> <td style="width: 14.18%; vertical-align: top; background-color: #CCEEFF;"> </td> <td style="width: 2.18%; vertical-align: top; background-color: #CCEEFF;"> </td> <td style="width: 14.95%; vertical-align: top; background-color: #CCEEFF;"><div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">1,609,000</div></td> </tr> <tr> <td style="width: 68.69%; vertical-align: top;"><div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">   Right of use asset - operating lease</div></td> <td style="width: 14.18%; vertical-align: top;"> </td> <td style="width: 2.18%; vertical-align: top;"> </td> <td style="width: 14.95%; vertical-align: top;"><div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">1,797,667</div></td> </tr> <tr> <td style="width: 68.69%; vertical-align: top; background-color: #CCEEFF;"><div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">   Other liabilities</div></td> <td style="width: 14.18%; vertical-align: top; background-color: #CCEEFF;"> </td> <td style="width: 2.18%; vertical-align: top; background-color: #CCEEFF;"> </td> <td style="width: 14.95%; vertical-align: top; background-color: #CCEEFF;"><div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(283,000)</div></td> </tr> <tr> <td style="width: 68.69%; vertical-align: top;"><div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">   Operating lease liability</div></td> <td style="width: 14.18%; vertical-align: top;"> </td> <td style="width: 2.18%; vertical-align: top;"> </td> <td style="width: 14.95%; vertical-align: top;"><div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(1,797,667)</div></td> </tr> <tr> <td style="width: 68.69%; vertical-align: top; background-color: #CCEEFF;"><div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">   Goodwill</div></td> <td style="width: 14.18%; vertical-align: top; background-color: #CCEEFF;"> </td> <td style="width: 2.18%; vertical-align: top; background-color: #CCEEFF; border-bottom: #000000 2px solid;"> </td> <td style="width: 14.95%; vertical-align: top; background-color: #CCEEFF; border-bottom: #000000 2px solid;"><div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">1,741,000</div></td> </tr> <tr> <td style="width: 68.69%; vertical-align: top;"><div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Net assets acquired</div></td> <td style="width: 14.18%; vertical-align: top;"> </td> <td style="width: 2.18%; vertical-align: top; border-bottom: #000000 4px double;"><div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"> $</div></td> <td style="width: 14.95%; vertical-align: top; border-bottom: #000000 4px double;"><div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">5,150,000</div></td> </tr> <tr> <td style="width: 68.69%; vertical-align: top; background-color: #CCEEFF;"> </td> <td style="width: 14.18%; vertical-align: top; background-color: #CCEEFF;"> </td> <td style="width: 2.18%; vertical-align: top; background-color: #CCEEFF;"> </td> <td style="width: 14.95%; vertical-align: top; background-color: #CCEEFF;"> </td> </tr> <tr> <td style="width: 68.69%; vertical-align: top;"><div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Finite-lived intangible assets</div></td> <td style="width: 14.18%; vertical-align: top;"> </td> <td style="width: 2.18%; vertical-align: top;"> </td> <td style="width: 14.95%; vertical-align: top;"> </td> </tr> <tr> <td style="width: 68.69%; vertical-align: top; background-color: #CCEEFF;"><div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">   Trade Names/Trademarks</div></td> <td style="width: 14.18%; vertical-align: top; background-color: #CCEEFF;"> </td> <td style="width: 2.18%; vertical-align: top; background-color: #CCEEFF;"><div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"> $</div></td> <td style="width: 14.95%; vertical-align: top; background-color: #CCEEFF;"><div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">513,000</div></td> </tr> <tr> <td style="width: 68.69%; vertical-align: top;"><div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">   Customer Relationships</div></td> <td style="width: 14.18%; vertical-align: top;"> </td> <td style="width: 2.18%; vertical-align: top;"> </td> <td style="width: 14.95%; vertical-align: top;"><div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">683,000</div></td> </tr> <tr> <td style="width: 68.69%; vertical-align: top; background-color: #CCEEFF;"><div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">   Non-Compete Agreement</div></td> <td style="width: 14.18%; vertical-align: top; background-color: #CCEEFF;"> </td> <td style="width: 2.18%; vertical-align: top; background-color: #CCEEFF; border-bottom: #000000 2px solid;"> </td> <td style="width: 14.95%; vertical-align: top; background-color: #CCEEFF; border-bottom: #000000 2px solid;"><div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">413,000</div></td> </tr> <tr> <td style="width: 68.69%; vertical-align: top;"><div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Total intangible assets</div></td> <td style="width: 14.18%; vertical-align: top;"> </td> <td style="width: 2.18%; vertical-align: top; border-bottom: #000000 4px double;"><div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"> $</div></td> <td style="width: 14.95%; vertical-align: top; border-bottom: #000000 4px double;"><div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">1,609,000</div></td> </tr> </table> 4472500 677500 <div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">The following table summarizes the approximate purchase price allocation based on estimated fair values of the net assets acquired at the acquisition date:</div> <div><br/></div> <table cellpadding="0" cellspacing="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;"> <tr> <td style="width: 68.69%; vertical-align: top; background-color: #CCEEFF;"><div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Purchase Consideration</div></td> <td style="width: 14.18%; vertical-align: top; background-color: #CCEEFF;"> </td> <td style="width: 2.18%; vertical-align: top; background-color: #CCEEFF;"> </td> <td style="width: 14.95%; vertical-align: top; background-color: #CCEEFF;"> </td> </tr> <tr> <td style="width: 68.69%; vertical-align: top;"><div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Cash Consideration paid</div></td> <td style="width: 14.18%; vertical-align: top;"> </td> <td style="width: 2.18%; vertical-align: top;"><div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">$</div></td> <td style="width: 14.95%; vertical-align: top;"><div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">5,150,000</div></td> </tr> <tr> <td style="width: 68.69%; vertical-align: top; background-color: #CCEEFF;"> </td> <td style="width: 14.18%; vertical-align: top; background-color: #CCEEFF;"> </td> <td style="width: 2.18%; vertical-align: top; background-color: #CCEEFF;"> </td> <td style="width: 14.95%; vertical-align: top; background-color: #CCEEFF;"> </td> </tr> <tr> <td style="width: 68.69%; vertical-align: top;"><div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Purchase price allocation</div></td> <td style="width: 14.18%; vertical-align: top;"> </td> <td style="width: 2.18%; vertical-align: top;"> </td> <td style="width: 14.95%; vertical-align: top;"> </td> </tr> <tr> <td style="width: 68.69%; vertical-align: top; background-color: #CCEEFF;"><div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">   Inventory</div></td> <td style="width: 14.18%; vertical-align: top; background-color: #CCEEFF;"> </td> <td style="width: 2.18%; vertical-align: top; background-color: #CCEEFF;"> </td> <td style="width: 14.95%; vertical-align: top; background-color: #CCEEFF;"><div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">805,000</div></td> </tr> <tr> <td style="width: 68.69%; vertical-align: top;"><div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">   Property and equipment</div></td> <td style="width: 14.18%; vertical-align: top;"> </td> <td style="width: 2.18%; vertical-align: top;"> </td> <td style="width: 14.95%; vertical-align: top;"><div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">1,278,000</div></td> </tr> <tr> <td style="width: 68.69%; vertical-align: top; background-color: #CCEEFF;"><div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">   Intangible assets</div></td> <td style="width: 14.18%; vertical-align: top; background-color: #CCEEFF;"> </td> <td style="width: 2.18%; vertical-align: top; background-color: #CCEEFF;"> </td> <td style="width: 14.95%; vertical-align: top; background-color: #CCEEFF;"><div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">1,609,000</div></td> </tr> <tr> <td style="width: 68.69%; vertical-align: top;"><div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">   Right of use asset - operating lease</div></td> <td style="width: 14.18%; vertical-align: top;"> </td> <td style="width: 2.18%; vertical-align: top;"> </td> <td style="width: 14.95%; vertical-align: top;"><div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">1,797,667</div></td> </tr> <tr> <td style="width: 68.69%; vertical-align: top; background-color: #CCEEFF;"><div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">   Other liabilities</div></td> <td style="width: 14.18%; vertical-align: top; background-color: #CCEEFF;"> </td> <td style="width: 2.18%; vertical-align: top; background-color: #CCEEFF;"> </td> <td style="width: 14.95%; vertical-align: top; background-color: #CCEEFF;"><div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(283,000)</div></td> </tr> <tr> <td style="width: 68.69%; vertical-align: top;"><div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">   Operating lease liability</div></td> <td style="width: 14.18%; vertical-align: top;"> </td> <td style="width: 2.18%; vertical-align: top;"> </td> <td style="width: 14.95%; vertical-align: top;"><div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(1,797,667)</div></td> </tr> <tr> <td style="width: 68.69%; vertical-align: top; background-color: #CCEEFF;"><div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">   Goodwill</div></td> <td style="width: 14.18%; vertical-align: top; background-color: #CCEEFF;"> </td> <td style="width: 2.18%; vertical-align: top; background-color: #CCEEFF; border-bottom: #000000 2px solid;"> </td> <td style="width: 14.95%; vertical-align: top; background-color: #CCEEFF; border-bottom: #000000 2px solid;"><div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">1,741,000</div></td> </tr> <tr> <td style="width: 68.69%; vertical-align: top;"><div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Net assets acquired</div></td> <td style="width: 14.18%; vertical-align: top;"> </td> <td style="width: 2.18%; vertical-align: top; border-bottom: #000000 4px double;"><div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"> $</div></td> <td style="width: 14.95%; vertical-align: top; border-bottom: #000000 4px double;"><div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">5,150,000</div></td> </tr> <tr> <td style="width: 68.69%; vertical-align: top; background-color: #CCEEFF;"> </td> <td style="width: 14.18%; vertical-align: top; background-color: #CCEEFF;"> </td> <td style="width: 2.18%; vertical-align: top; background-color: #CCEEFF;"> </td> <td style="width: 14.95%; vertical-align: top; background-color: #CCEEFF;"> </td> </tr> <tr> <td style="width: 68.69%; vertical-align: top;"><div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Finite-lived intangible assets</div></td> <td style="width: 14.18%; vertical-align: top;"> </td> <td style="width: 2.18%; vertical-align: top;"> </td> <td style="width: 14.95%; vertical-align: top;"> </td> </tr> <tr> <td style="width: 68.69%; vertical-align: top; background-color: #CCEEFF;"><div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">   Trade Names/Trademarks</div></td> <td style="width: 14.18%; vertical-align: top; background-color: #CCEEFF;"> </td> <td style="width: 2.18%; vertical-align: top; background-color: #CCEEFF;"><div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"> $</div></td> <td style="width: 14.95%; vertical-align: top; background-color: #CCEEFF;"><div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">513,000</div></td> </tr> <tr> <td style="width: 68.69%; vertical-align: top;"><div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">   Customer Relationships</div></td> <td style="width: 14.18%; vertical-align: top;"> </td> <td style="width: 2.18%; vertical-align: top;"> </td> <td style="width: 14.95%; vertical-align: top;"><div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">683,000</div></td> </tr> <tr> <td style="width: 68.69%; vertical-align: top; background-color: #CCEEFF;"><div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">   Non-Compete Agreement</div></td> <td style="width: 14.18%; vertical-align: top; background-color: #CCEEFF;"> </td> <td style="width: 2.18%; vertical-align: top; background-color: #CCEEFF; border-bottom: #000000 2px solid;"> </td> <td style="width: 14.95%; vertical-align: top; background-color: #CCEEFF; border-bottom: #000000 2px solid;"><div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">413,000</div></td> </tr> <tr> <td style="width: 68.69%; vertical-align: top;"><div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Total intangible assets</div></td> <td style="width: 14.18%; vertical-align: top;"> </td> <td style="width: 2.18%; vertical-align: top; border-bottom: #000000 4px double;"><div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"> $</div></td> <td style="width: 14.95%; vertical-align: top; border-bottom: #000000 4px double;"><div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">1,609,000</div></td> </tr> </table> 5150000 805000 1278000 1609000 1797667 283000 1797667 1741000 5150000 513000 683000 413000 1609000 <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;"><span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">Note 8. PROPERTY &amp; EQUIPMENT</span></div> <div><br/></div> <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">Property and equipment consist of the following:</span></div> <table cellpadding="0" cellspacing="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;"> <tr> <td style="width: 68.09%; vertical-align: bottom;"> </td> <td style="width: 0.13%; vertical-align: bottom; white-space: nowrap;"> </td> <td colspan="2" style="width: 14.31%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">June 30, 2022</div></td> <td style="width: 2.34%; vertical-align: bottom; white-space: nowrap;"> </td> <td style="width: 0.13%; vertical-align: bottom; white-space: nowrap;"> </td> <td colspan="2" style="width: 15%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">December 31, 2021</div></td> </tr> <tr> <td style="width: 68.09%; vertical-align: bottom;"><div style="background-color: #CCEEFF;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Displays</div></div></td> <td style="width: 0.13%; vertical-align: bottom;"> </td> <td style="width: 2.49%; vertical-align: bottom;"><div style="background-color: #CCEEFF;"><div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">$</div></div></td> <td style="width: 11.83%; vertical-align: bottom;"><div style="background-color: #CCEEFF;"><div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">305,558</div></div></td> <td style="width: 2.34%; vertical-align: bottom; white-space: nowrap;"> </td> <td style="width: 0.13%; vertical-align: bottom;"> </td> <td style="width: 2.76%; vertical-align: bottom;"><div style="background-color: #CCEEFF;"><div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">$</div></div></td> <td style="width: 12.24%; vertical-align: bottom;"><div style="background-color: #CCEEFF;"><div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">305,558</div></div></td> </tr> <tr> <td style="width: 68.09%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Building</div></td> <td style="width: 0.13%; vertical-align: bottom;"> </td> <td style="width: 2.49%; vertical-align: bottom;"> </td> <td style="width: 11.83%; vertical-align: bottom;"><div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">575,000</div></td> <td style="width: 2.34%; vertical-align: bottom; white-space: nowrap;"> </td> <td style="width: 0.13%; vertical-align: bottom;"> </td> <td style="width: 2.76%; vertical-align: bottom;"> </td> <td style="width: 12.24%; vertical-align: bottom;"><div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">-</div></td> </tr> <tr> <td style="width: 68.09%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Furniture and fixtures</div></td> <td style="width: 0.13%; vertical-align: bottom;"> </td> <td style="width: 2.49%; vertical-align: bottom;"> </td> <td style="width: 11.83%; vertical-align: bottom;"><div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">307,822</div></td> <td style="width: 2.34%; vertical-align: bottom; white-space: nowrap;"> </td> <td style="width: 0.13%; vertical-align: bottom;"> </td> <td style="width: 2.76%; vertical-align: bottom;"> </td> <td style="width: 12.24%; vertical-align: bottom;"><div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">246,496</div></td> </tr> <tr> <td style="width: 68.09%; vertical-align: bottom;"><div style="background-color: #CCEEFF;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Leasehold improvements</div></div></td> <td style="width: 0.13%; vertical-align: bottom;"> </td> <td style="width: 2.49%; vertical-align: bottom;"> </td> <td style="width: 11.83%; vertical-align: bottom;"><div style="background-color: #CCEEFF;"><div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">727,469</div></div></td> <td style="width: 2.34%; vertical-align: bottom; white-space: nowrap;"> </td> <td style="width: 0.13%; vertical-align: bottom;"> </td> <td style="width: 2.76%; vertical-align: bottom;"> </td> <td style="width: 12.24%; vertical-align: bottom;"><div style="background-color: #CCEEFF;"><div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">136,504</div></div></td> </tr> <tr> <td style="width: 68.09%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Computer hardware &amp; equipment</div></td> <td style="width: 0.13%; vertical-align: bottom;"> </td> <td style="width: 2.49%; vertical-align: bottom;"> </td> <td style="width: 11.83%; vertical-align: bottom;"><div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">133,059</div></td> <td style="width: 2.34%; vertical-align: bottom; white-space: nowrap;"> </td> <td style="width: 0.13%; vertical-align: bottom;"> </td> <td style="width: 2.76%; vertical-align: bottom;"> </td> <td style="width: 12.24%; vertical-align: bottom;"><div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">151,924</div></td> </tr> <tr> <td style="width: 68.09%; vertical-align: bottom;"><div style="background-color: #CCEEFF;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><span style="background-color: #CCEEFF;">Other</span></div></div></td> <td style="width: 0.13%; vertical-align: bottom;"> </td> <td style="width: 2.49%; vertical-align: bottom; border-bottom: #000000 2px solid;"> </td> <td style="width: 11.83%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="background-color: #CCEEFF;"><div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">311,294</div></div></td> <td style="width: 2.34%; vertical-align: bottom; white-space: nowrap;"> </td> <td style="width: 0.13%; vertical-align: bottom;"> </td> <td style="width: 2.76%; vertical-align: bottom; border-bottom: #000000 2px solid;"> </td> <td style="width: 12.24%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="background-color: #CCEEFF;"><div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">315,788</div></div></td> </tr> <tr> <td style="width: 68.09%; vertical-align: bottom;"> </td> <td style="width: 0.13%; vertical-align: bottom;"> </td> <td style="width: 2.49%; vertical-align: bottom;"> </td> <td style="width: 11.83%; vertical-align: bottom;"><div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">2,360,202</div></td> <td style="width: 2.34%; vertical-align: bottom; white-space: nowrap;"> </td> <td style="width: 0.13%; vertical-align: bottom;"> </td> <td style="width: 2.76%; vertical-align: bottom;"> </td> <td style="width: 12.24%; vertical-align: bottom;"><div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">1,156,270</div></td> </tr> <tr> <td style="width: 68.09%; vertical-align: bottom;"><div style="background-color: #CCEEFF;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><span style="background-color: #CCEEFF;">Less: accumulated depreciation and amortization</span></div></div></td> <td style="width: 0.13%; vertical-align: bottom;"> </td> <td style="width: 2.49%; vertical-align: bottom; border-bottom: #000000 2px solid;"> </td> <td style="width: 11.83%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="background-color: #CCEEFF;"><div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">(805,626)</div></div></td> <td style="width: 2.34%; vertical-align: bottom; white-space: nowrap;"> </td> <td style="width: 0.13%; vertical-align: bottom;"> </td> <td style="width: 2.76%; vertical-align: bottom; border-bottom: #000000 2px solid;"> </td> <td style="width: 12.24%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="background-color: #CCEEFF;"><div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(979,282)</div></div></td> </tr> <tr> <td style="width: 68.09%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Total property and equipment</div></td> <td style="width: 0.13%; vertical-align: bottom;"> </td> <td style="width: 2.49%; vertical-align: bottom; border-bottom: #000000 4px double;"><div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">$</div></td> <td style="width: 11.83%; vertical-align: bottom; border-bottom: #000000 4px double;"><div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">1,554,576</div></td> <td style="width: 2.34%; vertical-align: bottom; white-space: nowrap;"> </td> <td style="width: 0.13%; vertical-align: bottom;"> </td> <td style="width: 2.76%; vertical-align: bottom; border-bottom: #000000 4px double;"><div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">$</div></td> <td style="width: 12.24%; vertical-align: bottom; border-bottom: #000000 4px double;"><div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">176,988</div></td> </tr> </table> <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 12pt;"><br/></div> <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">The Company incurred approximately $</span>63,656<span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"> and $</span>27,951<span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"> of depreciation expense for the </span>three months ended<span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"> </span>June 30, 2022<span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"> and </span>2021<span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">, and $</span>113,592<span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"> and $</span>66,525<span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"> of depreciation expense for the </span>six months ended<span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"> </span>June 30, 2022<span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"> and </span>2021<span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">, respectively.</span></div> <div><br/></div> <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">The Company closed all vape stores in Q2 2022, and disposed all vape stores' furniture and fixtures, computer and equipment, and leasehold improvements. Total gross carrying amount of $</span>287,431<span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"> and total accumulated depreciation of $</span>287,247<span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"> were reduced from the consolidated balance sheet.</span></div> <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">Property and equipment consist of the following:</span></div> <table cellpadding="0" cellspacing="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;"> <tr> <td style="width: 68.09%; vertical-align: bottom;"> </td> <td style="width: 0.13%; vertical-align: bottom; white-space: nowrap;"> </td> <td colspan="2" style="width: 14.31%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">June 30, 2022</div></td> <td style="width: 2.34%; vertical-align: bottom; white-space: nowrap;"> </td> <td style="width: 0.13%; vertical-align: bottom; white-space: nowrap;"> </td> <td colspan="2" style="width: 15%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">December 31, 2021</div></td> </tr> <tr> <td style="width: 68.09%; vertical-align: bottom;"><div style="background-color: #CCEEFF;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Displays</div></div></td> <td style="width: 0.13%; vertical-align: bottom;"> </td> <td style="width: 2.49%; vertical-align: bottom;"><div style="background-color: #CCEEFF;"><div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">$</div></div></td> <td style="width: 11.83%; vertical-align: bottom;"><div style="background-color: #CCEEFF;"><div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">305,558</div></div></td> <td style="width: 2.34%; vertical-align: bottom; white-space: nowrap;"> </td> <td style="width: 0.13%; vertical-align: bottom;"> </td> <td style="width: 2.76%; vertical-align: bottom;"><div style="background-color: #CCEEFF;"><div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">$</div></div></td> <td style="width: 12.24%; vertical-align: bottom;"><div style="background-color: #CCEEFF;"><div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">305,558</div></div></td> </tr> <tr> <td style="width: 68.09%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Building</div></td> <td style="width: 0.13%; vertical-align: bottom;"> </td> <td style="width: 2.49%; vertical-align: bottom;"> </td> <td style="width: 11.83%; vertical-align: bottom;"><div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">575,000</div></td> <td style="width: 2.34%; vertical-align: bottom; white-space: nowrap;"> </td> <td style="width: 0.13%; vertical-align: bottom;"> </td> <td style="width: 2.76%; vertical-align: bottom;"> </td> <td style="width: 12.24%; vertical-align: bottom;"><div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">-</div></td> </tr> <tr> <td style="width: 68.09%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Furniture and fixtures</div></td> <td style="width: 0.13%; vertical-align: bottom;"> </td> <td style="width: 2.49%; vertical-align: bottom;"> </td> <td style="width: 11.83%; vertical-align: bottom;"><div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">307,822</div></td> <td style="width: 2.34%; vertical-align: bottom; white-space: nowrap;"> </td> <td style="width: 0.13%; vertical-align: bottom;"> </td> <td style="width: 2.76%; vertical-align: bottom;"> </td> <td style="width: 12.24%; vertical-align: bottom;"><div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">246,496</div></td> </tr> <tr> <td style="width: 68.09%; vertical-align: bottom;"><div style="background-color: #CCEEFF;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Leasehold improvements</div></div></td> <td style="width: 0.13%; vertical-align: bottom;"> </td> <td style="width: 2.49%; vertical-align: bottom;"> </td> <td style="width: 11.83%; vertical-align: bottom;"><div style="background-color: #CCEEFF;"><div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">727,469</div></div></td> <td style="width: 2.34%; vertical-align: bottom; white-space: nowrap;"> </td> <td style="width: 0.13%; vertical-align: bottom;"> </td> <td style="width: 2.76%; vertical-align: bottom;"> </td> <td style="width: 12.24%; vertical-align: bottom;"><div style="background-color: #CCEEFF;"><div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">136,504</div></div></td> </tr> <tr> <td style="width: 68.09%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Computer hardware &amp; equipment</div></td> <td style="width: 0.13%; vertical-align: bottom;"> </td> <td style="width: 2.49%; vertical-align: bottom;"> </td> <td style="width: 11.83%; vertical-align: bottom;"><div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">133,059</div></td> <td style="width: 2.34%; vertical-align: bottom; white-space: nowrap;"> </td> <td style="width: 0.13%; vertical-align: bottom;"> </td> <td style="width: 2.76%; vertical-align: bottom;"> </td> <td style="width: 12.24%; vertical-align: bottom;"><div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">151,924</div></td> </tr> <tr> <td style="width: 68.09%; vertical-align: bottom;"><div style="background-color: #CCEEFF;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><span style="background-color: #CCEEFF;">Other</span></div></div></td> <td style="width: 0.13%; vertical-align: bottom;"> </td> <td style="width: 2.49%; vertical-align: bottom; border-bottom: #000000 2px solid;"> </td> <td style="width: 11.83%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="background-color: #CCEEFF;"><div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">311,294</div></div></td> <td style="width: 2.34%; vertical-align: bottom; white-space: nowrap;"> </td> <td style="width: 0.13%; vertical-align: bottom;"> </td> <td style="width: 2.76%; vertical-align: bottom; border-bottom: #000000 2px solid;"> </td> <td style="width: 12.24%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="background-color: #CCEEFF;"><div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">315,788</div></div></td> </tr> <tr> <td style="width: 68.09%; vertical-align: bottom;"> </td> <td style="width: 0.13%; vertical-align: bottom;"> </td> <td style="width: 2.49%; vertical-align: bottom;"> </td> <td style="width: 11.83%; vertical-align: bottom;"><div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">2,360,202</div></td> <td style="width: 2.34%; vertical-align: bottom; white-space: nowrap;"> </td> <td style="width: 0.13%; vertical-align: bottom;"> </td> <td style="width: 2.76%; vertical-align: bottom;"> </td> <td style="width: 12.24%; vertical-align: bottom;"><div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">1,156,270</div></td> </tr> <tr> <td style="width: 68.09%; vertical-align: bottom;"><div style="background-color: #CCEEFF;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><span style="background-color: #CCEEFF;">Less: accumulated depreciation and amortization</span></div></div></td> <td style="width: 0.13%; vertical-align: bottom;"> </td> <td style="width: 2.49%; vertical-align: bottom; border-bottom: #000000 2px solid;"> </td> <td style="width: 11.83%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="background-color: #CCEEFF;"><div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">(805,626)</div></div></td> <td style="width: 2.34%; vertical-align: bottom; white-space: nowrap;"> </td> <td style="width: 0.13%; vertical-align: bottom;"> </td> <td style="width: 2.76%; vertical-align: bottom; border-bottom: #000000 2px solid;"> </td> <td style="width: 12.24%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="background-color: #CCEEFF;"><div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(979,282)</div></div></td> </tr> <tr> <td style="width: 68.09%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Total property and equipment</div></td> <td style="width: 0.13%; vertical-align: bottom;"> </td> <td style="width: 2.49%; vertical-align: bottom; border-bottom: #000000 4px double;"><div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">$</div></td> <td style="width: 11.83%; vertical-align: bottom; border-bottom: #000000 4px double;"><div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">1,554,576</div></td> <td style="width: 2.34%; vertical-align: bottom; white-space: nowrap;"> </td> <td style="width: 0.13%; vertical-align: bottom;"> </td> <td style="width: 2.76%; vertical-align: bottom; border-bottom: #000000 4px double;"><div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">$</div></td> <td style="width: 12.24%; vertical-align: bottom; border-bottom: #000000 4px double;"><div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">176,988</div></td> </tr> </table> 305558 305558 575000 0 307822 246496 727469 136504 133059 151924 311294 315788 2360202 1156270 805626 979282 1554576 176988 63656 27951 113592 66525 287431 287247 <div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Note 9. INTANGIBLE ASSETS</div> <div><br/></div> <div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Intangible assets, net are as follows:</div> <div><br/></div> <table cellpadding="0" cellspacing="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;"> <tr> <td style="width: 30%; vertical-align: bottom; background-color: #CCEEFF; border-bottom: #000000 2px solid;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;"><span style="text-indent: 0pt;">June 30, 2022</span></div></td> <td style="width: 2.36%; vertical-align: bottom; background-color: #CCEEFF;"> </td> <td colspan="2" style="width: 21.11%; vertical-align: bottom; background-color: #CCEEFF; border-bottom: #000000 2px solid;"><div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Useful Lives (Years)</div></td> <td style="width: 1.81%; vertical-align: bottom; background-color: #CCEEFF;"> </td> <td colspan="2" style="width: 15.28%; vertical-align: bottom; background-color: #CCEEFF; border-bottom: #000000 2px solid;"><div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Gross</div><div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Carrying Amount</div></td> <td style="width: 1.39%; vertical-align: bottom; background-color: #CCEEFF;"> </td> <td colspan="2" style="width: 11.81%; vertical-align: bottom; background-color: #CCEEFF; border-bottom: #000000 2px solid;"><div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Accumulated</div><div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Amortization</div></td> <td style="width: 1.67%; vertical-align: bottom; background-color: #CCEEFF;"> </td> <td colspan="2" style="width: 14.58%; vertical-align: bottom; background-color: #CCEEFF; border-bottom: #000000 2px solid;"><div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Net</div><div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Carrying Amount</div></td> </tr> <tr> <td style="width: 30%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Trade names / Trademarks</div></td> <td style="width: 2.36%; vertical-align: bottom;"> </td> <td style="width: 1.81%; vertical-align: bottom;"> </td> <td style="width: 19.31%; vertical-align: bottom;"><div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">8-10 years</div></td> <td style="width: 1.81%; vertical-align: bottom;"> </td> <td style="width: 1.94%; vertical-align: bottom;"><div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">$</div></td> <td style="width: 13.33%; vertical-align: bottom;"><div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">1,436,000</div></td> <td style="width: 1.39%; vertical-align: bottom;"> </td> <td style="width: 1.39%; vertical-align: bottom;"><div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">$</div></td> <td style="width: 10.42%; vertical-align: bottom;"><div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">(610,818)</div></td> <td style="width: 1.67%; vertical-align: bottom;"> </td> <td style="width: 1.81%; vertical-align: bottom;"><div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">$</div></td> <td style="width: 12.78%; vertical-align: bottom;"><div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">825,182</div></td> </tr> <tr> <td style="width: 30%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Customer relationships</div></td> <td style="width: 2.36%; vertical-align: bottom; background-color: #CCEEFF;"> </td> <td style="width: 1.81%; vertical-align: bottom; background-color: #CCEEFF;"> </td> <td style="width: 19.31%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">4-5 years</div></td> <td style="width: 1.81%; vertical-align: bottom; background-color: #CCEEFF;"> </td> <td style="width: 1.94%; vertical-align: bottom; background-color: #CCEEFF;"> </td> <td style="width: 13.33%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">1,566,000</div></td> <td style="width: 1.39%; vertical-align: bottom; background-color: #CCEEFF;"> </td> <td style="width: 1.39%; vertical-align: bottom; background-color: #CCEEFF;"> </td> <td style="width: 10.42%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">(836,128)</div></td> <td style="width: 1.67%; vertical-align: bottom; background-color: #CCEEFF;"> </td> <td style="width: 1.81%; vertical-align: bottom; background-color: #CCEEFF;"> </td> <td style="width: 12.78%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">729,872</div></td> </tr> <tr> <td style="width: 30%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Patents</div></td> <td style="width: 2.36%; vertical-align: bottom;"> </td> <td style="width: 1.81%; vertical-align: bottom;"> </td> <td style="width: 19.31%; vertical-align: bottom;"><div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">10 years</div></td> <td style="width: 1.81%; vertical-align: bottom;"> </td> <td style="width: 1.94%; vertical-align: bottom;"> </td> <td style="width: 13.33%; vertical-align: bottom;"><div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">372,165</div></td> <td style="width: 1.39%; vertical-align: bottom;"> </td> <td style="width: 1.39%; vertical-align: bottom;"> </td> <td style="width: 10.42%; vertical-align: bottom;"><div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">(140,841)</div></td> <td style="width: 1.67%; vertical-align: bottom;"> </td> <td style="width: 1.81%; vertical-align: bottom;"> </td> <td style="width: 12.78%; vertical-align: bottom;"><div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">231,324</div></td> </tr> <tr> <td style="width: 30%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Non-compete</div></td> <td style="width: 2.36%; vertical-align: bottom; background-color: #CCEEFF;"> </td> <td style="width: 1.81%; vertical-align: bottom; background-color: #CCEEFF;"> </td> <td style="width: 19.31%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">4-5 years</div></td> <td style="width: 1.81%; vertical-align: bottom; background-color: #CCEEFF;"> </td> <td style="width: 1.94%; vertical-align: bottom; background-color: #CCEEFF;"> </td> <td style="width: 13.33%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">651,000</div></td> <td style="width: 1.39%; vertical-align: bottom; background-color: #CCEEFF;"> </td> <td style="width: 1.39%; vertical-align: bottom; background-color: #CCEEFF;"> </td> <td style="width: 10.42%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">(197,813)</div></td> <td style="width: 1.67%; vertical-align: bottom; background-color: #CCEEFF;"> </td> <td style="width: 1.81%; vertical-align: bottom; background-color: #CCEEFF;"> </td> <td style="width: 12.78%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">453,187</div></td> </tr> <tr> <td style="width: 30%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Website</div></td> <td style="width: 2.36%; vertical-align: bottom;"> </td> <td style="width: 1.81%; vertical-align: bottom;"> </td> <td style="width: 19.31%; vertical-align: bottom;"><div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">4 years</div></td> <td style="width: 1.81%; vertical-align: bottom;"> </td> <td style="width: 1.94%; vertical-align: bottom; border-bottom: #000000 2px solid;"> </td> <td style="width: 13.33%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">10,000</div></td> <td style="width: 1.39%; vertical-align: bottom;"> </td> <td style="width: 1.39%; vertical-align: bottom; border-bottom: #000000 2px solid;"> </td> <td style="width: 10.42%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">(1,458)</div></td> <td style="width: 1.67%; vertical-align: bottom;"> </td> <td style="width: 1.81%; vertical-align: bottom; border-bottom: #000000 2px solid;"> </td> <td style="width: 12.78%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">8,542</div></td> </tr> <tr> <td style="width: 30%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Intangible assets, net</div></td> <td style="width: 2.36%; vertical-align: bottom; background-color: #CCEEFF;"> </td> <td style="width: 1.81%; vertical-align: bottom; background-color: #CCEEFF;"> </td> <td style="width: 19.31%; vertical-align: bottom; background-color: #CCEEFF;"> </td> <td style="width: 1.81%; vertical-align: bottom; background-color: #CCEEFF;"> </td> <td style="width: 1.94%; vertical-align: bottom; background-color: #CCEEFF; border-bottom: #000000 4px double;"><div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">$</div></td> <td style="width: 13.33%; vertical-align: bottom; background-color: #CCEEFF; border-bottom: #000000 4px double;"><div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">4,035,165</div></td> <td style="width: 1.39%; vertical-align: bottom; background-color: #CCEEFF;"> </td> <td style="width: 1.39%; vertical-align: bottom; background-color: #CCEEFF; border-bottom: #000000 4px double;"><div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">$</div></td> <td style="width: 10.42%; vertical-align: bottom; background-color: #CCEEFF; border-bottom: #000000 4px double;"><div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">(1,787,058)</div></td> <td style="width: 1.67%; vertical-align: bottom; background-color: #CCEEFF;"> </td> <td style="width: 1.81%; vertical-align: bottom; background-color: #CCEEFF; border-bottom: #000000 4px double;"><div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">$</div></td> <td style="width: 12.78%; vertical-align: bottom; background-color: #CCEEFF; border-bottom: #000000 4px double;"><div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">2,248,107</div></td> </tr> </table> <div><br/></div> <table cellpadding="0" cellspacing="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;"> <tr> <td style="width: 29.86%; vertical-align: bottom; background-color: #CCEEFF; border-bottom: #000000 2px solid;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><span style="text-indent: 0pt;">December 31, 2021</span></div></td> <td style="width: 2.22%; vertical-align: bottom; background-color: #CCEEFF;"> </td> <td colspan="2" style="width: 21.53%; vertical-align: bottom; background-color: #CCEEFF; border-bottom: #000000 2px solid;"><div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Useful Lives (Years)</div></td> <td style="width: 1.67%; vertical-align: bottom; background-color: #CCEEFF;"> </td> <td colspan="2" style="width: 14.58%; vertical-align: bottom; background-color: #CCEEFF; border-bottom: #000000 2px solid;"><div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Gross</div><div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Carrying Amount</div></td> <td style="width: 1.94%; vertical-align: bottom; background-color: #CCEEFF;"> </td> <td colspan="2" style="width: 11.53%; vertical-align: bottom; background-color: #CCEEFF; border-bottom: #000000 2px solid;"><div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Accumulated</div><div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Amortization</div></td> <td style="width: 1.81%; vertical-align: bottom; background-color: #CCEEFF;"> </td> <td colspan="2" style="width: 14.86%; vertical-align: bottom; background-color: #CCEEFF; border-bottom: #000000 2px solid;"><div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Net</div><div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Carrying Amount</div></td> </tr> <tr> <td style="width: 29.86%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Trade names / Trademarks</div></td> <td style="width: 2.22%; vertical-align: bottom;"> </td> <td style="width: 1.94%; vertical-align: bottom;"> </td> <td style="width: 19.58%; vertical-align: bottom;"><div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">8-10 years</div></td> <td style="width: 1.67%; vertical-align: bottom;"> </td> <td style="width: 2.22%; vertical-align: bottom;"><div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"> $</div></td> <td style="width: 12.36%; vertical-align: bottom;"><div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">923,000</div></td> <td style="width: 1.94%; vertical-align: bottom;"> </td> <td style="width: 1.53%; vertical-align: bottom;"> </td> <td style="width: 10%; vertical-align: bottom;"><div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(536,661)</div></td> <td style="width: 1.81%; vertical-align: bottom;"> </td> <td style="width: 2.22%; vertical-align: bottom;"><div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"> $</div></td> <td style="width: 12.64%; vertical-align: bottom;"><div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">386,339</div></td> </tr> <tr> <td style="width: 29.86%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Customer relationships</div></td> <td style="width: 2.22%; vertical-align: bottom; background-color: #CCEEFF;"> </td> <td style="width: 1.94%; vertical-align: bottom; background-color: #CCEEFF;"> </td> <td style="width: 19.58%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">4-5 years</div></td> <td style="width: 1.67%; vertical-align: bottom; background-color: #CCEEFF;"> </td> <td style="width: 2.22%; vertical-align: bottom; background-color: #CCEEFF;"> </td> <td style="width: 12.36%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">883,000</div></td> <td style="width: 1.94%; vertical-align: bottom; background-color: #CCEEFF;"> </td> <td style="width: 1.53%; vertical-align: bottom; background-color: #CCEEFF;"> </td> <td style="width: 10%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(685,823)</div></td> <td style="width: 1.81%; vertical-align: bottom; background-color: #CCEEFF;"> </td> <td style="width: 2.22%; vertical-align: bottom; background-color: #CCEEFF;"> </td> <td style="width: 12.64%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">197,177</div></td> </tr> <tr> <td style="width: 29.86%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Patents</div></td> <td style="width: 2.22%; vertical-align: bottom;"> </td> <td style="width: 1.94%; vertical-align: bottom;"> </td> <td style="width: 19.58%; vertical-align: bottom;"><div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">10 years</div></td> <td style="width: 1.67%; vertical-align: bottom;"> </td> <td style="width: 2.22%; vertical-align: bottom;"> </td> <td style="width: 12.36%; vertical-align: bottom;"><div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">372,165</div></td> <td style="width: 1.94%; vertical-align: bottom;"> </td> <td style="width: 1.53%; vertical-align: bottom;"> </td> <td style="width: 10%; vertical-align: bottom;"><div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(122,233)</div></td> <td style="width: 1.81%; vertical-align: bottom;"> </td> <td style="width: 2.22%; vertical-align: bottom;"> </td> <td style="width: 12.64%; vertical-align: bottom;"><div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">249,932</div></td> </tr> <tr> <td style="width: 29.86%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Non-compete</div></td> <td style="width: 2.22%; vertical-align: bottom; background-color: #CCEEFF;"> </td> <td style="width: 1.94%; vertical-align: bottom; background-color: #CCEEFF;"> </td> <td style="width: 19.58%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">4 years</div></td> <td style="width: 1.67%; vertical-align: bottom; background-color: #CCEEFF;"> </td> <td style="width: 2.22%; vertical-align: bottom; background-color: #CCEEFF;"> </td> <td style="width: 12.36%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">238,000</div></td> <td style="width: 1.94%; vertical-align: bottom; background-color: #CCEEFF;"> </td> <td style="width: 1.53%; vertical-align: bottom; background-color: #CCEEFF;"> </td> <td style="width: 10%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(133,646)</div></td> <td style="width: 1.81%; vertical-align: bottom; background-color: #CCEEFF;"> </td> <td style="width: 2.22%; vertical-align: bottom; background-color: #CCEEFF;"> </td> <td style="width: 12.64%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">104,354</div></td> </tr> <tr> <td style="width: 29.86%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Website</div></td> <td style="width: 2.22%; vertical-align: bottom;"> </td> <td style="width: 1.94%; vertical-align: bottom;"> </td> <td style="width: 19.58%; vertical-align: bottom;"><div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">4 years</div></td> <td style="width: 1.67%; vertical-align: bottom;"> </td> <td style="width: 2.22%; vertical-align: bottom; border-bottom: #000000 2px solid;"> </td> <td style="width: 12.36%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">10,000</div></td> <td style="width: 1.94%; vertical-align: bottom;"> </td> <td style="width: 1.53%; vertical-align: bottom; border-bottom: #000000 2px solid;"> </td> <td style="width: 10%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(209)</div></td> <td style="width: 1.81%; vertical-align: bottom;"> </td> <td style="width: 2.22%; vertical-align: bottom; border-bottom: #000000 2px solid;"> </td> <td style="width: 12.64%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">9,791</div></td> </tr> <tr> <td style="width: 29.86%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Intangible assets, net</div></td> <td style="width: 2.22%; vertical-align: bottom; background-color: #CCEEFF;"> </td> <td style="width: 1.94%; vertical-align: bottom; background-color: #CCEEFF;"> </td> <td style="width: 19.58%; vertical-align: bottom; background-color: #CCEEFF;"> </td> <td style="width: 1.67%; vertical-align: bottom; background-color: #CCEEFF;"> </td> <td style="width: 2.22%; vertical-align: bottom; background-color: #CCEEFF; border-bottom: #000000 4px double;"><div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">$</div></td> <td style="width: 12.36%; vertical-align: bottom; background-color: #CCEEFF; border-bottom: #000000 4px double;"><div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">2,426,165</div></td> <td style="width: 1.94%; vertical-align: bottom; background-color: #CCEEFF;"> </td> <td style="width: 1.53%; vertical-align: bottom; background-color: #CCEEFF; border-bottom: #000000 4px double;"><div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">$</div></td> <td style="width: 10%; vertical-align: bottom; background-color: #CCEEFF; border-bottom: #000000 4px double;"><div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(1,478,572)</div></td> <td style="width: 1.81%; vertical-align: bottom; background-color: #CCEEFF;"> </td> <td style="width: 2.22%; vertical-align: bottom; background-color: #CCEEFF; border-bottom: #000000 4px double;"><div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">$</div></td> <td style="width: 12.64%; vertical-align: bottom; background-color: #CCEEFF; border-bottom: #000000 4px double;"><div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">947,593</div></td> </tr> </table> <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 12pt;"><br/></div> <div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Intangible assets are amortized on a straight-line basis over their estimated useful lives. Amortization expense was approximately  $165,100 and $97,023 for the three months ended June 30, 2022 and 2021, and $308,486 and $195,046 for the six months ended June 30, 2022 and 2021, respectively. Future annual estimated amortization expense is as follows:</div> <div><br/></div> <table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000; width: 100%;"> <tr> <td style="vertical-align: bottom;" valign="bottom"><div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Years ending December 31,</span></div></td> <td colspan="1" style="vertical-align: bottom;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><span style="text-indent: 0pt;">2022 (remaining six months)</span></div></td> <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;">$</div></td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;">319,814</div></td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 88%;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><span style="text-indent: 0pt;">2023</span></div></td> <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;">411,149</div></td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><span style="text-indent: 0pt;">2024</span></div></td> <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;">411,149</div></td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 88%;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><span style="text-indent: 0pt;">2025</span></div></td> <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;">404,107</div></td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><span style="text-indent: 0pt;">2026</span></div></td> <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;">309,214</div></td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 88%; padding-bottom: 2px;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Thereafter</div></td> <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;">392,674</div></td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 88%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Total</div></td> <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">$</div></td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">2,248,107</div></td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> </tr> </table> <div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Intangible assets, net are as follows:</div> <div><br/></div> <table cellpadding="0" cellspacing="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;"> <tr> <td style="width: 30%; vertical-align: bottom; background-color: #CCEEFF; border-bottom: #000000 2px solid;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;"><span style="text-indent: 0pt;">June 30, 2022</span></div></td> <td style="width: 2.36%; vertical-align: bottom; background-color: #CCEEFF;"> </td> <td colspan="2" style="width: 21.11%; vertical-align: bottom; background-color: #CCEEFF; border-bottom: #000000 2px solid;"><div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Useful Lives (Years)</div></td> <td style="width: 1.81%; vertical-align: bottom; background-color: #CCEEFF;"> </td> <td colspan="2" style="width: 15.28%; vertical-align: bottom; background-color: #CCEEFF; border-bottom: #000000 2px solid;"><div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Gross</div><div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Carrying Amount</div></td> <td style="width: 1.39%; vertical-align: bottom; background-color: #CCEEFF;"> </td> <td colspan="2" style="width: 11.81%; vertical-align: bottom; background-color: #CCEEFF; border-bottom: #000000 2px solid;"><div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Accumulated</div><div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Amortization</div></td> <td style="width: 1.67%; vertical-align: bottom; background-color: #CCEEFF;"> </td> <td colspan="2" style="width: 14.58%; vertical-align: bottom; background-color: #CCEEFF; border-bottom: #000000 2px solid;"><div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Net</div><div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Carrying Amount</div></td> </tr> <tr> <td style="width: 30%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Trade names / Trademarks</div></td> <td style="width: 2.36%; vertical-align: bottom;"> </td> <td style="width: 1.81%; vertical-align: bottom;"> </td> <td style="width: 19.31%; vertical-align: bottom;"><div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">8-10 years</div></td> <td style="width: 1.81%; vertical-align: bottom;"> </td> <td style="width: 1.94%; vertical-align: bottom;"><div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">$</div></td> <td style="width: 13.33%; vertical-align: bottom;"><div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">1,436,000</div></td> <td style="width: 1.39%; vertical-align: bottom;"> </td> <td style="width: 1.39%; vertical-align: bottom;"><div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">$</div></td> <td style="width: 10.42%; vertical-align: bottom;"><div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">(610,818)</div></td> <td style="width: 1.67%; vertical-align: bottom;"> </td> <td style="width: 1.81%; vertical-align: bottom;"><div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">$</div></td> <td style="width: 12.78%; vertical-align: bottom;"><div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">825,182</div></td> </tr> <tr> <td style="width: 30%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Customer relationships</div></td> <td style="width: 2.36%; vertical-align: bottom; background-color: #CCEEFF;"> </td> <td style="width: 1.81%; vertical-align: bottom; background-color: #CCEEFF;"> </td> <td style="width: 19.31%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">4-5 years</div></td> <td style="width: 1.81%; vertical-align: bottom; background-color: #CCEEFF;"> </td> <td style="width: 1.94%; vertical-align: bottom; background-color: #CCEEFF;"> </td> <td style="width: 13.33%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">1,566,000</div></td> <td style="width: 1.39%; vertical-align: bottom; background-color: #CCEEFF;"> </td> <td style="width: 1.39%; vertical-align: bottom; background-color: #CCEEFF;"> </td> <td style="width: 10.42%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">(836,128)</div></td> <td style="width: 1.67%; vertical-align: bottom; background-color: #CCEEFF;"> </td> <td style="width: 1.81%; vertical-align: bottom; background-color: #CCEEFF;"> </td> <td style="width: 12.78%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">729,872</div></td> </tr> <tr> <td style="width: 30%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Patents</div></td> <td style="width: 2.36%; vertical-align: bottom;"> </td> <td style="width: 1.81%; vertical-align: bottom;"> </td> <td style="width: 19.31%; vertical-align: bottom;"><div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">10 years</div></td> <td style="width: 1.81%; vertical-align: bottom;"> </td> <td style="width: 1.94%; vertical-align: bottom;"> </td> <td style="width: 13.33%; vertical-align: bottom;"><div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">372,165</div></td> <td style="width: 1.39%; vertical-align: bottom;"> </td> <td style="width: 1.39%; vertical-align: bottom;"> </td> <td style="width: 10.42%; vertical-align: bottom;"><div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">(140,841)</div></td> <td style="width: 1.67%; vertical-align: bottom;"> </td> <td style="width: 1.81%; vertical-align: bottom;"> </td> <td style="width: 12.78%; vertical-align: bottom;"><div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">231,324</div></td> </tr> <tr> <td style="width: 30%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Non-compete</div></td> <td style="width: 2.36%; vertical-align: bottom; background-color: #CCEEFF;"> </td> <td style="width: 1.81%; vertical-align: bottom; background-color: #CCEEFF;"> </td> <td style="width: 19.31%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">4-5 years</div></td> <td style="width: 1.81%; vertical-align: bottom; background-color: #CCEEFF;"> </td> <td style="width: 1.94%; vertical-align: bottom; background-color: #CCEEFF;"> </td> <td style="width: 13.33%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">651,000</div></td> <td style="width: 1.39%; vertical-align: bottom; background-color: #CCEEFF;"> </td> <td style="width: 1.39%; vertical-align: bottom; background-color: #CCEEFF;"> </td> <td style="width: 10.42%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">(197,813)</div></td> <td style="width: 1.67%; vertical-align: bottom; background-color: #CCEEFF;"> </td> <td style="width: 1.81%; vertical-align: bottom; background-color: #CCEEFF;"> </td> <td style="width: 12.78%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">453,187</div></td> </tr> <tr> <td style="width: 30%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Website</div></td> <td style="width: 2.36%; vertical-align: bottom;"> </td> <td style="width: 1.81%; vertical-align: bottom;"> </td> <td style="width: 19.31%; vertical-align: bottom;"><div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">4 years</div></td> <td style="width: 1.81%; vertical-align: bottom;"> </td> <td style="width: 1.94%; vertical-align: bottom; border-bottom: #000000 2px solid;"> </td> <td style="width: 13.33%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">10,000</div></td> <td style="width: 1.39%; vertical-align: bottom;"> </td> <td style="width: 1.39%; vertical-align: bottom; border-bottom: #000000 2px solid;"> </td> <td style="width: 10.42%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">(1,458)</div></td> <td style="width: 1.67%; vertical-align: bottom;"> </td> <td style="width: 1.81%; vertical-align: bottom; border-bottom: #000000 2px solid;"> </td> <td style="width: 12.78%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">8,542</div></td> </tr> <tr> <td style="width: 30%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Intangible assets, net</div></td> <td style="width: 2.36%; vertical-align: bottom; background-color: #CCEEFF;"> </td> <td style="width: 1.81%; vertical-align: bottom; background-color: #CCEEFF;"> </td> <td style="width: 19.31%; vertical-align: bottom; background-color: #CCEEFF;"> </td> <td style="width: 1.81%; vertical-align: bottom; background-color: #CCEEFF;"> </td> <td style="width: 1.94%; vertical-align: bottom; background-color: #CCEEFF; border-bottom: #000000 4px double;"><div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">$</div></td> <td style="width: 13.33%; vertical-align: bottom; background-color: #CCEEFF; border-bottom: #000000 4px double;"><div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">4,035,165</div></td> <td style="width: 1.39%; vertical-align: bottom; background-color: #CCEEFF;"> </td> <td style="width: 1.39%; vertical-align: bottom; background-color: #CCEEFF; border-bottom: #000000 4px double;"><div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">$</div></td> <td style="width: 10.42%; vertical-align: bottom; background-color: #CCEEFF; border-bottom: #000000 4px double;"><div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">(1,787,058)</div></td> <td style="width: 1.67%; vertical-align: bottom; background-color: #CCEEFF;"> </td> <td style="width: 1.81%; vertical-align: bottom; background-color: #CCEEFF; border-bottom: #000000 4px double;"><div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">$</div></td> <td style="width: 12.78%; vertical-align: bottom; background-color: #CCEEFF; border-bottom: #000000 4px double;"><div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">2,248,107</div></td> </tr> </table> <div><br/></div> <table cellpadding="0" cellspacing="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;"> <tr> <td style="width: 29.86%; vertical-align: bottom; background-color: #CCEEFF; border-bottom: #000000 2px solid;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><span style="text-indent: 0pt;">December 31, 2021</span></div></td> <td style="width: 2.22%; vertical-align: bottom; background-color: #CCEEFF;"> </td> <td colspan="2" style="width: 21.53%; vertical-align: bottom; background-color: #CCEEFF; border-bottom: #000000 2px solid;"><div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Useful Lives (Years)</div></td> <td style="width: 1.67%; vertical-align: bottom; background-color: #CCEEFF;"> </td> <td colspan="2" style="width: 14.58%; vertical-align: bottom; background-color: #CCEEFF; border-bottom: #000000 2px solid;"><div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Gross</div><div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Carrying Amount</div></td> <td style="width: 1.94%; vertical-align: bottom; background-color: #CCEEFF;"> </td> <td colspan="2" style="width: 11.53%; vertical-align: bottom; background-color: #CCEEFF; border-bottom: #000000 2px solid;"><div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Accumulated</div><div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Amortization</div></td> <td style="width: 1.81%; vertical-align: bottom; background-color: #CCEEFF;"> </td> <td colspan="2" style="width: 14.86%; vertical-align: bottom; background-color: #CCEEFF; border-bottom: #000000 2px solid;"><div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Net</div><div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Carrying Amount</div></td> </tr> <tr> <td style="width: 29.86%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Trade names / Trademarks</div></td> <td style="width: 2.22%; vertical-align: bottom;"> </td> <td style="width: 1.94%; vertical-align: bottom;"> </td> <td style="width: 19.58%; vertical-align: bottom;"><div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">8-10 years</div></td> <td style="width: 1.67%; vertical-align: bottom;"> </td> <td style="width: 2.22%; vertical-align: bottom;"><div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"> $</div></td> <td style="width: 12.36%; vertical-align: bottom;"><div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">923,000</div></td> <td style="width: 1.94%; vertical-align: bottom;"> </td> <td style="width: 1.53%; vertical-align: bottom;"> </td> <td style="width: 10%; vertical-align: bottom;"><div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(536,661)</div></td> <td style="width: 1.81%; vertical-align: bottom;"> </td> <td style="width: 2.22%; vertical-align: bottom;"><div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"> $</div></td> <td style="width: 12.64%; vertical-align: bottom;"><div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">386,339</div></td> </tr> <tr> <td style="width: 29.86%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Customer relationships</div></td> <td style="width: 2.22%; vertical-align: bottom; background-color: #CCEEFF;"> </td> <td style="width: 1.94%; vertical-align: bottom; background-color: #CCEEFF;"> </td> <td style="width: 19.58%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">4-5 years</div></td> <td style="width: 1.67%; vertical-align: bottom; background-color: #CCEEFF;"> </td> <td style="width: 2.22%; vertical-align: bottom; background-color: #CCEEFF;"> </td> <td style="width: 12.36%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">883,000</div></td> <td style="width: 1.94%; vertical-align: bottom; background-color: #CCEEFF;"> </td> <td style="width: 1.53%; vertical-align: bottom; background-color: #CCEEFF;"> </td> <td style="width: 10%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(685,823)</div></td> <td style="width: 1.81%; vertical-align: bottom; background-color: #CCEEFF;"> </td> <td style="width: 2.22%; vertical-align: bottom; background-color: #CCEEFF;"> </td> <td style="width: 12.64%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">197,177</div></td> </tr> <tr> <td style="width: 29.86%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Patents</div></td> <td style="width: 2.22%; vertical-align: bottom;"> </td> <td style="width: 1.94%; vertical-align: bottom;"> </td> <td style="width: 19.58%; vertical-align: bottom;"><div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">10 years</div></td> <td style="width: 1.67%; vertical-align: bottom;"> </td> <td style="width: 2.22%; vertical-align: bottom;"> </td> <td style="width: 12.36%; vertical-align: bottom;"><div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">372,165</div></td> <td style="width: 1.94%; vertical-align: bottom;"> </td> <td style="width: 1.53%; vertical-align: bottom;"> </td> <td style="width: 10%; vertical-align: bottom;"><div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(122,233)</div></td> <td style="width: 1.81%; vertical-align: bottom;"> </td> <td style="width: 2.22%; vertical-align: bottom;"> </td> <td style="width: 12.64%; vertical-align: bottom;"><div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">249,932</div></td> </tr> <tr> <td style="width: 29.86%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Non-compete</div></td> <td style="width: 2.22%; vertical-align: bottom; background-color: #CCEEFF;"> </td> <td style="width: 1.94%; vertical-align: bottom; background-color: #CCEEFF;"> </td> <td style="width: 19.58%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">4 years</div></td> <td style="width: 1.67%; vertical-align: bottom; background-color: #CCEEFF;"> </td> <td style="width: 2.22%; vertical-align: bottom; background-color: #CCEEFF;"> </td> <td style="width: 12.36%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">238,000</div></td> <td style="width: 1.94%; vertical-align: bottom; background-color: #CCEEFF;"> </td> <td style="width: 1.53%; vertical-align: bottom; background-color: #CCEEFF;"> </td> <td style="width: 10%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(133,646)</div></td> <td style="width: 1.81%; vertical-align: bottom; background-color: #CCEEFF;"> </td> <td style="width: 2.22%; vertical-align: bottom; background-color: #CCEEFF;"> </td> <td style="width: 12.64%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">104,354</div></td> </tr> <tr> <td style="width: 29.86%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Website</div></td> <td style="width: 2.22%; vertical-align: bottom;"> </td> <td style="width: 1.94%; vertical-align: bottom;"> </td> <td style="width: 19.58%; vertical-align: bottom;"><div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">4 years</div></td> <td style="width: 1.67%; vertical-align: bottom;"> </td> <td style="width: 2.22%; vertical-align: bottom; border-bottom: #000000 2px solid;"> </td> <td style="width: 12.36%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">10,000</div></td> <td style="width: 1.94%; vertical-align: bottom;"> </td> <td style="width: 1.53%; vertical-align: bottom; border-bottom: #000000 2px solid;"> </td> <td style="width: 10%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(209)</div></td> <td style="width: 1.81%; vertical-align: bottom;"> </td> <td style="width: 2.22%; vertical-align: bottom; border-bottom: #000000 2px solid;"> </td> <td style="width: 12.64%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">9,791</div></td> </tr> <tr> <td style="width: 29.86%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Intangible assets, net</div></td> <td style="width: 2.22%; vertical-align: bottom; background-color: #CCEEFF;"> </td> <td style="width: 1.94%; vertical-align: bottom; background-color: #CCEEFF;"> </td> <td style="width: 19.58%; vertical-align: bottom; background-color: #CCEEFF;"> </td> <td style="width: 1.67%; vertical-align: bottom; background-color: #CCEEFF;"> </td> <td style="width: 2.22%; vertical-align: bottom; background-color: #CCEEFF; border-bottom: #000000 4px double;"><div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">$</div></td> <td style="width: 12.36%; vertical-align: bottom; background-color: #CCEEFF; border-bottom: #000000 4px double;"><div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">2,426,165</div></td> <td style="width: 1.94%; vertical-align: bottom; background-color: #CCEEFF;"> </td> <td style="width: 1.53%; vertical-align: bottom; background-color: #CCEEFF; border-bottom: #000000 4px double;"><div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">$</div></td> <td style="width: 10%; vertical-align: bottom; background-color: #CCEEFF; border-bottom: #000000 4px double;"><div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(1,478,572)</div></td> <td style="width: 1.81%; vertical-align: bottom; background-color: #CCEEFF;"> </td> <td style="width: 2.22%; vertical-align: bottom; background-color: #CCEEFF; border-bottom: #000000 4px double;"><div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">$</div></td> <td style="width: 12.64%; vertical-align: bottom; background-color: #CCEEFF; border-bottom: #000000 4px double;"><div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">947,593</div></td> </tr> </table> P8Y P10Y 1436000 610818 825182 P4Y P5Y 1566000 836128 729872 P10Y 372165 140841 231324 P4Y P5Y 651000 197813 453187 P4Y 10000 1458 8542 4035165 1787058 2248107 P8Y P10Y 923000 536661 386339 P4Y P5Y 883000 685823 197177 P10Y 372165 122233 249932 P4Y 238000 133646 104354 P4Y 10000 209 9791 2426165 1478572 947593 <div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Intangible assets are amortized on a straight-line basis over their estimated useful lives. Amortization expense was approximately  $165,100 and $97,023 for the three months ended June 30, 2022 and 2021, and $308,486 and $195,046 for the six months ended June 30, 2022 and 2021, respectively. Future annual estimated amortization expense is as follows:</div> <div><br/></div> <table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000; width: 100%;"> <tr> <td style="vertical-align: bottom;" valign="bottom"><div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Years ending December 31,</span></div></td> <td colspan="1" style="vertical-align: bottom;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><span style="text-indent: 0pt;">2022 (remaining six months)</span></div></td> <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;">$</div></td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;">319,814</div></td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 88%;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><span style="text-indent: 0pt;">2023</span></div></td> <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;">411,149</div></td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><span style="text-indent: 0pt;">2024</span></div></td> <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;">411,149</div></td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 88%;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><span style="text-indent: 0pt;">2025</span></div></td> <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;">404,107</div></td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><span style="text-indent: 0pt;">2026</span></div></td> <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;">309,214</div></td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 88%; padding-bottom: 2px;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Thereafter</div></td> <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;">392,674</div></td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 88%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Total</div></td> <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">$</div></td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">2,248,107</div></td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> </tr> </table> 165100 97023 308486 195046 319814 411149 411149 404107 309214 392674 2248107 <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Note 10. CONTRACT LIABILITIES</div> <div><br/></div> <div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">The Company’s contract liabilities consist of gift cards and loyalty rewards, for which the Company has a performance obligation to deliver products when customers redeem balances or terms expire through breakage. Our breakage policy is twenty four months for gift cards, twelve months for Grocery loyalty rewards, and six months for Vapor loyalty rewards. As such, all contract liabilities are expected to be recognized within a twenty four month period. Revenue is recognized when gift card and loyalty points are redeemed.</div> <div><br/></div> <div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">A summary of the net changes in contract liabilities activity at June 30, 2022 and December 31, 2021 is presented below:</div> <div><br/></div> <div><br/></div> <table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000; width: 100%;"> <tr> <td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"><div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"/></td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom"><div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">June 30, 2022</div></td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom"><div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">December 31, 2021</div></td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Beginning balance as January 1,</div></td> <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">$</div></td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">23,178</div></td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;">$</div></td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;">21,262</div></td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 76%;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Issued</div></td> <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">558,859</div></td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;">39,469</div></td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Redeemed</div></td> <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">(525,621</div></td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">)</div></td> <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(37,463</div></td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;">)</div></td> </tr> <tr> <td style="vertical-align: bottom; width: 76%; padding-bottom: 2px;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Breakage recognized</div></td> <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">(311</div></td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">)</div></td> <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(90</div></td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;">)</div></td> </tr> <tr> <td style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Ending balance</div></td> <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">$</div></td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">56,105</div></td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;">$</div></td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;">23,178</div></td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> </tr> </table> <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"> </div> P24M P12M P6M P24M <div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">A summary of the net changes in contract liabilities activity at June 30, 2022 and December 31, 2021 is presented below:</div> <div><br/></div> <div><br/></div> <table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000; width: 100%;"> <tr> <td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"><div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"/></td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom"><div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">June 30, 2022</div></td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom"><div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">December 31, 2021</div></td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Beginning balance as January 1,</div></td> <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">$</div></td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">23,178</div></td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;">$</div></td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;">21,262</div></td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 76%;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Issued</div></td> <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">558,859</div></td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;">39,469</div></td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Redeemed</div></td> <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">(525,621</div></td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">)</div></td> <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(37,463</div></td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;">)</div></td> </tr> <tr> <td style="vertical-align: bottom; width: 76%; padding-bottom: 2px;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Breakage recognized</div></td> <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">(311</div></td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">)</div></td> <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(90</div></td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;">)</div></td> </tr> <tr> <td style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Ending balance</div></td> <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">$</div></td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">56,105</div></td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;">$</div></td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;">23,178</div></td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> </tr> </table> 23178 21262 558859 39469 525621 37463 -311 -90 56105 23178 <div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Note 11. DEBT</div> <div><br/></div> <div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">The following table provides a breakdown of the Company's debt as of June 30, 2022 and December 31, 2021 is presented below:</div> <div><br/></div> <table cellpadding="0" cellspacing="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;"> <tr> <td style="width: 50.61%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div style="text-align: left; font-family: 'Times New Roman'; font-size: 1pt;">_</div></td> <td style="width: 2.36%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"> </td> <td style="width: 2.75%; vertical-align: bottom; background-color: #CCEEFF; border-bottom: #000000 2px solid; white-space: nowrap;"> </td> <td style="width: 18.74%; vertical-align: bottom; background-color: #CCEEFF; border-bottom: #000000 2px solid; white-space: nowrap;"><div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">June 30, 2022</div></td> <td style="width: 3.34%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"> </td> <td style="width: 2.56%; vertical-align: bottom; background-color: #CCEEFF; border-bottom: #000000 2px solid; white-space: nowrap;"> </td> <td style="width: 19.64%; vertical-align: bottom; background-color: #CCEEFF; border-bottom: #000000 2px solid; white-space: nowrap;"><div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">December 31, 2021</div></td> </tr> <tr> <td style="width: 50.61%; vertical-align: bottom; white-space: nowrap;"><div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Line of Credit</div></td> <td style="width: 2.36%; vertical-align: bottom; white-space: nowrap;"> </td> <td style="width: 2.75%; vertical-align: bottom; white-space: nowrap;"><div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">$</div></td> <td style="width: 18.74%; vertical-align: bottom; white-space: nowrap;"><div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">453,232</div></td> <td style="width: 3.34%; vertical-align: bottom; white-space: nowrap;"> </td> <td style="width: 2.56%; vertical-align: bottom; white-space: nowrap;"><div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">$</div></td> <td style="width: 19.64%; vertical-align: bottom; white-space: nowrap;"><div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">418,036</div></td> </tr> <tr> <td style="width: 50.61%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Other debt</div></td> <td style="width: 2.36%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"> </td> <td style="width: 2.75%; vertical-align: bottom; background-color: #CCEEFF; border-bottom: #000000 2px solid; white-space: nowrap;"> </td> <td style="width: 18.74%; vertical-align: bottom; background-color: #CCEEFF; border-bottom: #000000 2px solid; white-space: nowrap;"><div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">2,134</div></td> <td style="width: 3.34%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"> </td> <td style="width: 2.56%; vertical-align: bottom; background-color: #CCEEFF; border-bottom: #000000 2px solid; white-space: nowrap;"> </td> <td style="width: 19.64%; vertical-align: bottom; background-color: #CCEEFF; border-bottom: #000000 2px solid; white-space: nowrap;"><div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">3,419</div></td> </tr> <tr> <td style="width: 50.61%; vertical-align: bottom; white-space: nowrap;"><div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Total debt</div></td> <td style="width: 2.36%; vertical-align: bottom; white-space: nowrap;"> </td> <td style="width: 2.75%; vertical-align: bottom; border-bottom: #000000 4px double; white-space: nowrap;"><div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">$</div></td> <td style="width: 18.74%; vertical-align: bottom; border-bottom: #000000 4px double; white-space: nowrap;"><div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">455,366</div></td> <td style="width: 3.34%; vertical-align: bottom; white-space: nowrap;"> </td> <td style="width: 2.56%; vertical-align: bottom; border-bottom: #000000 4px double; white-space: nowrap;"> </td> <td style="width: 19.64%; vertical-align: bottom; border-bottom: #000000 4px double; white-space: nowrap;"><div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">421,455</div></td> </tr> </table> <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"> </div> <div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">The following table provides a breakdown of the Company's debt as of June 30, 2022 and December 31, 2021 is presented below:</div> <div><br/></div> <table cellpadding="0" cellspacing="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;"> <tr> <td style="width: 50.61%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div style="text-align: left; font-family: 'Times New Roman'; font-size: 1pt;">_</div></td> <td style="width: 2.36%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"> </td> <td style="width: 2.75%; vertical-align: bottom; background-color: #CCEEFF; border-bottom: #000000 2px solid; white-space: nowrap;"> </td> <td style="width: 18.74%; vertical-align: bottom; background-color: #CCEEFF; border-bottom: #000000 2px solid; white-space: nowrap;"><div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">June 30, 2022</div></td> <td style="width: 3.34%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"> </td> <td style="width: 2.56%; vertical-align: bottom; background-color: #CCEEFF; border-bottom: #000000 2px solid; white-space: nowrap;"> </td> <td style="width: 19.64%; vertical-align: bottom; background-color: #CCEEFF; border-bottom: #000000 2px solid; white-space: nowrap;"><div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">December 31, 2021</div></td> </tr> <tr> <td style="width: 50.61%; vertical-align: bottom; white-space: nowrap;"><div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Line of Credit</div></td> <td style="width: 2.36%; vertical-align: bottom; white-space: nowrap;"> </td> <td style="width: 2.75%; vertical-align: bottom; white-space: nowrap;"><div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">$</div></td> <td style="width: 18.74%; vertical-align: bottom; white-space: nowrap;"><div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">453,232</div></td> <td style="width: 3.34%; vertical-align: bottom; white-space: nowrap;"> </td> <td style="width: 2.56%; vertical-align: bottom; white-space: nowrap;"><div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">$</div></td> <td style="width: 19.64%; vertical-align: bottom; white-space: nowrap;"><div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">418,036</div></td> </tr> <tr> <td style="width: 50.61%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Other debt</div></td> <td style="width: 2.36%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"> </td> <td style="width: 2.75%; vertical-align: bottom; background-color: #CCEEFF; border-bottom: #000000 2px solid; white-space: nowrap;"> </td> <td style="width: 18.74%; vertical-align: bottom; background-color: #CCEEFF; border-bottom: #000000 2px solid; white-space: nowrap;"><div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">2,134</div></td> <td style="width: 3.34%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"> </td> <td style="width: 2.56%; vertical-align: bottom; background-color: #CCEEFF; border-bottom: #000000 2px solid; white-space: nowrap;"> </td> <td style="width: 19.64%; vertical-align: bottom; background-color: #CCEEFF; border-bottom: #000000 2px solid; white-space: nowrap;"><div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">3,419</div></td> </tr> <tr> <td style="width: 50.61%; vertical-align: bottom; white-space: nowrap;"><div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Total debt</div></td> <td style="width: 2.36%; vertical-align: bottom; white-space: nowrap;"> </td> <td style="width: 2.75%; vertical-align: bottom; border-bottom: #000000 4px double; white-space: nowrap;"><div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">$</div></td> <td style="width: 18.74%; vertical-align: bottom; border-bottom: #000000 4px double; white-space: nowrap;"><div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">455,366</div></td> <td style="width: 3.34%; vertical-align: bottom; white-space: nowrap;"> </td> <td style="width: 2.56%; vertical-align: bottom; border-bottom: #000000 4px double; white-space: nowrap;"> </td> <td style="width: 19.64%; vertical-align: bottom; border-bottom: #000000 4px double; white-space: nowrap;"><div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">421,455</div></td> </tr> </table> 453232 418036 2134 3419 455366 421455 <div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Note 12. STOCKHOLDERS’ EQUITY</div> <div><br/></div> <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold;">Rights Offering</div> <div><br/></div> <div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">On June 18, 2021, the Company issued 27,046,800,310 shares of common stock in connection with the Rights Offering at a subscription price of $0.0010 per share, generating gross proceeds of $27.0 million. The Company incurred direct financing related costs of $2.7 million in connection with the offering resulting in net proceeds to the Company of $24.3 million.</div> <div><br/></div> <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold;">Exchange Agreement</div> <div><br/></div> <div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">On March 29, 2021, the Company entered into exchange agreements with the holders of indebtedness pursuant to the $2.7 million Loan and Security Agreement (the "Credit Agreement"). Pursuant to the Credit Agreement with the holders of the Company’s indebtedness (the “Notes”) in an aggregate amount of $1.3 million exchanged the Notes for 1,172,964,218 shares at a conversion price of $0.0011 (the "Exchange"). The Notes were issued pursuant to the Credit Agreement dated as of August 18, 2020, among The Vape Store, Inc., the Company, Healthy Choice Markets, Inc., Sabby Healthcare Master Fund, Ltd., and Sabby Volatility Warrant Master Fund, Ltd.  In connection with the Exchange, the Credit Agreement and all related loan documents was terminated and the Holder’s on the assets of the Company and its subsidiaries was cancelled.  The Company recognized a loss on debt extinguishment of $0.1 million.</div> <div><br/></div> <div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold;">Restricted Stock</div> <div style="text-align: justify;"><br/></div> <div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">On </span>January 14, 2021<span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">, the Compensation Committee of the Board of Directors of the Company approved an issuance of restricted stock to the Officers and a Director of the Company, in consideration for agreeing to a new vesting schedule for the existing awarded restricted stock. Each individual was granted a </span>10%<span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"> increase from the original award agreement for a total of </span>2.3<span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"> billion shares of restricted common stock, which will vest quarterly and equal amounts until </span>December 31, 2022<span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">, provided that the grantee remains an employee of the Company through the vesting date.</span></div> <div><br/></div> <div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">On March 30, 2021, the Company and the Officers and a Director of the Company agreed to forfeit a total of 3.09 billion of restricted shares of common stock that were due to vest on March 31, 2021.</div> <div><br/></div> <div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">On June 29, 2021, the Company and the Officers and a Director of the Company agreed to forfeit a total of 3.09 billion of restricted shares of common stock that were due to vest on June 30, 2021.</div> <div><br/></div> <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold;">Stock Options</div> <div><br/></div> <div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">In the six months ended June 30, 2022, no stock options of the Company were exercised into common stock; in comparison to the<span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"> </span>six months ended<span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"> </span>June 30, 2021<span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">, where </span>2,275,000,000<span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"> </span>stock options of the Company were exercised into common stock.<span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"> During the three months ended </span>June 30, 2022<span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"> and </span>2021<span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">, the Company recognized stock-based compensation of </span>$0<span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"> and </span>$32,500<span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">, respectively. Stock based compensation is included as part of selling, general and administrative expense in the accompanying consolidated statements of operations.</span></div> <div><br/></div> <div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold;">Income (Loss) Per Share</div> <div><br/></div> <div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">The following table summarizes the Company’s securities, in common share equivalents, which have been excluded from the calculation of dilutive loss per share as their effect would be anti-dilutive:</div> <div><br/></div> <table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000; width: 100%;"> <tr> <td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"><div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"/></td> <td colspan="7" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom"><div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">As of June 30,</div></td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="3" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom"><div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">2022</div></td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="3" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom"><div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">2021</div></td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Preferred stock</div></td> <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">1,250,000,000</div></td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;">2,083,000,000</div></td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #FFFFFF;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Stock options</div></td> <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #FFFFFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #FFFFFF;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">67,587,000,000</div></td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #FFFFFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #FFFFFF;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;">67,587,000,000</div></td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Total</div></td> <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">68,837,000,000</div></td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;">69,670,000,000</div></td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> </tr> </table> <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"> </div> 27046800310 0.0010 27000000.0 2700000 24300000 2700000 1300000 1172964218 0.0011 -100000 0.10 2300000000 3090000000.00 3090000000.00 0 2275000000 0 32500 <div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">The following table summarizes the Company’s securities, in common share equivalents, which have been excluded from the calculation of dilutive loss per share as their effect would be anti-dilutive:</div> <div><br/></div> <table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000; width: 100%;"> <tr> <td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"><div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"/></td> <td colspan="7" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom"><div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">As of June 30,</div></td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="3" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom"><div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">2022</div></td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="3" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom"><div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">2021</div></td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Preferred stock</div></td> <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">1,250,000,000</div></td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;">2,083,000,000</div></td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #FFFFFF;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Stock options</div></td> <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #FFFFFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #FFFFFF;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">67,587,000,000</div></td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #FFFFFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #FFFFFF;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;">67,587,000,000</div></td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Total</div></td> <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">68,837,000,000</div></td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;">69,670,000,000</div></td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> </tr> </table> 1250000000 2083000000 67587000000 67587000000 68837000000 69670000000 <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Note 13. COMMITMENTS AND CONTINGENCIES</div> <div><br/></div> <div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold;">Legal Proceedings</div> <div><br/></div> <div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Two lawsuits were filed against the Company and its subsidiaries in connection with alleged claimed battery defects for an electronic cigarette device. Plaintiffs claim these batteries were sold by a store of the Company’s subsidiary and have sued for an undetermined amount of damages (other than a total of $0.4 million of medical costs). The initial complaints were filed between January 2019 and April 2019. We responded to the complaints in 2019 and we exchanged additional support information with the plaintiff for one of the lawsuits in 2021. Given the lack of information presented by the plaintiffs to date, the Company is unable to predict the outcome of these matters and, at this time, cannot reasonably estimate the possible loss or range of loss with respect to these legal proceedings.</div> <div><br/></div> <div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">On November 30, 2020, the Company filed a patent infringement lawsuit against Philip Morris USA, Inc. and Philip Morris Products S.A. in the U.S. District Court for the Northern District of Georgia.  The lawsuit alleges infringement on HCMC-owned patent(s) by the Philip Morris product known and marketed as “IQOS®”.  Philip Morris claims that it is currently approaching 14 million users of its IQOS® product and has reportedly invested over $3 billion in their smokeless tobacco products. On December 3, 2021, the District Court for the Northern District of Georgia effectively dismissed HCMC’s patent infringement action against Philip Morris USA, Inc. and Philip Morris Products S.A.  On December 14, 2021, the Company filed a notice of appeal of the District Court for the Northern District of Georgia’s dismissal of the Company’s patent infringement action against Philip Morris USA, Inc. and Philip Morris Products S.A. The appeal brief was filed on February 28, 2022.</div> <div><br/></div> <div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">On December 31, 2021, the District Court for the Northern District of Georgia effectively dismissed HCMC’s patent infringement action against Philip Morris USA, Inc. and Philip Morris Products S.A. In connection with such dismissal, the defendants sought to recover attorney’s fees from the Plaintiff. On February 22, 2022, the District Court for the Northern District of Georgia granted the defendant’s an award of approximately $575,000 in attorneys’ fees to be paid by the Company. The Company has fully provisioned this amount as of December 31, 2021. HCMC appealed this ruling on June 22, 2022.</div> <div><br/></div> <div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">From time to time the Company is involved in legal proceedings arising in the ordinary course of our business. We believe that there is </span>no<span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"> other litigation pending that is likely to have, individually or in the aggregate, a material adverse effect on our financial condition or results of operations as of </span>June 30, 2022<span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">. With respect to legal costs, we record such costs as incurred.</span></div> <div><br/></div> <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold;">Employment Agreement</div> <div><br/></div> <div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">On February 26, 2021, the Company entered into an amended and restated employment agreement (the “<span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-style: italic;">Employment Agreement Amendment</span>”) with the Company’s President and Chief Operating Officer, Christopher Santi. Pursuant to the Employment Agreement Amendment, Mr. Santi will continue to be employed as the Company’s President and Chief Operating Officer through January 30, 2024.  Mr. Santi will receive a base salary of $0.4 million for 2021 and his salary will increase 10% in each subsequent year.</div> <div><br/></div> <div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">On February 02, 2022, the Company entered into a Second Amended and Restated Employment Agreement (the “<span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-style: italic;">Employment Agreement Amendment</span>”) with the Company’s Chief Financial Officer, John Ollet.  Pursuant to the Employment Agreement Amendment, Mr. Ollet will continue to be employed as the Company’s Chief Financial Officer through February 14, 2025.  Mr. Ollet will receive a base salary of $0.3 million for 2022 and his salary will increase 10% in each subsequent calendar year.</div> 2 400000 14000000 3000000000 575000 400000 0.10 300000 0.10 19300000 -2700000 -500000 2000000.0 2 400000 EXCEL 56 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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

@!CVY-AD7^*! K_.\OI5"DM\'"]8_]R/+%,M/%$S9E;*/E0+S61N9;,"G(N2C?[&5[#@> MO<.(-@"@D)W MF:A0><4,&_24W("RT<1F%T6I!9K$<6$O9684[7+"F<'XZ_WC=#A^A-O)<#2Y MG3Q.KF=P_LCF&>J+GFLHA0UTXRW=J*0+WJ%KPIT4)M5P+1),WN)=DE;I"W;Z M1L%)PINUN(30JT/@!<$)OK"J-RSXPO^I]^=PKHVB#^37L8I+PL9Q0MLT7;UB M,?8=Z@J-ZAF=P<X?3&V$2RX$%TMJQ(R)&(%IN&%B M;;52T!D$8=UOM>W"KP?-H#;1>DW\4=2NMZ,.A)UZH]FI33%!S,E_'@51O4EJ M+N \;-%>"!>U$0VW)QI(-'-BN13\CPT,_2*HXU$ ?=N'&LX@:M9]+]JG/W;Q M[D&/YJB6Q232=)9K8^ON J(#ZE:/EM&:2.MW1 @)J:MP -"R$EN&VN)G=GNLOU[KITV%.CZ$E]? MWW-\KN/C:2O5K2X1#3S4E= SKS2FF?B^SDNLF3Z1#0I:64E5,T-3M?9UHY 5 M#E17?A0$8[]F7'CIU.6N5#J5&U-Q@5<*]*:NF7J<8R7;F1=ZN\0U7Y?&)OQT MVK UWJ#YVEPIFOD]2\%K%)I+ 0I7,^\LG,P36^\*OG%L]5X,MI-,REL[^5C, MO, *P@IS8QD8#?>XP*JR1"3C;LOI]5M:X'Z\8W_O>J=>,J9Q(:OOO##ES#OU MH, 5VU3F6K8?<-O/R/+ELM+N"VU7&U)QOM%&UELP*:BYZ$;VL#V'/%_2DW1M$J)YQ)SR_F2WBU9%F% M^O74-T1I%_Q\"Y]W\.@)^!@NI3"EA@M18/$WWB'27\M!$G$ =# MB((H.L(7]_W%CB\^UM^/LTP;11?@YZ$..X+D,($UQ40W+,>91[=>H[I'+WWQ M+!P'[X[(2WIYR3'V=$Y&NBUD*T"NX!PSA4?*> M%ZB!0;:_@Z':A:P;)AY?:KJ\F0&F[0(=._;'#DP4)";'.D,%<>BR(7 -[@2$ MP0(R:^?)X-<_R/]0@\\DU^ZP4%AP \\A&<7#*(YL%)X.@W@\^$*R5*01.&0XD-'[^^YH$:U=E[7D,N-,)TA^FS_G)QU M+OI3WKU%ETRMN=!0X8J@PJ\WZL*0G$94MH/65E&8W ML1OTCVSZ&U!+ P04 " "<1 %5@2OZ].X" !-!@ &0 'AL+W=O"F6-5HJ233.F"60KU*C2E1I9Z4"'".(IZ8<&X#,9#OS?3XZ&J MK. 29QI,511,/UV@4.M1T FV&[=\E5NW$8Z')5OA'.U=.=,4A0U+R@N4ABL) M&K-1<-XYNSAQ^3[A*\>UV5F#<[)4ZMX%5^DHB)P@%)A8Q\#H\8 3%,(1D8Q? M&\Z@N=(!=]=;]O?>.WE9,H,3);[QU.:C8!! BAFKA+U5ZP^X\7/J^!(EC/^& M=9W;[P>05,:J8@,F!067]9,];M[##F 0_0,0;P"QUUU?Y%5>,LO&0ZW6H%TV ML;F%M^K1)(Y+]Z/,K:933C@[GB\^3SY]^'Q].;V=OX3IE[NKQ7=XM6!+@>;U M,+1TA4L,DPW=14T7_X.N!S=*VMS 5*:8/L>')*W1%V_U7<0'"3]6\ABZ41OB M*(X/\'4;OUW/U_T?OS_.E\9J*I"?^QS7A"?["5W3G)F2)3@*J"L,Z@<,QDC&(._UW!@PFE>:6HVD#EY#4IHPWA8TI.ESG/,DA9Z1]B2@!G]ETU,ES MJ^G6JG!62[):LS(OA&O +*/^I]%0B90X@4G+WVQ19ZUSXUBHR- 56CUVZ>#?I/Z/&PM ME&4">H/VH+N3\[;=Z_]EWUI65M'6W-[O-K#RO1\3?]'K0 MWC"]XB148$;0Z+A_&H"NAU<=6%7Z@;%4EL:/7^8T[U&[!#K/E++;P%W0_(., M_P!02P,$% @ G$0!51CEKC.* @ L@8 !D !X;"]W;W)K&ULK55K;],P%/TK5I!X2-"DZ0,H;:2NVV!([::-A\2T#TYR MFUB+[6 [[<:OY]I)0X>RBDE\27SM>X[O\>-XNI7J5N< AMSQ0NB9EQM33GQ? M)SEPJGNR!($C:ZDX-1BJS->E IHZ$"_\, C&/J=,>-'4]5VH:"HK4S !%XKH MBG.J[H^@D-N9U_=V'9VUBE<12WMK@+)UY@2T("DB,9:#XV\ "BL(281D_&TZOG=(" M]]L[]E.G';7$5,-"%M]9:O*9]\XC*:QI59A+N?T$C1Y78"(+[;YD6^>.,3FI MM)&\ 6,%G(GZ3^^:==@#($\W(&P X=^ X2. 00,8.*%U94[6,34TFBJY)7'^>KLQ_S+V?G*_+R& QEA7Y%WI"E-#DH MM+PD4G'R"Y,KLF) M2"%]B/=10*LBW*DX"@\2?JY$CPR"UR0,PK"CGL5A^"G$/1*\[X(_*&?0+NK M\0T>X5M(7E)Q3\Y51@7[1=V!O9['VB@\MC=="U83#KL)[56>Z)(F,//PKFI0 M&_"BY\_ZX^!#E]K_1/9 ^[#5/CS$'JTJ>SB(7!-M#X?N$GN0X:EB:[*1([.> MM8EP"S<="D:M@M$_*K@'JC3!>T"29D=SJDD,( C:J,)]%5F7OL/\PZ F[A)S M$/G4G?/W;(&#RIQ;:M12"5,[1-O;&O+<^9#_)[UV\R55&1.:%+!&:-![BX6J MVB'KP,C2F4PL#5J6:^;XJ("R"3B^EM+L CM!^TQ%OP%02P,$% @ G$0! M5=U4R@+9 @ DP< !D !X;"]W;W)K&ULK55M M3]LP$/XK5H8FD!!Y:[/"VDA] =%)%-3"]F':!S>Y-!:.76RG9=)^_&RG#07: M:$++A\0O]SQWSYUS[JZY>)0Y@$+/!66RY^1*+2]<5R8Y%%B>\24PO9-Q46"E MIV+ARJ4 G%I00=W \R*WP(0Y<=>NW8FXRTM%"8,[@619%%C\'@#EZY[C.]N% M*5GDRBRX<7>)%S #];"\$WKFUBPI*8!)PAD2D/67K:]CH:1N^A%-IWVA=V4;G#DI*J7BQ >L("L*J+W[> MY&$'T H/ ((-('@#"((#@' #"*W0*C(K:X05CKN"KY$PUIK-#&QN+%JK(B& M,Y5+=,E22%_C71U5'5JP#6T0-!)^*]D9"KU3%'A!@!YF(W1\=(*N",,L(9B. MF51$E>8P[ EVV,P]@D1S^Y;;WW(WQ!S6Z0PM;W@HG5CFI\B\T>5325:8 E,2 M89:B*4@E2*(@K?9_]N=Z01_C7_MR7;EI[7=C?NT+N<0)]!S][TH0*W#BSY_\ MR/NZ+Q?_B>Q51EIU1EI-[/&D+.8@$,]0MJT<(B^E0W_^M:*#RD_;^C'-:17[ M77>UJ[,QD@_J;-ZYTC>P9->HI!IJ'?V15= 5%= -5%\:;OHG"O=D^TPU[&PO=V]R:W-H M965T_XBF7RDT>>IY&0I_G"+%8YB^954IJ8V+)<,XWB M;#095]=N\\F8KT429^PV-XIUFD;YSTN6\,WY"(V>+]S%BZ4H+YB3\2I:L'LF M/JUNV)0E24F2]_&]AHZ:-LO$W>-G^E75>=F9AZA@4YY\B>=B M>3[R1\:3.>%-5?8[.-=;R1,5L7@J=ULKR#-,ZV_Z,? M]4#L)$B..@'7";B?X.Q)L.L$^Z4M.'6"\](62)U0==W<]KT:N# 2T62<\XV1 ME]&25AY4HU]ER_&*LW*BW(MW8U/(-LM,/\;^JFF^ICII: M:MM9L8IF['PDQ:M@^1,;37[[!;G6GZH!AX2%D# *!.N4QFE*X^CHD[H0JM'? M)KI58OE%\#1QD8TMUQJ;3[L#.XRS;9_X >[&A<,XA)!O26@WD"H:]@ER'=+$ M=;I*FJX2;5<_1RN>&U_?L_2!Y*^5@FTBV7DB21!X/1U0!5F!WY.+WORI0!"(KP,0B_66! M(I*XCNOA0"T):,>WM< VH=$CID MD2IU>,G*04\Z>OI!TD)0&H6B=6O26CE$3J,/H!8/E!:"TB@4K5N@UN8AK571 MZH,[?/(=SR=XL(88!F+'E@N#@48, P./N,0F?9$8!CJ!:]L[Q&Y_6^^$].;I MBO.Y<2^',9XQ\XX5(EKG42;T:J%%'CT9(6DA*(U"T;K%:3T?\D^C%J!.$)06 M@M(H%*U;H-8-(JVCT:I%,'09JR?,:T&J%G'3L%06DA*(U"T;I5:3T@1B?1" QJ M"4%I(2B-0M&Z!6HM(=8Z&IU&U)F=9]_K.XFI(HJXF 0]@5"$!:[7^]F"*J)< M:7+VF W<^BJL]U5?ECQA192P%_D-/>SHR0?ZB@R41J%HW;*T'A [IU$'4$,( M2@M!:12*UBU0:PBQ_N6>3AW(X%$=2,,P!!/B]97A((@J0I!%]LI":Z>PWDZU MLG#X1TH]ZN@Y!_JR#)1&H6C=HK2>#WNG$050WP=*"T%I%(K6+5#K^[#^99]. M%/S!)H.!*!P,"0^'4$6(@WIR8.YLK)*68%'M:"N,&5]G8KO+IKG:[)J[J/:* M]:Y?HK,I4EP/T1G=[HEK\=LM>N^C?!%GA9&P1]F4]3\H&FKV'D_\ 4$L#!!0 ( )Q$ 55"-)&K M- 0 /P7 9 >&PO=V]R:W-H965TZ"C =GS),[@@2*V3U-,GR:0D./0L(WG M"_-XL^7R@CD:[/ &%L"_[AZH.#,KRBI.(6,QR1"%]= 8VS>AW9:"O,6W&([L MY!C)KBP)^2%/9JNA880I)(DLCCWQ)J5#&E\/3XF1[FG1>= M66(&4Y+\':_X=FCT#+2"-=XG?$Z.GZ#LD"MY$4E8_A\=B[9NQT#1GG&2EF*1 M01IGQ2]^+ ?B1&!?$CBEP'FKH%T*VN<"]X*@4PHZ;XW@E@+WK0*O%'CYV!># ME8^TCSD>#2@Y(BI;"YH\R.W*U6* XTP^60M.Q=U8Z/CH[OY+L$#S8!K,OHTG MGP,TOO/1_9=/P1S-[J;WMP%Z[P/'<<(^H(_HZ\)'[]]]&)AT\YSUQE,#Q?M-";?L/Y%B.W9#/5"U?P*Z% M+$_*[5Y3=]3RO_:9B&[ET9T&>?!V>5/RH5KN0W2I[[6Q;%?/0#OGM2_PYA!! M?,#+!)AX^O@6S=+=GL,*S3(.%!A'W\=+QJF8!?YIR'92T#O-=#DUWK =CF!H MB+F/ 3V ,?K]-]NS_FSR32?,UPD+=,)"3;":WYW*[XZ*/GJ@) )8L28OEB[/QO]-&:,T"=T M1SB@[[>0+H$VOEE*TK5NZ(3Y.F&!3EBH"5;SUJN\]?[7F=33Z;=.F*\3%NB$ MA9I@-;^[E=]=];N,G\0JFR-A;MKDIU)]K9\Z8;ZZ7VT/I?EZKSUE+S\3++8V*=EGO,F\WNM/B=>SG;-OR?1U,[?G.)Y5;^8K4[GV!=() M"S7!:A;T*POZ2@NJ>9%B#DTF%/+^R>A:+:MKU?[L,T=^0>,KT[S6'IVP4!.L M9H]MO6P/K5]>*Y;2TT??=JVS!W_:T*IC=\['7YW&M09HI86Z:'4+3G;HMM*" M"4X20C*T*SXVC4[8K^.TK/@D9?5 MMTM+ S7@VK6!5IK_D\[9Z DP;?109QJA+EK=PY>JB*W7 M&8KD&PO=V]R:W-H965T6CK%.GQ/Q+9US+LF/*(S3L\9%(5-N]5RFY$?Q(W!:?[9K1B<)DL9!C&_ M%21=1I$O7K[P,'D^:UB-UP_N@ME<9A\T!Z<+?\9'7#XL;H5::ZXHTR#B<1HD M,1'\\:QQ;ITPIYL%Y%O\%?#G=&V99(AO$N> M+WAY0)V,-TG"-/^?/!?;NOT&F2Q3F41EL-J#*(B+O_Z/\D2L!5CM+0%V&6#O M&N"4 <[;@,Z6@'89T-XU0Z<,Z.P:X)8!;G[NBY.5GVG/E_[@5"3/1&1;*UJV MD,N51ZL3',39E3620GT;J#@Y.!_^^7 YNKR_O+DF-XQW#R,Z&=R>3T\)A\]+OT@3#^1(_(P\LC'GS^=-J7:CXS6G)0YO2*G MO26G2ZZ26,Y30N,IG^KQ3;7_JX.P7P_BBVT$,CX^)JW^9V*W;+MF?X:[A/>V MAGOF\-^7\3%Q6EO#Z>[A5DTX,X=[?*+"K;IP[5PZJPO"R7G.M@MB\GT9I$%> M]LFC4DK.N2#4%W+^(24CF0@^3Y8I5Q=$K#)_/1^G4JCVX9^:7?]2I&K7I\H: MS9-TX4_X64.UBBD73[PQ^.4GRVW]6BALG$SRO27&X=I"Y(F(>$422,@6":SNY*9]=8 M;K\ER?0Y",,Z+8V1^VJ)A'GN1NW8;J>[66/(I&PS:5]MNI93$Z"[$J!K%&#K MW8U\O>+1F(O:,C,R]Y4&"?.0,(J$,1!,4[FW4KGW_W5I>DCQD3 /":-(& /! M-/'[*_'[B"Y-?Z-]:;>[=N=MHS8T)MM7,22,(F$,!-,4LUK5F+2U@V9^,"6/ MB2!!_,1C5:0O=;J5I'7AW&YW4S=SQGV%@](HE,90-%V[-3_!>E^[81*GP92+ MHM.:*5FKG9&T;UM:TM[M^WO0M!1*8RB:+IY=B6E$:A-(:B MZ7)75H]E-!,&E\:6%6K>E+3.6G7V6IV:XH0:,U :0]%TM2IOQC*;,[DLN]NKT0Z9ED)I#$73M:L,'JZ M0&D,1=.?HE>^BVWV7:[5_:WHGA _\TS%VZ?SY<-XI%\Q+&GKPM6/VZ%I*93& M4#1=N,ITL2WCN)T%<2#YT1_!$Y^2M;[F>2&F>?!N0VT8*,V#TBB4QE T7?/* MJ[&-YL!N0PHS8V]M[1V'%-"T%$IC*)HN6^6YV&;/Y?U'CN1?);:GPH:4Z[M]+0']M :11*8RB:?CE4IH[=/HCC:D,M'BC-@](HE,90 M-%WNR@>R 3Z0F;&WMIL^4,>J&85"LU(HC:%HNFJ5#62[!^Q>0;T@*,V#TBB4 MQE T7?/*,++-AM%NE0HUC.Q-PZB^4J%^$93&4#1=ME$:A-(:B MZ6\N5/Z58_:O=FJSS8R]7TK8=*_<.H\?FI5":0Q%TU6KS"OG@.:5 S6OH#0/ M2J-0&D/1=,TK\\H!F%=FQM[:;II7]94*]:Z@-(:BZ:JMO1H&\*ZND_AHF$0+ M+E4)SP3GV:]4C)TK<]:]=<:^)X9]40S[IM@AK"NGLJZL&Q-"L%$IC*)JN6F5=.0>TKARH=06E>5 : MA=(8BJ9K7EE7#L"Z,C/VUK:@N>]6*M2Z@M(8BE:HUER;DR'B8I;/GI&22;*, M93&SP>K3U0P=Y_F\%&\^]ZP36LRS46&*:3^N?#$+XI2$_%$A6\==U=2(8B:- M8D4FBWSFAW$B91+EBW/N3[G(-E#?/R:)?%W)$JSF,QG\!U!+ P04 " "< M1 %5313:J3H& 2- &0 'AL+W=OI.DV3K]F:\X%>@B#*#L?K85(SL;C;+'FH9>] MBA,>R5?NXC3TA'R:KL99DG)O612%P9AHFC4./3\:S:;%LJMT-HTW(O C?I6B M;!.&7OK]@@?Q]GR$1X\+KOW56N0+QK-IXJWX#1>?DJM4/AO7E*4?\BCSXPBE M_.Y\] :?,>+D!<4:GWV^S78>HWQ7;N/X:_[DW?)\I.5;Q .^$#G"D__N^9P' M04Z2V_&M@HYJS;QP]_$CG14[+W?FULOX/ [^]I=B?3Z:C-"2WWF;0%S'V[>\ MVB$SYRWB("O^HFVYKB%77FPR$8=5L=R"T(_*_]Y#U8B= LGI+R!5 >D6& <* M]*I 'ZI@5 7&4 6S*C"'%EA5@57TOFQ6T6G7$]YLFL9;E.9K2UK^H+"KJ)8- M]J/\R+H1J7S5EW5B=G7]X8I>?_P'/?/"Y#6B?WUZ=W5)__R(?G>Y\/P@>XY> MHD\W+OK]U^?3L9"*>=UX4=$O2CHY0-?191R)=89HM.3+GGI776\IZL=R3^O= M)8^[>T&4P#\VT2ND:R\0T0CIV9[Y\'+@+V]N,Y'*B?%OW_%2(HU^9#Y&S[+$ M6_#SD9R3&4_O^6CV[!=L::_[S(*$N9 P"@EC0+"6R49MLJ&B-R8G@2?-;5G] M JW2.,OZ;"ZA5@'-3V[W,Z);FCSPIN/[70>5XL=Y=;,)-X F^E*=+N3D+WRM/R-('+XQ3X?]7+.CSH!0P M=[;LY423FV9U/%!NR+$>#!2ED**L1]2Q'3(A_1Y8M0>6TH./L? "E/2.N;Z& M6WN;@4W3,.UNPY6JQS9\H"B%%&4]HK;E3";]_;;K?MO*?KN[1SA_D!^>,][7 M9WM/W=(ML]ME>W\:V(Z)VVNY^RR,==/ICHQ]F&69Q&ROQ92[=^*@GM3-FZB; MYV=R1'_/T)=+'M[RM/?LJT0<>_:%A+F0, H)8T"PEJE.;:H#_Q'+@309$N9" MPB@DC '!6B9CK?D.ICW%AZR*NCN\=,TTS4EG$JK5CS5QH"H%564_5FWW?N?[ M+U;V_F+C!TL_6BGGIIIQ['L*E.:"TB@HC4'1VMZ2QEL"/SXK)I37D#07E$9! M:0R*UO:Z"2.P\FOPR3-4WYLKIFUJFM:=H:!9PT!5"JK*>E0/?$O%33R U?D MVZ21+S8I+SK._(?\L?I#J)IX]!L,-$( I5%0&H.BM9UN @EL/L$PA?R>/P>E MN: T"DIC4+2VUTWP@=7)QZG#=#\7T#5[0KJIGUK]:!^'J5)05=:C2@S+<*P# M$[4)0; Z!7G/O8ROXV")WH5)&M_SO.D_F*A P4/E#B3-!:514!J#HK6=;A(; M/'F"B0J:X8#27% :!:4Q*%K;ZR;(P2)ZNQ-&9O8AN5T)RIH3C-0E8*J MLAY5K%NF9O1/5-+$*T0=K\SC,-D(GJ*W7KK<>O*S:O5C=_.64PQ7-?S8-QPH MS06E45 :@Z*U36]R'8+AARL!S7E :2XHC8+2&!2M[763\Q!EMG#J<*VH[8&C M:V9WN*K5C_9QF"H%565]JB9VR*'AVN0N1)V[?!!K.5F5 Q3TF@]0F@M*HZ T M!D5K&]LD.\1X@@$*FNV TEQ0&@6E,2A:V^LFVR'JJTU.':#[%U[H&!/'Z Y0 MT-QFH"H%5645S6JIFO:A:QY(D[40==;RV4LXNA&QW(;?4/XK?IQY@7J@0@89 MJK<4X=J)/] M4'%B&SKN#E30V&:@*@5595"TMD--($/4@0S !9:5PNXIX:5L'#'LKEV@ZG^0"]6U L_\!4$L#!!0 ( )Q$ 56=B,0UI@8 )PN 9 M >&PO=V]R:W-H965TY!MQA:JBR?123KLPT^2%=.4J"/+I5\2RS[GKW.. M>/F)Y/@I2;]E*\X%>H[".#L?K(18OQL.L_F*1W[V-EGS./_E(4DC7^27Z7*8 MK5/N+TJG*!P2RW*&D1_$@\FX_.XNG8R3C0B#F-^E*-M$D9]^O^!A\G0^P(.7 M+SX&RY4HOAA.QFM_R>^Y^+R^2_.KX4YE$40\SH(D1BE_.!],\;M+FQ0.I<5? M 7_*]CZC(I59DGPK+JX7YP.KB(B'?"X*"3__]\@O>1@62GD<_U2B@]T]"\?] MSR_JOY7)Y\G,_(Q?)N&78"%6YP-O@!;\P=^$XF/R]#NO$K(+O7D29N5?]+2U M=<@ S3>92*+*.8\@"N+M?_^Y*L2>0ZZC=R"5 ZD[."T.M'*@9:+;R,JTKGSA M3\9I\H32PCI7*SZ4M2F]\VR"N'B,]R+-?PUR/S&YOOTTO?UP??'G>S2]OW__ MZ?X-NHZ%'R^#692/,V_[>NYEM)II27G[!C_:K+UY"8DCW;9<\@]RCBE3#%2/4Z816WLV./AXWXR33O"B+-OI\1I[^*TP3BG\_DF MVH2^X(LBR%0$__K%J*0+=:MD[X5PAEW/M6RO%JO.D+F>[1)]L,XN6 <,MF@_ M!Y34:=R>$.9ARZV%V;0;,=<>47V0[BY(%PSR4^HO.+KU(YZA(2JO\FGE6X:^ MWO!HQE-MNP\]\K_=,9F](3,E^M,M^9*;7CQI-#S/J6)95 M:Z)-NQ&A^V9*F-B2X0I-;4HD@/P M"4 &R4!4VIJ!20+8!@&/F?\81.B,,?\3)LL[.ZA[]Q/=9Z7QWBJ24A0P# I M'-2V_>?NM@W>IO>3-:2F%D4""79.T+9!RNE= 4-J:@4D[6 8=SK;-NR.+:!Q M'^.JIB&Q!8-<,+DL7U!YBC[RL)P)LU6PAID-5NS]&$_!+5B""QZ=H"&#--2[ M H;4U)=GB40$1J*#V:W2V:<';#L:>-,8>EX[O1&)0P3&H3[T5DDI4.91!Y,Z MO>D,'<_V2,O[$)%41& J.I#>*I7]M/8X9&+7;X)6K;1=1I3:FH%)/(0&'DZ6S;L;@,M M^PA/-0G)+01><;G+)\%8P* &2_1^:J? %"HQA5HG6%8'T:?WNKHA-;4"DGXH M3#]=[;;#'7KC.,I534-2$86IZ&#>I$W>H2YI[A!TVZF1[FWDP%S4!SW EV98N6^C-Z6FUD'.[(R8'^.8T2T?4VIJ!20Q,)@8NL:X#G?@I1GV/#:Q MO5,='6S1TL0/>'N&E7L_X%.LBC#)+LP^01,W"C*FU-0*2)!A\))*9Q.'W8&W M9]CSV,0DGS 8";[P619T("DLT?M)GF(=A$EN823N-&;%: M3K/8DF-L(_LV=G/=P;-9?==&8S5R1_630<.]\[\13Y?EL>C\J1;WWAX%WGV[ M.WH]+0\<#Z7Y]MSVC9\N@SA#(7_(7:VW;EZ>='L4>GLADG5YFGB6")%$Y<<5 M]Q<\+0SRWQ^21+Q<%#?8'4B?_ ]02P,$% @ G$0!53]U.<7U P :!4 M !D !X;"]W;W)K&ULK5CO;^(V /U7K&R:>M*M ML?,+P@ )2K)UVE75T=L^3/O@@H'HDIBS3>GMKY^=I"DAOC3L_ 5BQ^\]^SW; M23P^4O:9[P@1X#E+@ M++4=" ,[PTEN3<=%W3V;CNE!I$E.[AG@ARS#[.NZ$JK"G MXSW>DB41G_;W3);LFF6=9"3G"*?VL M"K?KB055CTA*5D)18/GW1&Y(FBHFV8\O%:E5:RK@Z?4+>UP,7@[F$7-R0]._ MDK783:RA!=9D@P^I^$B/OY%J0+[B6]&4%[_@6+6%%E@=N*!9!98]R)*\_,?/ ME1$G ,FC!S@5P#D'>-\ N!7 [:O@50"OKX)? ?R^@* "!(7WI5F%TPLL\'3, MZ!$PU5JRJ8LBK@(M#4YR-;.6@LF[B<2)Z>W=P^SNU]OY'Q&8+9?1P_(]B _B MP B8Y?D!IR#B(I$!DC68992)Y%]%L:4KOBO+@R=SH) M?S_DU\"%[X$#'4?3GYO^<*0;SO>I1]^G'G?#%V0EX4@';WCIUC/,+?C4?W50IV3P]F]IH1WR/5V1BR9V4$_9$K.E//Z _J++R239PB19 M9)(L-D36R->K\_6ZV*>-;8&4VX(NUY(E*%C4\^YIB@(?03BVGTX3:S<+!]!Q MFZT6[58N''K#H-DLTFB&/O3.FL6= _R?]OFU?7[G\KAHM^U>.;[)E6.2;&&2 M+#))%ALB:T0?U-$'G2M';>_@BA'U ICD6\"39Y 5#S+M,[0D\T_G/ J'R#M; M0)V:EP;73S,RJ1D;(FM$,J@C&;P5B:OS?M#RP4,(>>&9]YWDEWK?3S,RJ1D; M(FMX/ZR]'[[EO:?S?MC/^T[R2[WOIQF9U(P-D36\#VOOP[>\]W7>AVT?H(?@ MX,S[3O)+O>^G&9G4C V1-;Q'\/4;#+[E?J#]:H+M[1>&3FO+[Z:_U/^>JI%1 MU=@46S."D\]@U!G!PXXP@C>",&T0J&U)Z 2#5A"=(A<'T4\U,JH:FV)K!N&\ M!N%T!G%'!%AAQKZJ-R*UU;'PO.BL.PL_HY&MT@3?T"C:+RT.^5 MOCR#_(#9-LDY2,E&2L'K@9RVK#S6*PN"[HMCJ$&ULM5A=<^(V%/TK&K?3V9WIQI;!!E)@!LAVRT[2 M9DAV^Y#I@[ OH(EMN9* L+^^\D=LG%7$DG%?@F7?Q@!E&4,2D=_Y:D5M5G!CQ^?F;_/3>OS"R)@!F+_J:AW(RLOH5"6)%M)!=L M_P>4AKR,+V"1R/^B?1'K^18*MD*RN 0K!3%-BE_R5 [$$4#QZ %N"7!? E[K MH5,".KG10EENZXI(,AYRMD<\BU9LV4,^-CE:N:%)-HUWDJNO5.'D>/;7G_>+ MR>P>7<\GT_GU_'[^\0Z]NP)):"3>HP_HR]T5>O?S^Z$M56\9Q@Y*YFG![+[" M[*,;ELB-0!^3$$(-?F;&8]= 8"N;E5?WV>O4-3)^WB87J./\BES'=76"S/ K M"!0Y5L!YQ"B!>P@V0)ZF"R%Y"JQ_]&-=D'6U9-EJ_U2 MI"2 D:66LP"^ VO\RT_8=W[3.6V)K.&[6_GNFMC',S6KF4L44;*D$944!(*G M5"UL-1@< K9.:+[&4^"4Z5)G:N[![:(X3QV==2/TC=:]RKIGG/+9AB1KY98F MJ!J%ZZ-1F&2;&I4']+!@48341K4G/-2F@]=F.K1$UA@3OQH3WSA94UC3)*') M6FW'$4D"T+DM*/R<(JM,N[';P;W^T-X=V]!$8==WJZB&OEZEKV?4-Q=BJ]V_ MI@7..^K.\_I];_!"U?=AG4'7'^A5]2M5?:.J!80 L5Y7_[L./WBNYV>;5D.8 M)J[3Z_H=O;)!I6Q@GD]UFGA4)X#GE?Q-+W*@Z1R_5*@)&CAZ>=BI*YYC%*C* MR8EL*PF.$\GSL>.]4*<):V9E4^!12<9&@9_H2J*96O@"/=Q O 2NW0',+.=N M 6VQ-3V[M6>WS6)8LK7EO26VIO?Z'("-Y;9>,2F+:' PE+T31,:Z9\:^U61= M]+&Y)G_B+ !^0-?L0")5X1:P/YWA+=7J<@#^C\J/Z]*/S;7_W QOM<"WQ=;T M7I=X?*+&_WB&FXG4/P6&##=BWVJR/B=@\T'A*TD9/R^_C81GSW%+;$W[]8$$ M]UO-;^/YYFSO+;$UO==''OR#9Y[3^6TF\DWI;82>Z]$^NC.(@:_SJQ2! K9- M9'%]4+VMKFLF^26%78<7=STWA*LCO$ 1K!34N>BIS887UR=%0[(TOX%8,BE9 MG#]N@(3 LP#U?<68?&YD'5276./_ %!+ P04 " "<1 %52 :"')$" "H M"0 &0 'AL+W=O%6)JI5*6I[8MDA1R(DY8"86:63&>$ZFZ?&V+D@-9&E&> MV=AQ0CLGM+#BR(Q=\3AB&YG1 JXX$IL\)_S/.61L-[5<:S]P3=>IU -V')5D M#3<@;\LKKGIVX[*D.12"L@)Q6$VM,_=T-M'Q)N [A9TX:"--LF#L3G<^+:>6 MHQ."#!*I'8AZ;&$&6::-5!J_:T^K^4LM/&SOW2\,NV)9$ $SEOV@2YE.K;&% MEK BFTQ>L]U'J'D"[9>P3)A?M*MB<6"A9",DRVNQRB"G1?4D]_5[.!"X_B," M7 OP_PJ\6N 9T"HS@S4GDL019SO$=;1RTPWS;HQ:T=!"K^*-Y&J6*IV,YQ_. MOZ&C.4A",W&,WJ';FSDZ>GTHWT*BGV<+(;DJE5]=/)6!WVV@M\^I*$D" M4TOM#P%\"U;\YI4;.N^[Z 8R:[%Z#:O7YVY8NP K56A4>CMO8S\(O#",[.UA MZAUAV%6135@K*;])RN]-ZJM,@:-J&2XA7P#O7(1>DZ6G#! MD*P#F;58PX8U?%;!5:K@H)*PZ_D/RNW?(,]W)]W%-FH2&O4F]$7U$5NA&8[8 M\<('16&ULK5=K;]LV%/TKA#9L#=!9#\NRFMH" M$DM=NZU+%C<=AJ(?:.G*)B*1*DG'W;\?22F:[O9CO& M'\0&0*+O94'%W-I(65W:MD@W4&(Q8A50]21GO,12=?G:%A4'G!E06=B>XP1V MB0FUHID9N^71C&UE02C<S"J]A"?*^ MNN6J9[6].PN,7J(\= _-V(<>& M;WR"[WC)OERMA.3J''[MR.VZYO*[N?3=="DJG,+<4I>/ /X(5O33#V[@O.VR M>4BR>$BR9""R@P7QVP7Q^]BC!2M+=1.J$YP^(+'!2@$1(;:0H9RS$K'VURL2HZ%O_,?*FCA^$CC-VG9G]N+\2SV-==^J]"7S/#0]#X][DS_5Y M(+(#GR>MSY->GY?;E4@YJ MJ_Q*X&M3<@NUG;94UH54.]I6]5>FF#T:CU6U7Q?G_]/4KPJJ3%H3*E !N:)T M1E.U&7E=?M<=R2I37ZZ85-6J:6[4&PMP':">YXS)IXX6:-^!HO\ 4$L#!!0 M ( )Q$ 56WFGNK1P8 #&PO=V]R:W-H965T12/'/Q-5DP)LE+M(R3R]9"RM5YNYU, M%BRBR1E?L5A],^,BHE+MBGD[60E&IYDH6K8-3>NW(QK&K?%%=NQ.C"_X6B[# MF-T)DJRCB(IOUVS)GR];>NOUP'TX7\CT0'M\L:)S]L#DY]6=4'OMDC(-(Q8G M(8^)8+/+UI5^'NB#5)"=\4?(GI.M;9)>RB/G7],=;WK9TM*,V))-9(J@ZN.) MW;#E,B6I//XIH*TR9BKRGO^ M[++B@GHI;\*72?:?/!?G:BTR62>21X5891"%]80;\0]'<%O0."02$8'!MA6 B&QPI&A6!T;$JZ]OK+ M:2O)FIA))1U?"/Y,1'J^XJ4;63O-]*IEA7%JJ0ATLGQ MPZ>/-X'[\8-IW3_\2JS?/WN?_GI'K)?)@L9S1J[F@C'E($EH/"7W+)$BG$@V M)0^23[Z2-R:3-%PF;\E[\OG!)&]^?GO1EBJM%-Z>%"DX>0K&@10ZY);';];W&_1M=3O*>V*\WI-KHQ'HK^,S8HS>$4,S])I\;HZ0Z\.#EH!^76$?*&Y.WO)$_3Y+L'Y/E==&]8VZ=?E#N_[_D M@Q].OM(,.Z4U.QFOL;*B$W;94IUO MPL03:XU_^4GO:[_5M7$DS$3"+"3,1L(<),Q%PCPDS$?" A"LXK!NZ;!N$WWL MJ0[C4?5F,4L20N?*9G,J&:$17\>RSF&-N%,=AH292)B5P_H9+!V3/XWUCI;^ M7;2?MLV##.H@82X2YB%A/A(6U/Q076W0Z_7+'ZKBBU[IBUZC+\J>A\](S"5+ MB)J[D61!54KIL0F/(C4=2O(Q8!@77]6-_:X;(YUJF1S6V[I>8Z!U^T--Z^@[ MC=-$!K;V ^OZP!CUNX8^W#$%,JZ#A+E(F(>$^4A8 ()5G-,OG=-O=,[-MC.H MFC61E9HP,;)BA7\RNTSY=W],X;#GF'TJZ=Y^Z>]UVM&F?YW M P;[9PSZ@U%'JQ\%#^NQF=;(Z2_D# 3";.0,!L)/47M^9H!>4[;EM1QMI6DU7?-,<\53GG!#9 M@D:VH30'2G.A- ]*\Z&T $6K^F/KS:?^8^,[\B_Y.)NI:;N:HJ>O/5":#Z4%*%K5:YNJ KWQE>KXCHD)BR7-7^^$\40PFC"U M0<3&A?D#['DZ@DS(3/"(A&J#BW >QG1)Z#,54T++N@3)%2OO,6O]"JU,@-), M*,V"TNR"-JH\0M]Y?NY 0[I0F@>E^5!:@*)5;;@I/=";:P^.G9U!2PZ@-!-* MLZ TNZ!57A5WM-JYI0.-[$)I'I3F0VD!BE9UT*9(06^N4OC :9S-SQ[89"U" M^6V[4*YII@8M28#23"C-@M)L*,V!TEPHS8/2?"@M0-&JIMO4-^C]QIG:R46I M.K2, 4HSH30+2K.A- =*71]@*W5".VJP^V5O0 M:@@HS=+W7_$;@[J25&A8!TISH30/2O.AM !%RVW3WEK>%#$QSU;@)622VB)? M3E$>+5?Y765KVW:.._JYI]<<]]-5@=ERJ@T^7U)X2\4\C!.R9#,52CL;J-Y7 MY*OT\AW)5]GBJD&PO=V]R:W-H965TBZM!O0?FCL\SW/O=CGT8B1-$Q31XED&%^1@O(YQ#2I<] MHV6L!2,R2X02F'ZWP#,8@[@K;IBM3N@I?:WPF<"2 M;XR1BF1"Z;V:7,4]PU(.00J14 Q8?A8P@#151-*-'Q6G49M4P,WQFOV=CEW& M,L$I&-'E)53Q: :\&M .YS+7@50(=NEK'KQ 588+_+ MZ!(QI2W9U$!G7Z-EODBNSLE8,+E*)$[XX]OAX,/E\&,0CL:O4?CI[NKVZPD: M"QK=HV&A]I*CHP $)BD_1J?H;AR@HY?'75-(XXK"C"I#_=*0O<.0@ZYI+A*. MPCR&N $?[,>W]^!-&70=N;V.O&_O)7P_S\^08YT@V[+M!G\&SX>WFL+Y/^OA M/UM_D RG/@:.YG-V\ UH)F\>CG7QABLU!C2"B,YR\@MB].UBP@635?V]:>=+ M;K>96]UT'5[@"'J&O,HXL 48_JL7K;;UMBGMAR0+#DD6'HCLP0:Y]0:Y^]C] MLB)I59&P A81+C?FB.2()U@:;*S)O:1_NS.') M*,D^3J6:V\*VNN=A,]V,- MVS[W+/VK51\DTZN3Z3V=S%/57V(4;9S\I@R63.W=?@X>:SBV9VUI!4_RA T\ MKG/N;85J;MSU&;"9;K)Z?6W)^ZW.H-4@#V3?+]OT'_KR MT7"-V8S(TY?"5)JRSLZEQZQLQ.5$T$)WF@D5LF_I82+?+L"4@ER?4BK6$V6@ M?@WYOP%02P,$% @ G$0!5<2X#*XZ P <0P !D !X;"]W;W)K&ULS5=M3]LP$/XK5B9M0V(D35]A;20H3+"!Z"ALFM ^ MN.FUM7#B8#LM^_<[.VEH($0@]0/]T-C.W>-['M\EE_Y*R#NU -#D(>*Q&C@+ MK9,#UU7A B*J]D0",=Z9"1E1C5,Y=U4B@4ZM4\1=W_,Z;D19[ 1]NS:205^D MFK,81I*H-(JH_'<$7*P&3L-9+URQ^4*;!3?H)W0.8] WR4CBS"U0IBR"6#$1 M$PFS@7/8.!@V/.-@+7XQ6*F-,3%4)D+R4RH@J'@O]E4+P9.SR%3F-&4ZRNQ.H6<4-O@A8(K M^T]6N:WGD#!56D2Y,T80L3B[TH=_Y?D4\P]>[-VK" M:1:*-BU>\P6\H8@BS,],L)/[E"TIAU@CWX>0ITB9S*2(R)#R,.74YK*8D6/& M4Y/0Q$B^H?CMX41IB]Q(EJ!D*DM2 M%N?)N5.E619(VP9B'G++H-/K-;N>_?7=Y:8D%;;[G=STT;;$N%TP;MNLQ;PFL1+I3D.Z\F]KH;%.T+8&51.L6HG7? M2VUTG^5[PV\_3?=,D>>FOM=KUE5&K^#;J^6;U<-E8JBHVKJHQ7GK$6\)K$1Y MOZ"\_V[J8G^;HFT)K"1:PWOL7;SW4AEY)*570;?=JWYMO-(X8^UN-&\1R+GM M:15&G<8Z:X**U:)O/K3=XI/U(]-/VZ;P$29KQB^HG#.L)0XSA/3VNAB9S/K; M;*)%8EO$B=#8<-KA K\)0!H#O#\30J\G9H/B*R/X#U!+ P04 " "<1 %5 MG06\A*D% !I+ &0 'AL+W=O."]6*U-=J ]'&SX"A[ ?-S,E-UK5Y2%2"#50J9$P?*F=>N_ M84$G"\C/^%/ 7A]LD^Q2YE)^SG;&BYN6E[4(8HA,AN#V8PQHMDK//_ M9%^>Z[5(M-5&)F6P;4$BTN*3?RUOQ$% $)P(",J X*4!G3*@\]* ;AG0?1+0 M.74-O3*@]S3#Y8F ?AG0S^]]<;/R.QURPX<#)?=$96=;6K:1RY5'VQLLTJQG M/1AEOQ4VS@Q']Y/)^,.$3C\\D-MI2$;WTP_CZ5LZ'8WI WD5@N$BUJ_)1PV* MB)1,1!S;'J$';6.S9XQV5&:B1:;@1*8^F! M$\A@?D&"X%<2>$% /CZ$Y-7/KX^T:_0"C/=C3/B2UO1SC._ 4#?FCVUZ03I> MLS7D'=_KK3!'<,R-F\I=A?,J7":F0X!.U7+=G-XYH?@[6/&8S)2, !969$T^WQOT-X="H69DR'!&D+U*Z'Z3J'&::0@R89>.]Y&]M.^!1+[HE9H M1X!':_NR.-?P99N=] VX.B:H,\FY@F+"P@)V?2"H=^$_41,S(4."-=2\K-2\ M=*I9E$XF4IY&P@ZP+RF=3N*YTF'"0DP8Q80Q)%A#XZM*XRO4TGF%J2\F+,2$ M44P80X(U]+VN]+W^-Z73&7RNG-?/JEWG2+4+,7-23!A#@C6$\KUZRNO]'\73 MG>5<34N:L^*%J"DI*HUAT9JB'O@8OE/4VSB&%=AI:,Q%8C_ON#%@U0QA"9'1 MA$E%:.9G*9F*B(S$BBNPI]@3=K;8.FNM._792F/20E0:1:4Q+%JS2P1UEPA0 M2VZ)PY(9DQ:BTB@JC6'1FC+7+I3OMJ&FV^S!)7))XL(FT^2[PS&[<^/.EAG5 M=D*ET9+6.Z@I0;.B,*R$3>UJ/\EWVAG#V5K$8D,F4BFAW6,PJI>$2@M1:125 MQK!H38%K0\GOX8[!J!X3*BU$I5%4&L.B-66N[2C?[4?58_#6PC7AFXV2]CW: MOHA]/_)S0ZDUJOV$2@M1:125QDK:X;#N=ZMQO:E@;4'Y;@]JG.Y &ZL73^0V M/5XX43TG5%J(2J.H-%;2GL_7&W/VIFZUK>0[78T3%=0^=3-NLMGK.%TJ.^X6 M\]UWPMAY3_Z3OK/6HII/J+00E491:0R+UNP*M0/E7^/66E13"I46HM(H*HUA MT9JK'FK[*G#;5[?&2)7"-[($T&3#Q>*8N"7D<-#I7?:>F80C=[)S94.E450: MPZ(U9:L-JL!M4$WL,QG9YW,DM6D,U/^E<^5NT[F/."HM1*515!K#HC7[2NU< M!;C.58#J7*'20E0:1:4Q+%I3YMJY"MS.5<@3OK)CN);;U?KH*[<;<+:PJ%X5 M*HV6M!\MX6!860O)V@Q:6=GZEB76NQ8^0F7X;J)RMF(W)V\_[E4YO)=Y.]''XZ..G>GEX?V$P>7Q?L?.+6[R.AX62F[3FQ!OL+RT9-$] M%2,RH8)/-0>O@I9]*G8JUH%ZR79H!35#3^,GP+_+YKEW:3LOXHTJ?J_,YZ7=CG1S:#%V MK5G!5VZ^*EH!&'L79Z=5)=:?!)_+DOG-/SO@>$@W?M%":?Y@HT&KS*R!:1+= M,VWX;-?R2]/JEJW,IIU6!:ZY]P8U_]T\SYEDFHI=T;;W7W.67ZPXN?A7DMU_ ME4/!08W-(??:1?;?@LCT+8A\G3T9-\?.SMFV=[*UU@C>($;D.[R)B&W0:+KD MPG#9S!8\SYE\=,!9>D.G]C5RC]^NSUE!E\+C'%3[@^V%.2 M)%D61@ +*T@2#(&G$4*NQS $P( L !?3T\$MP>:4#M.*2VBZD8_1!2 M:5K5N %(MB6/:(7->= MI3W;+T]!;X"O.DQQ0FE(2S,.\,W2?S+W\PPU1>5*(Y5;&GC3Y?YVX$G1H2)8 M%II%R=.B':5_' MHII==+4O#D]@&YGC>VT.AH^O=?/R5-"U79 M53QR]MK^;.^*Z!MO^1,ON?Q[9?7G);-0Q06O^ ^V6UE+"[6'^O6^;OB/6LB\ MI$53E^7*LH>&1]9(7ORGFG:06?[4]C4R?TIS!;*R;I:JPSUO6ME?T?>?*\9O M3%T\E$ZRON.E9$V82[9IZM.1B^>N&S6*A3:,/@[GXQ#$V^;_A+'>[WG!PKHX M54S((8X-*SM T1[XL;60R"NVLLZ7H%SL$!92!0D1,72EKNU&JFY-=L.HI<+5 M8MC<#O $@;\Q")NG&C\F??D82/;?O M *)W9HDB\OD+"4GV5<-Y#^"\-XNS]BFA*+E#VQ13'&=]I) ?JT2234PTR \ MY ?C4RU0;&D/1_5'\A)Z)B_-4H6$^IM-BC=#S%0,4_R(XR]X1 A:P[ VXB3# M5%$%F#SZZPCW>4VR>YPB$@>)C@EYPS8L#C]02X*2JN4D>E\D#1LP]8@:O7&&]+GF5*KQ$(#_8A@41XO4H@9 9;,-JH%D2_'&?1"%.Z9M^?HTL M84.:L U[(D@>'DC637?:/T6ZG))X@^/@7\F$-&%?U!/H2FTW2M;^JK\>0\)P M9A-&CZIC0M9PYK3&Z.W3 7<;YQ;FP6R;X7$@N[HQR M4:PZ)B07=U:YZ%\-7$@N[JQR&6&"'[-FD\O4](3LXE[:+F\1$3(7SQT'\G5, M2#&N8<5,8-Z=Y*E1B$*<QX1\XQKVS30F_EX?_B)_^ 5!+ P04 " "< M1 %5[DG=_YX! (&@ &@ 'AL+U]R96QS+W=O?P7UB?+GGV%4YD.=17WAR;V+N=3%>?%/J7FP[FXWH=S&?MU$ZKNS+9NSV7J MENW.->7Z6.Z"T\%@Y-KG&<5B]CRSM[HVX3\3Z^WVL Z?]?K['*KTQV#W4[?' MN \A%;U5V>Y"FA?N0CR M^8.&$#3,'S2"H%'^H#$$C?,'32!HDC]H"D'3_$$R0!D'!$DO6!-H+BOJK01Z*^JM!'HKZJT$>BOJK01Z*^JM!'HKZJT$>AOJ;01Z M&^IM!'H;ZFT$>MO+QQ("O0WU-@*]#?4V KT-]38"O0WU-@*]#?4V KT-]38" MO3WJ[0GT]JBW)]#;H]Z>0&^/>OMWZAW3]13BH^>^QON_D^K471L>M[\M[YLO MC\H-9P<_?A:_4$L#!!0 ( )Q$ 56HRH?9JP$ $$: 3 6T-O;G1E M;G1?5'EP97-=+GAM;,V9S6[",!"$7P7EBHBQG=(? 9>VUY9#7\!--B0BB2W; M4'C[.N%':D6C(BIU+K$2[\Z,O=)WR?1M9\@-MG75N%E4>&\>&'-I0;5RL3;4 MA)U7T<$A#IU=C2M*XX:A(&)G'=J=GPT.?:\; MLK;,:+!0UK^H.E2Q;<6H?K_=!VU&UL M4$L! A0#% @ G$0!50("*&KE!0 \1X !@ ("!#@@ M 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ G$0! M56>9H@"4!@ 72 !@ ("!+QD 'AL+W=O&PO=V]R:W-H M965T&UL4$L! A0#% @ G$0!5?F:+,5_!P ZA !@ M ("!;C\ 'AL+W=O&PO=V]R:W-H965T&UL M4$L! A0#% @ G$0!5:+("^#1 P PP@ !D ("!2E M 'AL+W=OZC M'ND# "$" &0 @(%25 >&PO=V]R:W-H965T&UL4$L! A0#% @ MG$0!5=40I^XU!0 =@L !D ("!;%P 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ G$0!5?O*^^JL P M'0@ !D ("!7&H 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ G$0!52U72GR?!@ $!$ !D M ("! W@ 'AL+W=O&PO=V]R:W-H M965T&UL4$L! M A0#% @ G$0!59%>1:=J @ 5P4 !D ("!W84 'AL M+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ G$0! M59/16>-_! LPH !D ("!C(\ 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ G$0!58$K^O3N @ 308 M !D ("! YH 'AL+W=O&PO=V]R:W-H965TF? !X;"]W;W)K&UL4$L! A0#% @ G$0!5;QL'@U^!0 AR@ !D M ("!^:( 'AL+W=O&PO=V]R:W-H965T M&UL4$L! A0# M% @ G$0!54T4VJDZ!@ $C0 !D ("!?+0 'AL+W=O M&PO=V]R:W-H965T&UL4$L! A0#% @ G$0!5?Q" M]@$/! T!( !D ("!]L4 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ G$0!5;>:>ZM'!@ -SD !D M ("!H= 'AL+W=O&PO M=V]R:W-H965T&UL4$L! A0#% @ G$0!59T%O(2I!0 :2P !D ("! MF]T 'AL+W=O&PO&PO7W)E;',O=V]R:V)O;VLN M>&UL+G)E;'-02P$"% ,4 " "<1 %5J,J'V:L! !!&@ $P M @ &$[0 6T-O;G1E;G1?5'EP97-=+GAM;%!+!08 ,P S -P- !@ %[P ! end XML 57 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 58 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 59 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.2 html 185 204 1 false 50 0 false 8 false false R1.htm 000100 - Document - Document and Entity Information Sheet http://healthiercmc.com/role/DocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 010000 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS Sheet http://healthiercmc.com/role/CondensedConsolidatedBalanceSheets CONDENSED CONSOLIDATED BALANCE SHEETS Statements 2 false false R3.htm 010100 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) Sheet http://healthiercmc.com/role/CondensedConsolidatedBalanceSheetsParenthetical CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) Statements 3 false false R4.htm 020000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS Sheet http://healthiercmc.com/role/CondensedConsolidatedStatementsOfOperations CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS Statements 4 false false R5.htm 030000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY Sheet http://healthiercmc.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquity CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY Statements 5 false false R6.htm 040000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS Sheet http://healthiercmc.com/role/CondensedConsolidatedStatementsOfCashFlows CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS Statements 6 false false R7.htm 060100 - Disclosure - ORGANIZATION Sheet http://healthiercmc.com/role/Organization ORGANIZATION Notes 7 false false R8.htm 060200 - Disclosure - LIQUIDITY Sheet http://healthiercmc.com/role/Liquidity LIQUIDITY Notes 8 false false R9.htm 060300 - Disclosure - BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES Sheet http://healthiercmc.com/role/BasisOfPresentationAndSignificantAccountingPolicies BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES Notes 9 false false R10.htm 060400 - Disclosure - CONCENTRATIONS Sheet http://healthiercmc.com/role/Concentrations CONCENTRATIONS Notes 10 false false R11.htm 060500 - Disclosure - DISAGGREGATION OF REVENUES Sheet http://healthiercmc.com/role/DisaggregationOfRevenues DISAGGREGATION OF REVENUES Notes 11 false false R12.htm 060600 - Disclosure - NOTES RECEIVABLE AND OTHER INCOME Notes http://healthiercmc.com/role/NotesReceivableAndOtherIncome NOTES RECEIVABLE AND OTHER INCOME Notes 12 false false R13.htm 060700 - Disclosure - ACQUISITION OF MOTHER EARTH'S STOREHOUSE, INC. Sheet http://healthiercmc.com/role/AcquisitionOfMotherEarthSStorehouseInc ACQUISITION OF MOTHER EARTH'S STOREHOUSE, INC. Notes 13 false false R14.htm 060800 - Disclosure - PROPERTY & EQUIPMENT Sheet http://healthiercmc.com/role/PropertyEquipment PROPERTY & EQUIPMENT Notes 14 false false R15.htm 060900 - Disclosure - INTANGIBLE ASSETS Sheet http://healthiercmc.com/role/IntangibleAssets INTANGIBLE ASSETS Notes 15 false false R16.htm 061000 - Disclosure - CONTRACT LIABILITIES Sheet http://healthiercmc.com/role/ContractLiabilities CONTRACT LIABILITIES Notes 16 false false R17.htm 061100 - Disclosure - DEBT Sheet http://healthiercmc.com/role/Debt DEBT Notes 17 false false R18.htm 061200 - Disclosure - STOCKHOLDERS' EQUITY Sheet http://healthiercmc.com/role/StockholdersEquity STOCKHOLDERS' EQUITY Notes 18 false false R19.htm 061300 - Disclosure - COMMITMENTS AND CONTINGENCIES Sheet http://healthiercmc.com/role/CommitmentsAndContingencies COMMITMENTS AND CONTINGENCIES Notes 19 false false R20.htm 080400 - Disclosure - CONCENTRATIONS (Tables) Sheet http://healthiercmc.com/role/ConcentrationsTables CONCENTRATIONS (Tables) Tables http://healthiercmc.com/role/Concentrations 20 false false R21.htm 080500 - Disclosure - DISAGGREGATION OF REVENUES (Tables) Sheet http://healthiercmc.com/role/DisaggregationOfRevenuesTables DISAGGREGATION OF REVENUES (Tables) Tables http://healthiercmc.com/role/DisaggregationOfRevenues 21 false false R22.htm 080600 - Disclosure - NOTES RECEIVABLE AND OTHER INCOME (Tables) Notes http://healthiercmc.com/role/NotesReceivableAndOtherIncomeTables NOTES RECEIVABLE AND OTHER INCOME (Tables) Tables http://healthiercmc.com/role/NotesReceivableAndOtherIncome 22 false false R23.htm 080700 - Disclosure - ACQUISITION OF MOTHER EARTH'S STOREHOUSE, INC. (Tables) Sheet http://healthiercmc.com/role/AcquisitionOfMotherEarthSStorehouseIncTables ACQUISITION OF MOTHER EARTH'S STOREHOUSE, INC. (Tables) Tables http://healthiercmc.com/role/AcquisitionOfMotherEarthSStorehouseInc 23 false false R24.htm 080800 - Disclosure - PROPERTY & EQUIPMENT (Tables) Sheet http://healthiercmc.com/role/PropertyEquipmentTables PROPERTY & EQUIPMENT (Tables) Tables http://healthiercmc.com/role/PropertyEquipment 24 false false R25.htm 080900 - Disclosure - INTANGIBLE ASSETS (Tables) Sheet http://healthiercmc.com/role/IntangibleAssetsTables INTANGIBLE ASSETS (Tables) Tables http://healthiercmc.com/role/IntangibleAssets 25 false false R26.htm 081000 - Disclosure - CONTRACT LIABILITIES (Tables) Sheet http://healthiercmc.com/role/ContractLiabilitiesTables CONTRACT LIABILITIES (Tables) Tables http://healthiercmc.com/role/ContractLiabilities 26 false false R27.htm 081100 - Disclosure - DEBT (Tables) Sheet http://healthiercmc.com/role/DebtTables DEBT (Tables) Tables http://healthiercmc.com/role/Debt 27 false false R28.htm 081200 - Disclosure - STOCKHOLDERS' EQUITY (Tables) Sheet http://healthiercmc.com/role/StockholdersEquityTables STOCKHOLDERS' EQUITY (Tables) Tables http://healthiercmc.com/role/StockholdersEquity 28 false false R29.htm 090100 - Disclosure - ORGANIZATION (Details) Sheet http://healthiercmc.com/role/OrganizationDetails ORGANIZATION (Details) Details http://healthiercmc.com/role/Organization 29 false false R30.htm 090400 - Disclosure - CONCENTRATIONS (Details) Sheet http://healthiercmc.com/role/ConcentrationsDetails CONCENTRATIONS (Details) Details http://healthiercmc.com/role/ConcentrationsTables 30 false false R31.htm 090500 - Disclosure - DISAGGREGATION OF REVENUES (Details) Sheet http://healthiercmc.com/role/DisaggregationOfRevenuesDetails DISAGGREGATION OF REVENUES (Details) Details http://healthiercmc.com/role/DisaggregationOfRevenuesTables 31 false false R32.htm 090600 - Disclosure - NOTES RECEIVABLE AND OTHER INCOME (Details) Notes http://healthiercmc.com/role/NotesReceivableAndOtherIncomeDetails NOTES RECEIVABLE AND OTHER INCOME (Details) Details http://healthiercmc.com/role/NotesReceivableAndOtherIncomeTables 32 false false R33.htm 090700 - Disclosure - ACQUISITION OF MOTHER EARTH'S STOREHOUSE, INC. (Details) Sheet http://healthiercmc.com/role/AcquisitionOfMotherEarthSStorehouseIncDetails ACQUISITION OF MOTHER EARTH'S STOREHOUSE, INC. (Details) Details http://healthiercmc.com/role/AcquisitionOfMotherEarthSStorehouseIncTables 33 false false R34.htm 090800 - Disclosure - PROPERTY & EQUIPMENT (Details) Sheet http://healthiercmc.com/role/PropertyEquipmentDetails PROPERTY & EQUIPMENT (Details) Details http://healthiercmc.com/role/PropertyEquipmentTables 34 false false R35.htm 090900 - Disclosure - INTANGIBLE ASSETS, Intangible Assets, Net (Details) Sheet http://healthiercmc.com/role/IntangibleAssetsIntangibleAssetsNetDetails INTANGIBLE ASSETS, Intangible Assets, Net (Details) Details 35 false false R36.htm 090902 - Disclosure - INTANGIBLE ASSETS, Future Annual Estimated Amortization Expense (Details) Sheet http://healthiercmc.com/role/IntangibleAssetsFutureAnnualEstimatedAmortizationExpenseDetails INTANGIBLE ASSETS, Future Annual Estimated Amortization Expense (Details) Details 36 false false R37.htm 091000 - Disclosure - CONTRACT LIABILITIES (Details) Sheet http://healthiercmc.com/role/ContractLiabilitiesDetails CONTRACT LIABILITIES (Details) Details http://healthiercmc.com/role/ContractLiabilitiesTables 37 false false R38.htm 091100 - Disclosure - DEBT (Details) Sheet http://healthiercmc.com/role/DebtDetails DEBT (Details) Details http://healthiercmc.com/role/DebtTables 38 false false R39.htm 091200 - Disclosure - STOCKHOLDERS' EQUITY, Rights Offering (Details) Sheet http://healthiercmc.com/role/StockholdersEquityRightsOfferingDetails STOCKHOLDERS' EQUITY, Rights Offering (Details) Details 39 false false R40.htm 091202 - Disclosure - STOCKHOLDERS' EQUITY, Exchange Agreement and Restricted Stock (Details) Sheet http://healthiercmc.com/role/StockholdersEquityExchangeAgreementAndRestrictedStockDetails STOCKHOLDERS' EQUITY, Exchange Agreement and Restricted Stock (Details) Details 40 false false R41.htm 091204 - Disclosure - STOCKHOLDERS' EQUITY, Stock Options (Details) Sheet http://healthiercmc.com/role/StockholdersEquityStockOptionsDetails STOCKHOLDERS' EQUITY, Stock Options (Details) Details 41 false false R42.htm 091206 - Disclosure - STOCKHOLDERS' EQUITY, Income (Loss) Per Share (Details) Sheet http://healthiercmc.com/role/StockholdersEquityIncomeLossPerShareDetails STOCKHOLDERS' EQUITY, Income (Loss) Per Share (Details) Details 42 false false R43.htm 091300 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details) Sheet http://healthiercmc.com/role/CommitmentsAndContingenciesDetails COMMITMENTS AND CONTINGENCIES (Details) Details http://healthiercmc.com/role/CommitmentsAndContingencies 43 false false All Reports Book All Reports form10q.htm ex31_1.htm ex31_2.htm ex32_1.htm ex32_2.htm hcmc-20220630.xsd hcmc-20220630_cal.xml hcmc-20220630_def.xml hcmc-20220630_lab.xml hcmc-20220630_pre.xml image1.jpg http://fasb.org/us-gaap/2021-01-31 http://xbrl.sec.gov/dei/2021q4 true true JSON 62 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "form10q.htm": { "axisCustom": 0, "axisStandard": 18, "contextCount": 185, "dts": { "calculationLink": { "local": [ "hcmc-20220630_cal.xml" ] }, "definitionLink": { "local": [ "hcmc-20220630_def.xml" ] }, "inline": { "local": [ "form10q.htm" ] }, "labelLink": { "local": [ "hcmc-20220630_lab.xml" ] }, "presentationLink": { "local": [ "hcmc-20220630_pre.xml" ] }, "schema": { "local": [ "hcmc-20220630.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2004/ref-2004-08-10.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd", "https://xbrl.sec.gov/country/2021/country-2021.xsd", "https://xbrl.sec.gov/currency/2021/currency-2021.xsd", "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd", "https://xbrl.sec.gov/exch/2021/exch-2021.xsd", "https://xbrl.sec.gov/naics/2021/naics-2021.xsd", "https://xbrl.sec.gov/sic/2021/sic-2021.xsd", "https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd" ] } }, "elementCount": 384, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2021q4": 6, "total": 6 }, "keyCustom": 29, "keyStandard": 175, "memberCustom": 25, "memberStandard": 24, "nsprefix": "hcmc", "nsuri": "http://healthiercmc.com/20220630", "report": { "R1": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "form10q.htm", "contextRef": "c20220101to20220630", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "000100 - Document - Document and Entity Information", "role": "http://healthiercmc.com/role/DocumentAndEntityInformation", "shortName": "Document and Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "form10q.htm", "contextRef": "c20220101to20220630", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "form10q.htm", "contextRef": "c20220101to20220630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ConcentrationRiskDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "060400 - Disclosure - CONCENTRATIONS", "role": "http://healthiercmc.com/role/Concentrations", "shortName": "CONCENTRATIONS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "form10q.htm", "contextRef": "c20220101to20220630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ConcentrationRiskDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "form10q.htm", "contextRef": "c20220101to20220630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "060500 - Disclosure - DISAGGREGATION OF REVENUES", "role": "http://healthiercmc.com/role/DisaggregationOfRevenues", "shortName": "DISAGGREGATION OF REVENUES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "form10q.htm", "contextRef": "c20220101to20220630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "form10q.htm", "contextRef": "c20220101to20220630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "060600 - Disclosure - NOTES RECEIVABLE AND OTHER INCOME", "role": "http://healthiercmc.com/role/NotesReceivableAndOtherIncome", "shortName": "NOTES RECEIVABLE AND OTHER INCOME", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "form10q.htm", "contextRef": "c20220101to20220630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "form10q.htm", "contextRef": "c20220101to20220630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessCombinationDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "060700 - Disclosure - ACQUISITION OF MOTHER EARTH'S STOREHOUSE, INC.", "role": "http://healthiercmc.com/role/AcquisitionOfMotherEarthSStorehouseInc", "shortName": "ACQUISITION OF MOTHER EARTH'S STOREHOUSE, INC.", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "form10q.htm", "contextRef": "c20220101to20220630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessCombinationDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "form10q.htm", "contextRef": "c20220101to20220630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "060800 - Disclosure - PROPERTY & EQUIPMENT", "role": "http://healthiercmc.com/role/PropertyEquipment", "shortName": "PROPERTY & EQUIPMENT", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "form10q.htm", "contextRef": "c20220101to20220630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "form10q.htm", "contextRef": "c20220101to20220630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "060900 - Disclosure - INTANGIBLE ASSETS", "role": "http://healthiercmc.com/role/IntangibleAssets", "shortName": "INTANGIBLE ASSETS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "form10q.htm", "contextRef": "c20220101to20220630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "form10q.htm", "contextRef": "c20220101to20220630", "decimals": null, "first": true, "lang": "en-US", "name": "hcmc:ContractWithCustomerAssetAndLiabilityTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "061000 - Disclosure - CONTRACT LIABILITIES", "role": "http://healthiercmc.com/role/ContractLiabilities", "shortName": "CONTRACT LIABILITIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "form10q.htm", "contextRef": "c20220101to20220630", "decimals": null, "first": true, "lang": "en-US", "name": "hcmc:ContractWithCustomerAssetAndLiabilityTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "form10q.htm", "contextRef": "c20220101to20220630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "061100 - Disclosure - DEBT", "role": "http://healthiercmc.com/role/Debt", "shortName": "DEBT", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "form10q.htm", "contextRef": "c20220101to20220630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "form10q.htm", "contextRef": "c20220101to20220630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "061200 - Disclosure - STOCKHOLDERS' EQUITY", "role": "http://healthiercmc.com/role/StockholdersEquity", "shortName": "STOCKHOLDERS' EQUITY", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "form10q.htm", "contextRef": "c20220101to20220630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "form10q.htm", "contextRef": "c20220101to20220630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "061300 - Disclosure - COMMITMENTS AND CONTINGENCIES", "role": "http://healthiercmc.com/role/CommitmentsAndContingencies", "shortName": "COMMITMENTS AND CONTINGENCIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "form10q.htm", "contextRef": "c20220101to20220630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "div", "td", "tr", "table", "body", "html" ], "baseRef": "form10q.htm", "contextRef": "c20220630", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "U002", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "010000 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS", "role": "http://healthiercmc.com/role/CondensedConsolidatedBalanceSheets", "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "td", "tr", "table", "body", "html" ], "baseRef": "form10q.htm", "contextRef": "c20220630", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "U002", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "form10q.htm", "contextRef": "c20220101to20220630", "decimals": null, "first": true, "lang": "en-US", "name": "hcmc:ScheduleOfCashAndCashEquivalentsAndRestrictedCashTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "080400 - Disclosure - CONCENTRATIONS (Tables)", "role": "http://healthiercmc.com/role/ConcentrationsTables", "shortName": "CONCENTRATIONS (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "form10q.htm", "contextRef": "c20220101to20220630", "decimals": null, "first": true, "lang": "en-US", "name": "hcmc:ScheduleOfCashAndCashEquivalentsAndRestrictedCashTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "form10q.htm", "contextRef": "c20220101to20220630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisaggregationOfRevenueTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "080500 - Disclosure - DISAGGREGATION OF REVENUES (Tables)", "role": "http://healthiercmc.com/role/DisaggregationOfRevenuesTables", "shortName": "DISAGGREGATION OF REVENUES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "form10q.htm", "contextRef": "c20220101to20220630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisaggregationOfRevenueTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "form10q.htm", "contextRef": "c20220101to20220630", "decimals": null, "first": true, "lang": "en-US", "name": "hcmc:ScheduleOfAccountsNotesReceivableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "080600 - Disclosure - NOTES RECEIVABLE AND OTHER INCOME (Tables)", "role": "http://healthiercmc.com/role/NotesReceivableAndOtherIncomeTables", "shortName": "NOTES RECEIVABLE AND OTHER INCOME (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "form10q.htm", "contextRef": "c20220101to20220630", "decimals": null, "first": true, "lang": "en-US", "name": "hcmc:ScheduleOfAccountsNotesReceivableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "form10q.htm", "contextRef": "c20220101to20220630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "080700 - Disclosure - ACQUISITION OF MOTHER EARTH'S STOREHOUSE, INC. (Tables)", "role": "http://healthiercmc.com/role/AcquisitionOfMotherEarthSStorehouseIncTables", "shortName": "ACQUISITION OF MOTHER EARTH'S STOREHOUSE, INC. (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "form10q.htm", "contextRef": "c20220101to20220630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "form10q.htm", "contextRef": "c20220101to20220630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "080800 - Disclosure - PROPERTY & EQUIPMENT (Tables)", "role": "http://healthiercmc.com/role/PropertyEquipmentTables", "shortName": "PROPERTY & EQUIPMENT (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "form10q.htm", "contextRef": "c20220101to20220630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "form10q.htm", "contextRef": "c20220101to20220630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "080900 - Disclosure - INTANGIBLE ASSETS (Tables)", "role": "http://healthiercmc.com/role/IntangibleAssetsTables", "shortName": "INTANGIBLE ASSETS (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "form10q.htm", "contextRef": "c20220101to20220630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "form10q.htm", "contextRef": "c20220101to20220630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "081000 - Disclosure - CONTRACT LIABILITIES (Tables)", "role": "http://healthiercmc.com/role/ContractLiabilitiesTables", "shortName": "CONTRACT LIABILITIES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "form10q.htm", "contextRef": "c20220101to20220630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "form10q.htm", "contextRef": "c20220101to20220630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDebtTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "081100 - Disclosure - DEBT (Tables)", "role": "http://healthiercmc.com/role/DebtTables", "shortName": "DEBT (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "form10q.htm", "contextRef": "c20220101to20220630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDebtTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "form10q.htm", "contextRef": "c20220101to20220630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "081200 - Disclosure - STOCKHOLDERS' EQUITY (Tables)", "role": "http://healthiercmc.com/role/StockholdersEquityTables", "shortName": "STOCKHOLDERS' EQUITY (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "form10q.htm", "contextRef": "c20220101to20220630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "div", "ix:continuation", "div", "body", "html" ], "baseRef": "form10q.htm", "contextRef": "c20220209_BusinessAcquisitionAxis_MotherEarthsStorehouseMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:NumberOfStores", "reportCount": 1, "unique": true, "unitRef": "U004", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "090100 - Disclosure - ORGANIZATION (Details)", "role": "http://healthiercmc.com/role/OrganizationDetails", "shortName": "ORGANIZATION (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "ix:continuation", "div", "body", "html" ], "baseRef": "form10q.htm", "contextRef": "c20220209_BusinessAcquisitionAxis_MotherEarthsStorehouseMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:NumberOfStores", "reportCount": 1, "unique": true, "unitRef": "U004", "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "span", "div", "td", "tr", "table", "body", "html" ], "baseRef": "form10q.htm", "contextRef": "c20220630", "decimals": "4", "first": true, "lang": null, "name": "us-gaap:CommonStockParOrStatedValuePerShare", "reportCount": 1, "unique": true, "unitRef": "U003", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "010100 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)", "role": "http://healthiercmc.com/role/CondensedConsolidatedBalanceSheetsParenthetical", "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "span", "div", "td", "tr", "table", "body", "html" ], "baseRef": "form10q.htm", "contextRef": "c20220630", "decimals": "4", "first": true, "lang": null, "name": "us-gaap:CommonStockParOrStatedValuePerShare", "reportCount": 1, "unique": true, "unitRef": "U003", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "div", "ix:continuation", "div", "body", "html" ], "baseRef": "form10q.htm", "contextRef": "c20220101to20220630", "decimals": "INF", "first": true, "lang": null, "name": "hcmc:NumberOfFinancialInstitution", "reportCount": 1, "unique": true, "unitRef": "U005", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "090400 - Disclosure - CONCENTRATIONS (Details)", "role": "http://healthiercmc.com/role/ConcentrationsDetails", "shortName": "CONCENTRATIONS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "ix:continuation", "div", "body", "html" ], "baseRef": "form10q.htm", "contextRef": "c20220101to20220630", "decimals": "INF", "first": true, "lang": null, "name": "hcmc:NumberOfFinancialInstitution", "reportCount": 1, "unique": true, "unitRef": "U005", "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "div", "td", "tr", "table", "body", "html" ], "baseRef": "form10q.htm", "contextRef": "c20220401to20220630", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "U002", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "090500 - Disclosure - DISAGGREGATION OF REVENUES (Details)", "role": "http://healthiercmc.com/role/DisaggregationOfRevenuesDetails", "shortName": "DISAGGREGATION OF REVENUES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "form10q.htm", "contextRef": "c20220401to20220630_ContractWithCustomerSalesChannelAxis_RetailVaporMember", "decimals": "0", "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unique": true, "unitRef": "U002", "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "div", "td", "tr", "table", "body", "html" ], "baseRef": "form10q.htm", "contextRef": "c20220101to20220630", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ProceedsFromSaleOfNotesReceivable", "reportCount": 1, "unitRef": "U002", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "090600 - Disclosure - NOTES RECEIVABLE AND OTHER INCOME (Details)", "role": "http://healthiercmc.com/role/NotesReceivableAndOtherIncomeDetails", "shortName": "NOTES RECEIVABLE AND OTHER INCOME (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "ix:continuation", "div", "body", "html" ], "baseRef": "form10q.htm", "contextRef": "c20220101to20220630_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_PromissoryNotesMember", "decimals": null, "lang": "en-US", "name": "hcmc:NotesReceivablePaymentTerm", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "div", "td", "tr", "table", "body", "html" ], "baseRef": "form10q.htm", "contextRef": "c20220101to20220630", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:PaymentsToAcquireBusinessesGross", "reportCount": 1, "unitRef": "U002", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "090700 - Disclosure - ACQUISITION OF MOTHER EARTH'S STOREHOUSE, INC. (Details)", "role": "http://healthiercmc.com/role/AcquisitionOfMotherEarthSStorehouseIncDetails", "shortName": "ACQUISITION OF MOTHER EARTH'S STOREHOUSE, INC. (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "ix:continuation", "div", "body", "html" ], "baseRef": "form10q.htm", "contextRef": "c20220209to20220209_BusinessAcquisitionAxis_MotherEarthsStorehouseMember", "decimals": "0", "lang": null, "name": "us-gaap:PaymentsToAcquireBusinessesGross", "reportCount": 1, "unique": true, "unitRef": "U002", "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "div", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "form10q.htm", "contextRef": "c20220630", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:PropertyPlantAndEquipmentGross", "reportCount": 1, "unitRef": "U002", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "090800 - Disclosure - PROPERTY & EQUIPMENT (Details)", "role": "http://healthiercmc.com/role/PropertyEquipmentDetails", "shortName": "PROPERTY & EQUIPMENT (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "form10q.htm", "contextRef": "c20211231", "decimals": "0", "lang": null, "name": "us-gaap:PropertyPlantAndEquipmentGross", "reportCount": 1, "unique": true, "unitRef": "U002", "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "div", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "form10q.htm", "contextRef": "c20220630", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:FiniteLivedIntangibleAssetsGross", "reportCount": 1, "unique": true, "unitRef": "U002", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "090900 - Disclosure - INTANGIBLE ASSETS, Intangible Assets, Net (Details)", "role": "http://healthiercmc.com/role/IntangibleAssetsIntangibleAssetsNetDetails", "shortName": "INTANGIBLE ASSETS, Intangible Assets, Net (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "form10q.htm", "contextRef": "c20220630", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:FiniteLivedIntangibleAssetsGross", "reportCount": 1, "unique": true, "unitRef": "U002", "xsiNil": "false" } }, "R36": { "firstAnchor": { "ancestors": [ "div", "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "form10q.htm", "contextRef": "c20220401to20220630", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AmortizationOfIntangibleAssets", "reportCount": 1, "unique": true, "unitRef": "U002", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "090902 - Disclosure - INTANGIBLE ASSETS, Future Annual Estimated Amortization Expense (Details)", "role": "http://healthiercmc.com/role/IntangibleAssetsFutureAnnualEstimatedAmortizationExpenseDetails", "shortName": "INTANGIBLE ASSETS, Future Annual Estimated Amortization Expense (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "form10q.htm", "contextRef": "c20220401to20220630", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AmortizationOfIntangibleAssets", "reportCount": 1, "unique": true, "unitRef": "U002", "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "div", "ix:continuation", "div", "body", "html" ], "baseRef": "form10q.htm", "contextRef": "c20220101to20220630", "decimals": null, "first": true, "lang": "en-US", "name": "hcmc:ContractLiabilitiesExpectedRecognitionPeriod", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "091000 - Disclosure - CONTRACT LIABILITIES (Details)", "role": "http://healthiercmc.com/role/ContractLiabilitiesDetails", "shortName": "CONTRACT LIABILITIES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "ix:continuation", "div", "body", "html" ], "baseRef": "form10q.htm", "contextRef": "c20220101to20220630", "decimals": null, "first": true, "lang": "en-US", "name": "hcmc:ContractLiabilitiesExpectedRecognitionPeriod", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R38": { "firstAnchor": { "ancestors": [ "div", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "form10q.htm", "contextRef": "c20220630", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:LongTermDebt", "reportCount": 1, "unique": true, "unitRef": "U002", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "091100 - Disclosure - DEBT (Details)", "role": "http://healthiercmc.com/role/DebtDetails", "shortName": "DEBT (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "form10q.htm", "contextRef": "c20220630", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:LongTermDebt", "reportCount": 1, "unique": true, "unitRef": "U002", "xsiNil": "false" } }, "R39": { "firstAnchor": { "ancestors": [ "div", "ix:continuation", "div", "body", "html" ], "baseRef": "form10q.htm", "contextRef": "c20210618to20210618", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockIssuedDuringPeriodSharesNewIssues", "reportCount": 1, "unitRef": "U001", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "091200 - Disclosure - STOCKHOLDERS' EQUITY, Rights Offering (Details)", "role": "http://healthiercmc.com/role/StockholdersEquityRightsOfferingDetails", "shortName": "STOCKHOLDERS' EQUITY, Rights Offering (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "ix:continuation", "div", "body", "html" ], "baseRef": "form10q.htm", "contextRef": "c20210618to20210618", "decimals": "-5", "lang": null, "name": "hcmc:GrossProceedsFromIssuanceOfCommonStock", "reportCount": 1, "unique": true, "unitRef": "U002", "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "div", "td", "tr", "table", "body", "html" ], "baseRef": "form10q.htm", "contextRef": "c20220401to20220630", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "U002", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "020000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS", "role": "http://healthiercmc.com/role/CondensedConsolidatedStatementsOfOperations", "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "td", "tr", "table", "body", "html" ], "baseRef": "form10q.htm", "contextRef": "c20220401to20220630", "decimals": "0", "lang": null, "name": "us-gaap:GrossProfit", "reportCount": 1, "unique": true, "unitRef": "U002", "xsiNil": "false" } }, "R40": { "firstAnchor": { "ancestors": [ "div", "ix:continuation", "div", "body", "html" ], "baseRef": "form10q.htm", "contextRef": "c20210329to20210329", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:StockIssuedDuringPeriodValueNewIssues", "reportCount": 1, "unique": true, "unitRef": "U002", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "091202 - Disclosure - STOCKHOLDERS' EQUITY, Exchange Agreement and Restricted Stock (Details)", "role": "http://healthiercmc.com/role/StockholdersEquityExchangeAgreementAndRestrictedStockDetails", "shortName": "STOCKHOLDERS' EQUITY, Exchange Agreement and Restricted Stock (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "ix:continuation", "div", "body", "html" ], "baseRef": "form10q.htm", "contextRef": "c20210329to20210329", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:StockIssuedDuringPeriodValueNewIssues", "reportCount": 1, "unique": true, "unitRef": "U002", "xsiNil": "false" } }, "R41": { "firstAnchor": { "ancestors": [ "div", "ix:continuation", "div", "body", "html" ], "baseRef": "form10q.htm", "contextRef": "c20220101to20220630", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised", "reportCount": 1, "unitRef": "U001", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "091204 - Disclosure - STOCKHOLDERS' EQUITY, Stock Options (Details)", "role": "http://healthiercmc.com/role/StockholdersEquityStockOptionsDetails", "shortName": "STOCKHOLDERS' EQUITY, Stock Options (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R42": { "firstAnchor": { "ancestors": [ "div", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "form10q.htm", "contextRef": "c20220101to20220630", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "U001", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "091206 - Disclosure - STOCKHOLDERS' EQUITY, Income (Loss) Per Share (Details)", "role": "http://healthiercmc.com/role/StockholdersEquityIncomeLossPerShareDetails", "shortName": "STOCKHOLDERS' EQUITY, Income (Loss) Per Share (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "form10q.htm", "contextRef": "c20220101to20220630", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "U001", "xsiNil": "false" } }, "R43": { "firstAnchor": { "ancestors": [ "div", "ix:continuation", "div", "body", "html" ], "baseRef": "form10q.htm", "contextRef": "c20210226to20210226_TitleOfIndividualAxis_PresidentAndChiefOperatingOfficerMember", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:SalariesWagesAndOfficersCompensation", "reportCount": 1, "unique": true, "unitRef": "U002", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "091300 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details)", "role": "http://healthiercmc.com/role/CommitmentsAndContingenciesDetails", "shortName": "COMMITMENTS AND CONTINGENCIES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "ix:continuation", "div", "body", "html" ], "baseRef": "form10q.htm", "contextRef": "c20210226to20210226_TitleOfIndividualAxis_PresidentAndChiefOperatingOfficerMember", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:SalariesWagesAndOfficersCompensation", "reportCount": 1, "unique": true, "unitRef": "U002", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "div", "td", "tr", "table", "body", "html" ], "baseRef": "form10q.htm", "contextRef": "c20201231_StatementClassOfStockAxis_ConvertiblePreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unique": true, "unitRef": "U002", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "030000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY", "role": "http://healthiercmc.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquity", "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "td", "tr", "table", "body", "html" ], "baseRef": "form10q.htm", "contextRef": "c20201231_StatementClassOfStockAxis_ConvertiblePreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unique": true, "unitRef": "U002", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "div", "td", "tr", "table", "body", "html" ], "baseRef": "form10q.htm", "contextRef": "c20220101to20220630", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "U002", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "040000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS", "role": "http://healthiercmc.com/role/CondensedConsolidatedStatementsOfCashFlows", "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "td", "tr", "table", "body", "html" ], "baseRef": "form10q.htm", "contextRef": "c20220101to20220630", "decimals": "0", "lang": null, "name": "us-gaap:DepreciationAndAmortization", "reportCount": 1, "unique": true, "unitRef": "U002", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "form10q.htm", "contextRef": "c20220101to20220630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "060100 - Disclosure - ORGANIZATION", "role": "http://healthiercmc.com/role/Organization", "shortName": "ORGANIZATION", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "form10q.htm", "contextRef": "c20220101to20220630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "form10q.htm", "contextRef": "c20220101to20220630", "decimals": null, "first": true, "lang": "en-US", "name": "hcmc:LiquidityTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "060200 - Disclosure - LIQUIDITY", "role": "http://healthiercmc.com/role/Liquidity", "shortName": "LIQUIDITY", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "form10q.htm", "contextRef": "c20220101to20220630", "decimals": null, "first": true, "lang": "en-US", "name": "hcmc:LiquidityTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "form10q.htm", "contextRef": "c20220101to20220630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "060300 - Disclosure - BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES", "role": "http://healthiercmc.com/role/BasisOfPresentationAndSignificantAccountingPolicies", "shortName": "BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "form10q.htm", "contextRef": "c20220101to20220630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 50, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://healthiercmc.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://healthiercmc.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://healthiercmc.com/role/DocumentAndEntityInformation" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://healthiercmc.com/role/DocumentAndEntityInformation" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://healthiercmc.com/role/DocumentAndEntityInformation" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://healthiercmc.com/role/DocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r387" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://healthiercmc.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r388" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://healthiercmc.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://healthiercmc.com/role/DocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://healthiercmc.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://healthiercmc.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://healthiercmc.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://healthiercmc.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://healthiercmc.com/role/DocumentAndEntityInformation" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://healthiercmc.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://healthiercmc.com/role/DocumentAndEntityInformation" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r385" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://healthiercmc.com/role/DocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://healthiercmc.com/role/DocumentAndEntityInformation" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://healthiercmc.com/role/DocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r385" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://healthiercmc.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://healthiercmc.com/role/DocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r385" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://healthiercmc.com/role/DocumentAndEntityInformation" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://healthiercmc.com/role/DocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r390" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://healthiercmc.com/role/DocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r385" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://healthiercmc.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r385" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://healthiercmc.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r385" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://healthiercmc.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r385" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://healthiercmc.com/role/DocumentAndEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://healthiercmc.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_NoTradingSymbolFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a security having no trading symbol.", "label": "No Trading Symbol Flag" } } }, "localname": "NoTradingSymbolFlag", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://healthiercmc.com/role/DocumentAndEntityInformation" ], "xbrltype": "trueItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r384" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://healthiercmc.com/role/DocumentAndEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r386" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://healthiercmc.com/role/DocumentAndEntityInformation" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://healthiercmc.com/role/DocumentAndEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "hcmc_AgeOfCompany": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The period of time the company has been in existence, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Age of Company", "terseLabel": "Number of years the company has been operating" } } }, "localname": "AgeOfCompany", "nsuri": "http://healthiercmc.com/20220630", "presentation": [ "http://healthiercmc.com/role/OrganizationDetails" ], "xbrltype": "durationItemType" }, "hcmc_AllegedClaimedBatteryDefectsForElectronicCigaretteDeviceMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Alleged claimed battery defects for an electronic cigarette device.", "label": "Alleged Claimed Battery Defects For Electronic Cigarette Device [Member]" } } }, "localname": "AllegedClaimedBatteryDefectsForElectronicCigaretteDeviceMember", "nsuri": "http://healthiercmc.com/20220630", "presentation": [ "http://healthiercmc.com/role/CommitmentsAndContingenciesDetails" ], "xbrltype": "domainItemType" }, "hcmc_BreakagePolicyPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Period of time between issuance and redemption of gift cards, rewards and points, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Breakage Policy Period", "terseLabel": "Breakage policy period" } } }, "localname": "BreakagePolicyPeriod", "nsuri": "http://healthiercmc.com/20220630", "presentation": [ "http://healthiercmc.com/role/ContractLiabilitiesDetails" ], "xbrltype": "durationItemType" }, "hcmc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiability": { "auth_ref": [], "calculation": { "http://healthiercmc.com/role/AcquisitionOfMotherEarthSStorehouseIncDetails": { "order": 5.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of operating lease liabilities assumed at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Operating Lease Liability", "negatedLabel": "Operating lease liability" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiability", "nsuri": "http://healthiercmc.com/20220630", "presentation": [ "http://healthiercmc.com/role/AcquisitionOfMotherEarthSStorehouseIncDetails" ], "xbrltype": "monetaryItemType" }, "hcmc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset": { "auth_ref": [], "calculation": { "http://healthiercmc.com/role/AcquisitionOfMotherEarthSStorehouseIncDetails": { "order": 3.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of operating lease right-of-use assets recognized as of the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Operating Lease, Right-of-use Asset", "terseLabel": "Right of use asset - operating lease" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset", "nsuri": "http://healthiercmc.com/20220630", "presentation": [ "http://healthiercmc.com/role/AcquisitionOfMotherEarthSStorehouseIncDetails" ], "xbrltype": "monetaryItemType" }, "hcmc_CommonShareEquivalentsExcludedFromCalculationOfDilutiveLossPerShareAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Common Share Equivalents Excluded from Calculation of Dilutive Loss Per Share [Abstract]", "terseLabel": "Common Share Equivalents Excluded from Calculation of Dilutive Loss Per Share [Abstract]" } } }, "localname": "CommonShareEquivalentsExcludedFromCalculationOfDilutiveLossPerShareAbstract", "nsuri": "http://healthiercmc.com/20220630", "presentation": [ "http://healthiercmc.com/role/StockholdersEquityIncomeLossPerShareDetails" ], "xbrltype": "stringItemType" }, "hcmc_CompanyOrganizationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Company Organization [Abstract]" } } }, "localname": "CompanyOrganizationAbstract", "nsuri": "http://healthiercmc.com/20220630", "presentation": [ "http://healthiercmc.com/role/OrganizationDetails" ], "xbrltype": "stringItemType" }, "hcmc_ContractLiabilitiesExpectedRecognitionPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Period in which contract liabilities is expected to be recognized, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Contract Liabilities Expected Recognition Period", "terseLabel": "Contract liabilities expected recognition period" } } }, "localname": "ContractLiabilitiesExpectedRecognitionPeriod", "nsuri": "http://healthiercmc.com/20220630", "presentation": [ "http://healthiercmc.com/role/ContractLiabilitiesDetails" ], "xbrltype": "durationItemType" }, "hcmc_ContractWithCustomerAssetAndLiabilityTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The entire disclosure of contract balances and changes in contract balances.", "label": "Contract with Customer, Asset and Liability [Text Block]", "verboseLabel": "CONTRACT LIABILITIES" } } }, "localname": "ContractWithCustomerAssetAndLiabilityTextBlock", "nsuri": "http://healthiercmc.com/20220630", "presentation": [ "http://healthiercmc.com/role/ContractLiabilities" ], "xbrltype": "textBlockItemType" }, "hcmc_ContractWithCustomerLiabilityBreakageRecognized": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in revenue recognized for adjustment from contract modification which (increases) decreases obligation to transfer good or service to customer for which consideration from customer has been received or is due.", "label": "Contract with Customer, Liability, Breakage Recognized", "terseLabel": "Breakage recognized" } } }, "localname": "ContractWithCustomerLiabilityBreakageRecognized", "nsuri": "http://healthiercmc.com/20220630", "presentation": [ "http://healthiercmc.com/role/ContractLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "hcmc_ContractWithCustomerLiabilityFulfillmentOfContract": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost associated with fulfillment of contract with customer.", "label": "Contract with Customer, Liability, Fulfillment of Contract", "negatedLabel": "Fulfillment of contract" } } }, "localname": "ContractWithCustomerLiabilityFulfillmentOfContract", "nsuri": "http://healthiercmc.com/20220630", "presentation": [ "http://healthiercmc.com/role/ContractLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "hcmc_ContractWithCustomerLiabilityIssued": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gift cards and loyalty rewards issued as obligation to transfer good or service to customer for which consideration has been received or is receivable.", "label": "Contract with Customer, Liability, Issued", "terseLabel": "Issued" } } }, "localname": "ContractWithCustomerLiabilityIssued", "nsuri": "http://healthiercmc.com/20220630", "presentation": [ "http://healthiercmc.com/role/ContractLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "hcmc_ContractWithCustomerLiabilityRedeemed": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense from redemption of gift cards and loyalty rewards in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.", "label": "Contract with Customer, Liability, Redeemed", "negatedLabel": "Redeemed" } } }, "localname": "ContractWithCustomerLiabilityRedeemed", "nsuri": "http://healthiercmc.com/20220630", "presentation": [ "http://healthiercmc.com/role/ContractLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "hcmc_ConvertiblePreferredStockConvertedToOtherSecuritiesShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares of convertible preferred stock that were converted to other securities.", "label": "Convertible Preferred Stock Converted to Other Securities, Shares", "terseLabel": "Preferred stock exercised (in shares)" } } }, "localname": "ConvertiblePreferredStockConvertedToOtherSecuritiesShares", "nsuri": "http://healthiercmc.com/20220630", "presentation": [ "http://healthiercmc.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquity" ], "xbrltype": "sharesItemType" }, "hcmc_DisplaysMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Displays [Member]", "terseLabel": "Displays [Member]" } } }, "localname": "DisplaysMember", "nsuri": "http://healthiercmc.com/20220630", "presentation": [ "http://healthiercmc.com/role/PropertyEquipmentDetails" ], "xbrltype": "domainItemType" }, "hcmc_ExchangeAgreementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Exchange Agreement [Abstract]", "terseLabel": "Exchange Agreement [Abstract]" } } }, "localname": "ExchangeAgreementAbstract", "nsuri": "http://healthiercmc.com/20220630", "presentation": [ "http://healthiercmc.com/role/StockholdersEquityExchangeAgreementAndRestrictedStockDetails" ], "xbrltype": "stringItemType" }, "hcmc_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour": { "auth_ref": [], "calculation": { "http://healthiercmc.com/role/IntangibleAssetsFutureAnnualEstimatedAmortizationExpenseDetails": { "order": 6.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, after Year Four", "terseLabel": "Thereafter" } } }, "localname": "FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour", "nsuri": "http://healthiercmc.com/20220630", "presentation": [ "http://healthiercmc.com/role/IntangibleAssetsFutureAnnualEstimatedAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "hcmc_FoodServiceAndRestaurantMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Refers to food service and restaurants stores that sell vapor products.", "label": "Food Service and Restaurant [Member]", "verboseLabel": "Food Service/Restaurant [Member]" } } }, "localname": "FoodServiceAndRestaurantMember", "nsuri": "http://healthiercmc.com/20220630", "presentation": [ "http://healthiercmc.com/role/DisaggregationOfRevenuesDetails" ], "xbrltype": "domainItemType" }, "hcmc_GiftCardsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Refers to product of gift cards.", "label": "Gift Cards [Member]", "terseLabel": "Gift Cards [Member]" } } }, "localname": "GiftCardsMember", "nsuri": "http://healthiercmc.com/20220630", "presentation": [ "http://healthiercmc.com/role/ContractLiabilitiesDetails" ], "xbrltype": "domainItemType" }, "hcmc_GroceryLoyaltyRewardsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Refers to product of the grocery loyalty rewards.", "label": "Grocery Loyalty Rewards [Member]", "terseLabel": "Grocery Loyalty Rewards [Member]" } } }, "localname": "GroceryLoyaltyRewardsMember", "nsuri": "http://healthiercmc.com/20220630", "presentation": [ "http://healthiercmc.com/role/ContractLiabilitiesDetails" ], "xbrltype": "domainItemType" }, "hcmc_GroceryMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A grocer is a bulk seller of food and products.", "label": "Grocery [Member]", "terseLabel": "Grocery [Member]" } } }, "localname": "GroceryMember", "nsuri": "http://healthiercmc.com/20220630", "presentation": [ "http://healthiercmc.com/role/CondensedConsolidatedStatementsOfOperations", "http://healthiercmc.com/role/DisaggregationOfRevenuesDetails" ], "xbrltype": "domainItemType" }, "hcmc_GrossProceedsFromIssuanceOfCommonStock": { "auth_ref": [], "calculation": { "http://healthiercmc.com/role/StockholdersEquityRightsOfferingDetails": { "order": 0.0, "parentTag": "us-gaap_ProceedsFromIssuanceOfCommonStock", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The gross proceeds from the additional capital contribution to the entity.", "label": "Gross Proceeds from Issuance of Common Stock", "verboseLabel": "Gross proceeds" } } }, "localname": "GrossProceedsFromIssuanceOfCommonStock", "nsuri": "http://healthiercmc.com/20220630", "presentation": [ "http://healthiercmc.com/role/StockholdersEquityRightsOfferingDetails" ], "xbrltype": "monetaryItemType" }, "hcmc_IncreaseDecreaseInLeaseLiability": { "auth_ref": [], "calculation": { "http://healthiercmc.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 18.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the period lease liability.", "label": "Increase (Decrease) in Lease liability", "negatedLabel": "Lease liability" } } }, "localname": "IncreaseDecreaseInLeaseLiability", "nsuri": "http://healthiercmc.com/20220630", "presentation": [ "http://healthiercmc.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "hcmc_IncreaseDecreaseInPrepaidExpenseAndVendorDeposits": { "auth_ref": [], "calculation": { "http://healthiercmc.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 12.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in prepaid expenses, and vendor deposits.", "label": "Increase (Decrease) in Prepaid Expense and Vendor Deposits", "negatedLabel": "Prepaid expenses and vendor deposits" } } }, "localname": "IncreaseDecreaseInPrepaidExpenseAndVendorDeposits", "nsuri": "http://healthiercmc.com/20220630", "presentation": [ "http://healthiercmc.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "hcmc_IssuanceOfCommonStockInConnectionWithCashlessExerciseOfSeriesWarrants": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Issuance of common stock in connection with cashless exercise of Series A warrants.", "label": "Issuance Of Common Stock In Connection With Cashless Exercise Of Series A Warrants", "verboseLabel": "Issuance of common stock" } } }, "localname": "IssuanceOfCommonStockInConnectionWithCashlessExerciseOfSeriesWarrants", "nsuri": "http://healthiercmc.com/20220630", "presentation": [ "http://healthiercmc.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "hcmc_LiquidityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "LIQUIDITY [Abstract]" } } }, "localname": "LiquidityAbstract", "nsuri": "http://healthiercmc.com/20220630", "xbrltype": "stringItemType" }, "hcmc_LiquidityTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The entire disclosure of liquidity.", "label": "Liquidity [Text Block]", "terseLabel": "LIQUIDITY" } } }, "localname": "LiquidityTextBlock", "nsuri": "http://healthiercmc.com/20220630", "presentation": [ "http://healthiercmc.com/role/Liquidity" ], "xbrltype": "textBlockItemType" }, "hcmc_LossContingenciesInvestmentAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of investment under litigation.", "label": "Loss Contingencies, Investment Amount", "terseLabel": "Invested amount" } } }, "localname": "LossContingenciesInvestmentAmount", "nsuri": "http://healthiercmc.com/20220630", "presentation": [ "http://healthiercmc.com/role/CommitmentsAndContingenciesDetails" ], "xbrltype": "monetaryItemType" }, "hcmc_MedicalCostsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Medical costs claimed by Plaintiffs.", "label": "Medical Costs [Member]" } } }, "localname": "MedicalCostsMember", "nsuri": "http://healthiercmc.com/20220630", "presentation": [ "http://healthiercmc.com/role/CommitmentsAndContingenciesDetails" ], "xbrltype": "domainItemType" }, "hcmc_MotherEarthsStorehouseMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "An organic and natural health food grocery store company.", "label": "Mother Earth's Storehouse [Member]", "terseLabel": "Mother Earth's Storehouse [Member]" } } }, "localname": "MotherEarthsStorehouseMember", "nsuri": "http://healthiercmc.com/20220630", "presentation": [ "http://healthiercmc.com/role/AcquisitionOfMotherEarthSStorehouseIncDetails", "http://healthiercmc.com/role/OrganizationDetails" ], "xbrltype": "domainItemType" }, "hcmc_NotesReceivableExtensionTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The extension term of notes receivable in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Notes Receivable, Extension Term", "terseLabel": "Extension term" } } }, "localname": "NotesReceivableExtensionTerm", "nsuri": "http://healthiercmc.com/20220630", "presentation": [ "http://healthiercmc.com/role/NotesReceivableAndOtherIncomeDetails" ], "xbrltype": "durationItemType" }, "hcmc_NotesReceivablePaymentTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The payment term of notes receivable in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Notes Receivable Payment Term", "terseLabel": "Payment term" } } }, "localname": "NotesReceivablePaymentTerm", "nsuri": "http://healthiercmc.com/20220630", "presentation": [ "http://healthiercmc.com/role/NotesReceivableAndOtherIncomeDetails" ], "xbrltype": "durationItemType" }, "hcmc_NumberOfFinancialInstitution": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of financial institutions in which company concentrated.", "label": "Number of Financial Institution", "terseLabel": "Number of financial institution" } } }, "localname": "NumberOfFinancialInstitution", "nsuri": "http://healthiercmc.com/20220630", "presentation": [ "http://healthiercmc.com/role/ConcentrationsDetails" ], "xbrltype": "integerItemType" }, "hcmc_NumberOfUsersApproached": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The number of users approached by the entity.", "label": "Number of Users Approached", "terseLabel": "Number of users approached" } } }, "localname": "NumberOfUsersApproached", "nsuri": "http://healthiercmc.com/20220630", "presentation": [ "http://healthiercmc.com/role/CommitmentsAndContingenciesDetails" ], "xbrltype": "integerItemType" }, "hcmc_OfficersAndDirectorMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Persons with designation of chief executive officer, chief operating officer, chief financial officer and a director of the company.", "label": "Officers and Director [Member]" } } }, "localname": "OfficersAndDirectorMember", "nsuri": "http://healthiercmc.com/20220630", "presentation": [ "http://healthiercmc.com/role/StockholdersEquityExchangeAgreementAndRestrictedStockDetails" ], "xbrltype": "domainItemType" }, "hcmc_OnlineAndECommerceMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Refers to the online stores and other e-commerce platforms that sell vape products.", "label": "Online and E-commerce [Member]", "verboseLabel": "Online/eCommerce [Member]" } } }, "localname": "OnlineAndECommerceMember", "nsuri": "http://healthiercmc.com/20220630", "presentation": [ "http://healthiercmc.com/role/DisaggregationOfRevenuesDetails" ], "xbrltype": "domainItemType" }, "hcmc_OtherDebtMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Related to other debt.", "label": "Other Debt [Member]", "terseLabel": "Other Debt [Member]" } } }, "localname": "OtherDebtMember", "nsuri": "http://healthiercmc.com/20220630", "presentation": [ "http://healthiercmc.com/role/DebtDetails" ], "xbrltype": "domainItemType" }, "hcmc_PatentInfringementLitigationMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The patent infringement litigation.", "label": "Patent Infringement Litigation [Member]", "terseLabel": "Patent Infringement Litigation [Member]" } } }, "localname": "PatentInfringementLitigationMember", "nsuri": "http://healthiercmc.com/20220630", "presentation": [ "http://healthiercmc.com/role/CommitmentsAndContingenciesDetails" ], "xbrltype": "domainItemType" }, "hcmc_PaymentsToAcquireInventory": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for purchases of inventory.", "label": "Payments to Acquire Inventory", "terseLabel": "Cash paid for inventory" } } }, "localname": "PaymentsToAcquireInventory", "nsuri": "http://healthiercmc.com/20220630", "presentation": [ "http://healthiercmc.com/role/AcquisitionOfMotherEarthSStorehouseIncDetails" ], "xbrltype": "monetaryItemType" }, "hcmc_PercentageOfForfeitedFromCurrentAmendedAwardAgreement": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The percentage of forfeited from current amended award agreement.", "label": "Percentage of Forfeited from Current Amended Award Agreement", "terseLabel": "Percentage of forfeited from current amended award agreement" } } }, "localname": "PercentageOfForfeitedFromCurrentAmendedAwardAgreement", "nsuri": "http://healthiercmc.com/20220630", "presentation": [ "http://healthiercmc.com/role/StockholdersEquityExchangeAgreementAndRestrictedStockDetails" ], "xbrltype": "percentItemType" }, "hcmc_PhilipMorrisMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the name of an entity.", "label": "Philip Morris [Member]" } } }, "localname": "PhilipMorrisMember", "nsuri": "http://healthiercmc.com/20220630", "presentation": [ "http://healthiercmc.com/role/CommitmentsAndContingenciesDetails" ], "xbrltype": "domainItemType" }, "hcmc_PrepaidExpenseAndVendorDepositsCurrent": { "auth_ref": [], "calculation": { "http://healthiercmc.com/role/CondensedConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of vendor deposits that are expected to be realized or consumed within one year or the normal operating cycle, if longer.", "label": "Prepaid Expense and Vendor Deposits, Current", "terseLabel": "Prepaid expenses and vendor deposits" } } }, "localname": "PrepaidExpenseAndVendorDepositsCurrent", "nsuri": "http://healthiercmc.com/20220630", "presentation": [ "http://healthiercmc.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "hcmc_PresidentAndChiefOperatingOfficerMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Person with designation of president and chief operating officer.", "label": "President and Chief Operating Officer [Member]", "terseLabel": "President and Chief Operating Officer [Member]" } } }, "localname": "PresidentAndChiefOperatingOfficerMember", "nsuri": "http://healthiercmc.com/20220630", "presentation": [ "http://healthiercmc.com/role/CommitmentsAndContingenciesDetails" ], "xbrltype": "domainItemType" }, "hcmc_ProceedsFromBalloonPayment": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the balloon payment.", "label": "Proceeds from Balloon Payment", "terseLabel": "Balloon payment" } } }, "localname": "ProceedsFromBalloonPayment", "nsuri": "http://healthiercmc.com/20220630", "presentation": [ "http://healthiercmc.com/role/NotesReceivableAndOtherIncomeDetails" ], "xbrltype": "monetaryItemType" }, "hcmc_PromissoryNotesAndSecuredNotesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Promissory notes a signed document containing a written promise to pay a stated sum to a specified person or the bearer at a specified date or on demand and Secured note is a type of loan that is backed by the borrower's assets.", "label": "Promissory Notes and Secured Notes [Member]" } } }, "localname": "PromissoryNotesAndSecuredNotesMember", "nsuri": "http://healthiercmc.com/20220630", "presentation": [ "http://healthiercmc.com/role/NotesReceivableAndOtherIncomeDetails" ], "xbrltype": "domainItemType" }, "hcmc_PromissoryNotesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Promissory notes a signed document containing a written promise to pay a stated sum to a specified person or the bearer at a specified date or on demand.", "label": "Promissory Notes [Member]", "terseLabel": "Promissory Note [Member]" } } }, "localname": "PromissoryNotesMember", "nsuri": "http://healthiercmc.com/20220630", "presentation": [ "http://healthiercmc.com/role/NotesReceivableAndOtherIncomeDetails" ], "xbrltype": "domainItemType" }, "hcmc_RetailGroceryMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A grocery retailer primarily sells food. Grocery stores also offer non-perishable foods that are packaged in bottles, boxes, and cans; some also have bakeries, butchers, delis, and fresh produce.", "label": "Retail Grocery [Member]", "terseLabel": "Retail Grocery [Member]" } } }, "localname": "RetailGroceryMember", "nsuri": "http://healthiercmc.com/20220630", "presentation": [ "http://healthiercmc.com/role/DisaggregationOfRevenuesDetails" ], "xbrltype": "domainItemType" }, "hcmc_RetailVaporMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A retail vapor outlet specializing in the selling of electronic cigarette products.", "label": "Retail Vapor [Member]", "terseLabel": "Retail Vapor [Member]" } } }, "localname": "RetailVaporMember", "nsuri": "http://healthiercmc.com/20220630", "presentation": [ "http://healthiercmc.com/role/DisaggregationOfRevenuesDetails" ], "xbrltype": "domainItemType" }, "hcmc_RightsOfferingAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Rights Offering [Abstract]", "terseLabel": "Rights Offering [Abstract]" } } }, "localname": "RightsOfferingAbstract", "nsuri": "http://healthiercmc.com/20220630", "presentation": [ "http://healthiercmc.com/role/StockholdersEquityRightsOfferingDetails" ], "xbrltype": "stringItemType" }, "hcmc_ScheduleOfAccountsNotesReceivableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of notes receivable.", "label": "Schedule Of Accounts Notes Receivable [Text Block]", "terseLabel": "Summary of Notes" } } }, "localname": "ScheduleOfAccountsNotesReceivableTextBlock", "nsuri": "http://healthiercmc.com/20220630", "presentation": [ "http://healthiercmc.com/role/NotesReceivableAndOtherIncomeTables" ], "xbrltype": "textBlockItemType" }, "hcmc_ScheduleOfCashAndCashEquivalentsAndRestrictedCashTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of cash and cash equivalents and cash and cash equivalents restricted as to withdrawal or usage.", "label": "Schedule of Cash and Cash Equivalents and Restricted Cash [Table Text Block]", "terseLabel": "Cash, Cash Equivalents and Restricted Cash" } } }, "localname": "ScheduleOfCashAndCashEquivalentsAndRestrictedCashTableTextBlock", "nsuri": "http://healthiercmc.com/20220630", "presentation": [ "http://healthiercmc.com/role/ConcentrationsTables" ], "xbrltype": "textBlockItemType" }, "hcmc_SeriesCConvertiblePreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Preferred stock that may be exchanged into common shares or other types of securities at the owner's option.", "label": "Series C Convertible Preferred Stock [Member]", "terseLabel": "Series C Convertible Preferred Stock [Member]" } } }, "localname": "SeriesCConvertiblePreferredStockMember", "nsuri": "http://healthiercmc.com/20220630", "presentation": [ "http://healthiercmc.com/role/CondensedConsolidatedBalanceSheets", "http://healthiercmc.com/role/CondensedConsolidatedBalanceSheetsParenthetical", "http://healthiercmc.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquity" ], "xbrltype": "domainItemType" }, "hcmc_SeriesDConvertiblePreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Preferred stock that may be exchanged into common shares or other types of securities at the owner's option.", "label": "Series D Convertible Preferred Stock [Member]", "terseLabel": "Series D Convertible Preferred Stock [Member]" } } }, "localname": "SeriesDConvertiblePreferredStockMember", "nsuri": "http://healthiercmc.com/20220630", "presentation": [ "http://healthiercmc.com/role/CondensedConsolidatedBalanceSheets", "http://healthiercmc.com/role/CondensedConsolidatedBalanceSheetsParenthetical", "http://healthiercmc.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquity" ], "xbrltype": "domainItemType" }, "hcmc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsIncreaseInVestingPercentageFromItsOriginalAwardsInPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The percentage of increase in grants from its original award agreement, made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).", "label": "Share Based Compensation Arrangement by Share Based Payment Award Equity Instruments Other Than Options Grants, Increase in Vesting Percentage from its Original Awards In Period", "terseLabel": "Percentage of increase in restricted stock grants from its original award agreement to officers" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsIncreaseInVestingPercentageFromItsOriginalAwardsInPeriod", "nsuri": "http://healthiercmc.com/20220630", "presentation": [ "http://healthiercmc.com/role/StockholdersEquityExchangeAgreementAndRestrictedStockDetails" ], "xbrltype": "percentItemType" }, "hcmc_StockIssuedDuringPeriodSharesNewIssuesRightsOffering": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of new stock issued in connection with Rights Offering during the period.", "label": "Stock Issued During Period, Shares, New Issues, Rights Offering", "terseLabel": "Issuance of common stock in connection with the Rights Offering, net of offering expenses (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesNewIssuesRightsOffering", "nsuri": "http://healthiercmc.com/20220630", "presentation": [ "http://healthiercmc.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquity" ], "xbrltype": "sharesItemType" }, "hcmc_StockIssuedDuringPeriodValueNewIssuesRightsOffering": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the value of new stock issued during the period in connection with Rights Offering.", "label": "Stock Issued During Period, Value, New Issues, Rights Offering", "terseLabel": "Issuance of common stock in connection with the Rights Offering, net of offering expenses" } } }, "localname": "StockIssuedDuringPeriodValueNewIssuesRightsOffering", "nsuri": "http://healthiercmc.com/20220630", "presentation": [ "http://healthiercmc.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "hcmc_TermLoanAndSecurityAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "On August 18, 2020, the Company agreed to a term loan and security agreement (the \"Loan\") with Sabby Healthcare Master Fund, LTD and Sabby Volatility Warrant Master Fund, LTD (\"collectively, the Lender\").", "label": "Term Loan and Security Agreement [Member]", "terseLabel": "Loan and Security Agreement [Member]" } } }, "localname": "TermLoanAndSecurityAgreementMember", "nsuri": "http://healthiercmc.com/20220630", "presentation": [ "http://healthiercmc.com/role/StockholdersEquityExchangeAgreementAndRestrictedStockDetails" ], "xbrltype": "domainItemType" }, "hcmc_VapeStoresDisposalsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Includes equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities, additions or improvements to assets held under a lease arrangement, and long lived, depreciable assets that are used in the creation, maintenance and utilization of information systems.", "label": "Vape Stores' Disposal [Member]", "terseLabel": "Vape Stores' Disposal [Member]" } } }, "localname": "VapeStoresDisposalsMember", "nsuri": "http://healthiercmc.com/20220630", "presentation": [ "http://healthiercmc.com/role/PropertyEquipmentDetails" ], "xbrltype": "domainItemType" }, "hcmc_VaporLoyaltyRewardsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Refers to product of the vapor loyalty rewards.", "label": "Vapor Loyalty Rewards [Member]", "terseLabel": "Vapor Loyalty Rewards [Member]" } } }, "localname": "VaporLoyaltyRewardsMember", "nsuri": "http://healthiercmc.com/20220630", "presentation": [ "http://healthiercmc.com/role/ContractLiabilitiesDetails" ], "xbrltype": "domainItemType" }, "hcmc_VaporMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Refers to a substance diffused or suspended in the air, especially one normally liquid or solid.", "label": "Vapor [Member]", "terseLabel": "Vapor [Member]" } } }, "localname": "VaporMember", "nsuri": "http://healthiercmc.com/20220630", "presentation": [ "http://healthiercmc.com/role/CondensedConsolidatedStatementsOfOperations", "http://healthiercmc.com/role/DisaggregationOfRevenuesDetails" ], "xbrltype": "domainItemType" }, "hcmc_WholesaleGroceryMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A person that is a dealer primarily engaged in the full-line wholesale distribution and resale of grocery and related nonfood items.", "label": "Wholesale Grocery [Member]", "terseLabel": "Wholesale Grocery [Member]" } } }, "localname": "WholesaleGroceryMember", "nsuri": "http://healthiercmc.com/20220630", "presentation": [ "http://healthiercmc.com/role/DisaggregationOfRevenuesDetails" ], "xbrltype": "domainItemType" }, "hcmc_WholesaleVaporMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A person that is a dealer primarily engaged in the full-line wholesale distribution of vape products.", "label": "Wholesale Vapor [Member]", "terseLabel": "Wholesale Vapor [Member]" } } }, "localname": "WholesaleVaporMember", "nsuri": "http://healthiercmc.com/20220630", "presentation": [ "http://healthiercmc.com/role/DisaggregationOfRevenuesDetails" ], "xbrltype": "domainItemType" }, "srt_BoardOfDirectorsChairmanMember": { "auth_ref": [ "r134" ], "lang": { "en-us": { "role": { "label": "Board of Directors Chairman [Member]", "verboseLabel": "Board Member [Member]" } } }, "localname": "BoardOfDirectorsChairmanMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://healthiercmc.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquity" ], "xbrltype": "domainItemType" }, "srt_ChiefExecutiveOfficerMember": { "auth_ref": [ "r134" ], "lang": { "en-us": { "role": { "label": "Chief Executive Officer [Member]" } } }, "localname": "ChiefExecutiveOfficerMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://healthiercmc.com/role/StockholdersEquityExchangeAgreementAndRestrictedStockDetails" ], "xbrltype": "domainItemType" }, "srt_ChiefFinancialOfficerMember": { "auth_ref": [ "r134" ], "lang": { "en-us": { "role": { "label": "Chief Financial Officer [Member]" } } }, "localname": "ChiefFinancialOfficerMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://healthiercmc.com/role/CommitmentsAndContingenciesDetails", "http://healthiercmc.com/role/StockholdersEquityExchangeAgreementAndRestrictedStockDetails" ], "xbrltype": "domainItemType" }, "srt_ChiefOperatingOfficerMember": { "auth_ref": [ "r134", "r328" ], "lang": { "en-us": { "role": { "label": "Chief Operating Officer [Member]" } } }, "localname": "ChiefOperatingOfficerMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://healthiercmc.com/role/StockholdersEquityExchangeAgreementAndRestrictedStockDetails" ], "xbrltype": "domainItemType" }, "srt_CounterpartyNameAxis": { "auth_ref": [ "r43", "r45", "r84", "r85", "r191", "r227" ], "lang": { "en-us": { "role": { "label": "Counterparty Name [Axis]" } } }, "localname": "CounterpartyNameAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://healthiercmc.com/role/CommitmentsAndContingenciesDetails" ], "xbrltype": "stringItemType" }, "srt_DirectorMember": { "auth_ref": [ "r134" ], "lang": { "en-us": { "role": { "label": "Director [Member]" } } }, "localname": "DirectorMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://healthiercmc.com/role/StockholdersEquityExchangeAgreementAndRestrictedStockDetails" ], "xbrltype": "domainItemType" }, "srt_LitigationCaseAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Litigation Case [Axis]" } } }, "localname": "LitigationCaseAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://healthiercmc.com/role/CommitmentsAndContingenciesDetails" ], "xbrltype": "stringItemType" }, "srt_LitigationCaseTypeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Litigation Case [Domain]" } } }, "localname": "LitigationCaseTypeDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://healthiercmc.com/role/CommitmentsAndContingenciesDetails" ], "xbrltype": "domainItemType" }, "srt_MaximumMember": { "auth_ref": [ "r190", "r226", "r271", "r273", "r332", "r333", "r334", "r335", "r336", "r337", "r338", "r369", "r371", "r382", "r383" ], "lang": { "en-us": { "role": { "label": "Maximum [Member]" } } }, "localname": "MaximumMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://healthiercmc.com/role/IntangibleAssetsIntangibleAssetsNetDetails", "http://healthiercmc.com/role/StockholdersEquityRightsOfferingDetails" ], "xbrltype": "domainItemType" }, "srt_MinimumMember": { "auth_ref": [ "r190", "r226", "r271", "r273", "r332", "r333", "r334", "r335", "r336", "r337", "r338", "r369", "r371", "r382", "r383" ], "lang": { "en-us": { "role": { "label": "Minimum [Member]" } } }, "localname": "MinimumMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://healthiercmc.com/role/IntangibleAssetsIntangibleAssetsNetDetails" ], "xbrltype": "domainItemType" }, "srt_OfficerMember": { "auth_ref": [ "r134" ], "lang": { "en-us": { "role": { "label": "Officers [Member]" } } }, "localname": "OfficerMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://healthiercmc.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquity" ], "xbrltype": "domainItemType" }, "srt_ProductOrServiceAxis": { "auth_ref": [ "r131", "r258", "r261", "r340", "r368", "r370" ], "lang": { "en-us": { "role": { "label": "Product and Service [Axis]" } } }, "localname": "ProductOrServiceAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://healthiercmc.com/role/CondensedConsolidatedStatementsOfOperations", "http://healthiercmc.com/role/ContractLiabilitiesDetails", "http://healthiercmc.com/role/DisaggregationOfRevenuesDetails" ], "xbrltype": "stringItemType" }, "srt_ProductsAndServicesDomain": { "auth_ref": [ "r131", "r258", "r261", "r340", "r368", "r370" ], "lang": { "en-us": { "role": { "label": "Product and Service [Domain]" } } }, "localname": "ProductsAndServicesDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://healthiercmc.com/role/CondensedConsolidatedStatementsOfOperations", "http://healthiercmc.com/role/ContractLiabilitiesDetails", "http://healthiercmc.com/role/DisaggregationOfRevenuesDetails" ], "xbrltype": "domainItemType" }, "srt_RangeAxis": { "auth_ref": [ "r190", "r226", "r269", "r271", "r273", "r332", "r333", "r334", "r335", "r336", "r337", "r338", "r369", "r371", "r382", "r383" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Axis]" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://healthiercmc.com/role/IntangibleAssetsIntangibleAssetsNetDetails", "http://healthiercmc.com/role/StockholdersEquityRightsOfferingDetails" ], "xbrltype": "stringItemType" }, "srt_RangeMember": { "auth_ref": [ "r190", "r226", "r269", "r271", "r273", "r332", "r333", "r334", "r335", "r336", "r337", "r338", "r369", "r371", "r382", "r383" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Domain]" } } }, "localname": "RangeMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://healthiercmc.com/role/IntangibleAssetsIntangibleAssetsNetDetails", "http://healthiercmc.com/role/StockholdersEquityRightsOfferingDetails" ], "xbrltype": "domainItemType" }, "srt_RepurchaseAgreementCounterpartyNameDomain": { "auth_ref": [ "r44", "r45", "r84", "r85", "r191", "r227" ], "lang": { "en-us": { "role": { "label": "Counterparty Name [Domain]" } } }, "localname": "RepurchaseAgreementCounterpartyNameDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://healthiercmc.com/role/CommitmentsAndContingenciesDetails" ], "xbrltype": "domainItemType" }, "srt_TitleOfIndividualAxis": { "auth_ref": [ "r134", "r328" ], "lang": { "en-us": { "role": { "label": "Title of Individual [Axis]" } } }, "localname": "TitleOfIndividualAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://healthiercmc.com/role/CommitmentsAndContingenciesDetails", "http://healthiercmc.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquity" ], "xbrltype": "stringItemType" }, "srt_TitleOfIndividualWithRelationshipToEntityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Title of Individual [Domain]" } } }, "localname": "TitleOfIndividualWithRelationshipToEntityDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://healthiercmc.com/role/CommitmentsAndContingenciesDetails", "http://healthiercmc.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES [Abstract]" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_AccountsNotesAndLoansReceivableLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Accounts, Notes, Loans and Financing Receivable [Line Items]" } } }, "localname": "AccountsNotesAndLoansReceivableLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/NotesReceivableAndOtherIncomeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis": { "auth_ref": [ "r39" ], "lang": { "en-us": { "role": { "documentation": "Information by type of receivable.", "label": "Receivable Type [Axis]" } } }, "localname": "AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/NotesReceivableAndOtherIncomeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent": { "auth_ref": [ "r31" ], "calculation": { "http://healthiercmc.com/role/CondensedConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.", "label": "Accounts payable and accrued expenses" } } }, "localname": "AccountsPayableAndAccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableNetCurrent": { "auth_ref": [ "r5", "r21", "r135", "r136" ], "calculation": { "http://healthiercmc.com/role/CondensedConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.", "label": "Accounts receivable, net" } } }, "localname": "AccountsReceivableNetCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": { "auth_ref": [ "r29", "r158" ], "calculation": { "http://healthiercmc.com/role/PropertyEquipmentDetails": { "order": 2.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.", "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment", "negatedLabel": "Less: accumulated depreciation and amortization" } } }, "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/PropertyEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapital": { "auth_ref": [ "r22", "r287", "r331" ], "calculation": { "http://healthiercmc.com/role/CondensedConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.", "label": "Additional paid-in capital" } } }, "localname": "AdditionalPaidInCapital", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r88", "r89", "r90", "r284", "r285", "r286", "r309" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital [Member]", "verboseLabel": "Additional Paid-In Capital [Member]" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for option under share-based payment arrangement.", "label": "Stock-based compensation expense" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments to reconcile net loss to net cash used in operating activities:" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_AmortizationOfIntangibleAssets": { "auth_ref": [ "r73", "r146", "r151" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.", "label": "Amortization expense" } } }, "localname": "AmortizationOfIntangibleAssets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/IntangibleAssetsFutureAnnualEstimatedAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "auth_ref": [ "r110" ], "lang": { "en-us": { "role": { "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.", "label": "Antidilutive securities excluded from computation of diluted loss per share (in shares)" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/StockholdersEquityIncomeLossPerShareDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": { "auth_ref": [ "r110" ], "lang": { "en-us": { "role": { "documentation": "Information by type of antidilutive security.", "label": "Antidilutive Securities [Axis]" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/StockholdersEquityIncomeLossPerShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/StockholdersEquityIncomeLossPerShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AntidilutiveSecuritiesNameDomain": { "auth_ref": [ "r110" ], "lang": { "en-us": { "role": { "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.", "label": "Antidilutive Securities, Name [Domain]" } } }, "localname": "AntidilutiveSecuritiesNameDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/StockholdersEquityIncomeLossPerShareDetails" ], "xbrltype": "domainItemType" }, "us-gaap_Assets": { "auth_ref": [ "r83", "r120", "r123", "r129", "r140", "r176", "r177", "r178", "r179", "r180", "r181", "r182", "r183", "r184", "r185", "r186", "r304", "r306", "r312", "r329", "r331", "r344", "r360" ], "calculation": { "http://healthiercmc.com/role/CondensedConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "totalLabel": "TOTAL ASSETS" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets [Abstract]", "verboseLabel": "ASSETS" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r7", "r8", "r41", "r83", "r140", "r176", "r177", "r178", "r179", "r180", "r181", "r182", "r183", "r184", "r185", "r186", "r304", "r306", "r312", "r329", "r331" ], "calculation": { "http://healthiercmc.com/role/CondensedConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Current", "totalLabel": "TOTAL CURRENT ASSETS" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CURRENT ASSETS" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AwardTypeAxis": { "auth_ref": [ "r277", "r282" ], "lang": { "en-us": { "role": { "documentation": "Information by type of award under share-based payment arrangement.", "label": "Award Type [Axis]" } } }, "localname": "AwardTypeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/StockholdersEquityExchangeAgreementAndRestrictedStockDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BuildingMember": { "auth_ref": [ "r157" ], "lang": { "en-us": { "role": { "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities.", "label": "Building [Member]" } } }, "localname": "BuildingMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/PropertyEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BusinessAcquisitionAcquireeDomain": { "auth_ref": [ "r270", "r272" ], "lang": { "en-us": { "role": { "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.", "label": "Business Acquisition, Acquiree [Domain]" } } }, "localname": "BusinessAcquisitionAcquireeDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/AcquisitionOfMotherEarthSStorehouseIncDetails", "http://healthiercmc.com/role/OrganizationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BusinessAcquisitionAxis": { "auth_ref": [ "r270", "r272", "r290", "r291" ], "lang": { "en-us": { "role": { "documentation": "Information by business combination or series of individually immaterial business combinations.", "label": "Business Acquisition [Axis]" } } }, "localname": "BusinessAcquisitionAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/AcquisitionOfMotherEarthSStorehouseIncDetails", "http://healthiercmc.com/role/OrganizationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessAcquisitionLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Business Acquisition [Line Items]" } } }, "localname": "BusinessAcquisitionLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/AcquisitionOfMotherEarthSStorehouseIncDetails", "http://healthiercmc.com/role/OrganizationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessCombinationAndAssetAcquisitionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ACQUISITION OF MOTHER EARTH'S STOREHOUSE, INC. [Abstract]" } } }, "localname": "BusinessCombinationAndAssetAcquisitionAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_BusinessCombinationConsiderationTransferred1": { "auth_ref": [ "r299", "r300", "r301" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.", "label": "Business Combination, Consideration Transferred", "terseLabel": "Cash Consideration paid" } } }, "localname": "BusinessCombinationConsiderationTransferred1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/AcquisitionOfMotherEarthSStorehouseIncDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationDisclosureTextBlock": { "auth_ref": [ "r303" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).", "label": "ACQUISITION OF MOTHER EARTH'S STOREHOUSE, INC." } } }, "localname": "BusinessCombinationDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/AcquisitionOfMotherEarthSStorehouseInc" ], "xbrltype": "textBlockItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwillAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill [Abstract]", "terseLabel": "Finite-Lived Intangible Assets [Abstract]" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwillAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/AcquisitionOfMotherEarthSStorehouseIncDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles": { "auth_ref": [ "r292", "r293" ], "calculation": { "http://healthiercmc.com/role/AcquisitionOfMotherEarthSStorehouseIncDetails": { "order": 2.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of identifiable intangible assets recognized as of the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles", "terseLabel": "Intangible assets" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/AcquisitionOfMotherEarthSStorehouseIncDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory": { "auth_ref": [ "r292", "r293" ], "calculation": { "http://healthiercmc.com/role/AcquisitionOfMotherEarthSStorehouseIncDetails": { "order": 0.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of inventory recognized as of the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory", "terseLabel": "Inventory" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/AcquisitionOfMotherEarthSStorehouseIncDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther": { "auth_ref": [ "r293" ], "calculation": { "http://healthiercmc.com/role/AcquisitionOfMotherEarthSStorehouseIncDetails": { "order": 4.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of other liabilities due after one year or the normal operating cycle, if longer, assumed at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other", "negatedLabel": "Other liabilities" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/AcquisitionOfMotherEarthSStorehouseIncDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment": { "auth_ref": [ "r292", "r293" ], "calculation": { "http://healthiercmc.com/role/AcquisitionOfMotherEarthSStorehouseIncDetails": { "order": 1.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of property, plant, and equipment recognized as of the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment", "terseLabel": "Property and equipment" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/AcquisitionOfMotherEarthSStorehouseIncDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Less Noncontrolling Interest [Abstract]", "terseLabel": "Purchase Price Allocation [Abstract]" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/AcquisitionOfMotherEarthSStorehouseIncDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet": { "auth_ref": [ "r293" ], "calculation": { "http://healthiercmc.com/role/AcquisitionOfMotherEarthSStorehouseIncDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.", "label": "Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net", "totalLabel": "Net assets acquired" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/AcquisitionOfMotherEarthSStorehouseIncDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Business Combinations [Abstract]", "terseLabel": "Acquisition of Mother Earth's Storehouse, Inc. [Abstract]" } } }, "localname": "BusinessCombinationsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/AcquisitionOfMotherEarthSStorehouseIncDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r3", "r27", "r75" ], "calculation": { "http://healthiercmc.com/role/CondensedConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash and cash equivalents" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r69", "r75", "r77" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents", "periodEndLabel": "CASH, CASH EQUIVALENTS AND RESTRICTED CASH - END OF PERIOD", "periodStartLabel": "CASH, CASH EQUIVALENTS AND RESTRICTED CASH - BEGINNING OF PERIOD" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents [Abstract]", "terseLabel": "Cash, Cash Equivalents and Restricted Cash [Abstract]" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/ConcentrationsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect": { "auth_ref": [ "r69", "r313" ], "calculation": { "http://healthiercmc.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect", "totalLabel": "NET (DECREASE) INCREASE IN CASH, CASH EQUIVALENT AND RESTRICTED CASH" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashFDICInsuredAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of cash deposited in financial institutions as of the balance sheet date that is insured by the Federal Deposit Insurance Corporation.", "label": "FDIC insured amount" } } }, "localname": "CashFDICInsuredAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/ConcentrationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "NON-CASH INVESTING AND FINANCING ACTIVITIES" } } }, "localname": "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_ChangeInContractWithCustomerLiabilityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Changes in Contract Liabilities Activity [Roll Forward]" } } }, "localname": "ChangeInContractWithCustomerLiabilityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/ContractLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [ "r80", "r83", "r103", "r104", "r105", "r107", "r109", "r114", "r115", "r116", "r140", "r176", "r180", "r181", "r182", "r185", "r186", "r224", "r225", "r229", "r233", "r312", "r389" ], "lang": { "en-us": { "role": { "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.", "label": "Class of Stock [Domain]" } } }, "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/CondensedConsolidatedBalanceSheets", "http://healthiercmc.com/role/CondensedConsolidatedBalanceSheetsParenthetical", "http://healthiercmc.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_CommitmentsAndContingencies": { "auth_ref": [ "r36", "r164", "r351", "r365" ], "calculation": { "http://healthiercmc.com/role/CondensedConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.", "label": "COMMITMENTS AND CONTINGENCIES (SEE NOTE 13)" } } }, "localname": "CommitmentsAndContingencies", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "COMMITMENTS AND CONTINGENCIES [Abstract]" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "auth_ref": [ "r161", "r162", "r163", "r173", "r378" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for commitments and contingencies.", "label": "COMMITMENTS AND CONTINGENCIES" } } }, "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/CommitmentsAndContingencies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r88", "r89", "r309" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]", "verboseLabel": "Common Stock [Member]" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r19" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common stock, par value (in dollars per share)" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/CondensedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r19" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common stock, shares authorized (in shares)" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/CondensedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r19" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common stock, shares issued (in shares)" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/CondensedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r19", "r239" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common stock, shares outstanding (in shares)" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/CondensedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r19", "r331" ], "calculation": { "http://healthiercmc.com/role/CondensedConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common Stock, $0.0001 par value per share, 750,000,000,000 shares authorized; 339,741,632,384 shares issued and outstanding as of June 30, 2022 and December 31, 2021, respectively" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComputerEquipmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Long lived, depreciable assets that are used in the creation, maintenance and utilization of information systems.", "label": "Computer Hardware & Equipment [Member]" } } }, "localname": "ComputerEquipmentMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/PropertyEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ConcentrationRiskDisclosureTextBlock": { "auth_ref": [ "r117" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date.", "label": "CONCENTRATIONS" } } }, "localname": "ConcentrationRiskDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/Concentrations" ], "xbrltype": "textBlockItemType" }, "us-gaap_ContractWithCustomerAssetAndLiabilityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CONTRACT LIABILITIES [Abstract]" } } }, "localname": "ContractWithCustomerAssetAndLiabilityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock": { "auth_ref": [ "r249" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.", "label": "Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]", "terseLabel": "Summary of Net Changes in Contract Liabilities" } } }, "localname": "ContractWithCustomerAssetAndLiabilityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/ContractLiabilitiesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ContractWithCustomerAssetNetCurrent": { "auth_ref": [ "r246", "r248", "r259" ], "calculation": { "http://healthiercmc.com/role/CondensedConsolidatedBalanceSheets": { "order": 6.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time, classified as current.", "label": "Contract assets" } } }, "localname": "ContractWithCustomerAssetNetCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractWithCustomerLiability": { "auth_ref": [ "r246", "r247", "r259" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.", "label": "Contract with Customer, Liability", "periodEndLabel": "Ending balance", "periodStartLabel": "Beginning balance" } } }, "localname": "ContractWithCustomerLiability", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/ContractLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractWithCustomerLiabilityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Deferred Revenue [Abstract]" } } }, "localname": "ContractWithCustomerLiabilityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/ContractLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ContractWithCustomerLiabilityCurrent": { "auth_ref": [ "r246", "r247", "r259" ], "calculation": { "http://healthiercmc.com/role/CondensedConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.", "label": "Contract liabilities" } } }, "localname": "ContractWithCustomerLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractWithCustomerSalesChannelAxis": { "auth_ref": [ "r258", "r267" ], "lang": { "en-us": { "role": { "documentation": "Information by sales channel for delivery of good or service in contract with customer.", "label": "Contract with Customer, Sales Channel [Axis]" } } }, "localname": "ContractWithCustomerSalesChannelAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/DisaggregationOfRevenuesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ContractWithCustomerSalesChannelDomain": { "auth_ref": [ "r258", "r267" ], "lang": { "en-us": { "role": { "documentation": "Sales channel for delivery of good or service in contract with customer. Includes, but is not limited to, directly to consumer and through intermediary.", "label": "Contract with Customer, Sales Channel [Domain]" } } }, "localname": "ContractWithCustomerSalesChannelDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/DisaggregationOfRevenuesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ConvertiblePreferredStockConvertedToOtherSecurities": { "auth_ref": [ "r240" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Value of convertible preferred stock that was converted to other securities.", "label": "Convertible Preferred Stock Converted to Other Securities", "negatedLabel": "Series C Preferred stock exercised" } } }, "localname": "ConvertiblePreferredStockConvertedToOtherSecurities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConvertiblePreferredStockMember": { "auth_ref": [ "r224", "r225", "r229" ], "lang": { "en-us": { "role": { "documentation": "Preferred stock that may be exchanged into common shares or other types of securities at the owner's option.", "label": "Convertible Preferred Stock [Member]" } } }, "localname": "ConvertiblePreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_CostOfGoodsAndServicesSold": { "auth_ref": [ "r55", "r340" ], "calculation": { "http://healthiercmc.com/role/CondensedConsolidatedStatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_GrossProfit", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.", "label": "Cost of sales" } } }, "localname": "CostOfGoodsAndServicesSold", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_CreditFacilityAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.", "label": "Credit Facility [Axis]" } } }, "localname": "CreditFacilityAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/DebtDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CreditFacilityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.", "label": "Credit Facility [Domain]" } } }, "localname": "CreditFacilityDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/DebtDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CustomerRelationshipsMember": { "auth_ref": [ "r297" ], "lang": { "en-us": { "role": { "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.", "label": "Customer Relationships [Member]", "verboseLabel": "Customer Relationships [Member]" } } }, "localname": "CustomerRelationshipsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/AcquisitionOfMotherEarthSStorehouseIncDetails", "http://healthiercmc.com/role/IntangibleAssetsIntangibleAssetsNetDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "DEBT [Abstract]" } } }, "localname": "DebtDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_DebtDisclosureTextBlock": { "auth_ref": [ "r79", "r193", "r194", "r195", "r196", "r197", "r198", "r199", "r204", "r211", "r212", "r214", "r223" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.", "label": "DEBT" } } }, "localname": "DebtDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/Debt" ], "xbrltype": "textBlockItemType" }, "us-gaap_DebtInstrumentAxis": { "auth_ref": [ "r13", "r15", "r16", "r82", "r86", "r187", "r188", "r189", "r190", "r191", "r192", "r194", "r200", "r201", "r202", "r203", "r205", "r206", "r207", "r208", "r209", "r210", "r217", "r218", "r219", "r220", "r322", "r345", "r346", "r358" ], "lang": { "en-us": { "role": { "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.", "label": "Debt Instrument [Axis]" } } }, "localname": "DebtInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/DebtDetails", "http://healthiercmc.com/role/StockholdersEquityExchangeAgreementAndRestrictedStockDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentFaceAmount": { "auth_ref": [ "r187", "r217", "r218", "r321", "r322", "r323" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Face (par) amount of debt instrument at time of issuance.", "label": "Face amount" } } }, "localname": "DebtInstrumentFaceAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/StockholdersEquityExchangeAgreementAndRestrictedStockDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Debt Instrument [Line Items]" } } }, "localname": "DebtInstrumentLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/DebtDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentNameDomain": { "auth_ref": [ "r35", "r82", "r86", "r187", "r188", "r189", "r190", "r191", "r192", "r194", "r200", "r201", "r202", "r203", "r205", "r206", "r207", "r208", "r209", "r210", "r217", "r218", "r219", "r220", "r322" ], "lang": { "en-us": { "role": { "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.", "label": "Debt Instrument, Name [Domain]" } } }, "localname": "DebtInstrumentNameDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/DebtDetails", "http://healthiercmc.com/role/StockholdersEquityExchangeAgreementAndRestrictedStockDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtInstrumentTable": { "auth_ref": [ "r35", "r82", "r86", "r187", "r188", "r189", "r190", "r191", "r192", "r194", "r200", "r201", "r202", "r203", "r205", "r206", "r207", "r208", "r209", "r210", "r213", "r217", "r218", "r219", "r220", "r240", "r241", "r242", "r243", "r320", "r321", "r322", "r323", "r357" ], "lang": { "en-us": { "role": { "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Schedule of Long-term Debt Instruments [Table]" } } }, "localname": "DebtInstrumentTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/DebtDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DeferredCompensationArrangementWithIndividualCashAwardsGrantedPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commitment made to pay deferred cash remuneration expressed as a percentage of the individual's base salary.", "label": "Increment percentage on salary each subsequent year" } } }, "localname": "DeferredCompensationArrangementWithIndividualCashAwardsGrantedPercentage", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/CommitmentsAndContingenciesDetails" ], "xbrltype": "percentItemType" }, "us-gaap_Depreciation": { "auth_ref": [ "r73", "r156" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.", "label": "Depreciation expense" } } }, "localname": "Depreciation", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/PropertyEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepreciationAndAmortization": { "auth_ref": [ "r73", "r156" ], "calculation": { "http://healthiercmc.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.", "label": "Depreciation and amortization" } } }, "localname": "DepreciationAndAmortization", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeLiabilitiesCurrent": { "auth_ref": [ "r42" ], "calculation": { "http://healthiercmc.com/role/CondensedConsolidatedBalanceSheets": { "order": 6.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled within one year or normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.", "label": "Derivative Liability, Current", "terseLabel": "Derivative liabilities, warrants" } } }, "localname": "DerivativeLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisaggregationOfRevenueAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disaggregation of Revenue [Abstract]", "terseLabel": "Disaggregation of Revenue [Abstract]" } } }, "localname": "DisaggregationOfRevenueAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/DisaggregationOfRevenuesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DisaggregationOfRevenueLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Disaggregation of Revenue [Line Items]" } } }, "localname": "DisaggregationOfRevenueLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/ContractLiabilitiesDetails", "http://healthiercmc.com/role/DisaggregationOfRevenuesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DisaggregationOfRevenueTable": { "auth_ref": [ "r258", "r261", "r262", "r263", "r264", "r265", "r266", "r267" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.", "label": "Disaggregation of Revenue [Table]" } } }, "localname": "DisaggregationOfRevenueTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/ContractLiabilitiesDetails", "http://healthiercmc.com/role/DisaggregationOfRevenuesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DisaggregationOfRevenueTableTextBlock": { "auth_ref": [ "r258" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.", "label": "Disaggregated Revenue" } } }, "localname": "DisaggregationOfRevenueTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/DisaggregationOfRevenuesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_EarningsPerShareBasic": { "auth_ref": [ "r52", "r93", "r94", "r95", "r96", "r97", "r101", "r103", "r107", "r108", "r109", "r111", "r112", "r310", "r311", "r353", "r367" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.", "label": "NET LOSS PER SHARE, BASIC (in dollars per share)" } } }, "localname": "EarningsPerShareBasic", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareDiluted": { "auth_ref": [ "r52", "r93", "r94", "r95", "r96", "r97", "r103", "r107", "r108", "r109", "r111", "r112", "r310", "r311", "r353", "r367" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "NET LOSS PER SHARE, DILUTED (in dollars per share)" } } }, "localname": "EarningsPerShareDiluted", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "perShareItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationAggregateDisclosuresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Compensation Expense Recognized [Abstract]" } } }, "localname": "EmployeeServiceShareBasedCompensationAggregateDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/StockholdersEquityStockOptionsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EmployeeStockOptionMember": { "auth_ref": [ "r281" ], "lang": { "en-us": { "role": { "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.", "label": "Share-based Payment Arrangement, Option [Member]", "verboseLabel": "Stock Options [Member]" } } }, "localname": "EmployeeStockOptionMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/StockholdersEquityIncomeLossPerShareDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "STOCKHOLDERS' EQUITY [Abstract]" } } }, "localname": "EquityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r0", "r48", "r49", "r50", "r88", "r89", "r90", "r92", "r98", "r100", "r113", "r141", "r239", "r244", "r284", "r285", "r286", "r288", "r289", "r309", "r314", "r315", "r316", "r317", "r318", "r319", "r372", "r373", "r374", "r391" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.", "label": "Equity Component [Domain]" } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_EquitySecuritiesRestrictedAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Restricted Stock [Abstract]" } } }, "localname": "EquitySecuritiesRestrictedAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/StockholdersEquityExchangeAgreementAndRestrictedStockDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetUsefulLife": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Useful lives" } } }, "localname": "FiniteLivedIntangibleAssetUsefulLife", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/IntangibleAssetsIntangibleAssetsNetDetails" ], "xbrltype": "durationItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": { "auth_ref": [ "r150" ], "calculation": { "http://healthiercmc.com/role/IntangibleAssetsIntangibleAssetsNetDetails": { "order": 1.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Accumulated Amortization", "negatedLabel": "Accumulated amortization" } } }, "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/IntangibleAssetsIntangibleAssetsNetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": { "auth_ref": [ "r152" ], "calculation": { "http://healthiercmc.com/role/IntangibleAssetsFutureAnnualEstimatedAmortizationExpenseDetails": { "order": 2.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "2023" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/IntangibleAssetsFutureAnnualEstimatedAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear": { "auth_ref": [], "calculation": { "http://healthiercmc.com/role/IntangibleAssetsFutureAnnualEstimatedAmortizationExpenseDetails": { "order": 1.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in remainder of current fiscal year.", "label": "2022 (remaining six months)" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/IntangibleAssetsFutureAnnualEstimatedAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": { "auth_ref": [ "r152" ], "calculation": { "http://healthiercmc.com/role/IntangibleAssetsFutureAnnualEstimatedAmortizationExpenseDetails": { "order": 5.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "2026" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/IntangibleAssetsFutureAnnualEstimatedAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": { "auth_ref": [ "r152" ], "calculation": { "http://healthiercmc.com/role/IntangibleAssetsFutureAnnualEstimatedAmortizationExpenseDetails": { "order": 4.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "2025" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/IntangibleAssetsFutureAnnualEstimatedAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": { "auth_ref": [ "r152" ], "calculation": { "http://healthiercmc.com/role/IntangibleAssetsFutureAnnualEstimatedAmortizationExpenseDetails": { "order": 3.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "2024" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/IntangibleAssetsFutureAnnualEstimatedAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": { "auth_ref": [ "r147", "r148", "r150", "r153", "r341", "r342" ], "lang": { "en-us": { "role": { "documentation": "Information by major type or class of finite-lived intangible assets.", "label": "Finite-Lived Intangible Assets by Major Class [Axis]" } } }, "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/AcquisitionOfMotherEarthSStorehouseIncDetails", "http://healthiercmc.com/role/IntangibleAssetsIntangibleAssetsNetDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Future Annual Estimated Amortization Expense [Abstract]" } } }, "localname": "FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/IntangibleAssetsFutureAnnualEstimatedAmortizationExpenseDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsGross": { "auth_ref": [ "r150", "r342" ], "calculation": { "http://healthiercmc.com/role/IntangibleAssetsIntangibleAssetsNetDetails": { "order": 0.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Gross carrying amount" } } }, "localname": "FiniteLivedIntangibleAssetsGross", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/IntangibleAssetsIntangibleAssetsNetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Finite-Lived Intangible Assets [Line Items]" } } }, "localname": "FiniteLivedIntangibleAssetsLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/IntangibleAssetsIntangibleAssetsNetDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": { "auth_ref": [ "r147", "r149" ], "lang": { "en-us": { "role": { "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.", "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]" } } }, "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/AcquisitionOfMotherEarthSStorehouseIncDetails", "http://healthiercmc.com/role/IntangibleAssetsIntangibleAssetsNetDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FiniteLivedIntangibleAssetsNet": { "auth_ref": [ "r150", "r341" ], "calculation": { "http://healthiercmc.com/role/CondensedConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_Assets", "weight": 1.0 }, "http://healthiercmc.com/role/IntangibleAssetsFutureAnnualEstimatedAmortizationExpenseDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://healthiercmc.com/role/IntangibleAssetsIntangibleAssetsNetDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Intangible assets, net of accumulated amortization", "totalLabel": "Net carrying amount" } } }, "localname": "FiniteLivedIntangibleAssetsNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/CondensedConsolidatedBalanceSheets", "http://healthiercmc.com/role/IntangibleAssetsFutureAnnualEstimatedAmortizationExpenseDetails", "http://healthiercmc.com/role/IntangibleAssetsIntangibleAssetsNetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsNetAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Intangible Assets, Net [Abstract]" } } }, "localname": "FiniteLivedIntangibleAssetsNetAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/IntangibleAssetsIntangibleAssetsNetDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FurnitureAndFixturesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.", "label": "Furniture and Fixtures [Member]" } } }, "localname": "FurnitureAndFixturesMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/PropertyEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_GainLossOnInvestments": { "auth_ref": [ "r56", "r73", "r139" ], "calculation": { "http://healthiercmc.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 }, "http://healthiercmc.com/role/CondensedConsolidatedStatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of realized and unrealized gain (loss) on investment.", "label": "Gain (Loss) on Investments", "negatedLabel": "Gain on investment", "terseLabel": "Gain (loss) on investment" } } }, "localname": "GainLossOnInvestments", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/CondensedConsolidatedStatementsOfCashFlows", "http://healthiercmc.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_GainsLossesOnExtinguishmentOfDebt": { "auth_ref": [ "r73", "r221", "r222" ], "calculation": { "http://healthiercmc.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 }, "http://healthiercmc.com/role/CondensedConsolidatedStatementsOfOperations": { "order": 5.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.", "label": "Loss on extinguishment of debt", "negatedLabel": "(Gain) on debt settlement", "terseLabel": "Gain on debt extinguishment, net" } } }, "localname": "GainsLossesOnExtinguishmentOfDebt", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/CondensedConsolidatedStatementsOfCashFlows", "http://healthiercmc.com/role/CondensedConsolidatedStatementsOfOperations", "http://healthiercmc.com/role/StockholdersEquityExchangeAgreementAndRestrictedStockDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_Goodwill": { "auth_ref": [ "r144", "r145", "r331", "r343" ], "calculation": { "http://healthiercmc.com/role/AcquisitionOfMotherEarthSStorehouseIncDetails": { "order": 6.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "weight": 1.0 }, "http://healthiercmc.com/role/CondensedConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill", "terseLabel": "Goodwill" } } }, "localname": "Goodwill", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/AcquisitionOfMotherEarthSStorehouseIncDetails", "http://healthiercmc.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "INTANGIBLE ASSETS [Abstract]" } } }, "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": { "auth_ref": [ "r155" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for goodwill and intangible assets.", "label": "INTANGIBLE ASSETS" } } }, "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/IntangibleAssets" ], "xbrltype": "textBlockItemType" }, "us-gaap_GranteeStatusAxis": { "auth_ref": [ "r274", "r275", "r281" ], "lang": { "en-us": { "role": { "documentation": "Information by status of recipient to whom award is granted.", "label": "Grantee Status [Axis]" } } }, "localname": "GranteeStatusAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/StockholdersEquityExchangeAgreementAndRestrictedStockDetails" ], "xbrltype": "stringItemType" }, "us-gaap_GranteeStatusDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Status of recipient to whom award is granted.", "label": "Grantee Status [Domain]" } } }, "localname": "GranteeStatusDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/StockholdersEquityExchangeAgreementAndRestrictedStockDetails" ], "xbrltype": "domainItemType" }, "us-gaap_GrossProfit": { "auth_ref": [ "r54", "r83", "r120", "r122", "r125", "r128", "r130", "r140", "r176", "r177", "r178", "r180", "r181", "r182", "r183", "r184", "r185", "r186", "r312" ], "calculation": { "http://healthiercmc.com/role/CondensedConsolidatedStatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.", "label": "Gross Profit", "totalLabel": "GROSS PROFIT" } } }, "localname": "GrossProfit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_ImpairmentOfIntangibleAssetsFinitelived": { "auth_ref": [ "r73", "r154" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value.", "label": "Impairment of Intangible Assets, Finite-lived", "terseLabel": "Impairment of intangible assets" } } }, "localname": "ImpairmentOfIntangibleAssetsFinitelived", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/IntangibleAssetsIntangibleAssetsNetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": { "auth_ref": [ "r72" ], "calculation": { "http://healthiercmc.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 15.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.", "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities", "terseLabel": "Accounts payable and accrued expenses" } } }, "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccruedLiabilities": { "auth_ref": [ "r72" ], "calculation": { "http://healthiercmc.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 16.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.", "label": "Accrued expenses" } } }, "localname": "IncreaseDecreaseInAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInContractWithCustomerAsset": { "auth_ref": [ "r72" ], "calculation": { "http://healthiercmc.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 13.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.", "label": "Increase (Decrease) in Contract with Customer, Asset", "negatedLabel": "Contract assets" } } }, "localname": "IncreaseDecreaseInContractWithCustomerAsset", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInContractWithCustomerLiability": { "auth_ref": [ "r72", "r339" ], "calculation": { "http://healthiercmc.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 17.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.", "label": "Increase (Decrease) in Contract with Customer, Liability", "verboseLabel": "Contract liabilities" } } }, "localname": "IncreaseDecreaseInContractWithCustomerLiability", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInInventories": { "auth_ref": [ "r72" ], "calculation": { "http://healthiercmc.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 11.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.", "label": "Increase (Decrease) in Inventories", "negatedLabel": "Inventories" } } }, "localname": "IncreaseDecreaseInInventories", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Changes in operating assets and liabilities:" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInOtherOperatingAssets": { "auth_ref": [ "r72" ], "calculation": { "http://healthiercmc.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 14.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in operating assets classified as other.", "label": "Increase (Decrease) in Other Operating Assets", "negatedLabel": "Other assets" } } }, "localname": "IncreaseDecreaseInOtherOperatingAssets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInReceivables": { "auth_ref": [ "r72" ], "calculation": { "http://healthiercmc.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the total amount due within one year (or one operating cycle) from all parties, associated with underlying transactions that are classified as operating activities.", "label": "Increase (Decrease) in Receivables", "negatedLabel": "Accounts receivable" } } }, "localname": "IncreaseDecreaseInReceivables", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]" } } }, "localname": "IncreaseDecreaseInStockholdersEquityRollForward", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquity" ], "xbrltype": "stringItemType" }, "us-gaap_InterestExpenseDebt": { "auth_ref": [ "r58", "r208", "r216", "r219", "r220" ], "calculation": { "http://healthiercmc.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the cost of borrowed funds accounted for as interest expense for debt.", "label": "Accrued interest on loan" } } }, "localname": "InterestExpenseDebt", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestIncomeExpenseNet": { "auth_ref": [ "r354" ], "calculation": { "http://healthiercmc.com/role/CondensedConsolidatedStatementsOfOperations": { "order": 8.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net amount of operating interest income (expense).", "label": "Interest income (expense), net" } } }, "localname": "InterestIncomeExpenseNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPaidNet": { "auth_ref": [ "r68", "r70", "r76" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.", "label": "Cash paid for interest" } } }, "localname": "InterestPaidNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_InternetDomainNamesMember": { "auth_ref": [ "r295" ], "lang": { "en-us": { "role": { "documentation": "String of typographic characters used to describe the location of a specific individual, business, computer, or piece of information online. Formally known as the Uniform Resource Locator or URL, it is often considered to be the address of a certain World Wide Web site.", "label": "Internet Domain Names [Member]", "terseLabel": "Website [Member]" } } }, "localname": "InternetDomainNamesMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/IntangibleAssetsIntangibleAssetsNetDetails" ], "xbrltype": "domainItemType" }, "us-gaap_InventoryNet": { "auth_ref": [ "r4", "r40", "r331" ], "calculation": { "http://healthiercmc.com/role/CondensedConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.", "label": "Inventories" } } }, "localname": "InventoryNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryWriteDown": { "auth_ref": [ "r143" ], "calculation": { "http://healthiercmc.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels.", "label": "Inventory Write-down", "terseLabel": "Write-down of obsolete and slow-moving inventory" } } }, "localname": "InventoryWriteDown", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_LeaseholdImprovementsMember": { "auth_ref": [ "r157" ], "lang": { "en-us": { "role": { "documentation": "Additions or improvements to assets held under a lease arrangement.", "label": "Leasehold Improvements [Member]" } } }, "localname": "LeaseholdImprovementsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/PropertyEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r32", "r83", "r124", "r140", "r176", "r177", "r178", "r180", "r181", "r182", "r183", "r184", "r185", "r186", "r305", "r306", "r307", "r312", "r329", "r330" ], "calculation": { "http://healthiercmc.com/role/CondensedConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Liabilities", "totalLabel": "TOTAL LIABILITIES" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r26", "r83", "r140", "r312", "r331", "r347", "r363" ], "calculation": { "http://healthiercmc.com/role/CondensedConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "LIABILITIES AND STOCKHOLDERS' EQUITY", "terseLabel": "Liabilities and Equity [Abstract]" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/CondensedConsolidatedBalanceSheets", "http://healthiercmc.com/role/CondensedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r34", "r83", "r140", "r176", "r177", "r178", "r180", "r181", "r182", "r183", "r184", "r185", "r186", "r305", "r306", "r307", "r312", "r329", "r330", "r331" ], "calculation": { "http://healthiercmc.com/role/CondensedConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities, Current", "totalLabel": "TOTAL CURRENT LIABILITIES" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CURRENT LIABILITIES" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LineOfCreditMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars.", "label": "Line of Credit [Member]" } } }, "localname": "LineOfCreditMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/DebtDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LinesOfCreditCurrent": { "auth_ref": [ "r13", "r345" ], "calculation": { "http://healthiercmc.com/role/CondensedConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The carrying value as of the balance sheet date of the current portion of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.", "label": "Current portion of line of credit" } } }, "localname": "LinesOfCreditCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LitigationSettlementAmountAwardedToOtherParty": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount awarded to other party in judgment or settlement of litigation.", "label": "Litigation Settlement, Amount Awarded to Other Party", "terseLabel": "Attorney fees paid" } } }, "localname": "LitigationSettlementAmountAwardedToOtherParty", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/CommitmentsAndContingenciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock": { "auth_ref": [ "r138" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for claims held for amounts due a entity, excluding financing receivables. Examples include, but are not limited to, trade accounts receivables, notes receivables, loans receivables. Includes disclosure for allowance for credit losses.", "label": "NOTES RECEIVABLE AND OTHER INCOME" } } }, "localname": "LoansNotesTradeAndOtherReceivablesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/NotesReceivableAndOtherIncome" ], "xbrltype": "textBlockItemType" }, "us-gaap_LoansPayableCurrent": { "auth_ref": [ "r33" ], "calculation": { "http://healthiercmc.com/role/CondensedConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of portion of long-term loans payable due within one year or the operating cycle if longer.", "label": "Current portion of loan payment" } } }, "localname": "LoansPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebt": { "auth_ref": [ "r16", "r201", "r215", "r217", "r218", "r346", "r361" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.", "label": "Long-term Debt", "terseLabel": "Debt" } } }, "localname": "LongTermDebt", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/DebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtByCurrentAndNoncurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Long-term Debt, by Current and Noncurrent [Abstract]", "terseLabel": "Debt [Abstract]" } } }, "localname": "LongTermDebtByCurrentAndNoncurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/DebtDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LongTermLoansPayable": { "auth_ref": [ "r35" ], "calculation": { "http://healthiercmc.com/role/CondensedConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of loans payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion.", "label": "Loan payable, net of current portion" } } }, "localname": "LongTermLoansPayable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LossContingenciesByNatureOfContingencyAxis": { "auth_ref": [ "r164", "r165", "r166", "r168", "r169", "r170", "r172", "r174", "r175" ], "lang": { "en-us": { "role": { "documentation": "Information by type of existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur.", "label": "Loss Contingency Nature [Axis]" } } }, "localname": "LossContingenciesByNatureOfContingencyAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/CommitmentsAndContingenciesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LossContingenciesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Loss Contingencies [Line Items]" } } }, "localname": "LossContingenciesLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/CommitmentsAndContingenciesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LossContingenciesTable": { "auth_ref": [ "r164", "r165", "r166", "r168", "r169", "r170", "r172", "r174", "r175" ], "lang": { "en-us": { "role": { "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations.", "label": "Loss Contingencies [Table]" } } }, "localname": "LossContingenciesTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/CommitmentsAndContingenciesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LossContingencyDamagesSoughtValue": { "auth_ref": [ "r164", "r167", "r171" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The value (monetary amount) of the award the plaintiff seeks in the legal matter.", "label": "Damages sought" } } }, "localname": "LossContingencyDamagesSoughtValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/CommitmentsAndContingenciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LossContingencyInformationAboutLitigationMattersAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Loss Contingency, Information about Litigation Matters [Abstract]", "terseLabel": "Legal Proceedings [Abstract]" } } }, "localname": "LossContingencyInformationAboutLitigationMattersAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/CommitmentsAndContingenciesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LossContingencyNatureDomain": { "auth_ref": [ "r164", "r165", "r166", "r168", "r169", "r170", "r172", "r174", "r175" ], "lang": { "en-us": { "role": { "documentation": "An existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur. Resolution of the uncertainty may confirm the incurrence of a loss or impairment of an asset or the incurrence of a liability.", "label": "Loss Contingency, Nature [Domain]" } } }, "localname": "LossContingencyNatureDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/CommitmentsAndContingenciesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LossContingencyPendingClaimsNumber": { "auth_ref": [ "r167" ], "lang": { "en-us": { "role": { "documentation": "Number of pending claims pertaining to a loss contingency.", "label": "Loss Contingency, Pending Claims, Number", "terseLabel": "Number of lawsuits" } } }, "localname": "LossContingencyPendingClaimsNumber", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/CommitmentsAndContingenciesDetails" ], "xbrltype": "integerItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r69" ], "calculation": { "http://healthiercmc.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "NET CASH PROVIDED BY FINANCING ACTIVITIES" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "FINANCING ACTIVITIES" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r69" ], "calculation": { "http://healthiercmc.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided by (Used in) Investing Activities", "totalLabel": "NET CASH USED IN INVESTING ACTIVITIES" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "INVESTING ACTIVITIES" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r69", "r71", "r74" ], "calculation": { "http://healthiercmc.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "NET CASH USED IN OPERATING ACTIVITIES" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "OPERATING ACTIVITIES" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r1", "r46", "r47", "r50", "r51", "r74", "r83", "r91", "r93", "r94", "r95", "r96", "r99", "r100", "r106", "r120", "r122", "r125", "r128", "r130", "r140", "r176", "r177", "r178", "r180", "r181", "r182", "r183", "r184", "r185", "r186", "r311", "r312", "r352", "r366" ], "calculation": { "http://healthiercmc.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 0.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://healthiercmc.com/role/CondensedConsolidatedStatementsOfOperations": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net loss", "terseLabel": "Net income (loss)", "totalLabel": "NET (LOSS) INCOME" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/CondensedConsolidatedStatementsOfCashFlows", "http://healthiercmc.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquity", "http://healthiercmc.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_NoncashMergerRelatedCosts": { "auth_ref": [ "r73" ], "calculation": { "http://healthiercmc.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense (income) related to the increase (decrease) in reserve for business combination costs. Includes, but is not limited to, legal, accounting, and other costs incurred to consummate the merger.", "label": "Acquisition non cash expense" } } }, "localname": "NoncashMergerRelatedCosts", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NoncompeteAgreementsMember": { "auth_ref": [ "r296" ], "lang": { "en-us": { "role": { "documentation": "Agreement in which one party agrees not to pursue a similar trade in competition with another party.", "label": "Non-Compete Agreement [Member]", "verboseLabel": "Non-Compete [Member]" } } }, "localname": "NoncompeteAgreementsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/AcquisitionOfMotherEarthSStorehouseIncDetails", "http://healthiercmc.com/role/IntangibleAssetsIntangibleAssetsNetDetails" ], "xbrltype": "domainItemType" }, "us-gaap_NonoperatingIncomeExpense": { "auth_ref": [ "r57" ], "calculation": { "http://healthiercmc.com/role/CondensedConsolidatedStatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).", "label": "Nonoperating Income (Expense)", "totalLabel": "Total other income (expense), net" } } }, "localname": "NonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_NonoperatingIncomeExpenseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Nonoperating Income (Expense) [Abstract]", "terseLabel": "OTHER INCOME (EXPENSE)" } } }, "localname": "NonoperatingIncomeExpenseAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_NotesAndLoansReceivableNetCurrent": { "auth_ref": [ "r5", "r6", "r20", "r135", "r136", "r350" ], "calculation": { "http://healthiercmc.com/role/CondensedConsolidatedBalanceSheets": { "order": 7.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of financing receivable, classified as current. Includes, but is not limited to, notes and loan receivable.", "label": "Notes receivable" } } }, "localname": "NotesAndLoansReceivableNetCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_NotesAndLoansReceivableNetNoncurrent": { "auth_ref": [ "r21" ], "calculation": { "http://healthiercmc.com/role/CondensedConsolidatedBalanceSheets": { "order": 6.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of financing receivable, classified as noncurrent.", "label": "Note receivable" } } }, "localname": "NotesAndLoansReceivableNetNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_NumberOfStores": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the number of stores.", "label": "Number of Stores", "terseLabel": "Number of stores" } } }, "localname": "NumberOfStores", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/OrganizationDetails" ], "xbrltype": "integerItemType" }, "us-gaap_OperatingExpenses": { "auth_ref": [], "calculation": { "http://healthiercmc.com/role/CondensedConsolidatedStatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.", "label": "OPERATING EXPENSES" } } }, "localname": "OperatingExpenses", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r120", "r122", "r125", "r128", "r130" ], "calculation": { "http://healthiercmc.com/role/CondensedConsolidatedStatementsOfOperations": { "order": 3.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Operating Income (Loss)", "totalLabel": "LOSS FROM OPERATIONS" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityCurrent": { "auth_ref": [ "r325" ], "calculation": { "http://healthiercmc.com/role/CondensedConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.", "label": "Operating lease liability, current" } } }, "localname": "OperatingLeaseLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityNoncurrent": { "auth_ref": [ "r325" ], "calculation": { "http://healthiercmc.com/role/CondensedConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.", "label": "Operating lease liability, net of current" } } }, "localname": "OperatingLeaseLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseRightOfUseAsset": { "auth_ref": [ "r324" ], "calculation": { "http://healthiercmc.com/role/CondensedConsolidatedBalanceSheets": { "order": 7.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's right to use underlying asset under operating lease.", "label": "Right of use asset - operating lease, net" } } }, "localname": "OperatingLeaseRightOfUseAsset", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense": { "auth_ref": [ "r73" ], "calculation": { "http://healthiercmc.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization expense for right-of-use asset from operating lease.", "label": "Operating Lease, Right-of-Use Asset, Amortization Expense", "terseLabel": "Amortization of right-of-use asset" } } }, "localname": "OperatingLeaseRightOfUseAssetAmortizationExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ORGANIZATION [Abstract]" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": { "auth_ref": [ "r2", "r308" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.", "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]", "terseLabel": "ORGANIZATION" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/Organization" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherAssetsNoncurrent": { "auth_ref": [ "r30" ], "calculation": { "http://healthiercmc.com/role/CondensedConsolidatedBalanceSheets": { "order": 8.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncurrent assets classified as other.", "label": "Other assets" } } }, "localname": "OtherAssetsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherMachineryAndEquipmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Other tangible personal property, nonconsumable in nature, with finite lives used to produce goods and services.", "label": "Other Machinery and Equipment [Member]", "verboseLabel": "Other [Member]" } } }, "localname": "OtherMachineryAndEquipmentMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/PropertyEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherNonoperatingIncomeExpense": { "auth_ref": [ "r59" ], "calculation": { "http://healthiercmc.com/role/CondensedConsolidatedStatementsOfOperations": { "order": 6.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.", "label": "Other income, net" } } }, "localname": "OtherNonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_PatentsMember": { "auth_ref": [ "r298" ], "lang": { "en-us": { "role": { "documentation": "Exclusive legal right granted by the government to the owner of the patent to exploit an invention or a process for a period of time specified by law.", "label": "Patents [Member]" } } }, "localname": "PatentsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/IntangibleAssetsIntangibleAssetsNetDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PaymentsOfStockIssuanceCosts": { "auth_ref": [ "r67" ], "calculation": { "http://healthiercmc.com/role/StockholdersEquityRightsOfferingDetails": { "order": 1.0, "parentTag": "us-gaap_ProceedsFromIssuanceOfCommonStock", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for cost incurred directly with the issuance of an equity security.", "label": "Direct financing costs" } } }, "localname": "PaymentsOfStockIssuanceCosts", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/StockholdersEquityRightsOfferingDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireBusinessesGross": { "auth_ref": [ "r62", "r302" ], "calculation": { "http://healthiercmc.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 0.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.", "label": "Payments to Acquire Businesses, Gross", "negatedLabel": "Acquisition of Mother Earth's Storehouse", "terseLabel": "Cash purchase price" } } }, "localname": "PaymentsToAcquireBusinessesGross", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/AcquisitionOfMotherEarthSStorehouseIncDetails", "http://healthiercmc.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireIntangibleAssets": { "auth_ref": [ "r63" ], "calculation": { "http://healthiercmc.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.", "label": "Payments to Acquire Intangible Assets", "negatedLabel": "Purchases of property and equipment" } } }, "localname": "PaymentsToAcquireIntangibleAssets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireNotesReceivable": { "auth_ref": [ "r61" ], "calculation": { "http://healthiercmc.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow to acquire an agreement for an unconditional promise by the maker to pay the entity (holder) a definite sum of money at a future date. Such amount may include accrued interest receivable in accordance with the terms of the note. The note also may contain provisions including a discount or premium, payable on demand, secured, or unsecured, interest bearing or noninterest bearing, among myriad other features and characteristics.", "label": "Payments to Acquire Notes Receivable", "negatedLabel": "Issuance of note receivable" } } }, "localname": "PaymentsToAcquireNotesReceivable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "auth_ref": [ "r63" ], "calculation": { "http://healthiercmc.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.", "label": "Payments to Acquire Property, Plant, and Equipment", "negatedLabel": "Purchases of patent" } } }, "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PreferredStockLiquidationPreferenceValue": { "auth_ref": [ "r80", "r229" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of the difference between preference in liquidation and the par or stated values of the preferred shares.", "label": "Preferred stock, aggregate liquidation preference" } } }, "localname": "PreferredStockLiquidationPreferenceValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/CondensedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "monetaryItemType" }, "us-gaap_PreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Preferred shares may provide a preferential dividend to the dividend on common stock and may take precedence over common stock in the event of a liquidation. Preferred shares typically represent an ownership interest in the company.", "label": "Preferred Stock [Member]" } } }, "localname": "PreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquity", "http://healthiercmc.com/role/StockholdersEquityIncomeLossPerShareDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "auth_ref": [ "r18", "r224" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.", "label": "Preferred stock, par value (in dollars per share)" } } }, "localname": "PreferredStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/CondensedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [ "r18" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.", "label": "Preferred stock, shares authorized (in shares)" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/CondensedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesIssued": { "auth_ref": [ "r18", "r224" ], "lang": { "en-us": { "role": { "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.", "label": "Preferred stock, shares issued (in shares)" } } }, "localname": "PreferredStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/CondensedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesOutstanding": { "auth_ref": [ "r18" ], "lang": { "en-us": { "role": { "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.", "label": "Preferred stock, shares outstanding (in shares)" } } }, "localname": "PreferredStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/CondensedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockValue": { "auth_ref": [ "r18", "r331" ], "calculation": { "http://healthiercmc.com/role/CondensedConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Convertible preferred stock" } } }, "localname": "PreferredStockValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfCommonStock": { "auth_ref": [ "r64" ], "calculation": { "http://healthiercmc.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 }, "http://healthiercmc.com/role/StockholdersEquityRightsOfferingDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from the additional capital contribution to the entity.", "label": "Proceeds from Issuance of Common Stock", "terseLabel": "Proceeds from Rights Offering", "totalLabel": "Net proceeds" } } }, "localname": "ProceedsFromIssuanceOfCommonStock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/CondensedConsolidatedStatementsOfCashFlows", "http://healthiercmc.com/role/StockholdersEquityRightsOfferingDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock": { "auth_ref": [ "r64" ], "calculation": { "http://healthiercmc.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Proceeds from issuance of capital stock which provides for a specific dividend that is paid to the shareholders before any dividends to common stockholders and which takes precedence over common stockholders in the event of liquidation.", "label": "Proceeds from preferred stock" } } }, "localname": "ProceedsFromIssuanceOfPreferredStockAndPreferenceStock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromLinesOfCredit": { "auth_ref": [ "r65", "r82" ], "calculation": { "http://healthiercmc.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 0.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.", "label": "Proceeds from line of credit" } } }, "localname": "ProceedsFromLinesOfCredit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromNotesPayable": { "auth_ref": [ "r65" ], "calculation": { "http://healthiercmc.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from a borrowing supported by a written promise to pay an obligation.", "label": "Proceeds from loan and security agreement" } } }, "localname": "ProceedsFromNotesPayable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromSaleOfNotesReceivable": { "auth_ref": [ "r60" ], "calculation": { "http://healthiercmc.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the sale of a borrowing supported by a written promise to pay an obligation.", "label": "Collection of note receivable", "terseLabel": "Proceeds" } } }, "localname": "ProceedsFromSaleOfNotesReceivable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/CondensedConsolidatedStatementsOfCashFlows", "http://healthiercmc.com/role/NotesReceivableAndOtherIncomeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromStockOptionsExercised": { "auth_ref": [ "r64", "r283" ], "calculation": { "http://healthiercmc.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.", "label": "Proceeds from exercise of stock options" } } }, "localname": "ProceedsFromStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "PROPERTY & EQUIPMENT [Abstract]" } } }, "localname": "PropertyPlantAndEquipmentAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "auth_ref": [ "r29", "r159" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.", "label": "Property, Plant and Equipment, Type [Axis]" } } }, "localname": "PropertyPlantAndEquipmentByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/PropertyEquipmentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": { "auth_ref": [ "r160", "r379", "r380", "r381" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.", "label": "PROPERTY & EQUIPMENT" } } }, "localname": "PropertyPlantAndEquipmentDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/PropertyEquipment" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentGross": { "auth_ref": [ "r28", "r157" ], "calculation": { "http://healthiercmc.com/role/PropertyEquipmentDetails": { "order": 1.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property plant and equipment, gross" } } }, "localname": "PropertyPlantAndEquipmentGross", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/PropertyEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Property, Plant and Equipment [Line Items]" } } }, "localname": "PropertyPlantAndEquipmentLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/PropertyEquipmentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentNet": { "auth_ref": [ "r10", "r11", "r159", "r331", "r355", "r364" ], "calculation": { "http://healthiercmc.com/role/CondensedConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_Assets", "weight": 1.0 }, "http://healthiercmc.com/role/PropertyEquipmentDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property and equipment, net of accumulated depreciation", "totalLabel": "Total property and equipment" } } }, "localname": "PropertyPlantAndEquipmentNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/CondensedConsolidatedBalanceSheets", "http://healthiercmc.com/role/PropertyEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentNetByTypeAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Property and equipment [Abstract]" } } }, "localname": "PropertyPlantAndEquipmentNetByTypeAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/PropertyEquipmentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentTextBlock": { "auth_ref": [ "r10", "r159" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Property, Plant and Equipment [Table Text Block]", "terseLabel": "Property and Equipment" } } }, "localname": "PropertyPlantAndEquipmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/PropertyEquipmentTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentTypeDomain": { "auth_ref": [ "r10", "r157" ], "lang": { "en-us": { "role": { "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.", "label": "Property, Plant and Equipment, Type [Domain]" } } }, "localname": "PropertyPlantAndEquipmentTypeDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/PropertyEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ProvisionForDoubtfulAccounts": { "auth_ref": [ "r53", "r142" ], "calculation": { "http://healthiercmc.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable.", "label": "Bad debt expense" } } }, "localname": "ProvisionForDoubtfulAccounts", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ReceivableTypeDomain": { "auth_ref": [ "r39" ], "lang": { "en-us": { "role": { "documentation": "Financing arrangement representing a contractual right to receive money either on demand or on fixed and determinable dates.", "label": "Receivable [Domain]" } } }, "localname": "ReceivableTypeDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/NotesReceivableAndOtherIncomeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ReceivableWithImputedInterestEffectiveYieldInterestRate": { "auth_ref": [ "r321", "r322" ], "lang": { "en-us": { "role": { "documentation": "Yield on the receivable, on which interest has been imputed, as calculated from its issuance value or purchase price. The calculated effective interest rate considers factors such as the issued face value or price paid for the receivable, the time period between payments, and the time until maturity [full receipt] of the receivable.", "label": "Receivable with Imputed Interest, Effective Yield (Interest Rate)", "terseLabel": "Interest rate" } } }, "localname": "ReceivableWithImputedInterestEffectiveYieldInterestRate", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/NotesReceivableAndOtherIncomeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ReceivableWithImputedInterestFaceAmount": { "auth_ref": [ "r321", "r322" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The principal amount of the receivable or note before consideration of the discount or premium.", "label": "Receivable with Imputed Interest, Face Amount", "terseLabel": "Loan amount" } } }, "localname": "ReceivableWithImputedInterestFaceAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/NotesReceivableAndOtherIncomeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ReceivableWithImputedInterestNetAmount": { "auth_ref": [ "r320" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The receivable or note face amount less the unamortized discount or premium.", "label": "Remaining balance" } } }, "localname": "ReceivableWithImputedInterestNetAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/NotesReceivableAndOtherIncomeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ReceivablesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "NOTES RECEIVABLE AND OTHER INCOME [Abstract]" } } }, "localname": "ReceivablesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_ReceivablesWithImputedInterestAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Receivables with Imputed Interest [Abstract]" } } }, "localname": "ReceivablesWithImputedInterestAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/NotesReceivableAndOtherIncomeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RepaymentsOfLinesOfCredit": { "auth_ref": [ "r66", "r82" ], "calculation": { "http://healthiercmc.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow for payment of an obligation from a lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.", "label": "Repayments of Lines of Credit", "negatedLabel": "Principal payment on the line of credit" } } }, "localname": "RepaymentsOfLinesOfCredit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_RepaymentsOfShortTermDebt": { "auth_ref": [ "r66" ], "calculation": { "http://healthiercmc.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for a borrowing having initial term of repayment within one year or the normal operating cycle, if longer.", "label": "Repayments of Short-term Debt", "negatedLabel": "Principal payments on loan payable" } } }, "localname": "RepaymentsOfShortTermDebt", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestrictedCashNoncurrent": { "auth_ref": [ "r9", "r12", "r77", "r377" ], "calculation": { "http://healthiercmc.com/role/CondensedConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.", "label": "Restricted cash" } } }, "localname": "RestrictedCashNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestrictedStockMember": { "auth_ref": [ "r110" ], "lang": { "en-us": { "role": { "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met.", "label": "Restricted Stock [Member]" } } }, "localname": "RestrictedStockMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/StockholdersEquityExchangeAgreementAndRestrictedStockDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r23", "r244", "r287", "r331", "r362", "r375", "r376" ], "calculation": { "http://healthiercmc.com/role/CondensedConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Accumulated deficit" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r0", "r88", "r89", "r90", "r92", "r98", "r100", "r141", "r284", "r285", "r286", "r288", "r289", "r309", "r372", "r374" ], "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Accumulated Deficit [Member]" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueFromContractWithCustomerAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "DISAGGREGATION OF REVENUES [Abstract]" } } }, "localname": "RevenueFromContractWithCustomerAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": { "auth_ref": [ "r118", "r119", "r121", "r126", "r127", "r131", "r132", "r133", "r257", "r258", "r340" ], "calculation": { "http://healthiercmc.com/role/CondensedConsolidatedStatementsOfOperations": { "order": 0.0, "parentTag": "us-gaap_GrossProfit", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.", "label": "SALES, NET", "terseLabel": "Revenue" } } }, "localname": "RevenueFromContractWithCustomerExcludingAssessedTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/CondensedConsolidatedStatementsOfOperations", "http://healthiercmc.com/role/DisaggregationOfRevenuesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenueFromContractWithCustomerTextBlock": { "auth_ref": [ "r249", "r250", "r251", "r252", "r253", "r254", "r255", "r256", "r260", "r268" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.", "label": "Revenue from Contract with Customer [Text Block]", "terseLabel": "DISAGGREGATION OF REVENUES" } } }, "localname": "RevenueFromContractWithCustomerTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/DisaggregationOfRevenues" ], "xbrltype": "textBlockItemType" }, "us-gaap_RevenuesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "SALES" } } }, "localname": "RevenuesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": { "auth_ref": [ "r326", "r327" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.", "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability", "terseLabel": "Lease acquired" } } }, "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_RisksAndUncertaintiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CONCENTRATIONS [Abstract]" } } }, "localname": "RisksAndUncertaintiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_SalariesWagesAndOfficersCompensation": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for salary and wage arising from service rendered by nonofficer and officer employees. Excludes allocated cost, labor-related nonsalary expense, and direct and overhead labor cost included in cost of good and service sold.", "label": "Base salary" } } }, "localname": "SalariesWagesAndOfficersCompensation", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/CommitmentsAndContingenciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable": { "auth_ref": [ "r39" ], "lang": { "en-us": { "role": { "documentation": "Schedule itemizing specific types of trade accounts and notes receivable, and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.", "label": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table]" } } }, "localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/NotesReceivableAndOtherIncomeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": { "auth_ref": [ "r110" ], "lang": { "en-us": { "role": { "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.", "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]" } } }, "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/StockholdersEquityIncomeLossPerShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": { "auth_ref": [ "r110" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.", "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]", "terseLabel": "Common Share Equivalent Excluded from Calculation of Dilutive Loss Per Share" } } }, "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/StockholdersEquityTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": { "auth_ref": [ "r290", "r291" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.", "label": "Schedule of Business Acquisitions, by Acquisition [Table]" } } }, "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/AcquisitionOfMotherEarthSStorehouseIncDetails", "http://healthiercmc.com/role/OrganizationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock": { "auth_ref": [ "r290", "r291" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of a material business combination completed during the period, including background, timing, and recognized assets and liabilities. This table does not include leveraged buyouts.", "label": "Preliminary Purchase Price Allocation for Mother Earth's Storehouse, Inc." } } }, "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/AcquisitionOfMotherEarthSStorehouseIncTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDebtTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.", "label": "Breakdown of Debt" } } }, "localname": "ScheduleOfDebtTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/DebtTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": { "auth_ref": [ "r147", "r149", "r341" ], "lang": { "en-us": { "role": { "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Schedule of Finite-Lived Intangible Assets [Table]" } } }, "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/IntangibleAssetsIntangibleAssetsNetDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": { "auth_ref": [ "r147", "r149" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.", "label": "Intangible Assets, Net" } } }, "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/IntangibleAssetsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": { "auth_ref": [ "r29", "r159" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Property, Plant and Equipment [Table]" } } }, "localname": "ScheduleOfPropertyPlantAndEquipmentTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/PropertyEquipmentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": { "auth_ref": [ "r277", "r282" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about share-based payment arrangement.", "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]" } } }, "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/StockholdersEquityExchangeAgreementAndRestrictedStockDetails", "http://healthiercmc.com/role/StockholdersEquityRightsOfferingDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": { "auth_ref": [ "r149" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.", "label": "Future Annual Estimated Amortization Expense" } } }, "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/IntangibleAssetsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ShareBasedCompensation": { "auth_ref": [ "r72" ], "calculation": { "http://healthiercmc.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense for share-based payment arrangement.", "label": "Stock-based compensation", "verboseLabel": "Stock-based compensation expense" } } }, "localname": "ShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/CondensedConsolidatedStatementsOfCashFlows", "http://healthiercmc.com/role/StockholdersEquityStockOptionsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": { "auth_ref": [ "r280" ], "lang": { "en-us": { "role": { "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).", "label": "Granted (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/StockholdersEquityExchangeAgreementAndRestrictedStockDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/StockholdersEquityExchangeAgreementAndRestrictedStockDetails", "http://healthiercmc.com/role/StockholdersEquityRightsOfferingDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "auth_ref": [ "r276", "r278" ], "lang": { "en-us": { "role": { "documentation": "Award under share-based payment arrangement.", "label": "Award Type [Domain]" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/StockholdersEquityExchangeAgreementAndRestrictedStockDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SharesIssuedPricePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Per share or per unit amount of equity securities issued.", "label": "Common stock at a price per share (in dollars per share)", "terseLabel": "Subscription price (in dollars per share)" } } }, "localname": "SharesIssuedPricePerShare", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/StockholdersEquityExchangeAgreementAndRestrictedStockDetails", "http://healthiercmc.com/role/StockholdersEquityRightsOfferingDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_SharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.", "label": "Shares, Outstanding", "periodEndLabel": "Balance (in shares)", "periodStartLabel": "Balance (in shares)" } } }, "localname": "SharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_ShortTermInvestments": { "auth_ref": [ "r14", "r348", "r349", "r359" ], "calculation": { "http://healthiercmc.com/role/CondensedConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.", "label": "Investment" } } }, "localname": "ShortTermInvestments", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r78", "r87" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.", "label": "BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES" } } }, "localname": "SignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/BasisOfPresentationAndSignificantAccountingPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [ "r17", "r18", "r19", "r80", "r83", "r103", "r104", "r105", "r107", "r109", "r114", "r115", "r116", "r140", "r176", "r180", "r181", "r182", "r185", "r186", "r224", "r225", "r229", "r233", "r239", "r312", "r389" ], "lang": { "en-us": { "role": { "documentation": "Information by the different classes of stock of the entity.", "label": "Class of Stock [Axis]" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/CondensedConsolidatedBalanceSheets", "http://healthiercmc.com/role/CondensedConsolidatedBalanceSheetsParenthetical", "http://healthiercmc.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquity" ], "xbrltype": "stringItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r0", "r38", "r48", "r49", "r50", "r88", "r89", "r90", "r92", "r98", "r100", "r113", "r141", "r239", "r244", "r284", "r285", "r286", "r288", "r289", "r309", "r314", "r315", "r316", "r317", "r318", "r319", "r372", "r373", "r374", "r391" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquity" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/CondensedConsolidatedBalanceSheets", "http://healthiercmc.com/role/CondensedConsolidatedBalanceSheetsParenthetical", "http://healthiercmc.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquity", "http://healthiercmc.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CONDENSED CONSOLIDATED BALANCE SHEETS [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY [Abstract]" } } }, "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r88", "r89", "r90", "r113", "r340" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/CondensedConsolidatedBalanceSheets", "http://healthiercmc.com/role/CondensedConsolidatedBalanceSheetsParenthetical", "http://healthiercmc.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquity", "http://healthiercmc.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities": { "auth_ref": [ "r37", "r205", "r239", "r240", "r244" ], "lang": { "en-us": { "role": { "documentation": "Number of shares issued during the period as a result of the conversion of convertible securities.", "label": "Stock Issued During Period, Shares, Conversion of Convertible Securities", "terseLabel": "Issuance of Convertible Preferred stock in connection with the Securities Purchase Agreement (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "auth_ref": [ "r18", "r19", "r239", "r244" ], "lang": { "en-us": { "role": { "documentation": "Number of new stock issued during the period.", "label": "Common stock shares issued from offering (in shares)", "terseLabel": "Exchange of notes for shares of common stock (in shares)", "verboseLabel": "Issuance of common stock (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesNewIssues", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquity", "http://healthiercmc.com/role/StockholdersEquityExchangeAgreementAndRestrictedStockDetails", "http://healthiercmc.com/role/StockholdersEquityRightsOfferingDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited": { "auth_ref": [ "r18", "r19", "r239", "r244" ], "lang": { "en-us": { "role": { "documentation": "Number of shares related to Restricted Stock Award forfeited during the period.", "label": "Stock Issued During Period, Shares, Restricted Stock Award, Forfeited", "negatedLabel": "Cancellation of awarded stock (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross": { "auth_ref": [ "r239", "r244" ], "lang": { "en-us": { "role": { "documentation": "Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards.", "label": "Issuance of awarded stock for officers and board (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardGross", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": { "auth_ref": [ "r18", "r19", "r239", "r244", "r279" ], "lang": { "en-us": { "role": { "documentation": "Number of share options (or share units) exercised during the current period.", "label": "Stock options exercised (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquity", "http://healthiercmc.com/role/StockholdersEquityStockOptionsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities": { "auth_ref": [ "r38", "r239", "r244" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The gross value of stock issued during the period upon the conversion of convertible securities.", "label": "Stock Issued During Period, Value, Conversion of Convertible Securities", "terseLabel": "Issuance of Convertible Preferred stock in connection with the Securities Purchase Agreement" } } }, "localname": "StockIssuedDuringPeriodValueConversionOfConvertibleSecurities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueNewIssues": { "auth_ref": [ "r18", "r19", "r239", "r244" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.", "label": "Indebtedness aggregate amount", "terseLabel": "Issuance of common stock" } } }, "localname": "StockIssuedDuringPeriodValueNewIssues", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquity", "http://healthiercmc.com/role/StockholdersEquityExchangeAgreementAndRestrictedStockDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures": { "auth_ref": [ "r18", "r19", "r239", "r244" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Value of stock related to Restricted Stock Awards forfeited during the period.", "label": "Stock Issued During Period, Value, Restricted Stock Award, Forfeitures", "negatedLabel": "Cancellation of awarded stock" } } }, "localname": "StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross": { "auth_ref": [ "r18", "r19", "r239", "r244" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate value of stock related to Restricted Stock Awards issued during the period.", "label": "Issuance of awarded stock for officers and board member" } } }, "localname": "StockIssuedDuringPeriodValueRestrictedStockAwardGross", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": { "auth_ref": [ "r38", "r239", "r244" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock issued as a result of the exercise of stock options.", "label": "Stock options exercised" } } }, "localname": "StockIssuedDuringPeriodValueStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r19", "r24", "r25", "r83", "r137", "r140", "r312", "r331" ], "calculation": { "http://healthiercmc.com/role/CondensedConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "Stockholders' Equity Attributable to Parent", "periodEndLabel": "Balance", "periodStartLabel": "Balance", "totalLabel": "TOTAL STOCKHOLDERS' EQUITY" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/CondensedConsolidatedBalanceSheets", "http://healthiercmc.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "STOCKHOLDERS' EQUITY" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/CondensedConsolidatedBalanceSheets", "http://healthiercmc.com/role/CondensedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "auth_ref": [ "r81", "r225", "r228", "r229", "r230", "r231", "r232", "r233", "r234", "r235", "r236", "r237", "r238", "r244", "r245" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.", "label": "Stockholders' Equity Note Disclosure [Text Block]", "verboseLabel": "STOCKHOLDERS' EQUITY" } } }, "localname": "StockholdersEquityNoteDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/StockholdersEquity" ], "xbrltype": "textBlockItemType" }, "us-gaap_SupplementalCashFlowInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION" } } }, "localname": "SupplementalCashFlowInformationAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_TimeDepositsAtOrAboveFDICInsuranceLimit": { "auth_ref": [ "r356" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of time deposit liabilities, including certificates of deposit, in denominations that meet or exceed the Federal Deposit Insurance Corporation (FDIC) insurance limit.", "label": "Total Cash and cash equivalents in excess of FDIC limits of $250,000" } } }, "localname": "TimeDepositsAtOrAboveFDICInsuranceLimit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/ConcentrationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_TradeNamesMember": { "auth_ref": [ "r294" ], "lang": { "en-us": { "role": { "documentation": "Rights acquired through registration of a business name to gain or protect exclusive use thereof.", "label": "Trade Names [Member]", "verboseLabel": "Trade Names / Trademarks [Member]" } } }, "localname": "TradeNamesMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/IntangibleAssetsIntangibleAssetsNetDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TrademarksAndTradeNamesMember": { "auth_ref": [ "r294" ], "lang": { "en-us": { "role": { "documentation": "Rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style, or rights either acquired through registration of a business name to gain or protect exclusive use thereof.", "label": "Trade Names/Trademarks [Member]" } } }, "localname": "TrademarksAndTradeNamesMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/AcquisitionOfMotherEarthSStorehouseIncDetails" ], "xbrltype": "domainItemType" }, "us-gaap_WarrantMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.", "label": "Warrant [Member]", "verboseLabel": "Warrants [Member]" } } }, "localname": "WarrantMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/StockholdersEquityIncomeLossPerShareDetails" ], "xbrltype": "domainItemType" }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "auth_ref": [ "r102", "r109" ], "lang": { "en-us": { "role": { "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.", "label": "WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING-DILUTED (in shares)" } } }, "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "auth_ref": [ "r101", "r109" ], "lang": { "en-us": { "role": { "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.", "label": "WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING-BASIC (in shares)" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://healthiercmc.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "sharesItemType" } }, "unitCount": 8 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "105", "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(13))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1448-109256" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1505-109256" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1252-109256" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1278-109256" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "55", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e2626-109256" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1337-109256" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(14))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e3842-109258" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e4984-109258" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055" }, "r117": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "275", "URI": "http://asc.fasb.org/topic&trid=2134479" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(17))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(19))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9031-108599" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9054-108599" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4647-111522" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707" }, "r138": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/subtopic&trid=2196772" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27405-111563" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(2))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "330", "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4542-108314" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=120320667&loc=SL49117168-202975" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(20))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(2)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(3)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275" }, "r155": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "350", "URI": "http://asc.fasb.org/topic&trid=2144416" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r160": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "360", "URI": "http://asc.fasb.org/topic&trid=2155823" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "440", "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "440", "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308" }, "r163": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "http://asc.fasb.org/topic&trid=2144648" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14394-108349" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14453-108349" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14472-108349" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349" }, "r173": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "http://asc.fasb.org/topic&trid=2127136" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=124440162&loc=d3e12021-110248" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=124440162&loc=d3e12053-110248" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(5))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(5))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(i)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611" }, "r2": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "205", "URI": "http://asc.fasb.org/topic&trid=2122149" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(3)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6036836-161870" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "69B", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "69C", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "69E", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "69F", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "40", "SubTopic": "50", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123467658&loc=d3e12317-112629" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "40", "SubTopic": "50", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123467658&loc=d3e12355-112629" }, "r223": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "470", "URI": "http://asc.fasb.org/topic&trid=2208564" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496180-112644" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21475-112644" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21506-112644" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21521-112644" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21538-112644" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770" }, "r245": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "505", "URI": "http://asc.fasb.org/topic&trid=2208762" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123360276&loc=SL49130531-203044" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123360276&loc=SL49130532-203044" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123360276&loc=SL49130533-203044" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130551-203045" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130556-203045" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130558-203045" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130543-203045" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130545-203045" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130549-203045" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130550-203045" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046" }, "r268": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "606", "URI": "http://asc.fasb.org/topic&trid=49130388" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(i)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.1)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(d)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "80", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=123468992&loc=SL116886442-113899" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=123468992&loc=d3e4549-113899" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a),(g)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.13)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "2A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=SL79508275-113901" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(g)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.14)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "37", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=123455525&loc=d3e2207-128464" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=123413009&loc=d3e4845-128472" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5263-128473" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5263-128473" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5263-128473" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5333-128473" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "38", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5504-128473" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "30", "SubTopic": "30", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6578-128477" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.17)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "30", "SubTopic": "30", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6613-128477" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)(1)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479" }, "r303": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "805", "URI": "http://asc.fasb.org/topic&trid=2303972" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r308": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "810", "URI": "http://asc.fasb.org/topic&trid=2197479" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19,20)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(4)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(2)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "53", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "852", "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "852", "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "852", "URI": "http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r335": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r336": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r337": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "910", "URI": "http://asc.fasb.org/extlink&oid=123353855&loc=SL119991595-234733" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "310", "Subparagraph": "(b)", "Topic": "912", "URI": "http://asc.fasb.org/extlink&oid=123371682&loc=d3e55415-109406" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r340": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856" }, "r341": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "926", "URI": "http://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959" }, "r342": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "340", "Topic": "928", "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004" }, "r343": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(10)(1))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r344": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r345": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(13))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r346": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(16))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r347": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r348": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(4))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r349": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(5))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r350": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(7))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r351": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.17)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r352": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r353": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(27))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r354": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.10)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r355": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630" }, "r356": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "405", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=116652737&loc=d3e64164-112818" }, "r357": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823" }, "r358": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(16))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r359": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(1)(g))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.25)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r360": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r361": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(16))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r362": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r363": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r364": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(8))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r365": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.(a),19)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r366": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r367": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(23))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r368": { "Name": "Accounting Standards Codification", "Paragraph": "4H", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438" }, "r369": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-30)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r370": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441" }, "r371": { "Name": "Accounting Standards Codification", "Paragraph": "29F", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117819544-158441" }, "r372": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r373": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r374": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r375": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r376": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r377": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "954", "URI": "http://asc.fasb.org/extlink&oid=120413173&loc=SL116631458-115580" }, "r378": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "440", "Subparagraph": "(a)", "Topic": "954", "URI": "http://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629" }, "r379": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Subparagraph": "(d)", "Topic": "958", "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99779-112916" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r380": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "958", "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99893-112916" }, "r381": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "958", "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=SL120174063-112916" }, "r382": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(c)", "Topic": "976", "URI": "http://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663" }, "r383": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(b)", "Topic": "978", "URI": "http://asc.fasb.org/extlink&oid=123360121&loc=d3e27327-108691" }, "r384": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r385": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r386": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r387": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a" }, "r388": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1" }, "r389": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1402" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.3,4)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r390": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r391": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.6(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.9)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226024-175313" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226049-175313" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(25))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(5))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.1,2)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.2(a),(d))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7(c),9(a))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.8)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.9)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3367-108585" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3521-108585" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3044-108585" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4297-108586" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=SL98516268-108586" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18726-107790" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(c))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6801-107765" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(d))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(e)(1))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(f))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(m)(1)(iii))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(m)(2)(ii))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-04(a))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690" }, "r87": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "http://asc.fasb.org/topic&trid=2122369" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6812-107765" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794" } }, "version": "2.1" } ZIP 63 0000844856-22-000031-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0000844856-22-000031-xbrl.zip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

  •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�.@GR>I^G:+M']SKHL0"!9TY ETYVS!IE9@BZU+V\94\ M^IS< DO?.'*GDZ3.D.Y79LC0D*TA7F!I1%BC_3Y(][1WC/O+F(DX^X0X!]7I M<+;1+K%*HA6,INXSM>=/5IT_SS:=RL[?<=:+[O]HIVS">WOW@9BY&YSY)O>#M# HY_XK(+ST M>I#V==N"\MSK0MJ4P$G2ZS-]KCH!69O',@]^76&-#]S$^4U41;;'#M]@,#>HAR1=>/Z/W]C !"M0S%& MP+CK0TXE6C_Z&&KS)#G"G3BT\:2: :XN90_A5;NV,P&Q"TVL-S0+P"?D[1E( MZ'L04 'P+HCR)PZT_K+*Y1-!5!-"-E05!)QHVG2"&#=^O(K7J9_"'5T\<@-C M6E(Q250:3<*(->R11^2C)R(IW&F22FJ%(=C!C\$370]$R+5#8>C'"3C@&$R) MY@[/E/C@=<9 M^.\__>FGGWXZK["E9,@9^)___-,9?EO\7]%F^(P@^_'0&<*U>4)DKN,W2 MHP_G]"G^7VSE ,ET*PQ'OBQ;B"(^+U5+&!E) >/<6)C(ML:3LN95.6%34I07 M5B5MYX8GV[WFAPTW1CDBH\W/$T^<*Y&:?HR8Q*KSJ51MD-SE$J_J96025)&"314M*9T: MUD?ET^&8PIBLYZ<7'HG&7V52)Q;QI;H3B&?7,G MP?_P]X=_.]U5YLY0G;1^D5%E-%C"4V ((K8Y)C?P!R.+Z.C)M$'RA\XLOKY* MR1H=E= MKK=1&=A8P[KV0YB01:X1#/E+1HV43BS44NK.0PTWEIFH[U'!15U#7KG<^PL6 M!H7T&:#R(%=P9;6J&5Q0E\IL,%9#G^&LMD=W63MY#IIK8_15-!F;J?3,5^)D M2+96_'7A:FE&EZE$P7&>UB!BP%*V"LTX2K1-&'KRYA8_E3NNVNRT&F:'U> [ MJVSMJ-+?274%[V%,MC'>PB<8':%#"\S;[I+JN#O*>%?4J]@-Q2DDO?NDW.)A(VALR#5DDD'?MA9,&F#6PA#- M<-VG_2-"6Y>A<[O,L>JMC_N]'[^0537D6FK%^07N!0!=T)DVV6(4M&BXZ\:, MFV]>6<9A@L6- *W]]T"#<_&@4/F '7Q M&G+IRP& #E7Y-:3)S).R%A-97VX1KPP2)OU-DXYFOSU,4X+I73"EX;%U MYS)CURQ;*7;G8R-;Z!ZYFE6MVY%LV8/4[CKVEO;5//1RJ9*.TTZX(I>_PX<@ MBMXPM@SRJ';@LG#+D,J%O5N$=#QU@M2%N$M0RKTUB(GNY[$&L7'OUT'1$XS3 M /<);N)\SL4S0"+4NAH'$KJ]X:-UUDL0QB+7V;!-AHM:57[:&U;C=2^Y6$K#5>M&%[?;B,FLRL;;?00H,-1]<8;J:(6 M]5S9B).DJ_N/".W(R64X77D*MC!9H["Y<5HE6')++-B95B+3=AFE\"(GDU39 M(^_))&A"%JZ.31AEC2+3;\_21*139XC<\HCDP%P-TFM_FZUNXJRM%PH49. ( M="5!PZ15\(NL2T'/5_*RYZ!XX<9:=W&5(=V/S*"\(5M#M\"2*ZCF[_.2B'"1 M;6L/%\=H?^C6WY\E4FLBW(U]5[+J$Z)*(RU&NB/[I?+AP5L8TLV8R6-P M2/@="+5D@7R99%<"B&V;\D#GE%2E-RDK%-I>(0!J$JYT%S3J&QE7#,,8L5*- M."K;_8+*W@B4VD\'/)U_58 2C0-90=2HXSI70>(_/,1D*!^7;'6?[[M:!!&< MIW#/IMBZXOEW4HMW))/*@M; M3:A&O6B1*5N_K"92Q;J;)!+M7C'2T:"5O1TJ6EZ&(IK)!A1].U7JG;9WNTLW MZ:)XX_K2)R!WW;N!/^;:U0U""<=$=U#YBS-A:@Z:LCX,Z_7L0)!@CL0F[<@0)XERJO=)4+ M%<%<(-253URS5K,FF03UATR^-L,$KGR- !*+KL!>V+60 M2W&!;['[P+?;'_2-N@@230I^EQ OS_K5GUF&>7YF+[,Y+NKG$6;@D1Q2S%EJ M(1:H8)T5L #SNDG;".=:5X&;H^21Y^#TPHFE%I(J0[H?N8GONBP+;9XE5U!] M[6_A9(^.C?W7*C$NPJMB5G%^,MP?VAL^]#'/J'KDW\"G#UR".Z<6A:#G?W$9 M]$\:8@*P5EVA 7?>02S!!;^E68:FS?X@KSVG(-#RUMM'N#N&D/1Q%RAZ>)_" M> ^8P)\X,J\@J4\A#52S"$UA,?C=F#.H%6DAFN&62W'QO[ WG\VWVQ\/6!?Z M7%@PD]9LRK-P9JI:4:-"!G _OXP%"^Y\M,RF*VQ8^GO(77NJ$N/RH2IFE1 G MP_TQHN%#GQ*,*LN),T $'%F5JJQ8(2WXE2#CQ4E#3 S6ZIC,R/8%D;0+GH+=T0^G?O(X^>+'N^0CEDCA[@;&Y+81_Z&95-DU M6S+/EMG.3+53$+O,MEHF>22PZ,J;1]N8ZI%[5?,W@%Q)YX?DW$;H;Q]!&G;E%&?$O>H3 )])/8^]IH57)4C]*5D^5'Y7#=.LMANXG$2[R1[% M:? /%4P%DAS4-B0M@IBQW1>F^6YT(<[3KB.>'('J5T3<@;ZHF@5,D-2'F!B, MDH@G7-MCTB8.GGQR07KEA&?^0:0ZHB5Q9**=F2,V;G]IEMJ9G$ *=>\D43UD M_PS@UI\T_2-O0]>J-RR-Q%IU'JFL]PPM>RNP-!QUP=5Y#5B58ZISF;>% M*M%R*TNP&G6AUX!T$NT+_TDV#+PE9 QE! MQ'K>D^\I7N\KI% M!E51)P=7O,H*B3UWV' 5A$?W9XNR;4M@-8FR5!BM -#)AU>5!K-L8H'<-H4> MHN ?.':XLF'$'F)YD<0&: 0!IZUI;F#J5LX1X]??C^1Z2EQ:%.'6A[L 2"I3 MQ!F^3-?8P;-J-1Y('$@Y+M3SLE>@?.?(8A]Y)2*#;\[0B2=>HXC8WMBP/QVN M?0LQ'8,M[LF)VF5MA1HAY I6V"%S89\J&M[4O%$:\4[/BR.M76GM]''0X)1N M3?$()M-MLDWM:6SJ26DFI91E^O1'%6-:U"FPWJRF__'+:G$UNUU_#V9__3S? M_,TQ&J@AKPMO,91=@>UU$ 4I7 1/<#>/4ER1Y !Y>M]ALH2I ,YF2OF'T57J M"'\]-S9I8>111A<#0]Y)(+O)-SFC]UV[0B1#A* N]5YK@,J/>YK M5K%V+)#8TXP-RA*]EEAQ"TG7=0?CU?UUD&S]D/R,3H%#:K%5%!%8'#2D<,LP M7GR1%<=>L!%[(9'G KR+J0"YJ#8)GL$>1>EC,O)-E_P8A%AUY'X 1!+0HRZ\B78:>M/4(R7ISD7_)9+L][H\A.1%;LGVMO0&- MMEEDH,>&F>]2F[?ZMX^W+D3;EEEBU*N\=&C/7 =L:;;3ZMK6;Z3YMG1;:%E) M1H&[M26+[=W;1_KY=UZF^)YJ LX0?)4*DV]4$"^/'(,+HRZHE!3YD_]?*)Z& M?I((SRIJJ:UN)?G:_<4,GK^!>JT2URUCA="B,DY034!573HYJ2W,]**$JNZU M(P3/D&9X$)?!R="P$!SE9Z*B#@(+:X?\Z3@9B.ZLOY8CZX4P?*(=&F9 MC$G_L[-,UT)6MU%IMIH[CTL3@QU'ID]E/X MA2RE<>&:">UZUR-MHVZTB9E]&SWR5;PX23!.6%C"YW3S!89/\!-=/-6IXR R MUJK_T#0V:#>"=3]>;T)0$GN="JX#TK?XX&P,, %?ZRZ&# )=>AJLW?8=#GX) MG8P]ER^GT4_.Q6_JYUUYC=UX?C[%%\&4 M7*#EO[;%,54H:&_+:[L=3W\;7M^+67(71@M74I3Z8F34J(S^/(*B19Q2'M+UV'.T>XBG.A+4< SNFN M"]_SP&VEZ]VPV!NP-;O1?)T&J!WH#8LK2P1H><^V(2H$LPN]U(^83@N4)*MH M'CW!)*7W![-PELD4D.;+=(4USVH/>S9D?J0H%^IYY!6Y.R\H7XP,7^@PZRFJ[N:1NFF%CO,<'N]"_/:'MX4205^P/4R:/3]K.+FP MUD+*/+2"R$4!D44!D8K :\?(A6V,7(S=A":D6! 7;/:2>%6]^2Z M84YSJB5?:5H5\A8((O704Y.KXU/%'K4-[QV1HQS:D:NQ$YCBDK@1:_5P@%I6 M59->4E66:AI^A@">_=9;R?+C_'(Q Y/U>K99 MCTS;=LA!-NJ3X;.1G1JY6Y1@?*(+*"P@IS7:]4$H ZKD8VGYO]S O@S5:KSR MD&@GEZX8LYPR,Y9U*^[\M=6<*&U55-VH:Q.THIE@]UHK79,TP-K^-"-O@R.69DQC@5<&5O&-T_6ZM/?QEEXG?+NZGF_&GDUN5@52?D-V!KD4JL\=,[IV MZ]/:N6 5YLN,L>O:;:%*4/6M4Y:A(QWQ_\(,Z&-QI[9NG:3'(X*'O_ MN:%6_E6TM3K"6]./<2A39F2$&=JK%./TT# M56H:^1P.IM8BM*%/2Q@]9T'*.7PMWTQ%=;X&R J:C'XQ.VY3$VW1GBZ HU.P M@IZI0JIH2D1273G)MVNS7REW(66<1-.;KI97L^5Z=@7P7^O58GXUV>!_K#?X M/Y]F2]QW7%V#UI*J^D9&E<.0B:]0(X_,YJA M35%$2_9;D#Y.CTF*2QU3CC?Y8ZIYXI2^9G>>Z?KJ806*N7<%+8VL><5K-Q*T M%GA!G2NRP5-=(PQWS7P/"UI[29NY7XMX)%3H_X'X&*''\!>N!0O$L M2^F^)E2+TQ9(QI3GUFX;UI>&S)G/E&%X5 _0-7JG^-J._4V-F"O6.-WF2[)><[)#?^BT_&7J(=?A(?<2_D%"&5;9^)$6$3 MJ&?$>LS0<6M_O+U+,3.==:&D%/&CY,@: * M(CKVY+%$OT2CL:+'!M6D"/U00MR\EE2YJ5 E-P(6[N:6P[-%N\T=CB[NM< M MVML6K>L@;6G'EM,X1%AJ(D4-HNMM7UON=FO73&FITV:-RD&R-3?"[G3(QY$5 MLJXF:YUN%>N#3#4T_9GQC-7W*@]S3@I->9-'[$E#$"RM[P0S&>1:>>I,B#_9]>8J@20E+8Z5:NBL,B&G,]R MSTYQ.WV$<5G<; &8FM<2)3&GN4KV^1(8^^<70%B!03(MW,+@ MB0S_J=L/CJRPV:C)6J=GQ?H@C433GQDC6?W3U%%XZG3H@2A_:*X%M#F';T;@LQQV+U.D7;/QY1N(-Q,OO[,4A? M;E$87J/XBQ\WMNVUTQ;&ZN:WX-,%_Q.M$&N M/OZ>CE8XD_)%+,$>-9P'Z@7^-"!/E?5*]YB I#7X%T^;_^# \>6*BN60P59)?#Y MP&KP2,&W.CXS;OQ@)R8$\Y;A0?G6$OQS>WV@OFY:!^Q5#6_J)X_@@)^ >Q27 MD=X-;+-UQ($TY\/RD9P+\@!;_ N"5+HR'UJZDIEP:_Z_AP:\%0:A!#;[1,U%H>2%%Y:0^8\ M3PC(O:GY!5U4XLTA2#ALU!5"(P\796M17GZ+,>VOT!?V.CZQ0!E0FP*=.<&: M["&$"ES(B@NP45(L\7J28B^O-^C)S(]%A3J8U-"6*-( MMPY8#K"R=?#S+?4"$HL14V3>'"'GIR68+^ $EM<+ V$L-,>!&]&/UR-JOF(C MGIV^T,F8W8Y0PZX6<"O=?&>6=')J@@=118_G),5%I0-]G0490R:#Q_/](49/ M]+PA?F]'0S+_^5+)CMB5V+8)9;4;&;)5VEXI *H2CN2O.A6-C&ND3@V)4I4I M2MLC$D>XJ4N\=\OF%JTN>YA5QQ^;[;IJ;*[:K#:3!5C,)Y?SQ7PSGXU\28AB M$Y767BG!EBC;NW7[VH)KN*^VN5G6F8VO9I4I2!KU:G/4-+%2EDFT:T[Q"K9( MF*HU Y-"S1[ I8ZLMN5F/C6)H3;E52(@F"S)L9>KZ7_\LEI\>-J6=;H*V'>CJ<5"SE<>1HUJ$@ MJVXZ>L<XV.86-CV,CT3M<^\V29PR[D%&34K[0]:4/*]NV'"0<':2_ZRNFE MSKJB3]@DO$VHM8S[IEAS)KTP M4(= ;1PX%N;4HR8"06'8ZV-DA#'=TU@(WXL9_)F#(-R/A9J]0TD-J#BAZ !R M+8])D0BN[JT]0<4 MIP&BR\W"'/5;*CT^V(7UB/2_>Q/PK#0+>;ZU,4&?!@\^J:,U3/&/H5='[KCQ8\Y07@O=DB9&NIWY8^#-^AK.-M[EM#.UYTU2#* (OH![ M"!.Z861L K:!#K)0HRQE#J?FT8%_;!AP+YN#UWY$?%8=^"]$TL431+/(FNQ&W:M)J["LO59K8&M[/I M;/[KY'(QHS.]J\TOLULP7TY7GV8.T+8UV%AB=ZE[#O5-S36"0[ORC!D^HH<- MC/><8U5XKTJR5U]UYO#)F/WN5M.XG':,N$?^&ILPG'I ZN_'POLD54J2]!OPH_<8,WOP^JI5E,]KUNO(V?BI,)*@&OZ52@FHMR&B*8ZG@?%:B^A M6\^M/: VPOX9N'LIEEC0Q6@GO:\2SAH-2U]X=J)1JG;J!%R!-ZHAJ=W*N/'KG!*&Y571H6AL3 M]TE";B(.H@<8;0.87+XL_11W2E?WI\@L2W56+'DB+YB9^;HNK++)T.O MFTV:ICR7NUQYJY3E>.B/J6)G^@05V?#RYR"A+USBH:S6A?135(R, M=1Q5,=F$?ESA&(X&BR""\Q3NE2UD0U#4(E8$;;> I>E>6SS6BU$+5U=F6S2R M:>AW(@*HC&M-6K..94T8MS8435:I(VVB&,L.T67#[5K)A$0TV5CJ7O',]DJ/ MC7872ZC(I05][1HC-N+.E>K#*YBP:7:PQ!9=8<#+#8QVY*;%T _VR?+(6R2O MKQK,U71JD9R(C7O8W7=/B?TF.P=B7P!E@0)RD*6I)FJ5Q M="5IFM#3(+"S.#2MZZX[YLZ;G?4SD,N"3/@,9.)O%XK"X6;[6!QY>+E6Q&SX M(#M+61[\>9+\J%^7M,N[JNT>.^ <-P8\:VAS^%6,AF523J5*_*H6,TI4)U(F M594D%&K:=H8Z\^@>Q7NZ]'ARAX[I:27R)S\E.85P\4 W,WS2&9BQRTAMQWVG M9:8%,2"TF6EO 1_\$-S$: LA:0 2AR9P.V)/' 5:X4 :(K0M2N*'8:E&I$9? MJ:-Q(?KB!3?-K%@ /C%1V0D"K7^=7LRMP^3=P/5].EM/Y\B.83#?S7QTXCJ,%A%#7RJU37]]&E>RF MG@=%L;7VT-RM/0CC-H_0WS-;9@LJ^U6Q6V# "^1;5L2YV+" MZ@!C/VV1P4H4Y3& J]@/]SFNALI@Q:Y;$%YD[)3!?E[C['6^!*N;V>UD\PJ8 M+X./FO&*BM5B.L>&!L.%G@=%<-_9J\2M/?BJL]=2T?7LM1U=Y;1 .546^^_'6V?@UMF Z@U.S7K&*M M(""QI1$,E"5Q+B9PPI=93- P8)S-]AT3)"X'B EJ[W8RA'I,>,UY;8N8H%G% M;1,#@YB@+(ES,8$3Q5KG!ZWS@@'S@:%ZM&+7=I( 08_V-6<#W;( &ZU_NU:_ MSQZMP%W?/5J)6WOP5?=H2T77>[2]H-FL1VL5SF/W:.?1%NTA6?_0;(R:[T[M M3?5==T*>K%E?+L>SKF 6(T^Y$]!GX%V(G_XP.C,X-8,T/F@#WBIA[PKV^22U8X8A(T ))^*9-6?($XSNDR-Y4SE1LD2A[^/W[ M:2;@R%5/&O6+3&NB212^#LL4F>5>(60O-U2Z:8^>\SI\2I$W""11EFD!2>/V M?E&$BE'D+%V:94UE,^C*Y4XQ5R37G2]\R_;'6!6>%(21Z'H;XAL@>@=,T9O. MT31C:CKMQ+:PQE,;=\#^8YBG*1L8=E MK %('' [(LC-<"N:&=>55X5?>_/>*@_V!R\U/;:B%#.37;F3!%/J?]_,ENN9 MJY223EV;U)(FP[@3TWI^AL!<_[';9+>LIA%Y+'=F]VM_�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end